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Materials form the foundation of technologies that govern our everyday life, 
from housing and household appliances to handheld phones, drug delivery 
systems, airplanes, and satellites. Development of new and increasingly tai-
lored materials is key to further advancing important applications with the 
potential to dramatically enhance and enrich our experiences.
The Advances in Materials Science and Engineering series by CRC Press/
Taylor & Francis Group is designed to help meet new and exciting chal-
lenges in materials science and engineering disciplines. The books and 
monographs in the series are based on cutting-edge research and develop-
ment and are thus up to date with new discoveries, new understanding, and 
new insights in all aspects of materials development, including processing 
and characterization and applications in metallurgy, bulk or surface engi-
neering, interfaces, thin films, coatings, and composites, to name a few. The 
series aims at delivering an authoritative information source to readers in 
academia, research institutes, and industry. The publisher and its series edi-
tor are fully aware of the importance of materials science and engineering as 
the foundation for many other disciplines of knowledge. As such, the team 
is committed to making this series the most comprehensive and accurate 
literary source to serve the whole materials world and the associated fields.
As series editor, I would like to thank all the authors and editors of the 
books in this series for their noble contributions to the advancement of mate-





This book, Hydroxyapatite Coatings for Biomedical Applications, is dedicated 
to hydroxyapatite (HA) coatings (films) for biomedical applications. HA 
coatings are very important in the biological and biomedical coatings 
fields, especially in the current era of nanotechnology and bioapplications, 
given the advances that society has made in recent years. Stainless steel 
implants or titanium alloy implants are not biotoxic, but they are not bio-
active either—they are only bioinsert. For a fast healing effect, a bioactive 
surface is needed to promote bone growth. HA coatings or its variations 
can be applied to otherwise bioinactive implants to make their surface 
bioactive, thus achieving fast healing and recovery. HA has a bone-like 
structure and is not only biocompatible but is also bioactive. Thus, it can 
be rapidly integrated into the human body, with the body not being aware 
of the foreign, albeit friendly, invasion. HA bonds to bone and forms indis-
tinguishable unions. Bulk HA materials (powder) have been used in den-
tal treatments as refills. However, they do not have the strength needed to 
be used alone for most biomedical applications; thus, their coating finds 
great applications in biomedical implants as well as in drug delivery. HA 
coatings in biological and biomedical applications have been researched 
extensively and are still gaining momentum. The aim of this book is to 
capture developments in the processing and property characterization and 
applications of HA to provide timely information for researchers to refer to 
and for newcomers to learn from, thus contributing to the advancement of 
the technology.
This book is special in that it not only compiles data (tables and figures) but 
also covers material that will be useful for both novices and veterans. I have 
paid special attention in guiding the authors of each chapter to prepare their 
chapters in such a way that novices will find the book to be a useful stepping 
stone to their field and veterans will find it to be a rich source of information 
for their research. Researchers in the fields of nanoscience and nanotechnol-
ogy, materials scientists, engineers, postgraduate students, especially those 
dealing with biomedical and medical research or studies, should also find 
this book useful.
This book consists of eight chapters written by experts in the field of HA 
from the United States, Japan, Singapore, and China, covering deposition 
processes (magnetron sputtering, electrochemical, and sol–gel), applications 
in implants and drug delivery, etc. Chapter 1 deals with magnetron sput-
tering; Chapter 2 focuses on electrochemical deposition; Chapters 3 and 4 
discuss modifying properties of HA by sol–gel deposition to incorporate the 
other elements found in natural bones, such as Zn, Mg, and F; Chapters 5 and 
6 describe pure HA in drug delivery applications; Chapter 7 deals with the 
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application of shape memory alloy; and Chapter 8 deals with HA composite 
coatings (HA with CNT, HA with TiO2, etc.) on the Ti alloy.
I would like to thank all the contributing authors for their painstaking 
work that finally resulted in this informative book. Special thanks go to the 
reviewers who patiently went through the long chapters (one or two review-
ers for each chapter) to provide their professional critique, which enabled 
the authors to improve the chapters to their current form. Their professional 
contributions were the guarantee for the quality of the book. Last, but not 
least, the editor would also like to thank the staff at CRC Press, especially 
project managers Allison Shatkin and Jennifer Ahringer at Taylor & Francis 
Group, for their invaluable assistance throughout the endeavor that made 







Professor	 Sam	 Zhang	 Shanyong, better known as Sam Zhang, received 
his PhD in ceramics from the University of Wisconsin-Madison, Madison, 
Wisconsin, in 1991, and is a tenured full professor at the School of Mechanical 
and Aerospace Engineering, Nanyang Technological University. Professor 
Zhang serves as editor in chief for Nanoscience and Nanotechnology Letters and 
principal editor for Journal of Materials Research (United States).
After completing his PhD, Professor Zhang entered the field of cermets 
and engineering coatings/thin films. He has been in the processing and 
characterization of nanocomposite thin films and coatings for 20 years and 
has authored/coauthored more than 250 peer-reviewed international jour-
nal papers, with an average of more than 12 citations per paper, 8 books, 
20 book chapters, and guest edited more than 20 journal volumes. His 
book Materials Characterization Techniques (CRC Press, Boca Raton, Florida, 
2008) has been adopted as a textbook by eight American universities and 
one European university: Purdue University (Department of Materials 
Engineering), New York University (Department of Biomaterials and Biomi-
metics), Louisiana State University–Baton Rouge (Department of Mecha-
nical Engineering), California Polytechnic State University (Department of 
Materials Engi neering), University of Missouri (Department of Chemical 
and Biological Engineering), Rutgers University–Camden (Department 
of Physics), Johns Hopkins University (Department of Materials Science 
and Engineering), North Seattle Community College (Math, Science, and 
Social Sciences), and the University of Southern Denmark's Centre for 
Nanotechnology in Europe, was translated into Chinese and published by the 
China Science Press in 2010. His other books include Nanocomposite Thin Films 
and Coatings: Processing, Properties and Performance (Imperial College Press, 
London, United Kingdom, 2007); a three-volume set: vol. 1—Nanostructured 
Thin Films and Coatings: Mechanical Properties, vol. 2—Nanostructured Thin 
Films and Coatings: Functional Properties, and vol. 3—Organic Nanostructured 
Thin Film Devices and Coatings for Clean Energy (CRC Press, Taylor & Francis 
Group, Boca Raton, Florida, 2010); a two- volume set: vol. 1—Biological and 
Biomedical Coatings Handbook: Processing and Characterization and vol. 2—
Biological and Biomedical Coatings Handbook: Applications (CRC Press, Taylor & 
Francis Group, Boca Raton, Florida, 2011); and Aerospace Materials Handbook 
(CRC Press, Taylor & Francis Group, Boca Raton, Florida, 2012). In addition, 
Surface Technologies (Springer, 2014) is in the pipeline.
Professor Zhang was conferred the title of honorary professor by the 
Institute of Solid State Physics, Chinese Academy of Sciences. He also holds 
a guest professorship at Shenyang University, Zhejiang University, Harbin 
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Institute of Technology, and the Central Iron and Steel Research Institute. 
He was featured in the first ever Who’s Who in Engineering Singapore (2007) 
and also in the 26th and 27th edition of Who’s Who in the World. He became a 
fellow of the Institute of Materials, Minerals and Mining, United Kingdom, 
in 2007. He has been invited to present invited or plenary keynote lec-
tures more than 60 times at international conferences in Taiwan, Japan, the 
United States, France, Spain, Mainland China, Portugal, New Zealand, and 
Germany. He has also been invited by universities or industries to conduct 
short courses and workshops more than 20 times. He founded the Thin 
Films conference series in 2002 and has been the chair of this very success-
ful conference series ever since. Professor Zhang is also the president of the 
Thin Films Society established in Singapore in 2009.
Professor Zhang’s current research centers on the following four aspects: 
(1) hard yet tough nanocomposite coatings for tribological applications by 
physical vapor deposition; measurement of fracture toughness of ceramic 
films and coatings; (2) biological coatings and drug delivery application; 
(3) electronic thin films in optoelectronic applications, data storage, etc.; 
and (4) energy films and coatings for dye-sensitized solar cells. Details of 
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Techniques for the reconstruction of bone defects are important in order to 
maintain the quality of life of patients since bones support our body and 
enable us to perform various motions. Although our bodies have the ability 
to self-reconstruct damaged tissues through the normal supply of nutrients, 
the loss of bone and its function may lead to loss of function of related tissues 
when the amount of damaged bone is too large for self-reconstruction. In 
such a case, the damaged bones are reconstructed using alternative materi-
als. The most popular transplantation is autograft, which is transferred from 
other parts of the bones of the same patient. As the bone tissue is extracted 
from the patient, autograft has the problem of a limited amount of tissue 
being available. Another candidate is allograft, which is transferred from 
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other people. Allograft has problems related to overcoming the foreign 
body reaction and infections when it is implanted into the recipient. There 
have been major advancements in the development of biomedical materials 
for bone replacements, where prosthetic components are strongly attached 
to the bone without using bone cement, during the past three decades.1,2 
Emphasis has now shifted toward the use of bioactive ceramic materials, 
particularly calcium phosphates (CaPs), due to their similarity with the min-
eral phase found in bone.3 CaP is bioactive and, as follows, has the ability to 
encourage direct bone apposition, which distinguishes it from many other 
metallic or polymeric biomaterials.4 However, their inherent mechanical 
properties, i.e., brittleness, poor tensile strength, and poor impact resistance, 
restrict their application and therefore cannot be used in load-bearing parts.
CaPs, in particular hydroxyapatite (HA), are often used in the form of coat-
ings on metallic implants to confer the biological and mechanical advantages 
of both types of materials. The HA-coated metallic implants show high ten-
sile strength and ductility of the metal and bioactivity of HA. The thickness 
of such an apatite coating must be a compromise among a number of limit-
ing conditions. The thinner the coating, the better its mechanical proper-
ties, but in the first few months, some 10–15 μm of an apatite surface may 
dissolve during the process of acquiring bone union. On the other hand, a 
thick coating of 100–150 μm may suffer from fatigue failure under tensile 
loading. The required compromise leads to an ideal thickness of approxi-
mately 50 μm.5 Currently, a standard protocol for producing HA coatings 
on implant surfaces does not exist. The methods of HA coating of metallic 
implants are summarized in Table 1.1. Various HA coatings have shown dif-
ferences in coating properties through contradicting results in animal and 
clinical studies.6,7 This is because there are many properties that determine 
the performance of HA coating both in vitro and in vivo such as chemi-
cal composition, crystallinity and purity, surface morphology, porosity, and 
thickness.2,8 These properties differ from one technique to another, and some 
of them can be controlled by varying the operating parameters of each tech-
nique. Plasma-spraying technology has been used for HA coatings, in which 
it consists of partially dehydrated HA, with amorphous CaP and other sol-
uble CaP phases such as tricalcium phosphate (TCP). This occurs during 
the high-temperature deposition plasma-spraying process. Plasma-spraying 
technology is able to deposit HA coating with a crystallinity of 30%–70%. 
The normal crystallinity for plasma-sprayed HA coatings during the depo-
sition process is approximately 65%. The ratio of HA to TCP is crucial for 
osteoinduction, whereby undifferentiated cells are collected and developed 
into differentiated bone cells.9,10
Surfaces of HA-coated implants that are high in amorphous and TCP 
phases are susceptible to a faster dissolution. Cellular viability and prolif-
eration were affected by the dissolution of HA composites.16–18 It is impor-
tant to note that bone–implant interfacial strength is greatly influenced by 
HA coating crystallinity.8 Therefore, there is a need to study the interaction 
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Table 1.1








Rapid cooling produces 
amorphous coating














Dip coating 50–500 Inexpensive









Can coat complex substrates
High sintering 
temperatures












Biomimetic coating <30 Bone-like apatite formation
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Table 1.1 (continued)
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crack
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and physical coating 
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Nonuniform thickness
Poor control of 
biodegradation
Liquid plasma 
spray (LPS) and 
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spray (SPS)
∼5–50 High deposition rates
Pure (only HA phase)
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highly porous coating can 
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Can coat heat-sensitive 
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High-purity films
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<95 Low processing temperature
Highly crystalline deposit
Can coat complex shapes
Control over thickness 
composition and 
microstructure
Long deposition time 
causes uneven 
thickness and 
formation of crack and 
holes
Source: Albrektsson, T. et al., Eur. Spine J. 2(10 Suppl.), S96, 2001; Kurashina, K. et al., Biomaterials, 
23, 407, 2002; Surmenev, R., Surf. Coat. Technol., 206, 2035, 2012; Abdel-Aal, E. et al., 
Saudi Med. J., 202, 5895, 2008; Kamitakahara, M. et al., Biomed. Mater. (Bristol, England)., 
2, R17, 2007; Eliaz, N. and Sridhar, T. M., Cryst. Growth Des., 8, 3965, 2008; Yang, Y. et al., 
Biomaterials, 26, 327, 2005.
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between coating crystallinity and optimum dissolution properties in order 
to produce a better bone–implant interfacial strength.
However, HA, in comparison with bioactive glasses and glass ceramics, has 
a relatively low bone-bonding rate.19 This effect will inevitably result in the 
requirement for a long postoperative rehabilitation program. One approach 
toward improving the osteointegration rate of HA is to chemically dope HA 
with small amounts of elements that are commonly found in human bone,20 
since the HA structure is very tolerant for ionic substitution.
The idea of developing silicon-substituted hydroxyapatite (SiHA) is largely 
based on the role of silicon (Si) ions in bone and the excellent bioactivity of 
silica-based glasses and glass ceramics. Carlisle21–23 reported that chicks on 
dietary silicon showed enhanced bone growth and development. Significant 
upregulation of bone cell proliferation and gene expression was observed for 
bioactive glasses, due to the release of low levels of Si4+ ions into the physi-
ological environment.24–26 All of these studies suggested that Si incorporation 
into the HA structure would certainly lead to an enhancement of bioac-
tive performance of HA, since researches have demonstrated a significant 
increase in the amount of bone apposition and the quality of bone repair, 
compared to HA ceramics.27–29
Based on the success of using dense SiHA, alternative techniques for the 
deposition of SiHA as thin films onto metallic surfaces were subsequently 
explored.
1.2	 Sputter	Deposition
The most common technique to deposit CaP on the surface of implants is 
by plasma spraying. Even though this technique has a high deposition rate, 
it still has numerous disadvantages such as nonstoichiometric, porous, and 
nonuniform coating, poor adhesion between the coating and the substrate, 
microcracks on coating surface, and relatively low crystallinity.30,31 Moreover, 
the tendency of cracks to appear on the coating and titanium interface after 
implantation of the device leads to the dissociation of the coating from the 
titanium interface. As the dissociation increases, there is an increasing pos-
sibility of phagocytosis and inflammation to occur.32 Hence, CaP coatings 
on titanium substrates must be able to adhere strongly, must not possess 
any defects, and must be thick enough, as this plays a very important role in 
osteogenesis and bone tissue replacement.
An alternative to plasma spraying would be sputtering. The advantage 
of using sputter coating to deposit CaP onto a surface is that it produces 
strong adhesion between the coating and the substrate, compact microstruc-
ture, and controlled elemental composition.33 The strong bond between the 
coating and the substrate is due to mechanical interlocking and chemical 
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bonding. Sputtering is usually carried out in a vacuum environment at room 
temperature. This process involves the removal and deposition of a coat-
ing material (target) onto an adjacent surface (substrate). Plasma or ion guns 
produce high-energy gaseous ions under high-voltage acceleration that will 
collide with the atoms or molecules on the surface of the target. As the colli-
sion occurs, the target’s atoms or molecules are ejected from the surface and 
propelled toward the substrate. This would then result in the formation of 
thin film.
Sputtering can be considered as a versatile coating technique since it is able 
to coat a variety of substrates with thin films of electrically conductive and 
nonconductive materials. The use of direct current (DC), however, allows 
only the sputtering of conductive material. As opposed to conventional DC 
sputtering, radiofrequency (RF) sputtering, which uses alternating current 
(AC), can be utilized to sputter both conductive and nonconductive materi-
als. Other modifications could also be made to fit certain types of material 
and applications. Reactive, ion beam, and magnetron sputtering techniques, 
for instance, are some well-known modified methods. From the modus ope-
randi point of view, sputtering technique uses mechanical approach rather 
than chemical or thermal approach in coating a substrate.
Though magnetron sputtering possesses several advantages, it has its 
own limitations. As it is a line-of-sight process, it is not possible to coat com-
plex or intricate shapes. Moreover, as-sputtered CaP coatings are generally 
amorphous unless heating is supplied to the substrates during deposition. 
Sputtering is also considered as a relatively time-consuming process.
1.2.1 Technical Knowledge behind Sputtering Deposition
The target material acts as a cathode and it is connected to the negative ter-
minal of a DC or RF power supply and subjected to large negative potential. 
On the other hand, the substrate, also known as the anode, is placed facing 
the cathode and usually grounded, biased positively or negatively, heated, 
cooled, or any combination of these. Air is then pumped out of the chamber, 
which is followed by the injection of argon gas. Argon gas is normally used 
for sputtering since it produces high sputter yield for most metals, chemi-
cally inert, nontoxic, and relatively cheap. The gas pressure is usually set and 
maintained between 1 and 100 mTorr.
The sputtering process relies on the parallel plate glow discharge, which 
plays a role in the formation of the plasma. The plasma can be described as 
a low-pressure gas where a high-energy field is used to drive the creation of 
ions and free electrons by ionization. In ionization, collisions with energetic 
particles cause a loss or gain of electrons to atoms or molecules, thus causing 
them to be electrically charged. As such, mobile positive ions, negative ions, 
electrons, and radicals can be found in the space between the electrodes.34 
Since these ions are in high electrical field, the negatively charged ions are 
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forced toward the grounded or positively charged substrate at high accelera-
tion. As a result, this bombardment of ions contributes to the growing coat-
ing film. A small amount of current flows through due to the small number 
of initial charge carriers in the system.
As mentioned, glow discharge normally occurs when there is a current 
running through the gas at low pressure.35 Hence, it is crucial for a dis-
charge tube to be connected to a DC voltage at both ends of A and C in 
order to maintain the discharge (Figure 1.1). The Townsend discharge nor-
mally occurs during this process. Townsend discharge can be interpreted 
as a gas ionization process where a small initial amount of free electrons, 
accelerated by strong electric field, will increase the electrical conduction 
through a gas by avalanche multiplication (a form of current multiplica-
tion). As such, the discharge itself is self-sustainable with the right amount 
of electrons being generated to produce enough ions to regenerate the same 
number of initial electrons by positive ion bombardment of the cathode. 
As a result, a luminous glow is produced as the voltage drops followed by 
a sharp rise in the current. The increase in power signifies higher voltage 
and current density levels, indicating that it has reached the abnormal glow 
region, which is suitable for sputtering. At this stage, the ion bombardment 
over the entire substrate’s surface would increase until the current density 
is almost uniform.
Different characteristic regions of a typical discharge tube connected to 
a DC source are presented schematically in Figure 1.1. The cathode glow is 
described as a highly luminous layer that can be found adjacent to the cath-
ode. In the cathode glow region, the discharged ions and positive cathode 
ions are neutralized causing the secondary electrons to shift away and col-
lide with nearby neutral gas atoms. The rise of cathode glow is caused by 




















A discharge tube where both A and C are connected to a DC source. (From Gambhir, S. K. et al., 
Foundations of Physics, Vol. II, New Age International, Darya Ganj, Delhi, India, 1993.)
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known as the Crookes dark space, where the positive ion density is very high 
and a high drop in voltage occurs. Negative glow region is a region after 
the Crookes dark space. This is where the electrons are highly excited by 
the DC potential across the electrodes.36 At the same time, the plasma is cre-
ated due to the ionization of neutral gas molecules by the excited electrons. 
The electrons tend to lose their energy after several collisions and end up 
drifting toward the anode. Since they are lacking in excitation and ionization 
energy, this region is considered to be dark or also known as the Faraday 
dark space.35 The region between the Faraday dark space and the anode glow 
is called the positive column, whose length is influenced by the length of the 
discharge tube. The positive column can be continuous or striated depend-
ing on the pressure. Beyond the positive column, the anode glow, where the 
electrons accelerated by the anode cause the gas to illuminate once again, can 
be found. Therefore, in order to obtain a better deposition rate, the substrate 
needs to be placed in the negative glow region, before the Faraday dark space.
1.2.2 Various Sputtering Deposition Techniques
1.2.2.1  DC Sputtering
The mechanism of DC sputtering has been explained in the previous sec-
tion. DC sputtering is also known as diode or cathodic sputtering. The limi-
tation of conventional DC sputtering is that it cannot be used for dielectric 
deposition or sputtering of insulating materials. This is because the positive 
charges acquired during sputtering leads to the neutralization of the target 
and this would prevent the necessary continuous discharge.
1.2.2.2  RF Sputtering
RF sputtering is typically used to sputter nonconductive materials. In 
RF sputtering, AC is used instead of DC. A sinusoidal wave generator is 
normally employed, and this would cause the target surface to accumulate 
positive charges during one cycle (Figure 1.2). Using a low frequency, which 
is normally less than 50 kHz, the ions can adequately mobile such that each 
electrode will take turns in being the anode and cathode. However, when a 
higher frequency is used (more than 50 kHz), two things will occur. First, the 
transfer of power from the cathode may occur through the insulating target 
by capacitive coupling. Second, the need to maintain secondary electrons 
in the cathode region will not be necessary, as ionizing collision will 
occur due to the energetic electrons that are oscillating in the glow region. 
RF frequency may range from 5 to 30 MHz, but the widely used frequency 
for RF sputtering is 13.56 MHz.37,38
RF sputtering works because target converts the insulating target to a 
negative potential, so that it may be sputtered by the bombarding positive 
ions. The electrons of negative target bias are known to be more mobile than 
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ions and can easily adapt to the periodical change in the electric field. In this 
sputtering technique, the target is coupled to the RF generator. The ion flux 
is uniform throughout the plasma, thus causing the target of a small area to 
receive small ion current. The plasma potential being relative to the surface 
and independent of the surface area determines the electron current. This in 
turn will cause a negative potential due to the target receiving less ion cur-
rent than electron current.
1.2.2.3  Reactive Sputtering
Reactive sputtering uses reactive gases (e.g., oxygen) instead of the inert 
gases like argon. This enables the deposition of insulating compounds such 
as oxides, nitrides, carbides, and sulfides by using DC sputtering with a 
metallic target.39,40 By depositing oxides from metallic targets using reac-
tive sputtering, a metallic target with high purity can be easily produced. 
Parameters such as gas pressure and sputter rate can cause the stoichiomet-
ric control to vary.
1.2.2.4  Ion Beam Sputtering
Ion beam sputtering is capable of producing thin, homogeneous, and adher-
ent coating onto a surface. This process is carried out in a vacuum cham-
ber where the target material will be coated onto the substrates in a cold 
plasma atmosphere. Unlike plasma spraying, ion beam sputtering is carried 
out under a high vacuum or in a cold plasma atmosphere. The target mate-
rial is sputtered with inert gas ions and evaporated with electron beams 
(Figure 1.3). Argon is typically used in ion beam sputtering. The substrate is 
usually subjected to negative voltage ranging from a few hundred to a few 
thousand volts.41 Plasma is produced due to glow discharge, and the ions 







A schematic on RF sputtering where an AC with an RF of 13.56 MHz is used to coat the 
substrate.
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field in the system, the ions of the target material will be accelerated and 
deposited onto the surface of the substrate at high energies.
1.2.2.5  Magnetron Sputtering
Magnetron sputtering is a good deposition technique since it allows a 
magnetic field to be created above and parallel to the target surface and 
perpendicular to the electric field. Overall, this sputtering technique 
is good for thin film deposition, except that it does not utilize the target 
material efficiently.
By applying a magnetic field, the electrons are contained in orbits close 
to the cathode. The electrons are subjected to a force known as the Lorentz 
force, F = −q[E + (v × B)], where q is the electric charge of the particle, E is the 
electric field, v is the instantaneous velocity of the particle, and B is the mag-
netic field.42 The free electrons are reoriented to the target surface by the 
magnetic field before losing their orientation to the anode. The discharging 
effectiveness is amplified with the increase in the collision of electrons with 
argon carrier molecules.
The planar magnetron is commonly the magnetic field of choice during 
sputtering. In this setup, magnets are positioned behind the target as shown 
in Figure 1.4. The magnetic field emanates at a right angle to the target and 
bends the magnetron component parallel to the target surface. Consequently, 
the electrons move in cycloid trajectory because of a force (Figure 1.4). Due to 







Ion beam (argon) is used to deposit the target material onto the substrate.
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confined to a region called the “race track.” The “race track” erodes greatly 
due to the great ionization of the gas right above it.
The use of magnetron sputtering process at room temperature to deposit 
SiHA thin films by using a combination of phase-pure HA and Si targets has 
been reported to allow the formation of uniform well-adhered films with the 
possibility of incorporating controlled amounts of Si. Thian et al.43,44 reported 
a systematic approach to deposit SiHA thin films. Figure 1.5 shows a typi-
cal setup for producing these films using a custom-built sputter deposition 
system. A constant flow of argon gas at a working pressure of 0.6 Pa was sup-
plied to the chamber at each deposition run. The composition of SiHA film 
was controlled by the relative discharge power density supplied to each tar-
get. An RF (13.56 MHz) power density of 3.1 W cm−2 was supplied to the HA 
target, and three different DC power densities of 0.2, 0.5, and 0.8 W cm−2 were 
supplied to the Si target to achieve films with three different Si contents.
Following the successful deposition of SiHA thin films by magnetron 
sputtering, there have been a number of recent reports on the fabrication of 
SiHA films. Solla et al.45,46 reported that SiHA films were obtained by pulsed 
laser deposition technique since analyses revealed that Si was incorporated 
into the HA structure. In a separate study, the authors found that osteoblasts 
proliferate and differentiate well on these films.47 Hijon et al.48 produced 
SiHA films with Si contents up to 2.1 wt.% using a sol–gel technique, and 
these films supported cell proliferation in vitro.49 SiHA thin films have also 
been produced by electrophoretic deposition50 and biomimetic51,52 deposition 













Deposited film onto the substrate with the use of magnetic fields in magnetron sputtering.
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1.3	 Physicochemical	Properties
The mechanical properties of HA depend on two factors, namely, density (or 
porosity) and grain size of the ceramics. A dense HA with small grain size 



























Magnetron sputtering deposits a layer of film onto the substrate with the use of magnetic 
fields. (With kind permission from Springer Science + Business Media: J. Mater. Sci., Silicon-
substituted hydroxyapatite (SiHA): A novel calcium phosphate coating for biomedical applica-
tions, 41, 2006, 709–717, Thian, E. et al.)
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and time are crucial in improving density and governing the grain size. 
The usage of sputter coating technique is shown to produce coatings that 
have high coating–substrate bonding strength.33 The surface roughness of 
the coating is dependent on the annealing temperature and time.15,54,55
It is crucial to maintain the integrity of HA coatings during the sputtering 
process. The conversion of amorphous to HA coatings according to the dif-
ferent degrees of crystallinity is carried out by controlling the heat-treatment 
temperatures and heating environment. Coating crystallinity is affected by 
the absence or presence of water vapor. The former will produce an increase 
in coating crystallinity when temperature is increased, while the presence of 
the latter will produce high crystallinity at a fixed temperature during the 
sputter coating.54
Depending on the type of sputtering system and deposition parameters, it 
is possible for the Ca/P ratio of the coating to differ from the target material. 
The Ca/P ratio sputter-coated onto the target surface can range from 1.6 to 
2.6.15,56 The range of Ca/P ratio between the HA target and coatings is influ-
enced by the selective deposition of Ca ions and the loss of P ions. The cause 
for the loss of P ions might have been due to it being pumped away before 
reaching the substrate57 or due to the weak P ion bonds being sputtered away 
by ions or electrons.58
Coating–substrate interface is another important factor that needs to be 
considered for an HA-coated bone implant. It has been reported that the 
average adhesion strength for sputter coating is 38 MPa.59 The mechanical 
integrity and the adhesion strength of the coating–substrate interface are 
influenced by annealing and the types of annealing and surface condition 
used. The reduced strength of 17.9 and 9.0 MPa is caused by quenched and 
furnace cooled coatings respectively on passivated Ti surfaces.59 The adhe-
sion strength of 45.8 MPa was achieved only when the nonpassivated Ti sur-
faces were annealed first, followed by quenching. The difference in adhesion 
strength was due to the different substrate treatments used after annealing. 
The thickness of the oxide film and lateral oxide layer is caused by passiv-
ation and during annealing respectively.60 The existing oxide layer is weak-
ened due to the presence of the aforementioned lateral oxide layer. Therefore, 
the mechanical integrity of the coating–substrate interface is heavily influ-
enced by the surface condition of the substrate.
The use of monolithic HA coating using RF magnetron sputtering by Ding 
et al. showed high bond strength of 59.9 MPa.61 However, surface cracks 
and granular-shaped structures were formed with monolithic HA coat-
ing. Multilayered coating was developed to improve the bonding strength 
between the coating and the target material.37
Thian et al.44 have fabricated SiHA films of thickness 0.7 μm. The Si com-
position in the film (0.8, 2.2, and 4.9 wt.%) was increased with the DC power 
density on the Si target. Following annealing at 600°C, the amorphous 
films transformed into phase-pure, polycrystalline films, with major peaks 
matching that of HA [Joint Committee on Powder Diffraction Standards 
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(JCPDS) #9-432] was indicated by the x-ray diffraction (XRD) scans (Figure 
1.6). There was no evidence of secondary phases such as TCP, tetracalcium 
phosphate, or calcium oxide present in the films. Also, the lattice plane 
reflections were found to become broader and less intense with increasing 
Si level.
Annealing led to several changes in the infrared (IR) spectra, with four 
typical absorption bands for HA being observed: one at 3571 cm−1, which was 
assigned to the stretching mode of hydroxyl (O–H); the second at 1089 cm−1, 
which was assigned to v3 phosphate (P–O) stretching mode, became sharper 
and more intense; the third at 1038 cm−1, which was also assigned to v3 P–O 
stretching mode; and the last at 962 cm−1, which was assigned to v1 P–O 
stretching mode (Figure 1.7). Though all the IR spectra exhibited absorption 
bands associated with HA, the band intensities corresponding to O–H and 
P–O (most noticeably at 962 cm−1) decreased with increasing Si level.
All these results signified the transformation of an amorphous film into 
a well-crystallized, phase-pure HA film after annealing. However, there 
has been an ongoing debate concerning the performance of amorphous and 
crystalline films. As crystalline HA has a considerably lower dissolution rate 
than amorphous HA,62–64 it may thus be beneficial for long-term implant per-
formance since it can lead to a decreased incidence of osteolysis.63,65 On the 
other hand, amorphous HA was observed to enhance early bone apposition 





















































XRD patterns of SiHA films (a) as-deposited; (b) annealed, 0.8 wt.% Si; (c) annealed, 2.2 wt.% Si; 
and (d) annealed, 4.9 wt.% Si. (With kind permission from Springer Science + Business Media: 
J. Mater. Sci., Silicon-substituted hydroxyapatite (SiHA): A novel calcium phosphate coating for 
biomedical applications, 41, 2006, 709–717, Thian, E. et al.)




































IR spectra of SiHA films (a) as-deposited; (b) annealed, 0.8 wt.% Si; (c) annealed, 2.2 wt.% Si; 
and (d) annealed, 4.9 wt.% Si. (With kind permission from Springer Science + Business Media: 
J. Mater. Sci., Silicon-substituted hydroxyapatite (SiHA): A novel calcium phosphate coating for 
biomedical applications, 41, 2006, 709–717, Thian, E. et al.)
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than 1 μm) since secondary CaP phases will dissolve faster than HA.67 This 
effect will cause the film to dissolve completely into the physiological envi-
ronment even before it is able to trigger the promotion of direct attachment 
at the bone/implant interface.
A change in the crystallite size and unit cell parameters of the annealed 
coatings was noted with the substitution of Si into the HA structure.43 
With Si addition from 0.8 to 4.9 wt.%, the crystallite size of SiHA decreased 
from 50 to 19 nm. These results are in agreement with those works done 
by Gibson et al.68 and Arcos et al.,69 for which Si addition inhibited grain 
growth, the effect being more significant as the Si level increased. The 
unit cell parameter’s axes (a from 0.9436 to 0.9466 nm and c from 0.6915 to 
0.6956 nm) increased with Si substitution, following the trend as described 
by Kim et al.70 Although Si addition increased and decreased the cell 
parameters and crystallite size, respectively, the XRD scans did not show 
any significant changes in the relative peak intensities, for which such 
changes are normally expected when there is an atomic substitution. This 
is because Si and phosphorus (P) are adjacent to each other in the periodic 
table (differ by only 1 atomic number) and the level of Si substitution is 
relatively low (less than 5 wt.%).
From the physicochemical viewpoints, it appears that Si4+ ions are struc-
turally incorporated into the HA lattice in solid solution and are not segre-
gated as a second phase. The phosphate tetrahedral was basically replaced 
by the silicate tetrahedral, as reflected by a decrease in IR P–O intensity 
with increasing Si. It also appears that a substituted Si level as high as 4.9 
wt.% could be incorporated into the HA structure while maintaining phase 
purity. Thus, magnetron sputtering technique with annealing allows the 
production of SiHA thin films with predictable properties.
1.4	 Dissolution
The solubility of CaP coating is susceptible to dissolution based on its 
chemical composition, and this plays a role between the coated surface and 
cell adhesion.62,63 Besides the chemical composition, quantity and structure 
of porosity in the HA coatings are also influenced by the degree of crystal-
linity or amorphous content in the coating.64,65 Annealed coatings dissolved 
slower than amorphous coatings, and the crystallinity of the coatings will 
increase due to the rise in temperatures. Degradation of HA occurs when 
it dissolves readily in decreasing pH solutions71 and also by the diffusion 
phenomenon caused by crystal defects such as impurities, vacancies, or 
dislocations.72,73
Solubility of HA coatings can be reduced using several ways such as 
increasing the crystal growth to a specific size,74 using fluorine or hydroxyl 
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ions as substitutes,73,74 or adding sodium and carbonate ions to HA. Reports 
have shown that 100% amorphous plasma-sprayed coatings had lower dis-
solution rate compared to coatings with 40% amorphous and 60% crystallin-
ity.75 The decrease in porosity, surface area, and particle size had an effect on 
the decreasing solubility of HA coatings.76,77 Moreover, the over- or under-
saturation of the solution containing hydroxide, calcium, phosphate, and 
fluoride ions with the presence of proteins and amino acids in the solution 
influences the solubility of HA coatings.78,79 The presence of amino acids and 
proteins have been reported to inhibit the formation of CaP on HA- or CaP-
coated surfaces. It was also shown that osteoclasts also affected the dissolu-
tion rates of HA in hydrochloric acid.71
1.5	 Biological	Property:	Acellular	Testing
The development of a rapid means of ranking the bioactivity of materials 
has been the use of simulated body fluid (SBF), developed by Kokubo and 
coworkers.80 As such, the rate at which a material is able to induce surface 
CaP precipitation from SBF-K9 solution is a measure of its level of bioactivity. 
Immersion testing using SBF-K9 solution demonstrated that annealed SiHA 
films possessed better bioactivity under physiological conditions, compared 
to as-deposited SiHA films or even as-deposited HA films and uncoated tita-
nium (Ti) substrates.43
Dissolution of the as-deposited SiHA film, as evidenced by the appearance 
of submicrometer-sized pits on the surface, was observed after 1 day of 
immersion. This phenomenon seemed too exuberant by day 4 (Figure 
1.8a). However, newly precipitated circular patches, comprising freshly 
nucleated crystallites, seemed to form on the surface by day 7 (Figure 1.8b). 
A homogeneous porous layer was observed after 14 days of immersion 
(Figure 1.8c). Surface cracks on the annealed SiHA film appeared to be 
exacerbated after immersion for 1 day. This effect possibly could be caused 
by the preferential dissolution along the crack regions. By day 4, freshly 
nucleated crystallites were observed, covering as much as 85% of the film 
surface (Figure 1.9a). A homogeneous, porous layer was then observed 
after day 7 (Figure 1.9b), which transformed into a dense layer by day 14 
(Figure 1.9c). In contrast, porous layers consisting of short interconnecting 
rods (similar to Figure 1.9c) and loosely packed globules (Figure 1.10) were 
formed on the surface of as-deposited HA film and on the uncoated Ti 
substrate after 14 days of immersion, respectively.
Detailed characterization of the newly formed layer confirmed that 
it was rich in calcium and phosphorus, along with the incorporation of 
sodium and magnesium. Broad and diffuse XRD peaks ascribed to HA 
were observed, indicating that the CaP layer was apatitic in nature. 
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With prolonged immersion, the peak intensity corresponding to lattice 
plane reflection (002) increased, implying that this CaP layer is preferen-
tially aligned along the c-axis. The appearance of carbonate (C–O) bands 
at 867 and 1416 cm−1 in the IR spectra confirmed the presence of carbonate-
containing apatite layer. It was also noted that the hydroxyl (O–H) band 
intensity decreased while the intensities of the C–O bands became more 
pronounced, suggesting substitution of CO32− ions for OH− ions in the 
HA structure.83
In the case of as-deposited SiHA film, the effect of precipitation process is 
attributed to the lack of coating crystallinity. Dissolution occurs in the ini-
tial stage where Ca2+ and P5+ ions are released into the SBF. These ions will 
increase the degree of supersaturation of SBF solution, thereby facilitating 
the initial formation of CaP nuclei on the film surface, by consuming the Ca2+ 
and P5+ ions in the SBF solution. CaP crystallite growth then proceeded along 
with the continued formation of additional nuclei.
As for the annealed SiHA film, the apatite nucleation process can be 









SEM images of as-deposited 0.8 wt.% SiHA film after immersion in SBF solution for (a) 4 days, 
(b) 7 days, and (c) 14 days. (From Thian, E. S. et al., J. Biomed. Mater. Res. B Appl. Biomater., 
76, 326, 2006.)
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more bioactive than as-deposited SiHA. It is proposed that the nanocrystal-
line structure creates an increased grain boundary area, thereby providing 
an abundance of nucleation sites for CaP crystallites to form since crystallite 
formation usually commences at areas of low surface energy. Once formed, 
these crystallites grow spontaneously and transform into an apatite layer 
on the film.
When comparing SiHA and HA films, a dense carbonate-containing 
apatite layer was formed on SiHA by day 14, but this was not the case for 
HA, suggesting that SiHA was more bioactive than HA. As dissolution–
precipitation is a surface-mediated process, the presence of surface silicate 
anions (due to the released Si4+ ions from SiHA) could have altered the 
surface properties of the material, thus attributing to the high bioactivity of 
SiHA. Botelho et al.84 demonstrated that, with the presence of silicate anions, 
the surface charge of SiHA decreased, thereby inducing favorable sites for 










SEM images of annealed 0.8 wt.% SiHA film after immersion in SBF solution for (a) 4 days, 
(b) 7 days, and (c) 14 days. (From Thian, E. S. et al., J. Biomed. Mater. Res. B Appl. Biomater., 
76, 326, 2006.)
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1.6	 Biological	Property:	Cellular	Testing
The biological response of human osteoblast-like (HOB) cells to SiHA thin 
films, taking into account the effect of variation in Si substitution on the film 
stability and its bioactivity, was investigated using the alamarBlue™ assay. 
The results indicated that an increase in the growth of HOB cells with cul-
ture time was generally observed on all samples (Figure 1.11a).85 HOBs grow-
ing on annealed 0.8 wt.% SiHA (S2) sample showed the highest growth at 
all time points. In addition, a significant difference was seen at days 3, 7, 
and 14 when comparing as-deposited 0.8 wt.% SiHA (S1) and S2 samples, or 
uncoated titanium (Ti) substrate and S2 samples. Thian et al.86 also found 
that the metabolic activity of HOB cells varied with different levels of Si 
substitution (Figure 1.11b). Generally, all samples were able to support cell 
growth, with annealed 2.2 wt.% SiHA (S3) samples exhibiting the highest 
growth throughout the culture period. A statistically significant increase in 
cell growth was observed at day 14 on annealed 4.9 wt.% SiHA (S4) as com-
pared to S2 samples. Furthermore, a significant increase was noted for S3 
when compared to S2 at days 4 and 7.
HOBs attaching on S1 and S2 samples displayed numerous well-developed 




SEM image of uncoated Ti substrate after immersion in SBF solution for 14 days. (From Thian, 
E. S.: Ceramic Nanocoatings and Their Applications in the Life Sciences. 2011. Copyright Wiley-VCH 
Verlag GmbH & Co. KGaA. Reproduced with permission.)



























































S1 S2Uncoated Ti (control)
S2 S3 S4Uncoated Ti (control)
Figure 1.11
Growth of HOB cells with culturing time. ap < 0.05: higher on uncoated Ti substrate (control) 
between groups; bp < 0.05: higher on S1 between groups; cp < 0.05: higher on S2 between groups; 
dp < 0.05: higher on S3 between groups; ep < 0.05: higher on S4 between groups; fp < 0.05: higher 
on S2 than control within groups; gp < 0.05: higher on S2 than S1 within groups; hp < 0.05: 
higher on coated (S2, S3 or S4) than control within groups, ip < 0.05: higher on S4 than S2 within 
groups; jp < 0.05: higher on S3 than S2 within groups. (Reprinted from Biomaterials, 26, Thian, 
E. S., Huang, J., Best, S. M., Barber, Z. H., and Bonfield, W., Magnetron co-sputtered silicon-
containing hydroxyapatite thin films—An in vitro study, 2947–2956, Copyright 2005, with 
permission from Elsevier; Biomaterials, 27, Thian, E. S. et al., The response of osteoblasts to 
nanocrystalline silicon-substituted hydroxyapatite thin films, 2692–2698, Copyright 2006, with 
permission from Elsevier.)
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plaques (being stained red) throughout the cell membranes (Figure 1.12a and b). 
In contrast, very few adhesion plaques were expressed on the uncoated Ti sub-
strate, and the cytoskeleton organization was poorly developed (Figure 1.12c).85 
The cytoskeleton organization revealed distinctive differences in its quality 
among SiHA films with varying Si levels.86 Well-developed actin filaments 
aligning along the long axis of the cells were apparent within HOBs on both 
S3 and S4 samples (Figure 1.12d and e), but less distinct and diffuse within 
HOBs on S2 sample.
Cells seem to attach, spread, and grow on all samples, with filopodia 
extending from the cell edges.86 Cell spreading was less pronounced, dis-
playing underdeveloped lamellipodia on the uncoated substrate (Figure 
1.13a). On the other hand, well-flattened cells were observed to cover the 
surfaces completely on all SiHA films (Figure 1.13b). Beyond day 42, sign of 
mineralization was observed on the surfaces of all samples. The formation of 
CaP mineral deposits on the uncoated Ti substrate was sparse (Figure 1.13c), 
while numerous and large mineral deposits were seen on all SiHA films, 
being the most significant for S4 (Figure 1.13d).
40.00 µm







(See	color	insert.) Confocal fluorescence microscopy of nuclear DNA (stained blue), actin cyto-
skeleton (stained green), and vinculin plaque (stained red) in HOB cell as revealed with multi-
ple labeling using TOTO-3, FITC conjugated phalloidin, and Texas red conjugated streptavidin 
on (a) S1, (b) S2, (c) uncoated Ti substrate (control), (d) S3, and (e) S4. (Reprinted from Biomaterials, 
26, Thian, E. S., Huang, J., Best, S. M., Barber, Z. H., and Bonfield, W., Magnetron co-sputtered 
silicon-containing hydroxyapatite thin films—An in vitro study, 2947–2956, Copyright 2005, 
with permission from Elsevier; Biomaterials, 27, Thian, E. S. et al., The response of osteoblasts to 
nanocrystalline silicon-substituted hydroxyapatite thin films, 2692–2698, Copyright 2006, with 
permission from Elsevier.)
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An apparent difference in the film behavior was revealed after subjecting 
to cell culture medium.85,86 For S1 sample, the surface was covered by a lacy 
CaP network structure, with CaP spherulites seen precipitating and coalesc-
ing on the dissolving coating surface (Figure 1.14a). Nanocrystallites started 
to nucleate on the surfaces of S2, S3, and S4 samples (Figure 1.14b through d). 
Furthermore, surface dissolution was observed on S4, as evidenced by the 
appearance of dissolution pits. A porous CaP structure was obtained for S2 
sample while a dense structure was achieved for both S3 and S4 samples. 
In contrast, a CaP layer was formed on the uncoated substrate only after 42 
days in culture.
Silicon (Si) has shown to inhibit crystal growth and that this effect was 
more significant with increasing Si level.68,69,81 As such, one might expect 
that with increased Si content, HA crystals tend to dissolve faster, thereby 
facilitating the rapid precipitation of a carbonated-apatite layer that provides 
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Figure 1.13
Cell morphology at different culture times. (a) Uncoated Ti substrate (control) at day 2, (b) 
S2 at day 2, (c) control at day 42, and (d) S4 at day 42. (With kind permission from Springer 
Science + Business Media: J. Mater. Sci., Silicon-substituted hydroxyapatite (SiHA): A novel cal-
cium phosphate coating for biomedical applications, 41, 2006, 709–717, Thian, E. et al.)
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also have a positive protein adsorption. The formed silicate network struc-
ture has shown to be capable of adsorbing proteins;88 thus, SiHA films tend 
to contain a higher protein concentration than that of either uncoated Ti sub-
strates or HA-coated substrates. These adsorbed proteins are likely to trigger 
specific mRNA for gene expression, thereby carrying the code information 
to the ribosome sites of protein synthesis in the cell, thereby stimulating 
osteoblast outgrowth. Studies by Keeting et al.89 and Reffitt et al.90 supported 
the hypotheses since they showed that soluble Si simulated the proliferation 
and differentiation of HOB cells in vitro.
Cell growth was retarded at early culture period for films with high 
Si level (4.9 wt.%), due to the rapid dissolution of the films owing to their 
small crystallite size. However, when the surface was modified by the 
growth of a new carbonated apatite layer, cells began to migrate, adhere, 
and grow rapidly.
All these findings indicated that Si tends to control the dissolution rate of 
the film and, at the same time, plays an important role in the mineralization 
(b)(a)
(d)(c)
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Coating morphology at different culture times. (a) S1 at day 4, (b) S2 at day 2, (c) S3 at day 2, and 
(d) S4 at day 2. (Reprinted from Biomaterials, 27, Thian, E. S. et al., The response of osteoblasts to 
nanocrystalline silicon-substituted hydroxyapatite thin films, 2692–2698, Copyright 2006, with 
permission from Elsevier.)
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process. As such, of the three compositions studied, 2.2 wt.% SiHA is the 
preferred optimal one and merits further investigation.
1.7	 Conclusions
The usage of magnetron sputtering process can be used to coat surfaces 
with metallic and inorganic materials. This process enables the coatings to 
be dense, highly uniform, and continuous. Unlike plasma-sprayed coatings, 
sputter coating produces a much higher coating–metal interfacial bonding 
strength.33 Moreover, sputter coatings also produce nano-sized crystals, 
which are good for osteoblast activities.
In vitro studies showed that these films exhibited excellent bioactivity 
over uncoated substrates and HA-coated substrates. A high Si level not only 
resulted in the enhancement of biomineralization process but also led to a 
rapid coating dissolution rate due to different coating structures. The choice 
of coating depends on the final application, but these SiHA thin films offer 
a good substitute to the HA thin films. Even though sputter coating is seen 
as a better alternative in producing better bone strength and initial osseo-
integration rate than plasma-spraying coating, there is still a need to carry 
out further studies on HA and CaP properties for better bone formation for 
HA coatings on dental and orthopedic implant surfaces with this method. 
Moreover, more clinical trials need to be carried out to further evaluate 
and optimize the sputter coating technique of HA and CaP for dental and 
orthopedic implants.
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Electrochemical deposition has been widely used for the preparation 
of thin films (TFs) and coatings [1]. It has been developed as an effective 
method of metal coating for the processing of electronic components, but 
electrochemical deposition of ceramic coatings onto metals has also been 
carried out for various applications, including the improvement of corrosion 
resistance of the metal or the creation of a more refractory surface for a high-
temperature service. Although electrochemical deposition can be performed 
by cathodic or anodic methods, anodic deposition has limited utility in 
terms of the materials that can be deposited by this method and the types 
of substrates that can be used for deposition. Cathodic deposition, however, 
has important advantages for industrial applications. Two processes are 
commonly used to prepare ceramic coatings by cathodic electrochemical 
deposition: the electrophoretic process using suspensions of ceramic 
particles and the electrolytic process using solutions of metal salts, as shown 
in Figure 2.1 [2]. The electrophoretic deposition (EPD) process is often used 
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for thick ceramic films, whereas the electrolytic deposition (ELD) process is 
often used for the formation of nanostructured thin ceramic films.
In the biomedical field, ceramic coatings have been used to modify the sur-
faces of orthopedic and dental metallic implants and, in some cases, to cre-
ate an entirely new surface that gives the implant properties that are quite 
different from the uncoated device. Titanium (Ti) metal and its alloys are 
widely used for orthopedic and dental applications because they exhibit excel-
lent mechanical properties and biocompatibility [3,4]. Ti metal has a passive 
layer of TiO2 a few nanometers thick on its surface, which is responsible for 
its chemical stability and therefore its biocompatible characteristics. However, 
although Ti metal is biocompatible, it is not a bioactive material and hence can-
not tightly bond to living bone. Here, a bioactive material is defined as a mate-
rial that elicits a specific biological response at the interface of the material that 
results in the formation of a bond between the tissues and the material [5].
Calcium phosphate (CaP) ceramics such as hydroxyapatite (HA) are widely 
studied for orthopedic and dental applications due to their osteoconductive 
(i.e., bioactive) properties [5–10]. However, bulk CaP ceramics are intrinsically 
brittle and relatively weak compared to common implant metals and alloys 
and high-strength ceramics such as alumina and zirconia. Consequently, in 
order to combine the mechanical strength of metals with the bioactivity of CaP 
ceramics in load-bearing implant applications, many attempts to integrate 
CaP ceramic coatings with metallic implants, which are not intrinsically 
bioactive, have been made. As a coating method, the plasma-spraying 
technique [11,12] has been the most successful in applying CaP coatings to 
implants up to now because of its high deposition rate and the ability to 
coat large areas. The osteoconductivity of plasma-sprayed coatings has been 







Schematic representations of (a) the EPD process and (b) ELD process.
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the process, such as the unpredictable phase change of CaP ceramics during 
the coating process, particle release, delamination, and so on [13]. In order 
to overcome the drawbacks of plasma spraying, various deposition methods 
such as hot isostatic pressing [14], sputter deposition [15], sol–gel deposition 
[16], biomimetic deposition [17], and others have been proposed. Here, we 
focus on EPD and ELD of CaP ceramics, including HA.
2.2	 Electrochemical	Deposition	of	CaP	Ceramics
Numerous studies have been reported on EPD of CaP ceramics such as HA 
onto metallic biomaterials [18]. Early studies on EPD of CaP ceramics onto 
Ti metal and its alloys were done by Ducheyne and his colleagues from the 
late 1980s to the early 1990s [19–21]. They attempted EPD of various kinds of 
CaP ceramics, including commercially available HA particles, HA particles 
prepared by a precipitation method, β-calcium phosphate (β-TCP) particles, or 
HA–TCP particles. The CaP ceramic particles were suspended in isopropanol, 
and an electric field was applied between the lead anode and the cathode 
made of Ti metal or its alloys. After EPD, calcination was performed under 
various conditions. It was found that EPD coupled with calcination has a 
remarkable effect on the composition and crystalline phase of the deposited 
layer. In the late 1990s, Zhitomirsky and colleagues developed a stable 
suspension of stoichiometric HA nanoparticles 55 nm in size in isopropanol 
and achieved a high deposition rate as well as a low current density [22].
Over the last decade, most studies about EPD of HA nanoparticles have 
mainly focused on improving the uniformity and adhesion of the deposited 
layers. For example, it was reported that the ripening of HA nanoparticles [23], 
the stability of HA suspensions [24], and the surface finishing of substrates 
[25] affect the morphology and adhesion of the deposited HA. Recently, thin 
and uniform coatings of HA nanoparticles by the EPD process were found 
to have the potential to provide novel biosensors [26–29]. Figure 2.2 shows 
atomic force microscopic (AFM) images of Au/Cr-plated quartz substrates 
(a) before and (b) after EPD of HA nanoparticles, which indicate that the 
nanoparticles were coated onto the substrates [29].
Studies on ELD of CaP ceramics onto metallic substrates have been active 
since the 1990s. For example, Redepenning et al. [30,31] and Shirkhanzadeh 
[32,33] reported (ELDs) of dicalcium phosphate dihydrate (DCPD: 
CaHPO4 · 2H2O) and HA on orthopedic alloys from acidic CaP solutions. Royer 
and Rey reported that amorphous CaP-containing carbonate was coated 
onto a Ti−6Al−4V alloy via electrochemical deposition using an aqueous 
solution saturated with DCPD and that it was transformed into carbonate 
apatite via heat treatment at 650°C under vacuum [34]. Monma investigated 
the influences of electrolyte concentration, temperature, and additives on 
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the ELD of CaPs onto stainless steel substrates [35,36]. His studies revealed 
that apatite deposits were composed of ellipsoidal grains, needles, or fine 
granules, depending on the temperature and current, and that apatite 
deposited from fluorine-containing solutions resulted in fluoridated 
calcium-deficient apatites having a composition similar to (Ca, Na)9(HPO4)
(PO4)5(F, H2O)2·nH2O with Ca/P molar ratios near 1.50.
The early investigations introduced earlier mainly focused on the 
electrochemical deposition of a CaP coating in a CaP solution having a 
relatively simple composition. However, in order to obtain CaP coatings 
with composition and structure similar to that of apatite in bone, simulated 
body fluid (SBF) [37,38] is appropriate to use as an electrolyte because the 
composition of SBF is almost identical to that of human blood plasma, and 
SBF has been used for biomimetic apatite coating on substrates [39]. Ban et al. 
first used modified simulated body fluid (m-SBF) as an electrolyte in the 
electrochemical deposition of a CaP coating on titanium (Ti) substrates [40,41]. 
This SBF had the composition of well-known SBF but without MgCl2·6H2O, 
KCl, or NaHCO3. They extensively investigated the morphology and 
microstructure of CaP coatings and found that needle-like apatite crystals 
were deposited on the Ti substrates in m-SBF at an electrolyte temperature 
higher than 52°C and at a current density higher than 12.9 mA/cm2 [40]. 
They also proposed a hydrothermal–electrochemical method in an autoclave 
with two electrodes and showed that at 150°C−160°C, the HA rod grew very 
homogeneously perpendicular to the substrate. Their study also showed 
that the edge of the needle had a flat hexagonal plane [42,43], and thus the 
























AFM images of substrates. (a) Original Au/Cr-plated quartz substrates before EPD and (b) after 
EPD of HA nanoparticles. (With kind permission from Springer Science+Business Media: J. Mater. 
Sci. Mater. Med., Preparation of low-crystalline apatite nanoparticles and their coating onto quartz 
substrates, 23, 2012, 1355–1362, Kawashita, M., Taninai, K., Li, Z., Ishikawa, K., and Yoshida, Y.)
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Recently, apatite deposition on Ti substrates was attempted in the 
electrolyte of a metastable CaP solution (1.5SBF) [45] that had 1.5 times 
the ion concentrations of normal SBF. It was expected that apatite might 
form rapidly on the titanium by electrochemical deposition in 1.5SBF 
at a lower temperature and lower current density because the degree of 
supersaturation of 1.5SBF with respect to apatite is much higher than that 
of normal SBF. Indeed, as shown in Figure 2.3, apatite can be formed in 
modified 1.5SBF (m-1.5SBF), which has 1.5 times the ion concentrations of 
a normal SBF but does not contain MgCl2·6H2O, at 41°C and 8.7 mA/cm2, 
although it is not formed in 1.5SBF. Table 2.1 gives the ion concentrations 
of SBF, 1.5SBF, m-1.5SBF, and human plasma. These results indicate that 
magnesium ions may play an important role in the apatite formation in 
the electrochemical deposition of CaP in SBFs. Actually it was reported 
that magnesium ions enter the structure of forming HA nuclei by replacing 
calcium, resulting in a distorted atomic structure that slows the subsequent 
growth of HA [46]. In addition, apatite was not formed after 1 min 
deposition, but it started to precipitate after 5 min deposition. The area of 
apatite increased after 10 min deposition, and a dense apatite layer was 
partially formed after 20 min deposition. After 40 and 60 min deposition, 
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Thin-film (TF)-XRD patterns of titanium substrates after electrochemical deposition in 
1.5SBF and m-1.5SBF at 41°C for 60 min at 13 mA. (With kind permission from Springer 
Science+Business Media: J. Mater. Sci. Mater. Med., Apatite formation on titanium substrates 
by electrochemical deposition in metastable calcium phosphate solution, 19, 2008, 137–142, 
Kawashita, M., Itoh, S., Miyamoto, K., and Takaoka, G.H.)
36 Hydroxyapatite Coatings for Biomedical Applications
substrates, as shown in Figure 2.4. The thickness of the deposited apatite 
increased with increasing current, but the current did not have a significant 
effect on the crystallite size of apatite, as shown in Figure 2.5. In the previous 
study using m-SBF without MgCl2·6H2O, KCl, or NaHCO3 [40], CaP, 
including HA and octacalcium phosphate (OCP: Ca8H2(PO4)6·5H2O), was 
formed on the Ti substrates. However, only apatite formed on the titanium 
substrates when the electrochemical deposition was performed in m-1.5SBF 
that did not contain MgCl2·6H2O but did contain both KCl and NaHCO3. 
Table 2.1
Ion Concentrations and pH of SBFs and Human 
Blood Plasma
Ion	Concentration	(mM)
Ion Blood	Plasma SBF 1.5SBF m-1.5SBF
Na+ 142.0 142.0 213.0 213.0
K+ 5.0 5.0 7.5 7.5
Mg2+ 1.5 1.5 2.3 0
Ca2+ 2.5 2.5 3.8 3.8
Cl− 103.0 147.8 221.7 217.2
HCO3− 27.0 4.2 6.3 6.3
HPO42− 1.0 1.0 1.5 1.5
SO42− 0.5 0.5 0.8 0.8
pH 7.2–7.4 7.40 7.40 7.40
5 min 10 min
60 min40 min20 min
60 µm













Field emission-SEM photographs of titanium substrates after electrochemical deposition in 
m-1.5SBF at 41°C for different deposition times at 13 mA. (With kind permission from Springer 
Science+Business Media: J. Mater. Sci. Mater. Med., Apatite formation on titanium substrates 
by electrochemical deposition in metastable calcium phosphate solution, 19, 2008, 137–142, 
Kawashita, M., Itoh, S., Miyamoto, K., and Takaoka, G.H.)
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It is therefore speculated that the apatite formed by electrochemical 
deposition in m-1.5SBF is more similar to bone apatite in its composition 
and structure than the apatite that was reported in the previous study 
using m-SBF [40].
The electrochemical deposition in m-1.5SBF makes it possible to coat apatite 
onto metallic substrates, but it still has the following drawbacks. This method 
increases the pH at the interface between Ti and the electrolyte due to electron 
incorporation, forming OH− ions and H2 through water reduction [47]. The H2 
gas evolution at the interface leads to a heterogeneous coating [48]. Further-
more, the adhesive strength between apatite and the substrate is often low, 
and the total amount of apatite crystals deposited on the Ti substrate is much 
smaller than that theoretically calculated from the total electric charge [49]. 
To solve these problems, electrochemical deposition of apatite under pulse 
current has been attempted. The electrodeposition under a long pulse (15 s) 
was more effective for crystal growth and apatite formation than that under 
direct current [50]. The studies also revealed that when the Ti metals were 
previously etched in 75% sulfuric acid (H2SO4), followed by electrodeposition 
and heat treatment, a dense and uniform apatite layer with good adhesive 
properties was formed onto the Ti substrates, as shown in Figure 2.6.
The pulse current has an effect on the structure and adhesion of apatite 
electrochemically deposited onto Ti substrates [51]. In this study, current is 
applied as a square-wave pulse, and the current-on time (Ton) is equal to the 





















Change in crystallite size of apatite as a function of current. (With kind permission from 
Springer Science + Business Media: J. Mater. Sci. Mater. Med., Apatite formation on titanium 
substrates by electrochemical deposition in metastable calcium phosphate solution, 19, 2008, 
137–142, Kawashita, M., Itoh, S., Miyamoto, K., and Takaoka, G.H.)
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current-off time (Figure 2.7). As shown in Figure 2.7, the samples prepared 
using Ton of 100 and 10 ms exhibit better adhesive strength between the apa-
tite and the Ti substrates than do the samples prepared using Ton of 1 and 
15 s. The glue remains in the samples with Ton of 100 and 10 ms, but bare 
Ti is seen in the samples with Ton of 1 and 15 s. It is considered that small 
CaP crystals with low crystallinity were deposited on the Ti surface without 
reacting with other CaP crystals, H2O, or HCO3− in the surrounding environ-
ment. This resulted in the relaxation of the lattice mismatch and improve-





SEM photographs of Ti substrates treated with 75% H2SO4 and then subjected to ELD in 
m-1.5SBF and a peeling test using Scotch® tape. The deposited apatite was not peeled off, and 
the glue of the Scotch tape remained on the substrate. (From Hayakawa, T. et al., J. Ceram. 
Soc. Jpn., 116, 68, 2008. With permission from The Ceramic Society of Japan.)
Apatite







SEM photographs of Ti substrates subjected to ELD in m-1.5SBF at various Ton followed by a 
peeling test using Scotch® tape. (a) Ton = 10 ms, (b) Ton = 100 ms, (c) Ton = 1 s, and (d) Ton = 15 s. (From 
Hayakawa, T. et al., J. Mater. Res., 23, 3176, 2008. With permission from Cambridge University Press.)
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Chitosan is a biodegradable and biocompatible polymer that has found 
widespread use in the cosmetics and food industries. It also has been widely 
studied for applications in medicine because it is known to be osteoconduc-
tive. Studies have shown that chitosan is a hemostatic material and that it has 
a beneficial influence on wound-healing and bone reformation. Recently, ELD 
of HA/chitosan composite coatings was proposed [52]. Composite coatings 
containing CaHPO4·2H2O and chitosan were prepared by electrochemical 
deposition. The CaHPO4·2H2O/chitosan composites were converted to HA/
chitosan composites in aqueous solutions of sodium hydroxide. The coatings 
ranged from approximately 1% to 15% chitosan by weight. Qualitative assess-
ment of the coatings showed that adhesion significantly improved over that 
observed for electrochemical deposition of pure HA coatings.
2.3	 	Mechanism	of	Electrochemical	
Deposition	of	CaP	Ceramics
Numerous studies have been done on EPD of CaP ceramics, but the 
exact mechanism is still not entirely clear. In a review paper on EPD [53], 
four mechanisms are introduced: (1) flocculation by particle accumulation 
mechanism, (2) particle charge neutralization mechanism, (3) electrochemical 
particle coagulation mechanism, and (4) electrical double-layer distortion and 
thinning mechanism [54]. Among them, mechanism (4) is the most plausible 
for the EPD of CaP ceramics such as HA because it considers the movement of 
a positively charged oxide particle, similar to HA particles in most solvents, 
toward the cathode without an increase in electrolyte concentration near the 
electrode. As shown in Figure 2.8, when positively charged particles move 
toward the cathode, the double-layer envelope is distorted to become thinner 
in front of and wider behind the particle (Figure 2.8a). The counter anions 
behind the positively charged particle will react with the cations around 
them to reduce the double-layer envelope behind the particle (Figure 2.8b). 
As a result, the next incoming particle can approach the particle to induce 
coagulation and deposition (Figure 2.8c).
The mechanism of ELD of a CaP coating in a CaP electrolyte system has 
also been discussed in some studies [47,55]. Figure 2.9 shows a schematic 
representation of the reactions occurring during the electrochemical 
deposition of a CaP coating [47]. The composition of the resulting CaP coating 
depends on the reaction pH, temperature, and solution composition [55]. 
Cathodic polarization of metallic substrates leads to an increase in pH at the 
interface between the alloy and electrolyte due to the formation of OH− ions. 
The sudden increase in pH triggers crystal nucleation and initiates crystal 
growth of the desired CaP phase directly on the substrate surface.
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Reactions at cathode surface are
 2H O 2e  H 2OH2 2+ → ↑ +
− −  (2.1)
 2H O O 4e 4OH2 2+ + →
− −  (2.2)
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Schematic representation of mechanisms in EPD process. (a) Distortion of diffuse double 
layer by EPD, (b) local thinning of diffuse double layer, and (c) coagulation and deposition. 
(From Prog. Mater. Sci., 52, Besra, L. and Liu, M., A review on fundamentals and applications of 
electrophoretic deposition (EPD), 1, Copyright 2007, with permission from Elsevier.)
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As can be seen in reactions (2.3) through (2.5), depending on the reaction 
pH, temperature, and solution composition, different crystalline phases of 
CaP coating are deposited on the substrates. Actually, HA is preferentially 
deposited when the pH of the electrolyte adjacent to cathode surface is higher 
than around 4.5 because the solubility of HA is lower than those of other 
CaPs such as DCPD and OCP [56], but by using an acidic CaP solution as the 
electrolyte, DCPD or OCP is likely to be deposited.
2.4	 	Mechanical	Properties	of	the	HA	Films	
Fabricated	by	Electrodeposition
In order for the HA coating to exhibit bioactivity over a long implantation 
period, the coating should tightly adhere to the substrates. Several tech-
niques have been used to quantitatively measure the adhesive strength of 
the electrochemically deposited HA layer. Among them, the tensile, shear, 
and scratch tests are most popular.
In the tensile test, the specimen is attached to metal jig with epoxy glue, 
and then tensile stress is applied perpendicular to the interface between the 
HA and the substrate until fracture occurs. ASTM standards of C633 and 
Metastable calcium
phosphate solution
Reactions at cathode surface:
+ 2OH–
















Schematic representation of reactions occurring during ELD process in metastable CaP 
solution. (From Lin, S. et al., J. Biomed. Mater. Res., 66A, 819, 2003. With permission.)
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F1147 are generally referred to in the case of the HA coating on Ti, as shown 
in Figure 2.10. In these tests, penetration of the glue into the coating layer 
should be taken into account. In general, most conventional plasma-sprayed 
HA coatings are highly dense due to complete melting by the plasma. 
Therefore, the effect of the glue penetration into the plasma-sprayed coat-
ing is minimal. On the other hand, most electrically deposited HA layers 
exhibit a porous structure composed of plate-like and rod-like nanocrystals. 
Therefore, it should be noted that the measured strength is easily affected by 
glue penetration.
In order to precisely analyze fracture behavior, the interface between the 
HA coating and the substrate after the test is observed by using an optical 
or electron microscope. A schematic representation of the fracture mode 
is shown in Figure 2.11. If the fracture occurs inside the coating or at the 
coating/substrate interface, the measured strength closely reflects the actual 
adhesion strength of the coating. On the other hand, if the fracture occurs 
inside the glue or in the glue/coating interface, the actual adhesion strength 
is higher than the measured value.
In shear strength measurements, jigs are attached to the specimens, as 
shown in Figure 2.12. Shear stress is applied to the specimens parallel to the 
interface between the coating and the substrate. In most research papers, 
shear strength was measured according to the ASTM F1044 standard. In a 
scratch test, a needle of diamond and sapphire is attached to the specimen 
and then the surface is scratched, as shown in Figure 2.13. During the test, 
the applied load is continuously increased. The bonding strength is then 
calculated from the critical load at fracture.
A significant amount of research on the tensile adhesion strength of 
electrochemically deposited HA coatings has been reported. LeGeros et al. 
measured the adhesive strength of the OCP layer deposited by ELD in an 
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Tensile test designated by ASTM C633 and F1147.























Schematic representation of scratch test.
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aqueous solution containing 5 mM of Ca2+ and 3.4 mM of H2PO4− at pH 5.0 
under a pulsed current density of 4 mA/cm2 [47]. The obtained coating 
showed adhesion strength of 35−50 MPa. They attempted HA deposition on 
various substrates, including grit-blasted Ti, Ti plates coated with Ti wire by 
arc deposition (arc-deposited), acid-etched Ti, and a Co−Cr substrate coated 
with Co−Cr beads. The adhesion strength increased in the following order: 
Co−Cr beaded < acid-etched ≈ arc-deposited < grit-blasted. The authors also 
examined HA deposition on Ti substrates by treatment with a CaP solution at 
pH 2.67 and subsequent NaOH treatment. In this case, the adhesion strength 
was as low as 5.2 MPa, suggesting that electrochemical treatment is effective 
for improving the adhesion of the coating.
Han et al. deposited HA in an aqueous solution containing 50 mM of Ca2+ 
and 25 mM of H2PO4− on Ti−6Al−4V under a current density of 0.2–15 mA/cm2 
at 60°C [57]. The film was then treated with 1 M NaOH at 80°C for 2 h. The 
film showed tensile adhesion strength ranging from 4 to 14 MPa. The strength 
showed a tendency to decrease with increasing current density, and a dense 
coating was obtained at low-current density. In this case, fracture occurred 
at the interface between the coating and the substrate. On the other hand, 
a porous coating was formed at high-current density. In this case, fracture 
occurred inside the coating.
Huang et al. fabricated an HA coating by ELD in an aqueous solution 
containing 2 mM of Ca2+ and 1.2 mM of H2PO4− at pH 4.7 on Ti substrates [58]. 
Then, the HA-coated Ti was autoclaved at 200°C for 3 h and heated at 700°C 
for 2 h. DC voltage at 30 mV was applied to the specimens. Tensile adhesion 
strength of the coating was 38 MPa.
Wei et al. performed a shear strength test of the HA layer formed by EPD 
and sintered at 875°C−1000°C [59]. The measured strengths were 12 MPa for 
a Ti substrate and 22 MPa for a stainless steel substrate. High shear adhesion 
strength of the coating on the stainless steel was residual compressive stress 
in the coating caused by a higher thermal expansion coefficient for the 
stainless steel than for the HA.
Magnesium alloys are expected for novel metallic biomaterials exhibiting 
not only biological compatibility but also bioresorbability. Wang et al. exam-
ined HA deposition by EPD on Mg–Zn–Ca alloy substrates in an aqueous 
solution containing 4.2 mM of Ca2+ and 2.5 mM of H2PO4− at pH 5.0 under 
a pulse current [60]. The shear strength was measured to be 41.8 ± 2.7 MPa, 
which is higher than that of natural cortical bone (35 MPa).
Ban et al. prepared an HA coating on Ti metal with an intermediate glass 
layer [61]. At first, a composite layer of HA and aluminoborosilicate glass 
containing Na2O and K2O was formed on the metal by heat treatment. The 
HA layer was then further formed by ELD in an aqueous solution containing 
137.8 mM of Na+, 2.5 mM of Ca2+, and 1.6 mM of HPO42− with a current density 
of 160 mA/cm2. The coating layer had a functionally graded structure, as 
shown in Figure 2.14. The authors compared adhesion after implantation in 
rabbit tibia with and without composite coating. After 9 weeks of implantation, 
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the HA layer with an intermediate glass–HA composite layer showed a 
pullout strength of 29.8 MPa, while the electrochemical HA coating with 
directly deposited Ti showed a pullout strength of 20.6 MPa. This means that 
the intermediate composite coating is effective in improving in vivo bone 
adhesion.
The scratch test has also been applied for the mechanical property evalua-
tion of HA coatings formed by ELD. Kuo and Yen fabricated an HA coating 
on Ti substrates in an aqueous solution containing 42 mM of Ca2+ and 25 mM 
of H2PO4− at pH 4.1 [62]. The current density ranged from 1 to 20 mA/cm2, 
and the critical scratch load for the fracture of the coating was 20 N. The 
corresponding shear stress was 106.3 MPa.
Plasma-sprayed HA coatings are reported to show bonding strength rang-
ing from 10 to 80 MPa [63]. The bonding strength of most electrochemically 
deposited HA coatings is lower than the maximum value of plasma-sprayed 
HA coatings. NaOH- and heat-treated Ti alloys show high bioactivity and 
are clinically used for a novel artificial hip joint in orthopedic surgery [64]. 
The apatite layer formed on the modified Ti in a simulated body environ-
ment shows a tensile bonding strength of 30 MPa [65]. This means that most 
of the electrochemically deposited HA coatings match the bonding strength 
of commercially available bioactive materials.
2.5	 Biomedical	Applications
Research showing good biological performance has been reported for 
in vitro and in vivo tests on electrochemically coated Ti metals. Many 
electrochemically deposited HA coatings have been proven to be highly 
biocompatible, similar to clinically utilized biomaterials.
Huang et al. performed cell and animal experiments of HA-coated Ti [58]. 
They showed that HA-coated Ti implant materials have little cytotoxicity 







HA coating on Ti intermediated with glass–HA composite.
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no statistical disparity between Ti implants with and without HA coating. 
This means that HA-coated Ti exhibits good biocompatibility.
Ban et al. examined the improvement in the biological compatibility by 
combinations with biologically active molecules such as bone morphogenic 
protein (BMP) [66]. Fifteen microliters of 10% gelatin aqueous solution was 
mixed with 5 mg of BMP, and the mixture was deposited on Ti substrates 
coated with HA TFs by ELD. They were implanted in rabbit tibia for 3 weeks. 
Bone formation was observed around the substrates without BMP, while 
it extended to the interior of the bone marrow with BMP. In addition, the 
amount of the formed bone was twice as large with BMP as it was without.
Generally, HA ceramics and HA-coated materials are well known to 
induce bone formation along the material surfaces after implantation in 
bony effects. This phenomenon is called osteoconduction and is recognized 
as an important trigger for bone integration.
In addition, it is known that some specific kinds of materials can induce bone 
formation even in non-bony tissues, meaning that the implanted materials 
trigger ectopic bone formation. This specific biological phenomenon is called 
osteoinduction and is quite attractive for the design of novel biomaterials 
that facilitate bone regeneration. Various artificial materials such as HA [67], 
tricalcium phosphate (TCP) [68], and NaOH- and heat-treated Ti metals [69] 
have been known to be osteoinductive. In addition, it is considered that a 
porous structure is essential for achieving osteoinduction [70]. The difference 
between osteoconduction and osteoinduction is schematically illustrated in 
Figure 2.15.
Chai et al. investigated osteoinduction of three-dimensional (3D) porous 
Ti scaffolds coated with HA [71]. The HA layer was deposited on Ti by ELD 
with current densities of 5 and 10 A/m2. The specimens were seeded with 
human periosteum-derived cells and implanted subcutaneously on the 
backs of mice in the cervical region. Larger bone formation was observed 
for the HA coating deposited at a current density of 10 A/m2 than for that at 
5 A/m2. The former showed a greater amount of dissolution than the latter. 
The authors assume that osteoclastic activity was vigorously occurred to 
enhance the osteoinduction in the former.







Schematic representation of osteoconduction and osteoinduction.
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2.6	 Electrodeposition	of	HA-Based	Composite	Films
Not only pure HA but also various kinds of HA-based composites can be 
coated on metals by electrochemical deposition. These composite coatings 
can control various mechanical and chemical properties, as well as improve 
biological performance.
Electrochemical composite coatings can enhance the mechanical properties 
of the coating. Xiao et al. produced an HA–TiO2 composite coating in an 
aqueous solution containing various concentrations of TiO2 powder (particles 
1 μm in diameter), as well as 10 mM of Ca2+ and 6 mM of H2PO4− at pH 4.6 
[72]. The current density ranged from 0.1 to 10 mA/cm2. The coating was 
then heat treated at temperatures ranging from 500°C to 1200°C. The coating 
was composed of HA and anatase TiO2 after heat treatment at 500°C, while 
rutile TiO2 and α-TCP were newly observed at 1200°C. The bonding strength 
increased with increasing TiO2 content. The improvement of the bonding 
strength was attributed to dispersion strengthening by the homogeneous 
distribution of TiO2 particles in the HA coatings and the increase in density 
of the coating. The increase in the bonding strength was attributed to graded 
structure construction on the surface. An HA–ZrO2 composite coating is also 
available by electrochemical processing [73].
Biological performance is also enhanced by construction of a composite 
layer. Ou et al. compared the in vitro differentiation behavior of mesenchymal 
stem cells (MSc) on nanoporous HA films with and without the incorporation 
of reconstructed collagen [74]. As a result, cells exhibited a fibroblast-like 
morphology without collagen, whereas they exhibited more spread-out 
filopods with collagen. These results mean that an HA–collagen composite 
enhances osteogenic differentiation of MSc.
Antibacterial properties can be provided on the HA coating by EPD 
processing. Pang and Zhitomirsky attempted an HA–chitosan composite 
coating on stainless steel substrates [75,76]. The composite film was deposited 
in chitosan solutions containing needle-like HA nanoparticles in a mixed 
ethanol–water solvent. The electrodeposition was performed at a constant 
current density of 0.1 mA/cm2. The XRD patterns of the composite coatings 
showed an increased intensity of the 300 diffraction and a suppression of 
the 002 diffraction of HA. These results indicate that a preferred orientation 
of the c axes of the HA crystals parallel to the coating surface was constructed. 
The authors also evaluated the addition of Ag into the HA–chitosan composite 
coating to provide it with antibacterial properties. The coating on stainless 
3 × 6 cm2 in size released 30 ppm of Ag within 200 h into 20 mL of pure water.
The chemical durability of the surface HA film can be controlled by the 
composite coating. HA–hyaluronic acid composite deposition was examined 
by Sun and Zhitomirsky [77]. Composite formation was performed in a 
mixed solution of sodium hyaluronate and HA. The composite film formation 
of different thicknesses in the range of 0.1−100 μm was possible with this 
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method. The composite films showed corrosion protection of stainless steel 
substrates in Ringer’s physiological solutions.
Hu et al. produced an HA–poly(vinyl acetate) composite coating [78]. The 
electrolyte was an aqueous solution containing 1 mM of Ca(NO3)2, 1.67 mM 
of NH4H2PO4, with or without 0.0125 vol% of vinyl acetate at pH 6 and at 
80°C. The deposition was performed under constant current density ranging 
from 1 to 2 mA/cm2. The cell adhesion number was significantly improved 
by the addition of the poly(vinyl acetate). The authors attributed the 
enhancement of cell affinity to the formation of a highly oriented structure 
by the addition of the poly(vinyl acetate) and secondary HA nucleation on 
the electrochemically deposited HA in a simulated body environment.
Biological molecules such as proteins can be incorporated by electrochemical 
deposition. Cheng et al. examined the preparation of HA/bovine serum 
albumin (BSA) composites [79]. The electrolyte was an aqueous solution 
containing 42 mM of Ca(NO3)2 and 25 mM of NH4H2PO4 with 2 mg/mL of 
BSA at 0.09 mA/cm2. Release of the BSA was measured in a phosphate buffer 
solution. The substrates released 15% of incorporated BSA after 70 h. These 
results indicate that novel biomaterials with a potential for drug delivery can 
be designed by electrodeposition.
Composites of carbon nanotubes (CNTs) and HA have been fabricated by 
ELD on CNT thin films (CNT TFs) [80] and by an EPD process in chitosan 
solution dispersed with CNT and HA [81]. This type of coating is expected 
to improve mechanical properties such as adhesion strength and hardness 
of the surface layer.
In addition to the research described previously, preparations of various 
kinds of HA-based composites by electrochemical deposition have been 
reported. They are summarized in Table 2.2.
Table 2.2













Bovine serum albumin (BSA) [79]
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2.7	 Summary
In this chapter, electrochemical deposition of CaP ceramics represented 
by HA was introduced. The electrochemical deposition method can be 
performed by simple apparatus compared with vacuum processes such 
as the plasma-spray method, and hence is environment friendly. This method 
can be also used to control the composition, structure, and adhesion of the 
deposited layer with comparative ease. It is believed that the electrochemical 
deposition of CaP ceramics such as HA will provide novel biomedical 
devices with novel surface functions in future.
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3.1	 Introduction
In orthopedic medical engineering, there are two main concerns regarding 
the application of implants: short-term osseointegration and long-term sta-
bility. Osseointegration is the stable anchorage of an implant achieved by 
direct bone-to-implant contact [1]. Stability refers to a long-term service life 
of the implant with the ability to carry and sustain the static and dynamic 
loads [2]. It is obviously very important to achieve both of them within the 
shortest possible healing time and with a very small failure rate.
Metallic, ceramic, and polymeric biomaterials have been widely used 
as bone replacements. Metals like titanium and titanium alloys are often 
employed as basic materials for load-bearing implants because of their excel-
lent mechanical properties. Even though these materials are mostly bio-
inert, they are not bioactive, i.e., they do not form a mechanically stable link 
between the implant and bone tissue. Thus, it is difficult to integrate into the 
body. As such, the metal surface has to be properly engineered. Many ways 
have been sought to improve the mechanical contact at the interface. The 
most effective way is to coat the metal with calcium phosphate ceramics that 
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can promote bone bonding between the metal and the bone. Hydroxyapatite 
(Ca10(PO4)6(OH)2; HA) has similar composition and molecular structure as 
that of the natural bone; thus, it has been widely used as a coating on metallic 
implants to promote cellular activities and stimulate formation of new bone. 
It has been suggested that the more similar HA is to bone mineral in compo-
sition, crystallinity, crystal structure, crystal size, and morphology, the better 
osteoconductivity would be achieved [3].
However, bulk HA or HA coatings vary extensively from natural bone min-
eral in composition. Natural bone is a non-stoichiometric apatite containing 
many trace elements, such as Na+ (ca. 0.7 wt%), K+ (ca. 0.03 wt%), Mg2+ (ca. 0.55 
wt%), Cl− (ca. 0.10 wt%), and F− (ca. 0.02 wt%), which play important roles in 
the physiological systems [4]. Pure HA does not have this composition; there-
fore, its bioactivity is inferior to the bone mineral [5], which adversely affects 
the short-term osseointegration. Pure HA coating does not have strong adhe-
sion strength on metallic substrate either. Moreover, it dissolves rapidly in 
body fluids, which in turn creates a long-term stability problem.
To resemble bone mineral in composition, various cations and anions are 
incorporated into HA or HA coatings. In brief, incorporation of cations like 
Mg2+ into HA decreases its crystallinity and improves the biological perfor-
mances, i.e., good bioactivity and better cell behaviors [6]. The incorporation 
of anions (F−) into HA crystal structure decreases the solubility of the HA 
coating [3,7] and enhances the adhesion strength between the coating and 
the substrate [8]. Therefore, it is interesting and desirable to incorporate both 
Mg and F ions into HA coatings on Ti6Al4V substrates to have a combination 
of their individual functions in one coating/substrate system to achieve both 
short-term osseointegration and long-term stability.
3.2	 Cation-	and	Anion-Incorporated	Hydroxyapatite
Bone has an apatite structure, and the general chemical formula is expressed 
as M10(XO4)6Y2, where M is a bivalent ion, XO4 a trivalent ion, and Y a mon-
ovalent ion. In general, it is represented as Ca10(PO4)6(OH)2, and many trace 
elements are contained in the bone mineral. They do not only play pivotal 
roles in the behavior of biological apatite but also contribute to various bio-
chemical reactions in the human body. For example, sodium (Na+) is a mon-
ovalent ion available in abundance next to calcium and phosphorus, playing 
a significant role in bone metabolism and osteoporosis [9,10]. Magnesium 
(Mg2+) has its own significance in cell proliferation, calcification process, and 
bone fragility. Moreover, it indirectly influences mineral metabolism. Mg 
deficiency may directly result in a decrease in osteoblastic bone formation 
and delay the onset of mineralization of newly formed cartilage matrix and 
bones [4,11,12]. Potassium (K+) is active in mineralization and biochemical 
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processes [13]. Fluorine (F−) is well recognized for its potential behavior of 
decreasing the solubility of the apatite and its prevention role in dental caries 
in a bacteria-containing acidic environment. Also F− promotes the mineral-
ization and crystallization of calcium phosphate in the bone-forming pro-
cess [7,14,15]. The significance of chloride (Cl−) ions resides in their ability to 
develop an acidic environment on the surface of bone that activates osteo-
blasts in the bone resorption process [16,17].
With the presence of trace elements, partial/total substitutions may occur 
without significant changes in the crystal structure. This is due to the apatite 
structure readily accepting a wide variety of anionic and cationic dopants 
[18]. Numerous attempts of substituted apatite have been reported: the sub-
stitution of Ca2+ with Mg2+ [19–21], Zn2+ [19,22–24], Sr2+ [25,26], Pb2+ [27], etc., 
the replacement of PO43− by HPO42− [28], CO32− [19,29–33] or SiO44− [34–36], and 
OH− by F− [19,37–40] or Cl− [41].
3.2.1 incorporation of Cation into Ha
The chemical composition of hexagonal HA (within the ideal P63/m space 
group) is Ca(I)4Ca(II)6(PO4)6(OH)2. The local atomic configurations are dis-
played in Figure 3.1. The Ca(I) site is surrounded by six PO43− tetrahedral 
and coordinated by nine oxygen ions. The Ca(II) site is seven-coordinated 
with six oxygen ions from PO43− and one oxygen ion from OH− [42,43]. It has 
been reported that the larger cations usually occupy the Ca(II) sites and the 
smaller ones prefer the Ca(I) sites, because the nearest distance among Ca(I) 
sites is smaller than that among Ca(II) sites [44]. The substitution of cations 
into HA tends to cause the HA structure disordered and influence the phase, 
its mechanical and biological properties.
Among the incorporated cations, Sr2+ and Pb2+ ions could replace 
Ca2+ ions in the whole range of composition [45,46], while the incorporation 















Crystal structure of HA viewed along the c-axis (a) and the local atomic structures of Ca(I) (b) 
and Ca(II) (c). (From Matsunaga, K. et al., Theoretical calculations of the thermodynamic sta-
bility of ionic substitutions in hydroxyapatite under an aqueous solution environment, J. Phys. 
Cond. Matter, 22, 384210, 2010. With permission from Institute of Physics.)
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it seems that cations having larger atomic numbers tend to be more easily 
exchanged with Ca2+ in HA. However, ionic size and/or electronegativity of 
cations also affect the substitution of Ca2+ in HA. The ionic size difference 
between Ca2+ and M2+ (substitutional divalent cation) causes variations in 
the interatomic distances between substitutional divalent cations and sur-
rounding oxygen atoms; thus, the formation energy varies. The relevance 
of the formation energies to the ionic sizes was investigated and plotted in 
Figure 3.2. It was found that the formation energies increased more with 
increasing the ionic size difference between Ca2+ and M2+. This is because 
the smaller- or larger-sized cations allow for larger lattice relaxations of the 
surrounding oxygen by substitution; as such, they may be suffering from 
more significant energy expenses [42].
3.2.1.1  Phase Evolution and Substitution of Cation into HA
The substitution of Ca2+ with M2+ leads to the changes of as-formed phases. 
Figure 3.3 shows the phase evolution of Mg-substituted HA powders 
2.5






























Formation energies of substitutional divalent cations against experimental ionic radii (Ionic 
substitution in HA under an aqueous solution at pH 7). (From Matsunaga, K. et al., Theoretical 
calculations of the thermodynamic stability of ionic substitutions in hydroxyapatite under an 
aqueous solution environment, J. Phys. Cond. Matter, 22, 384210, 2010. With permission from 
Institute of Physics.)
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(MgHA) (Ca10−xMgx(PO4)6(OH)2, x varies from 0 to 10) prepared by the 
mechanochemical−hydrothermal method. With increasing x (lower than 
6.0), the HA diffraction peaks broaden and weaken, indicating the gradual 
decrease in crystallinity of the apatite phase. At x = 6.0, only an amorphous 
phase (Mg-containing amorphous calcium phosphate, Mg-ACP) is detected; 
at x = 10.0, only the NH4MgPO4·H2O phase is produced instead of HA or ACP. 
These results reveal that Mg has limited solubility in HA, and it is difficult 
to obtain a pure HA phase with a complete Mg substitution (x = 10.0) [20]. 
The decrease in crystallinity with increasing Mg content was also proved 
by other researchers [44,47]. The gradual decrease in crystallinity is one of 
the indications that the incorporation of Mg into the HA crystal structure 
leads to the increased lattice disorder [20]. Heat treatment of as-prepared 
MgHA powders at 900°C for 1 h in air shows that MgHA phase becomes 
thermally unstable with the increasing Mg content. Besides HA peaks at low 
Mg contents (x = 0.5 − 1.0), weak peaks of whitlockite [(Ca, Mg)3(PO4)2] are also 
observed; at x = 2.0 − 4.0, HA-derived peaks disappear, and other phases such 
as (Ca, Mg)3(PO4)2, Ca4Mg5(PO4)6, and β-Ca2P2O7 form [20].
When the synthesis method is different, the substitution amount of Mg 

















































XRD patterns of as-prepared Mg-HA powders. (From Biomaterials, 25, Suchanek, W.L., 
Byrappa, K., Shuk, P., Riman, R.E., Janas, V.F., and Tenhuisen, K.S., Preparation of magnesium-
substituted hydroxyapatite powders by the mechanochemical-hydrothermal method, 4647, 
Copyright 2004, with permission from Elsevier.)
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apatite (Ca10−xMgx(PO4)6(OH)2, x varies from 0 to 10) by the wet-chemical 
precipitation method. Phase identification revealed that the apatite phase 
could be preserved only in the Mg concentration range of 0–1.5. However, 
the Mg/(Ca + Mg) molar ratio in the final apatite was significantly lower 
than that in the initial solutions. In their research, the upper limit of Mg 
substitution in the HA lattice was between 5 and 7 mol%. The thermal 
stability of Mg-substituted apatite was studied by thermogravimetric 
analyzer (TGA) (Figure 3.4). The decomposition temperature of HA to 
β-TCP in the region of 690°C–800°C decreases with Mg content as indicated 
in the TGA curves. Since Mg substitution in HA lattice could destabilize 
the crystal structure, the decrease in the decomposition temperature 
confirms that Mg enters the HA lattice because the surface adsorbed Mg 
on the apatite surface would not affect the decomposition temperature of 
HA to β-TCP.
Mg-incorporated apatite coating (Ca10−xMgx(PO4)6(OH)2, x varies from 
0 to 2) has been deposited on Ti6Al4V substrates by the sol–gel method [49]. 
With the incorporation of Mg, Mg-substituted β-TCP (whitlockite, β-TCMP) 
forms in the coating and dominates at x = 1.0−2.0 (Figure 3.5). These results 
are consistent with Mg-substituted HA powders as discussed earlier: 
Mg-substituted HA is thermally unstable, and Mg stabilizes whitlockite 



































TGA curves for Mg-substituted apatite. (From Acta Biomater., 6, Ren, F., Leng, Y., Xin, R., 
and Ge, X., Synthesis, characterization and ab initio simulation of magnesium-substituted 
hydroxyapatite, 2787, Copyright 2010, with permission from Elsevier.)
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The substitution of cation into HA lattice can be reflected by tracing the 
change of the lattice parameters. The incorporation of larger or smaller 
cations into the HA lattice will cause the expansion or contraction of the 
unit cell. In MgHA powder, the unit cell dimensions a and c decrease almost 
linearly with increasing xMg (xMg = Mg/(Mg+Ca)) (shown in Figure 3.6), 
induced by the substitution of Ca2+ ions (0.99 Å) by smaller Mg2+ (0.69 Å) ions 
[44]. The same results were also found by other researchers [50]. When the 
larger cations such as Sr2+ ions (1.13 Å) are incorporated into the apatite, the 
lattice parameters of both a and c linearly increase with the addition of Sr 
(Figure 3.7) [46], indicating structural incorporation of Sr2+ into HA lattice. 
Similar results were also reported by Li et al. [51].
3.2.1.2  Mechanical Properties
Currently, most researchers are focusing on the preparation of cation-
incorporated HA bulk, and the mechanical properties of bulk materials 
depend on the structures processed. For example, when Mg ions were added 
into the apatite reactant solution to be introduced into a cement system, it 
resulted in a reduction in compressive strength of the cement [21]. When 

























XRD patterns of the coatings with different Mg contents. (From Appl. Surf. Sci., 255, Qi, G., 
Zhang, S., Khor, K.A., Lye, S.W., Zeng, X., Weng, W., Liu, C., Venkatraman, S.S., and Ma, L.L., 
Osteoblastic cell response on magnesium-incorporated apatite coatings, 304, Copyright 2008, 
with permission from Elsevier.)
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addition of 1.0 wt% of MgO enhanced the compressive strength of HA by 
33.8%, and the addition of 1.0 wt% of ZnO increased it by 6.2% [52].
Adhesion strength between the coating and the substrate is a critical factor 
for the successful implantation and long-term stability of the coated implant. 
Normally, scratch and pull-off tests are widely used. Scratch testing is a 
simple method to determine the coating adhesion and failure modes [53–55]. 























Unit cell dimensions vs. xMg: a (○); c (□). (From Yasukawa, A., Ouchi, S., Kandori, K., and 
Ishikawa, T., Preparation and characterization of magnesium-calcium hydroxyapatites, 
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Figure 3.7
Variation in lattice parameters, a and c for (SrxCa1−x)5(PO4)3OH. (From Acta Biomater., 4, 
O’Donnell, M.D., Fredholm, Y., de Rouffignac, A., and Hill, R.G., Structural analysis of a series 
of strontium-substituted apatites, 1455, Copyright 2008, with permission from Elsevier.)
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deformation takes place. At a certain load, damage occurs in the scratch-
ing region: the adhesive strength of the coating–substrate system is charac-
terized by the critical load Lc. For the increasing load scratch test, it can be 
defined as the smallest load at which some recognizable failure occurs and 
the load-bearing capacity is lost. As the scratch test is basically a comparison 
test, the critical load Lc determined by this method is the representative of 
coating adhesion behavior [55].
The pull-off test is useful in providing information on the adhesion prop-
erties at the interface of the coating and the substrate and is a relatively quan-
titative method for adhesion strength assessment. The adhesion strength is 
determined by applying a uniaxial tensile load to a cylindrical test assem-
bly composed of one coated specimen bonded to an uncoated component. 
The coated and uncoated components are bonded together by the adhesive. 
The materials and dimensions of the uncoated component shall be the same 
as those of the coated specimen. After the preparation, the test assembly 
is placed in the grips of the tensile testing machine, and the tensile load is 
applied at a constant velocity until complete separation of the components 
is achieved [56]. Together with other testing methods of adhesion strength, 
the detailed bonding characteristics of the coating and the substrate can be 
obtained.
ASTM C633 standard governs the determination of the degree of adhe-
sion of a coating to a substrate or the cohesion strength of the coating in a 
tension normal to the surface. According to the standard, two kinds of fail-
ure modes are defined: (1) adhesive failure happens at the coating–substrate 
interface and is referred to as “the adhesion strength of the coating” and (2) 
cohesive failure occurs within the coating and is referred to as “the cohesion 
strength.” The failure between the epoxy and the coating is also regarded as 
the cohesive failure [57]. However, a combination of these failures is often 
observed in one specimen. Figure 3.8 gives a schematic illustration of the 
failure modes for clear identification. Figure 3.8a shows the typical adhesive 
failure, Figure 3.8b shows the typical cohesive failure, and a combination of 


















Schematic illustration of the failure modes: (a) adhesive failure, (b) cohesive failure, and (c) 
combination of all the failures.
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The adhesion strength between Mg-incorporated apatite coating and 
Ti6Al4V substrate was evaluated by the scratch test [58]. The adhesion 
strength increases almost linearly as more Mg ions are incorporated in the 
apatite coatings. The chemical bonds Ca-P-H-O-Ti-Mg at the interface of the 
coating and substrate contribute to the enhancement of adhesion strength. 
More Mg-Ti-O chemical bonds are formed as more Mg ions are incorporated 
in the coating, giving rise to higher adhesion strength in Mg-containing 
apatite coatings.
3.2.1.3  Biological Performances
Understanding the performance of both natural and synthetic biomaterials 
is important for the development of new and more biocompatible implant 
materials. The evaluation involves both in vitro and in vivo assessments. 
In vitro assessment uses cell and/or tissue derived from both animals and 
humans and maintained in tissue-culturing conditions. In vivo test uses ani-
mal models to evaluate the biological responses to biomaterials in living ani-
mals. By obtaining the clinical data during the trial period and histological 
data from the examination of postmortem tissues, we are able to assess the 
tissue responses to the implanted materials.
The prerequisite for the biomaterials to bond with living bone is the 
formation of a layer of biologically active hydroxylcarbonate apatite (HCA) 
on the biomaterial surface when it is exposed to physiological fluids. The 
behavior of HCA formation on biomaterials in a simulated body fluid (SBF) 
is known as the in vitro bioactivity, which is used to evaluate the in vivo 
bioactivity of bone-forming biomaterials [59]. Zn-incorporated HA with 
Zn concentrations (Zn/Zn+Ca) at 0.5, 1, 2, and 5 at% was immersed into 
biological fluids to study the physicochemical reactions at the material’s 
periphery [60]. A Ca-P-Mg layer was formed at the periphery of the HA 
incorporated with 5 at% Zn, representing the bioactive properties of 
Zn-incorporated HA. Biomimetic Mg-substituted HA (∼1.0 wt% of Mg) 
prepared via wet-chemical synthesis made the apatite more bone-like, 
enhanced the solubility of the material at the physiological pH value, and 
improved the cell behaviors of MSCs and MG63 in terms of adhesion, 
proliferation, and metabolic activation compared with stoichiometric HA 
[61]. Sr-containing HA (Sr-HA) cement prepared for primary hip replace-
ment showed good bioactivity and bone-bonding ability after the implan-
tation using a rabbit model, and the direct contact was confirmed between 
the Sr-HA cement and cancellous and cortical bone under load-bearing 
conditions [62,63].
Cation-incorporated HA coatings were also evaluated by in vitro and 
in vivo tests. Sr-HA coatings on Ti6Al4V substrates were prepared by 
plasma spraying, aiming at the applications of load-bearing implants such 
as artificial hip replacement. The coating exhibited strong bonding with 
substrate, its good bioactivity was demonstrated by forming a bone-like 
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apatite layer on the surface of the coating when immersed in the SBF solu-
tion, and its excellent biocompatibility was indicated by cell culture tests 
with human osteoblasts [64]. Also Sr-substituted apatite coating could be 
grown on Ti6Al4V substrate through biomimetic synthesis. The presence 
of Sr ions in the solution inhibited the coating formation and resulted in 
the decrease in coating thickness. The as-formed Sr-substituted biomi-
metic coatings presented a bone-like structure similar to human bone, 
which might have a positive effect in enhancing bone formation and con-
tributing to better osseointegration [25]. Mg-containing apatite coatings 
prepared by the sol–gel method promoted the formation of apatite layer in 
the SBF solution and showed good bioresponses with MG63 cells just like 
the HA coatings [65,66].
3.2.2 incorporation of anion into Ha
There are two kinds of anions in HA crystal structure, phosphate group 
(PO43−) and hydroxyl group (OH−). PO43− can be replaced by HPO42−, CO32−, 
or SiO44−, and OH− by F− or Cl−. In this review, the emphasis is on the 
substitution of OH− groups. In turn, the effect of anion incorporation into 
HA will be discussed through phase evolution, solubility, and mechanical 
and biological properties.
3.2.2.1  Phase Evolution and Substitution of Anion into HA
When OH− groups in HA are partially substituted by F− ions, fluoride-
substituted or fluoridated hydroxyapatite (FHA) forms with a composition 
of Ca10(PO4)6Fx(OH)2–x (0 < x < 2). If all the OH− groups are substituted by 
F− ions, it is called fluorapatite (FA, Ca10(PO4)6F2). FA has a very similar crys-
tal structure to HA and belongs to the same space group as HA. The arrange-
ment of OH− groups and F− ions in HA, FHA, and FA is shown in Figure 3.9. 
Theoretically, F− ions easily replace OH− groups in HA on thermodynamic 
ground (∆Ex = −0.4−0.6 kJ mol−1). The lowest energy of the crystal structure is 
reached at x = 1.0 with a configuration that HA crystal consists of alternating 
planes of F− ions and OH− groups, where they are alternating in the c-axis but 
colocated within the a/b-plane [67].
The incorporation of F ions in HA improved the thermal and chemical 
stability of HA. Figure 3.10 is the TGA data of HA, FHA, and FA powders 
heated from 25°C to 1400°C in dry air, which shows different degrees of 
weight loss of samples with different F contents [68]. For pure HA powder, 
the weight loss from 25°C to 200°C is caused by the evaporation of absorbed 
water in the powder, that from 800°C to 850°C is due to the release of OH− 
groups from the HA crystals, and the decomposition of HA and further loss 
of OH− groups happen above 1000°C. However, the decomposition stage is 
not observed with F incorporation, suggesting the retarded decomposition 
and improved thermal stability of HA. Moreover, the dilatometer analysis 




Arrangement of OH− groups and F− ions in HA, FHA, and FA crystal structures. (From 
Biomaterials, 26, Chen, Y., and Miao, X., Thermal and chemical stability of fluorohydroxyapatite 






















TGA data of HA, FHA, and FA powders heated to 1400°C in dry air. (From Biomaterials, 26, 
Chen, Y., and Miao, X., Thermal and chemical stability of fluorohydroxyapatite ceramics with 
different fluorine contents, 1205, Copyright 2005, with permission from Elsevier.)
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showed that the onset sintering temperature of FHA powder was increased 
to 1150°C compared with that of HA powder around 1000°C.
When F− ions are incorporated into HA lattice, the lattice parameters are 
changed accordingly. Since F− (1.32 Å) is smaller than OH− (1.68 Å), the sub-
stitution results in a contraction in the a-axis, but no significant change along 
the c-axis [69–71]. The substitution is reflected from x-ray diffraction (XRD) 
patterns (Figure 3.11): the (300) peak of FA shifts toward a higher 2θ relative 
to that of cal-HA (calcined from HA at 1000°C for 1 h in air) [70,72].
The incorporation of F− ions also influences the vibration behavior of 
OH− groups [38,69]. As shown in Figure 3.12, the bands at 3570 and 630 cm−1 
are assigned to the stretching and wagging of free OH−, respectively. With 
increasing F content, the intensities of OH− peaks decrease, and an additional 
OH−−F− stretching band appears at a lower frequency due to the partial 
substitution of OH− groups with F− ions. When OH− groups in HA were 
completely replaced by F− ions, the OH− peak at 3570 cm−1 disappears. The 
split and shift of OH stretching peak at 3570 cm−1 can be an indication of the 
substitution of OH− groups with F− ions.
X-ray photoelectron spectroscopy (XPS) is another way to identify the F 
incorporation into the HA structure. In Figure 3.13, F 1s is not detected in 
the original sample (A). As F concentration increases, the peak at 684.3 eV 
intensifies. While for CaF2, F 1s peak locates at 685.0 eV. Moreover, the bind-
ing energy of Ca 2p shifts to 347.4 eV, which is different from that in the 

















Short-range XRD patterns of calc-HA, calc-FHA, and FA. (With kind permission from Springer 
Science + Business Media: J. Mater. Sci. Mater. Med., Synthesis and characterization of hydroxy-
apatite, fluoride-substituted hydroxyapatite and fluorapatite, 14, 2003, 311, Wei, M., Evans, J.H., 
Bostrom, T., and Grøndahl, L.)
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the chemical shift relative to the incorporation of F− ions in the apatite [73]. 
The fingerprint of F 1s in FHA or FA at 684.3 eV was also reported by other 
researchers [74,75].
When OH− groups in HA are partially replaced by Cl− ions, chlorine-
substituted HA (chlorapatite, Clap) is obtained [41]. The hexagonal apatite 
structure retains for all the chlorine substituted samples with no major 
structural distortion. The calculated lattice parameters of the samples 
provide the evidence for the incorporation of Cl− ions in the apatite structure. 
A significant expansion of all the parameters of a-axis and c-axis was 
observed for Clap with respect to that of HA due to the substitution of bigger 
Cl− ions (1.81 Å) for OH− groups (1.68 Å).
3.2.2.2  Solubility
Solubility is an important factor influencing both the short-term osseo-
integration and the long-term stability. Immediately after the implanta-
tion, a certain extent of dissolution of the coating is necessary to increase 




















FTIR spectra of the coatings: (a) HA, (b) 25 FHA, (c) 50 FHA, (d) 75 FHA, and (e) FA. (From 
Biomaterials, 26, Lee, E.-J., Lee, S.-H., Kim, H.-W., Kong, Y.-M., and Kim, H.-E., Fluoridated 
apatite coatings on titanium obtained by electron-beam deposition, 3843, Copyright 2005, with 
permission from Elsevier.)
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the local ion concentrations of calcium and phosphate to stimulate the 
formation of new bone. From the viewpoint of the long-term stabil-
ity of the implant, the dissolution resistance of the coating should be 
strong enough to avoid the detachment of the coating from the substrate. 
Therefore, it is vital to investigate the solubility of the coating. Factors 
affecting the solubility of a material include the preparation method, the 
resultant crystallinity and density, and the extent of ion substitutions into 
the apatite lattice [76].
It is well known that fluoride can prevent caries. The mechanism of 
reduced solubility of HA by addition of fluoride has been investigated 
intensively [77–80]. Moreno et al. [80] discussed the solubility of FHA 
(Ca5(PO4)3(OH)1−xFx) theoretically and experimentally. A series of solid 
solutions with different fluoridation degrees x, from 0 to 1, were prepared. 
The solubility of these compounds was obtained by equilibrating them for 
more than 1 month with a series of dilute phosphoric acid solutions at 37°C. 
The solubility product constant Kx at various substitution concentrations 
was calculated according to the experimental data shown in Figure 3.14. 
From Figure 3.14, a minimum in Kx is seen at a substitution degree of 0.56. 
The decreased solubility can be explained on the basis of the disordered 
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Figure 3.13
XPS spectra of F 1s (A) and Ca 2p (B) of CaHA treated with various F concentrations (mol/dm3): 
(a) 0, (b) 0.01, (c) 0.03, (d) 0.05, (e) 0.10, and (f) CaF2. (From Coll. Surf. A Physicochem. Eng. Asp., 
204, Tanaka, H., Yasukawa, A., Kandori, K., and Ishikawa, T., Surface structure and properties 
of fluoridated calcium hydroxyapatite, 251, Copyright 2002, with permission from Elsevier.)
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F− ions. Also the solubility of heterogeneous FHA was studied by Okazaki 
et al. [81,82]. The apparent solubility of FHA decreased with the increased 
fluoridation degree no matter if the fluoride was supplied in the initial or 
final half of the experimental period.
Similar dissolution behaviors were also found in FHA coatings 
regardless of preparation methods (such as thermal spraying [83], 
electron-beam deposition [38], and sol–gel deposition [7,15]). For example, 
Figure 3.15 shows that the incorporation of F− ions decreased the solubility 
of HA coatings prepared by sol–gel deposition. Besides the experimental 
studies of the effect of F incorporation on the solubility of HA, a com-
puter modeling study was also done using molecular dynamic simulations 
[67,84]. In pure HA material, the onset of dissolution is induced through 
the leaching of surface hydroxyl groups from the material into solution 
in the presence of water. When F− ions partially replace OH− groups, OH− 
group may dissolve, but the F− ion at the surface does not dissolve as 
readily but remains in the crystal. Moreover, the surface Ca2+ ions persist 
more closely coordinated to the material surface in the vicinity of the sub-
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Solubility of the solid solutions as a function of the degree of fluoride substitution 
(Ca5(PO4)3(OH)1−xFx, [a] pH 5; [b] pH 6; [c] pH 7). (Reprinted by permission from Macmillan 
Publishers Ltd., Nature, Moreno, E.C., Kresak, M., and Zahradnik, R.T., Fluoridated hydroxy-
apatite solubility and caries formation, 247, 64, Copyright 1974.)
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the materials more dissolution resistant through two aspects: the resis-
tance toward dissolution into the solvent of F− ions themselves and strong 
anchoring of the surface Ca2+ ions.
3.2.2.3  Mechanical Properties
Fluorine incorporation into HA also changes the mechanical properties 
of HA. Bulk FHA has been widely synthesized, and their mechanical 
properties were measured using indentation, including hardness, elastic 
modulus, fracture toughness, and brittleness [85,86]. Both the fluoridation 
degree and the sintering temperature have an effect on the mechanical 
properties of bulk HA, which are not reviewed here. However, the depen-
dence of F incorporation on the mechanical properties of FHA coatings is 
reviewed later in detail.
Wang et al. [8,87,88] have systematically investigated the mechanical prop-
erties of sol–gel derived FHA (Ca10(PO4)6(OH)2−xFx, x varies from 0 to 2) coat-
ings on Ti6Al4V substrates. The adhesion strength between the coating and 
the substrate was evaluated through both scratch and pull-out tensile tests. 
Scratch test revealed that the adhesion strength was up to 35% better as the F 












































Dissolution behavior of FHA coatings in physiological saline solution: Ca2+ concentration as 
a function of soaking time. (From Acta Biomater., 3, Wang, Y.S., Zhang, S., Zeng, X.T., Ma, L.L., 
Weng, W.J., Yan, W.Q., and Qian, M., Osteoblastic cell response on fluoridated hydroxyapatite 
coatings, 191, Copyright 2007, with permission from Elsevier.)
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much more obvious at higher firing temperatures. The pull-out tensile test 
showed that the adhesion strength increased up to about 40% from ∼19 MPa 
for HA to ∼26 MPa for FHA (x = 1) as shown in Figure 3.16. After soaking in 
tris-buffered physiological saline (TPS) solutions for 21 days, the enhance-
ment became more significant because the rougher surface after the dissolu-
tion resulted in stronger bonding between the epoxy and the coating and in 
turn reduced the area fraction of the “adhesive failure.”
The toughness, interfacial shear strength, and residual stress of FHA coat-
ings have also been evaluated [8,87,88]. At the fluoridation degree of x = 1, the 
toughness of the coating doubled as compared with HA coating. The inter-
facial shear strength was evaluated by the shear strain lag method, and the 
“wafer curvature method” was employed to measure the residual stresses. 
The resultant interfacial shear strength increased from ∼393 MPa (pure HA) 
to ∼459 MPa (1.96 at% fluorine) and further to ∼572 MPa (3.29 at% fluorine). 
The residual stress in the coating also decreased from ∼273 to ∼190 MPa 
and further to ∼137 MPa as F concentration in the coating increased. Other 
researchers also studied the mechanical properties of FHA coatings on 
metal substrates. For instance, Kim et al. [69] deposited an HA/FHA double-
layered film on titanium by a sol–gel method, which was highly dense and 































Adhesion strength of FHA coating before and after soaking in TPS solutions. (From Thin Solid 
Films, 516, Zhang, S., Wang, Y.S., Zeng, X.T., Khor, K.A., Weng, W., and Sun, D.E., Evaluation 
of adhesion strength and toughness of fluoridated hydroxyapatite coatings, 5162, 2008, with 
permission from Elsevier.)
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3.2.2.4  Biological Performances
Fluoride has an affinity for skeletal tissue and also has a specific mitogenic 
activity and attraction for cells of skeletal origin. Fluoride seems to be an 
enhancer of bone cell growth factors and requires the presence of appro-
priate growth factors to induce calcification. It may act primarily on the 
osteoprogenitor cells and/or undifferentiated osteoblasts cells rather than 
stimulating the proliferation of highly differentiated osteoblasts. It is impor-
tant in bone healing and bone regeneration because it will induce the differ-
entiation of osteoprogenitor cells and undifferentiated precursor cells into 
osteoblasts (Figure 3.17) [89].
In vitro cell culture tests are widely used to evaluate the effect of fluo-
rine content in FHA bulks and coatings on the cell activities in terms of cell 
attachment, morphology, proliferation, and differentiation [15,90–92]. For 
FHA bulks, more cell attachment and proliferation were observed on FHA 
bulks than on pure HA, and cells on FHA bulks demonstrated a higher 
alkaline phosphatase (ALP) activity than those on pure HA after 3 weeks of 
culturing [92]. Wang et al. [15] found that F incorporation had positive stimu-









Effect of fluoride in cell differentiation and new bone formation. (From Ellingsen, J.E., 
Thomsen, P., and Lyngstadaas, S.P.: Advances in dental implant materials and tissue regen-
eration. Periodontology. 2000, 2006. 41. 136. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. 
Reproduced with permission.)
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especially at the fluoridation degree of 0.8–1.1. However, Kim et al. [7] found 
that the osteoblast-like MG63 and HOS cells grew and proliferated favorably 
on all the HA and FHA coatings as well as on pure Ti. The osteoblast cells 
proliferated on FHA coatings to a lower extent than on pure HA coating 
obtained by electron-beam deposition, and the ALP activity of the cells on 
the FHA coatings was not significantly different from that on the HA coating 
[38]. The positive or negative effect of fluorine ions in FHA coatings on the 
cell behaviors is still under argument.
In addition, several phenomena were observed during in vivo studies of 
FHA coatings. The degradation of plasma-sprayed HA, FA, and FHA coat-
ings on dental implants evaluated in dog jaws till 12 months indicated good 
integration between FHA coating and bone tissue. HA and FA coatings (even 
at 100 μm thickness) were almost completely degraded within the implanta-
tion period. In contrast, FHA coatings did not show significant degradation 
during the same period [93]. Savarino et al. [94] have investigated the in vivo 
compatibility and degradation of plasma-sprayed FHA, HA coatings, and 
titanium oxide (TiOx). The bone at the interface was not mineralized in all 
samples after 2 weeks of implantation. After 12 weeks, the newly formed 
bone tissue at the interface with both FHA and HA coating was shown to 
be fully mineralized. Also the in vivo tests done by Caulier et al. [95] proved 
that no significant differences were found in bone reaction among uncoated, 
plasma-sprayed HA and FA coatings on titanium on the initial bone healing 
of oral implants.
3.2.3 Problems involved in Cation- or anion-incorporated Ha
To make the implant more acceptable to bone cells and stimulate rapid 
integration with bone rather than fibrous encapsulation, the surface coat-
ing should have suitable biochemical and structural characteristics to elicit 
wanted cell activity and finally result in full osseointegration. Moreover, 
the resultant bone–implant interface must have the internal strength and 
bonding capacity to the underlying metal substrate so as to endure the 
forces produced by the implant loading. Cation or anion substitution into 
HA improves the mechanical and biological properties in comparison with 
pure HA. For example, the cations like Mg2+ incorporation is beneficial to 
the biological performance of HA, while the anions like F− incorporation 
improves the adhesion strength between the coating and the substrate. 
However, it is found that the short-term osseointegration and the long-
term stability are difficult to be addressed at the same time if only a cation 
or an anion is incorporated. As such, simultaneous incorporation of cation 
and anion into HA is proposed to exert their special advantages in biologi-
cal and mechanical performances and achieve the short-term osseointe-
gration and the long-term stability of the implant, which will be reviewed 
in the next section.
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3.2.4 Simultaneous incorporation of Cations and anions into Ha
The apatite structure has the ability to accept a wide number of possible 
substitutions in its lattice, and trace elements are important to bone mineral, 
so the simultaneous incorporation of several elements into apatite structure 
is expected to improve the performances of apatite. So far, many attempts 
have been made to synthesize the apatite substituted with different cations 
and anions. The simultaneous incorporation of cations and anions into HA 
is summarized in Table 3.1. As shown in Table 3.1, aqueous precipitation is 
the most commonly used method for the synthesis of cation- and anion-
incorporated bulk HA, while sol–gel method is preferred to deposit HA 
and derivative coatings because the method allows precise control of the 
coatings’ composition.
When cations and anions are incorporated into HA simultaneously, crys-
tallographic properties, thermal behaviors, mechanical and biological prop-
erties, etc., differ from individual substitution of cations or anions into HA. 
For example, cations themselves (Al3+, Mg2+, Zn2+, or Sr2+) at low levels in 
the solution had negative effects on the properties of apatite, e.g., lower 
crystallinity, lower Ca/P ratios, higher HPO4/PO4, and higher dissolution 
in an acid buffer. When only F− ions were present in the precipitation solu-
tion, positive effects on the apatite were observed, e.g., greater crystallinity, 
higher Ca/P, lower HPO4/PO4, and lower dissolution. However, the simul-
taneous presence of F− ions with the cations (Al3+, Mg2+, Zn2+, or Sr2+) mini-
mized the negative effects caused by the cations, suppressed the formation 
Table 3.1
Summary of Simultaneous Incorporation of Cations and Anions into HA
Cation Anion Method References
Bulk K+ Cl− Melt salt method [142]
Al3+ F− Aqueous precipitation method [96]
Sr2+ F− Aqueous precipitation method [96]
Zn2+ F− Aqueous precipitation method [96]
Mg2+ F− Aqueous precipitation method [96,98,100,101]
Mg2+ F− Heterogeneous synthesis with 
two-step supply system
[99]
Mg2+ CO32− Aqueous precipitation method [97,143]
Mg2+ CO32− Precipitation method with 
gradient Mg supply system
[144]
Mg2+ CO32− Neutralization method [61]
Mg2+ CO32−, F− Aqueous precipitation method [145]
Na+, Mg2+ F− Aqueous precipitation method [14]
Na+, K+, Mg2+ F−, Cl− Aqueous precipitation method [146]
Coating Zn2+ F− Sol–gel method [23,24,147,148]
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of Mg-substituted β-TCP (β-TCMP), and allowed a greater incorporation of 
cations in the apatite [96].
Among different cations and anions, Mg and F ions have their own 
advantages. As the fourth abundant element in the human body, Mg could 
reduce the risks of cardiovascular disease, promote the catalytic reac-
tions, and control the biological functions. Mg content in the natural bone 
is affected by a great variability depending on aging: it is contained in 
high concentrations in cartilage and natural bone tissue during the initial 
stages of osteogenesis, while it tends to disappear when the bone is mature. 
For example, 1.0 wt% Mg was found in the new-born rats, and this level 
decreased to 0.5 wt% after 1 year [97]. So it is vital to introduce Mg ions 
during the stage of new bone formation. Furthermore, F ions as well are 
recognized for their potential behavior on the long-term stability of the 
apatite coating, such as the improvement of mechanical properties and dis-
solution resistance.
Okazaki [98,99] has systematically investigated the crystallographic prop-
erties of Mg-free and Mg-containing fluoridated apatite (Mg-FHApI and 
Mg-FHApII with different Mg concentration) synthesized by aqueous pre-
cipitation and two-step supply system. The inverse of the half-value breadth 
calculated from (300) and (002) reflections is represented as the crystallinity 
along the a-axis and c-axis, as shown in Figure 3.18. The crystallinity varies 
in each series with increasing F content. A minimum crystallinity of FHAp 
is observed at the low F content, and then the crystallinity increases with 
the increasing F content (Figure 3.18a). At lower Mg content, Mg-FHApI, this 
minimum crystallinity is invisible, and an overall increase in crystallinity 
is found (Figure 3.18b). At higher Mg content, Mg-FHApII, the crystallin-
ity steadily reaches a maximum at about half of the maximum F content 
(Figure 3.18c), and the whole crystallinity of Mg-FHApII is lower than that 
of Mg-FHApI. The minimum crystallinity seen at lower F content in FHAp 
might be due to the imbalance between F− ions and OH− groups, which is 
relieved by the increase in F content. When Mg2+ ions are added, especially 
at higher concentrations, the positive effect of F− ions on the crystallinity is 
weakened by the addition of Mg2+ ions.
The influence of Mg and F ions on the crystallinity of Mg-containing 
fluoridated apatite was also reported by Hidouri et al. [100]. As shown in 
Figure 3.19, a slight broadening of the reflections is observed as the increased 
Mg concentration (Figure 3.19b through d), indicating the lower crystallinity 
of Mg-containing fluoridated apatite compared with pure fluoridated apatite 
(Figure 3.19a).
The lattice dimensions of three series of FHAp were calculated from (300) 
and (002) reflections using silicon as standard, as shown in Figure 3.20. The 
decrease in a-axis of Mg-free and Mg-containing FHAp with the increased 
fluoridation degree suggests the substitution of F− ions into the apatite 
crystal structures. The c-axis also decreases with the increased Mg content 
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over the whole range of F content due to the substitution of Ca2+ with Mg2+ 
ions. This substitution can also be reflected from the shifting of (002) peaks 
(Figure 3.21). With the increasing Mg content, (002) peak shifts toward higher 
degree. In addition, the decreased a- and c-axes with the increase in Mg con-
tent further confirmed the substitution [100].
The thermal behavior of Mg-containing FHA was investigated by Hidouri 
[100]. As-prepared powders were calcined at different temperatures to deter-
mine possible changes of sintered phases. Take 1.00 MgFap as an example 
(Figure 3.22). A secondary-phase Mg2F(PO4) is detected in the range of 
650°C–1120°C, and the amount of this phase increases with increasing Mg 
concentration. Mg2F(PO4) phase disappears at 1300°C due to its dissolu-
tion in the liquid phase or incorporation into the apatite structure. Since no 
decomposition of the material is observed at 1300°C, it is concluded that the 
incorporation of Mg into apatite does not affect its thermal stability.
Figure 3.23 shows the solubility of Mg-free and Mg-containing FHAp as 
the function of dissolved Ca2+ concentration in 0.5 mol/L acetate buffer solu-
tions (pH 4.0, 37°C). The solubility of Mg-free FHAp is lower than that of 
Mg-containing FHAp at lower F content, but the difference between them is 































































Crystallinity of Mg-free (FHAp [a]) and Mg-containing fluoridated hydroxyapatite (Mg-FHApI 
[b] and Mg-FHApII [c]). (From J. Fluor. Chem., 41, Okazaki, M., Magnesium-containing fluori-
dated apatites, 45, Copyright 1988, with permission from Elsevier.)
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the solubility of FHA, the strong bonding of F− ions with neighboring ions 
may be maintained to stand against the acid attack, so that the solubility of 
different series at higher F content does not vary extensively.
Most recently, Sun et al. [101] synthesized Mg2+/F−-doped nanophase HA 
powder by a precipitation method followed by sintering at 1100°C for 1 h. 
The highest microhardness was achieved in 1% Mg- and 2.5% F-doped HA. 
Cytocompatibility testing shown in Figure 3.24 demonstrates no statisti-
cal difference in osteoblast cell densities after 4 h between HA, HA1Mg, 
HA2.5Mg, HA7.5Mg, HA1Mg2.5F, and HA2.5Mg2.5F. Significant increases 
in osteoblast cell densities are found on HA7.5Mg2.5F and HA2.5Mg7.5F 
(where 7.5Mg and 2.5F refer to the mole percent of Mg and F in HA, respec-
tively). However, the reason for the greater osteoblast adhesion on these two 
samples is still unknown.
The preliminary investigation shows that the simultaneous incorporation 
of cations and anions results in different crystallinity, thermal stability, solu-
bility, and mechanical and biological performances from those of cation- or 
anion-incorporated HA. However, up to date, the exploration of simultane-
ous incorporation of cations and anions (especially Mg and F ions) into HA 
is not systematical and needs further investigation, especially when they are 
employed as coatings on metal substrates.








XRD patterns of as-prepared powders with different Mg concentrations: (a) Fap, (b) 0.25 MgFap, 
(c) 0.50 MgFap, and (d) 1.00 MgFap. (From Mater. Chem. Phys., 80, Hidouri, M., Bouzouita, K., 
Kooli, F., and Khattech, I., Thermal behaviour of magnesium-containing fluorapatite, 496, 
Copyright 2003, with permission from Elsevier.)


























Dimensions of a- and c-axes for Mg-free (FHAp) and Mg-containing fluoridated hydroxyapa-
tite (Mg-FHApI and Mg-FHApII). (From J. Fluor. Chem., 41, Okazaki, M., Magnesium-containing 









(002) peak reflections of as-prepared powders: (a) Fap, (b) 0.25 MgFap, (c) 0.50 MgFap, 
and (d) 1.00 MgFap. (From Mater. Chem. Phys., 80, Hidouri, M., Bouzouita, K., Kooli, F., and 
Khattech, I., Thermal behaviour of magnesium-containing fluorapatite, 496, Copyright 2003, 
with permission from Elsevier.)












XRD patterns of as-prepared 1.00 MgFap powder sintered at different temperatures. 
(a) 1300°C, (b) 1120°C, (c) 1050°C, (d) 750°C, (e) 650°C, and (f) 500°C. (From Mater. Chem. Phys., 
80, Hidouri, M., Bouzouita, K., Kooli, F., and Khattech, I., Thermal behaviour of magnesium-



















Solubility of Mg-free (FHAp) and Mg-containing fluoridated hydroxyapatite (Mg-FHApI and 
Mg-FHApII) as dissolved Ca2+ concentration. (From J. Fluor. Chem., 41, Okazaki, M., Magnesium-
containing fluoridated apatites, 45, Copyright 1988, with permission from Elsevier.)
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3.3	 	Preparation	of	Magnesium	and	Fluorine	
Co-Substituted	Hydroxyapatite	Coatings*
Sol–gel dip-coating method is most preferred to deposit ion-substituted HA 
coating, especially when two or more ions are incorporated simultaneously. 
It can control the composition and thickness of the coating precisely and 
realize a multilayered structure easily.
To make the sols, calcium nitrate tetrahydrate (Ca(NO3)2·4H2O, Merck, 
AR) and magnesium nitrate hexhydrate (Mg(NO3)2·6H2O, Merck, AR) were 
dissolved in ethanol to prepare 2 M of Ca-precursor and Mg-precursor. 
They were mixed together to form a Ca–Mg mixture according to the 
* From Thin Solid Films, 517, Cai, Y., Zhang, S., Zeng, X., Wang, Y., Qian, M., and Weng, W., 
Improvement of bioactivity with magnesium and fluorine ions incorporated hydroxyapatite 

































































Four-hour osteoblast adhesion test (*p < 0.05 with respect to HA7.5Mg2.5F, #p < 0.05 with 
respect to HA2.5Mg7.5F). (From Sun, Z.P., Ercan, B., Evis, Z., and Webster, T.J.: Microstructural, 
mechanical, and osteocompatibility properties of Mg2+/F−-doped nanophase hydroxyapatite. 
J. Biomed. Mater. Res. Part A. 2010. 94A, 806. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. 
Reproduced with permission.)
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designed amount. 2 M of P-precursor was prepared by dissolving phospho-
rous pentoxide (P2O5, Merck, GR) in ethanol followed by a refluxing pro-
cess for 24 h. Then F-precursor (diluting hexafluorophosphoric acid (HPF6, 
Sigma-Aldrich, GR) in ethanol) was added to P-precursor to obtain a P–F 
mixture. The Ca–Mg mixture was added drop-wise into the P–F mixture 
to form a solution with a (Ca, Mg)/P ratio of 1.67. This mixture was further 
refluxed for 24 h to obtain the sol. The coating composition is controlled dur-
ing this process by adjusting the ratios of Ca-precursor and Mg-precursor, 
and P-precursor and F precursor.
Fine-polished Ti6Al4V (20 × 30 × 2 mm3) were used as substrates. It was 
dipped vertically into the sol and withdrawn at a speed of 3 cm min−1 for the 
first layer. The as-dipped coating was then dried at 150°C for 15 min followed 
by firing at 600°C for 15 min. This dipping–drawing–drying–firing process 
was further repeated four times at a speed of 4.5 cm min−1 for a thicker coat-
ing with a thickness of 1.5–2 μm.
This work aims at developing a bilayer structured Mg and F ion co-
substituted HA coating on Ti6Al4V substrate to achieve an integration of 
short-term osseointegration and long-term stability. Ca10−xMgx(PO4)6F1(OH)1 
or MgxFHA in short, Ca9Mg1(PO4)6Fy(OH)(2−y) or MgFyHA in short, and the 
bilayer structured HA (BHA in brief) coatings were deposited by a sol–gel 
dip-coating method. The compositional dependence of co-substitution 
of Mg and F ions was systematically studied on material structure, 
in vitro bioactivity, cell response, dissolution rate, and adhesion strength.
3.4	 	Effect	of	Magnesium	Incorporation	in	
Fluoridated	Hydroxyapatite	Coatings*
Magnesium ions are incorporated into FHA coatings to improve the bio-
logical performances. The as-deposited coatings are denoted by MgxFHA 
(Ca(10−x)Mgx(PO4)6F(OH), x varies from 0 to 2). The corresponding samples 
were labeled as FMA0, FMA1, FMA2, FMA3, and FMA4, or the correspond-
ing coatings as Mg0FHA, Mg0.5FHA, Mg1FHA, Mg1.5FHA, and Mg2FHA for 
further discussion.
* From Thin Solid Films, 519, Cai, Y., Zhang, S., Zeng, X., Qian, M., Sun, D., and Weng, W., 
Interfacial study of magnesium-containing fluoridated hydroxyapatite coatings, 4629, 2011, 
with permission from Elsevier.
 From Thin Solid Films, 517, Cai, Y., Zhang, S., Zeng, X., Wang, Y., Qian, M., and Weng, W., 
Improvement of bioactivity with magnesium and fluorine ions incorporated hydroxyapatite 
coatings via sol-gel deposition on Ti6Al4V alloys, 5347, 2009, with permission from Elsevier.
 From Cai, Y., Zhang, J., Zhang, S., Mondal, D., Venkatraman, S.S., and Zeng, X., Osteoblastic 
cell response on fluoridated hydroxyapatite coatings: The effect of magnesium incorporation, 
Biomed. Mater., 5, 054114, 2010. With permission from Institute of Physics.
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3.4.1 Co-Substitution of Mg and F ions in the MgxFHa Coatings
3.4.1.1  Phase Evolution
Grazing incidence x-ray diffraction (GIXRD) patterns of MgxFHA coatings 
on Ti6Al4V substrates are shown in Figure 3.25. The diffraction peaks of 
all the samples are assigned to apatite phase and Ti6Al4V substrate. With 
reference to pure HA (PDF#09-0432), there is no other calcium phosphate 
found in the coating. All the main diffraction peaks in FMA0 sample have 
a slight shift toward higher degree, especially the (300) peak shifting from 
32.90° of pure HA to 33.04°. This is because some of the hydroxyl groups 
(OH−) are substituted by the fluorine ions (F−) to form FHA [91]. There is 
not much difference in peak positions when the concentration of Mg is low 
(see FMA1 and FMA2) except slight peak shift toward higher degree. It is 
expected as the smaller Mg2+ (0.69 Å) substituted the larger Ca2+ (0.99 Å) ion. 
As Mg concentration increases further, i.e., FMA3 and FMA4, a new phase 
of Mg-substituted β-tricalcium phosphate (β-TCMP) is detected, signaling it 
beyond the maximum “solubility” of Mg in HA crystal structure.
In our previous study [65], β-TCMP is the main phase when Mg is incor-
porated into HA coatings with the same concentration as FMA2 in the sol. 
This is because the substitution of Mg2+ into Ca2+ positions makes the apatite 
structure resemble β-TCP. Moreover, Mg favors the conversion of HA into 
β-TCMP during the heat treatment [47,102]. However, when Mg and F ions 
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Figure 3.25
GIXRD patterns of as-deposited MgxFHA coatings on Ti6Al4V substrates. (From Thin Solid 
Films, 517, Cai, Y., Zhang, S., Zeng, X., Wang, Y., Qian, M., and Weng, W., Improvement of bio-
activity with magnesium and fluorine ions incorporated hydroxyapatite coatings via sol-gel 
deposition on Ti6Al4V alloys, 5347, 2009, with permission from Elsevier.)
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of β-TCMP is found in FMA3 and FMA4, meaning F-incorporation in HA 
increases the “solubility” of Mg in the HA structure. Similar results are also 
reported by other researchers who prepared apatite powders in the pres-
ence of Mg and F ions [96]. The shrinkage along c-direction caused by the 
substitution of OH− groups by F− ions would lead to larger “rattling” space. 
This makes the lattice structure less stable, and as a result, Mg ions can have 
more chances to enter the HA crystal structure to occupy the Ca position.
3.4.1.2  Co-Substitution of Mg and F Ions in the MgxFHA Coatings
Theoretically, Mg2+ (0.69 Å) substitutes Ca2+ (0.99 Å), and F− (1.32 Å) replaces 
OH− (1.68 Å) in HA crystal structure when Mg or F ions are incorporated into 
HA powders or coatings. The incorporation of foreign ions into HA crystal 
structure influences the lattice parameters, chemical states, and mechani-
cal and biological properties of HA correspondingly. Therefore, it is vital to 
confirm the substitution of Mg and F ions into HA crystal structure, which is 
studied from lattice parameters, chemical states, and chemical groups.
The lattice parameters are modified when fluorine ions are incorporated 
into HA crystal structure. There is a significant decrease in the a-axis from 
9.418 Å for pure HA down to 9.3710 Å for pure FA, but the c-axis shows 
no obvious change [69–71]. In this case, the shift of (002) peak and the 
change of c-axis can reflect the substitution of Ca2+ with Mg2+ when Mg and 
F ions are simultaneously incorporated into HA coating. Table 3.2 lists the 
two-theta of (002) peak and calculated c-axis of MgxFHA coatings. As Mg 
concentration increases from 0 to 1.0, the (002) peak shifts toward higher 
degree due to the substitution of larger Ca2+ (0.99 Å) with smaller Mg2+ 
(0.69 Å). However, when Mg concentration increases further to 1.5 and 2.0, 
(002) peak shifts to lower degree as compared to when x = 1.0, but still higher 
than that when x = 0.5. The same trend is also observed from the change of 
c-axis. The change of c-axis is related to the phase analysis stated earlier. At 
higher Mg concentrations (FMA3 and FMA4), β-TCMP is detected as well as 
FHA, implying that Mg2+ cannot completely replace Ca2+. The formation of 
β-TCMP competes with the Ca2+ substitution on the assumption of Mg2+ in 
the sol. Therefore, there is a little increase in c-axis at higher Mg concentra-
tions. Although the change of c-axis is not linear with the increasing Mg 
concentration, the decrease in c-axis indicates the replacement of Ca2+ by 
Mg2+ in the HA crystal structure.
Table 3.2
Two-Theta of (002) Peak and Calculated c-Axis 
of MgxFHA Coatings
Sample FMA0 FMA1 FMA2 FMA3 FMA4
Two-theta (°) 25.84 25.86 25.94 25.90 25.90
c-axis (Å) 6.89 6.88 6.86 6.87 6.87
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The chemical compositions of MgxFHA coatings are confirmed by XPS, 
as shown in Figure 3.26. The survey scans (Figure 3.26a) demonstrate that 
all the elements in MgxFHA coatings are detected (the presence of C 1s in 
all the samples is due to inevitable surface contamination even from air). 
The narrow scans of F 1s are shown in Figure 3.26b, and the binding energy 
of F 1s at 684.3 ± 0.1 eV reveals that F ions have been incorporated into the 
HA crystal structure (F 1s at 684.3 ± 0.1 eV is the fingerprint of F in FHA or 
FA, while the peak of F 1s in CaF2 is at 686.7 eV [8,75]). This is also supported 
by the GIXRD analysis. Figure 3.26c shows the narrow scans of Mg 2p. With 
increasing Mg in the sols, Mg 2p peak gradually intensifies, indicating more 
Mg ions are included in the HA coating. Moreover, only one symmetri-
cal peak is located at 50.3 eV belonging to Mg 2p, which means only one 
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XPS profiles of MgxFHA coatings on Ti6Al4V substrates: (a) survey scan, (b) F 1s narrow 
scan, and (c) Mg 2p narrow scan. (From Thin Solid Films, 517, Cai, Y., Zhang, S., Zeng, X., 
Wang, Y., Qian, M., and Weng, W., Improvement of bioactivity with magnesium and fluorine 
ions incorporated hydroxyapatite coatings via sol-gel deposition on Ti6Al4V alloys, 5347, 2009, 
with permission from Elsevier.)
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of Mg2+ in apatite structure [65]. The result confirms that Mg ions have been 
incorporated into the HA lattice. Mg bonds with phosphate groups in both 
Mg-containing HA and Mg-substituted β-TCP, thus the binding energy of 
Mg 2p between them has no difference. As a result, only one symmetrical 
peak of Mg 2p is detected for FMA3 and FMA4 samples, though a second 
phase of β-TCMP is discovered by GIXRD.
Element concentration in the coating can be determined by the ratio of 
area under the respective elemental peak in an XPS narrow scan. Figure 3.27 
shows the measured Mg concentration in the coating (indicated by capital X) 
in comparison with the designed value before and after Ar+ etching. The 
squares show the ideal situation when all the designed Mg are completely 
incorporated into the HA crystal structure. The circles represent the measured 
Mg concentrations on the surface of the coatings before the Ar+ etching, and 
triangles for that after the etching. Although the measured Mg concentra-
tion (X value) increases with the increase in designed x value, a discrepancy 
is observed between the designed and measured concentrations, especially 
after x > 0.5. After the etching, the measured Mg concentration has shown to 
decrease significantly with contents much lower than that on the surface of 
the coating. The difference in the Mg concentration before and after the etch-
ing indicates that only a portion of Mg is incorporated into the HA crystal 
structure (x > 0.5), and the remaining ions are abundant on the surface of the 
coating. After the removal of the Mg on the surface of the coating, the mea-
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Comparison of the measured Mg concentration in the MgxFHA coatings before and after 
etching with the designed Mg concentration in the sols. (From Thin Solid Films, 519, Cai, Y., 
Zhang, S., Zeng, X., Qian, M., Sun, D., and Weng, W., Interfacial study of magnesium-containing 
fluoridated hydroxyapatite coatings, 4629, 2011, with permission from Elsevier.)
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structure, and the corresponding formula is Ca9.2–9.5Mg0.8–0.5(PO4)6F1(OH)1, i.e., 
about 1.2–1.9 wt% of Mg replaces Ca in the HA crystal structure.
Fourier transform infrared spectroscopy (FTIR) identifies chemical 
groups in different coatings, as shown in Figure 3.28. There are three peaks 
at 1002–1015, 1086–1088, and 1120–1122 cm−1 for each coating, due to the 
triply asymmetric v3 stretching vibration of the phosphate group (PO43−). 
A weak peak at 964–965 cm−1 represents the v1 symmetric stretching vibra-
tion of PO43−. The presence of typical peaks of PO43− indicates the formation 
of apatite on the substrate [103]. Also there are two weak peaks between 
1400 and 1500 cm−1, ascribing to the v3 stretching vibration of carbonate 
(CO32−) [104]. The existing of carbonate groups in the coating is from the 
coating preparation process.
Furthermore, there is a weak peak around 3540 cm−1 relating to the F incor-
poration into the apatite crystal structure. For pure HA coating, a peak at 
about 3570 cm−1 is detected due to the stretching of O−H in an infinite OH 
chain. While for FHA coatings, the new peak at about 3540 cm−1 is caused 
by the direct influences of incorporated F on the stretching vibration of OH 
groups through the hydrogen bonds along OH channel, i.e., −OH−F− [69]. 
The presence of the peak at 3540 cm−1 is another evidence of the replacement 
of OH− groups by F− ions.
3.4.1.3  Surface and Interface
Figure 3.29 shows the SEM surface and cross-sectional views of the coat-
ing on Ti6Al4V substrate. The coatings are dense and uniform with a thick-





















FTIR spectra of MgxFHA coatings on Ti6Al4V substrates.
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repeated abrading and polishing, suggesting good bonding between the 
coating and the substrate.
Glow discharge optical emission spectroscopy (GDOES) provides elemen-
tal information and is used to acquire elemental distribution from coating to 
substrate through depth profiling. GDOES depth profile of FMA4 is plotted 
in Figure 3.30. It shows the distribution of main elements of the coating and 
the substrate along the depth direction, including Ca, P, O, Mg, F, Ti, and Al. 
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Figure 3.29
Surface (a) and cross-sectional view (b) of FMA4 on Ti6Al4V substrates. (From Thin Solid Films, 
519, Cai, Y., Zhang, S., Zeng, X., Qian, M., Sun, D., and Weng, W., Interfacial study of magnesium-





















GDOES depth profile of FMA4 (Mg20: 20 times of Mg concentration; F100: 100 times of F 
concentration). (From Thin Solid Films, 519, Cai, Y., Zhang, S., Zeng, X., Qian, M., Sun, D., and 
Weng, W., Interfacial study of magnesium-containing fluoridated hydroxyapatite coatings, 
4629, 2011, with permission from Elsevier.)
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Along the depth direction, the elemental distribution at cross section can 
be divided into three regions: the coating region (Rc), the transitional region 
(Rt), and the substrate region (Rs). The masses of Ca, P, O, and F in the coat-
ing are very stable in the coating region. The mass of Mg decreases from 
the coating to the substrate, in agreement with our previous study that Mg 
ions can only be partially incorporated into HA lattice, whereas extraneous 
ions are abundant on the surface of the coating. At the boundary between 
the Rc and the Rt, the concentrations of Ca, P, Mg, and F begin to decrease, 
whereas there is a slight increase in O concentration followed by a sharp 
decrease. The increase in O might owe to the presence of F ions, because 
nc-CaF2 formed in the dipping sol could be easily absorbed on the substrate 
surface through hydrogen bond, which could attract more O near the inter-
face [8]. As can be seen in Figure 3.30, the transitional region Rt is around 
700 nm. As all the elements of the coating and substrate are seen in the Rt, 
diffusion of coating elements into the substrate and substrate elements into 
the coating occur at the interface. At the boundary between the Rt and the Rs, 
all the elements in the coating disappear and the elements of the substrate, 
Ti and Al, begin to stabilize.
The chemical bonding near the interface of the coating and the substrate is 
analyzed through XPS. Figure 3.31 presents the results of XPS narrow scan 
near the interface of the Mg2FHA coating and the substrate. Ti 2p spectrum 
is shown in Figure 3.31a. Only Ti4+ is detected, Ti 2p3/2 at 458.3 eV and Ti 2p1/2 
at 464.0 eV, which can be attributed to TiO2/TiO32− [105,106]. Ca 2p (Figure 
3.31b) contains two different states: Ca 2p3/2 at 347.2 eV is the typical binding 
energy of Ca2+ in HA or FHA, and Ca 2p3/2 at 346.4 eV corresponds to that 
in CaTiO3 [105,107]. In consideration of the elemental diffusion during the 
firing stage, it is speculated that CaTiO3 forms at the coating/substrate inter-
face. Figure 3.31c shows O 1s spectrum. The main component at the binding 
energy of 529.7 eV is attributable to O2− species in TiO2/TiO32−, while that at 
531.3 eV can be assigned to O2− in HA or FHA [105,107]. Correspondingly, 
the binding energy of P 2p of PO43− in HA or FHA is located at 133.2 eV (not 
shown here) [107]. Mg 2p spectrum in Figure 3.31d presents only one peak at 
50.4 eV, which is the typical binding energy of Mg2+. As reported in the litera-
ture [108], MgTiO3 could be formed around 400°C. Also Mg is detected in the 
transitional region (Rt) (Figure 3.30). Therefore, it is speculated that MgTiO3 
also forms during the firing at 600°C. From the aforementioned GDOES and 
XPS analyses, it can be concluded that chemical bonds, especially Ca-O-Ti 
and Mg-O-Ti bonds, form at the coating/substrate interface.
3.4.2 Short-Term Osseointegration
It is a great concern that a stable anchorage achieves by direct bone-to-implant 
contact within the shortest time, so it is worthy of investigating the short-
term osseointegration in vitro. Moreover, Mg incorporation has shown to 
result in better biological performances. Thus, it is expected to have positive 
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effects on the in vitro bioactivity and cell response of the MgxFHA coatings, 
which are studied in the following text.
3.4.2.1  In Vitro Bioactivity
Figure 3.32 exhibits the GIXRD profiles of MgxFHA coatings after soaking in 
the SBF solutions for 7 and 28 days. After 7 days, as shown in Figure 3.32a, an 
obvious difference is observed around 32° for FMA3 and FMA4 as compared 
with that in Figure 3.25. For FMA3 and FMA4, the peaks of (211), (112), and 
(300) are combined into one broad peak, which implies the poorly crystallized 
apatite grown in the solution—evidence of precipitation of a new apatite layer 
on the primary coating. The diffraction peaks of substrate and calcium phos-
phate are found in all the samples. Figure 3.32b shows the GIXRD profiles 
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Figure 3.31
XPS spectra of Ti 2p (a), Ca 2p (b), O 1s (c), and Mg 2p (d) near the interface of the Mg2FHA coat-
ing and the substrate. (From Thin Solid Films, 519, Cai, Y., Zhang, S., Zeng, X., Qian, M., Sun, D., 
and Weng, W., Interfacial study of magnesium-containing fluoridated hydroxyapatite coatings, 
4629, 2011, with permission from Elsevier.)
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which are assigned to the newly formed apatite layer. Some other intermedi-
ate products like CaH2P2O7 and CaP4O11 are also detected.
Figure 3.33 shows SEM images of MgxFHA coatings before and after soak-
ing in the SBF solutions for 7 and 28 days. After soaking in the SBF solution for 
7 days, the surface morphology of FMA3 shows a newly formed porous layer 
(Figure 3.33, FMA3a). Similar observations are found on FMA4 (Figure 3.33, 









































GIXRD profiles of MgxFHA coatings on Ti6Al4V substrates after soaking in the SBF solu-
tions for (a) 7 days and (b) 28 days. (From Thin Solid Films, 517, Cai, Y., Zhang, S., Zeng, X., 
Wang, Y., Qian, M., and Weng, W., Improvement of bioactivity with magnesium and fluorine 
ions incorporated hydroxyapatite coatings via sol-gel deposition on Ti6Al4V alloys, 5347, 2009, 
with permission from Elsevier.)
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Surface morphology of MgxFHA coatings on Ti6Al4V substrates after soaking in the SBF 
solutions for (a) 7 days and (b) 28 days. (From Thin Solid Films, 517, Cai, Y., Zhang, S., Zeng, X., 
Wang, Y., Qian, M., and Weng, W., Improvement of bioactivity with magnesium and fluorine 
ions incorporated hydroxyapatite coatings via sol-gel deposition on Ti6Al4V alloys, 5347, 2009, 
with permission from Elsevier.)
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coatings. After 28 days (the b-series images), FMA2b, FMA3b, and FMA4b 
exhibit similar porous layer as FMA3a and FMA4a (precipitation of apatite), 
but FMA0b and FMA1b still show the dissolution characteristics.
The dissolution and precipitation behavior of HA coating are two of the 
main factors governing the bioactivity of HA coating [109]. When samples 
are immersed in the SBF solution, both the dissolution of the coating and 
the precipitation of the new apatite layer occur at the same time. When the 
precipitation is dominant, the new apatite layer forms. At the beginning of 
the process, the dissolution dominates. The kinetics of this process can be 




k s c c n= −∞1 1( )
where
dc/dt is the dissolution rate
k1 is the rate constant for dissolution
s1 represents the specific area
c∞ stands for the equilibrium concentration
c for the concentration of solution at different times
n is the effective order of reaction
As soon as the coatings are immersed in the SBF solution, the difference of 
coatings in terms of (c∞ − c) can be ignored. Thus, the specific area of the coat-
ings, s, has main influence on the dissolution rate. The dissolution increases 
with the increase in the contact surface area with the solution. The specific 
area of the coatings depends on the crystallite size of the coating: the larger 
the crystallite size, the less the specific area of the coating is. Scherrer for-
mula (Dhkl = Kλ(β1/2cosθ)−1) is used to calculate the crystallite size in different 
coatings. In the formula, Dhkl is the crystallite size measured in the direction 
perpendicular to the diffraction planes hkl; K is the Scherrer constant (0.91 is 
used here); λ is the wavelength of x-ray (1.5406 Å); β1/2 is the broadening of the 
diffraction peak at half-maximum intensity; and θ is the half value of the dif-
fraction angle 2θ for hkl. The crystallite size of MgxFHA coatings calculated 
at (002) is 187.8, 182.0, 173.9, 155.6, and 169.7 Å; therefore, Mg1.5FHA coating 
has the highest dissolution rate, followed by Mg2FHA, Mg1FHA, Mg0.5FHA, 
and Mg0FHA coating, respectively. Namely, the higher the Mg concentra-
tion in the coatings (i.e., Mg1.5FHA and Mg2FHA), the faster the dissolution 
is. Another reason attributing to the high dissolution rate of Mg1.5FHA and 
Mg2FHA is the existence of small amount of β-TCMP, which has higher solu-
bility than Mg-containing HA [110]. As a result, the concentrations of cal-
cium ions and phosphate groups increase sharply, leading to the increase in 
local supersaturation, which is beneficial to the nucleation and growth of the 
new apatite crystals. The crystal growth (precipitation) can be described by a 
similar empirical equation [109]:
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− = − ∞
dc
dt
k s c c n2 2( )
where
−dc/dt is the crystal growth rate (precipitation)
k2 is the rate constant for crystal growth (precipitation)
s2 is a function of the total number of available nucleation sites
c∞ stands for the equilibrium concentration
c for the concentration of solution at different times
n is the effective order of reaction
The dissolution and precipitation are reversible, of which the direction is 
determined by the difference between the concentration of the solution (c) 
and the equilibrium concentration (c∞). When c∞ > c, the precipitation process 
predominates. Since the dissolution of Mg1.5FHA and Mg2FHA proceeds 
much faster than other coatings, Mg1.5FHA and Mg2FHA firstly reverse to 
the precipitation. This is evident in Figure 3.33a where a new apatite layer is 
observed only after 7 days. The new apatite layer is also observed on FMA2 
after 28 days, while not found on FMA0 and FMA1 even after 28 days. The 
rate of precipitation is governed by the concentration difference (c − c∞) and 
the number of available nucleation sites (s2). This again confirms that high 
Mg concentration favors the formation of new apatite layer. Both surface 
morphology observation and phase analysis show that the existence of Mg 
in the coating significantly affects the bone growth (formation of new apatite 
layer) in the SBF solution, i.e., the in vitro bioactivity of the coating. Higher 
concentration of Mg has better in vitro bioactivity.
The chemical groups are identified by FTIR after the in vitro bioactivity 
test, as shown in Figure 3.34. Compared with the FTIR spectra of the as-
deposited coatings (Figure 3.28), some changes are seen. For all the coatings, 
the weak peak between 1120 and 1122 cm−1 vanishes. The two peaks located 
at around 603 and 565 cm−1 correspond to the phosphate group (PO43−), 
ascribing to the deformation vibration of PO43− [22]. In addition, in Mg0FHA 
and Mg0.5FHA coatings, two peaks around 1041 and 1095 cm−1 belonging 
to (PO43−) are visible. In Mg1FHA, Mg1.5FHA, and Mg2FHA coatings, PO43− 
peak around 1031 cm−1 broadens, indicating the poor crystallinity of apa-
tite. Besides PO43− peaks, carbonate group (CO32−) peaks are also detected 
in Mg1FHA, Mg1.5FHA, and Mg2FHA coatings between 1400 and 1500 cm−1 
due to the v3 stretching vibration of carbonate, and another peak at about 
872 cm−1 ascribes to the v2 mode of CO32− [104]. Since the CO32− peaks do 
not show in the Mg0FHA and Mg0.5FHA coatings, CO32− forms during the 
growth of new apatite layer. The changes in chemical groups before and 
after soaking in the SBF solutions support the phase analysis and surface 
morphology observation that a new apatite layer forms on the surface of 
FMA2, FMA3, and FMA4.
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The chemical compositions of MgxFHA coatings after the bioactivity test 
are studied using the XPS technique. The survey scan profiles are shown 
in Figure 3.35. The main elements of the apatite coatings, Ca, P, and O, are 
detected in all the samples. F 1s is visible in FMA0 and FMA1 profiles, while 
not in FMA2, FMA3, and FMA4. It suggests a new apatite layer on the pri-
mary coating of FMA2, FMA3, and FMA4, while not on that of FMA0 and 
FMA1. A small amount of Mg is also detected after the in vitro bioactiv-
ity test. For FMA2, FMA3, and FMA4, Mg may be contained in the newly 
formed apatite layer during the biomimetic growth in the SBF solutions [111]. 
While for FMA0 and FMA1, the detected Mg might be due to the immersion 
in Mg-containing SBF solutions.
In summary, after soaking in the SBF solutions for 28 days, phase analy-
sis shows the formation of poorly crystallized apatite layer on the surface 
of FMA2, FMA3, and FMA4. FTIR spectra further confirm the existence 
of CO32− as well as PO43− in the new layer. This newly formed layer is also 
observed from SEM images, and all the elements in the apatite coatings are 
also detected by XPS. On the other hand, no obvious change is found in the 
phases, chemical groups, and chemical compositions in FMA0 and FMA1, 
and only the dissolution features are observed. Therefore, it is concluded 
that HCA layer forms on the surfaces of FMA2, FMA3, and FMA4, i.e., Mg in 
the coating results in better in vitro bioactivity as revealed by faster forma-





















FTIR spectra of MgxFHA coatings on Ti6Al4V substrates after soaking in the SBF solutions for 
28 days. 
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3.4.2.2  Cell Response
Osteoblastic cells are responsible for the synthesis and mineralization of 
bone during both initial bone formation and later bone remodeling. Human 
osteosarcoma MG63 cells exhibit fundamental phenotypic characteristics of 
osteoblastic cells, thus they are cultured for the evaluation of cell response 
on the coatings. Cell response on the MgxFHA coatings is studied in terms of 
cell morphology, cell proliferation, and differentiation.
Figure 3.36 shows typical SEM micrographs of MG63 cells after 3 days of 
culture on MgxFHA coatings. The dark areas signify the spreading of cell 
while the rough base is due to the coating dissolution in the culture medium. 
No significant difference is observed in cell morphology on different coat-
ings. All cells spread well and grow favorably on the coating surface. Under 
higher magnification (Figure 3.36c), the cell’s filopodium and lamellipodium 
are seen to be flat and adhered tightly on the coating surface, suggesting 
good viability on the coating. The well-spread cells on all MgxFHA coatings 
are expected to be favorable for cell growth.
Figure 3.37 shows the quantification of cell numbers at each cell culture 
period to monitor the cell proliferation process. On the first day, there is 
no significant difference between the coatings. After incubation for 3 days, 
FMA1 and FMA3 have significantly higher cell numbers than that on FMA0. 
After 5 days, the cell numbers on FMA3 are significantly higher than those 
on all the other coatings. Compared with the initial seeded cell density, all 
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Figure 3.35
XPS survey scan profiles of MgxFHA coatings on Ti6Al4V substrates after soaking in the SBF 
solutions for 28 days.
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5 days (four to six times as many as the seeded cell density). It indicates that 
all the coatings, regardless of the degree of Mg incorporation, have favor-
able viability with MG63 cells. Meanwhile, the most cell numbers on FMA3 
after 5 days predict that FMA3 coating (a relatively higher Mg concentration) 
stimulates cell proliferation more.
To evaluate the cell differentiation, ALP activity, an early differentiation 
marker, was first measured. Figure 3.38 reveals the intracellular ALP activity 
of MG63 cells cultured on MgxFHA coatings for different periods. A signifi-
cant increase (p < 0.05) in ALP activity is observed for all the coatings except 
for FMA4 in the first 2 weeks. From day 14 to day 21, a downregulation is 
seen for all the coatings: a significant decrease for FMA0, FMA1, and FMA3 
and an insignificant change for FMA2 and FMA4. The significant decrease 
indicates that more cells step into the next differentiation stage. However, 
there is no significant difference between Mg-incorporated coatings (from 
FMA1 to FMA4) and Mg-free one (FMA0).
20 kV ×200 100 µm 17 25 SEI 20 kV ×200 100 µm 17 25 SEI




Cell morphology after incubation on MgxFHA coatings for 3 days: (a) FMA0, (b) FMA3, and (c) 
FMA2 (higher magnification of a single cell). (From Cai, Y., Zhang, J., Zhang, S., Mondal, D., 
Venkatraman, S.S., and Zeng, X., Osteoblastic cell response on fluoridated hydroxyapatite coat-
ings: The effect of magnesium incorporation, Biomed. Mater., 5, 054114, 2010. With permission 
from Institute of Physics.)































(See	color	insert.) Cell proliferation on MgxFHA coatings in terms of cell density: *At day 3, 
FMA1 and FMA3 have a significantly higher cell number than that on FMA0 (p < 0.05). **At 
day 5, cell numbers on FMA3 are significantly higher than all the other coatings (p < 0.05). 
(From Cai, Y., Zhang, J., Zhang, S., Mondal, D., Venkatraman, S.S., and Zeng, X., Osteoblastic 
cell response on fluoridated hydroxyapatite coatings: The effect of magnesium incorporation, 
Biomed. Mater., 5, 054114, 2010. With permission from Institute of Physics.)


























(See	color	 insert.) Intracellular ALP activities of MG63 cells cultured on MgxFHA coatings 
over the culture period: no significant difference between Mg-incorporated coatings (from 
FMA1 to FMA4) and Mg-free one (FMA0). (From Cai, Y., Zhang, J., Zhang, S., Mondal, D., 
Venkatraman, S.S., and Zeng, X., Osteoblastic cell response on fluoridated hydroxyapa-
tite coatings: The effect of magnesium incorporation, Biomed. Mater., 5, 054114, 2010. With 
permission from Institute of Physics.)
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As a late marker of cell differentiation, OC expression is also measured 
as shown in Figure 3.39. At day 7, FMA3 exhibits a significantly higher OC 
expression than all the other coatings (p < 0.05), showing the fastest entry to 
the late differentiation stage. Then, a significant decrease in OC expression 
follows at days 14 and 21, which implies that more cells finish the differ-
entiation stage and shift to other stages. Also FMA2 at day 7 has a signifi-
cant higher OC expression than FMA0 and FMA4 (p < 0.05). However, FMA0 
reaches its maximum OC expression at day 14 over the whole culture period, 
meaning most cells undergo the late cell differentiation at day 14. The afore-
mentioned comparison reveals that Mg incorporation can accelerate late cell 
differentiation. However, considering Mg concentration on the accelerating 
effect, it is not the higher the better, since it is not observed on FMA4.
The healing of damaged bone should originate from the binding or adhe-
sion of cells to biomaterials, which is thought to be mediated primarily by 
membrane-associated adhesion receptors belonging to the integrin family 
[112]. The expression of specific integrin will determine cell proliferation, dif-
ferentiation, or even death. Moreover, divalent cations have been suggested 
to play a regulatory role in integrin-dependent cell adhesion. The binding of 
integrins to specific ligands depends on the presence of divalent cations, with 
most but not all cells preferring Mg2+ to Ca2+ ions. It was also reported that 
Mg2+ enhanced cell adhesion to collagen type I and to laminin in a concen-
tration-dependent manner [113]. Zreiqat et al. also proved that the adhesion 
of human bone-derived cell to Mg2+ ions modified bioceramic (Al2O3-Mg2+) 
































(See	color	insert.) Intracellular OC expression of MG63 cells cultured on MgxFHA coatings 
over the culture period: *FMA3 has a significantly higher OC expression than all the other coat-
ings (p < 0.05). (From Cai, Y., Zhang, J., Zhang, S., Mondal, D., Venkatraman, S.S., and Zeng, X., 
Osteoblastic cell response on fluoridated hydroxyapatite coatings: The effect of magnesium 
incorporation, Biomed. Mater., 5, 054114, 2010. With permission from Institute of Physics.)
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cell adhesion depends on integrin-associated signal transduction pathways 
involving signaling protein [114].
Since the F concentration is fixed for all the coatings, the stimulating effect 
on cell responses should come from incorporation of Mg2+ ions. Mg2+ ions 
seem to contribute to cell adhesion on the surface of the coating through 
the action of the integrin family existing on the cell membrane. Mg2+ ions 
bind cells to the coating surface to accelerate cell adhesion, proliferation, dif-
ferentiation, and finally bone formation. Considering that FMA3 shows a 
significant difference in cell proliferation (the most cell numbers) and late 
cell differentiation (the highest OC expression), it is probable that Mg2+ ions 
both in the apatite lattice and in the surface of apatite crystals act directly 
or indirectly to promote cell responses. However, regarding the Mg2+ con-
centration in the coating, it is not the higher the better. In the present study, 
MgxFHA coating exhibits optimum cell responses at x = 1.5. Furthermore, the 
dissolved Mg2+ ions from the coating can contribute to becoming a source for 
the remodeling of new bone.
3.4.3 long-Term Stability
The long-term stability study of surface-coated medical implants is to relieve 
mainly two concerns: dissolution rate of coating and adhesion strength 
between coating and substrate. Therefore, in this part, the long-term stability 
of the MgxFHA coatings is investigated based on both the dissolution rate 
of coating and the adhesion strength between the coating and the substrate.
3.4.3.1  Dissolution Rate
The dissolution behaviors of MgxFHA coatings in the tris-buffered saline 
(TBS) solution are shown in Figure 3.40. The concentration of Ca2+ released 
from the coating into the solution increases (Figure 3.40), while the dissolu-
tion rate of the coating decreases (Figure 3.41) with the soaking time. The 
dissolution curves divide into two distinct stages: the initial sharp increase 
in Ca2+ concentration and the sharp decrease in the dissolution rate during 
the first 7 days, followed by a slow increase in Ca2+ concentration and finally 
a nearly constant dissolution rate. The different dissolution behaviors in the 
two stages are due to the different driving force to the dissolution. In the first 
stage, the dissolution should be surface dissolution limited. In the prepared 
coatings, other phases, such as amorphous phase, must be existent in the 
coatings. The solubilities of some calcium phosphates are as follows [115]:
 ACP TTCP TCP DCPD DCP OCP TCP HA FHA ≈ > > > > >α β- -
Therefore, more soluble phases on or near the coating surface are dissolved 
into the solution very quickly, leading to the sharp increase in Ca2+ concen-
tration during the first 7 days. As the driving forces for all the coatings are 
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Figure 3.40
Dissolution behaviors of MgxFHA coatings in the TBS solution: Ca2+ concentration as a func-
tion of both soaking time and Mg concentration. (From Cai, Y., Zhang, J., Zhang, S., Mondal, D., 
Venkatraman, S.S., and Zeng, X., Osteoblastic cell response on fluoridated hydroxyapatite coat-
ings: The effect of magnesium incorporation, Biomed. Mater., 5, 054114, 2010. With permission 
from Institute of Physics.)
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same, there is no significant difference on the dissolution behavior among 
different coatings. After the removal of these more soluble phases near the 
surface of the coating, the dissolution of the coating becomes diffusion lim-
ited, and the effective dissolution rate is approaching to that of the phases 
in the coating. As discussed in Section 3.4.1.1, FHA phases are the main 
phases in all the coatings, and a small amount of β-TCMP exists in FMA3 
and FMA4. Because β-TCMP is more soluble than FHA, FMA3 and FMA4 
releases more Ca2+ into the solution after the first 7 days, and FMA3 shows 
the fastest dissolution.
On the other hand, the dissolution behavior shows that Mg incorpora-
tion into the coating has a negative effect on the dissolution resistance of 
the coating, which was also reported by other researchers [98]. The pos-
sible reason is that the substitution of Ca atom with Mg atom in the apa-
tite structure destabilizes the crystal structure. When the central Ca atom 
is replaced by Mg atom, the structure becomes asymmetrical. Hydroxyl 
groups locate on one side of the central atom, and the six external calcium 
atoms displace contralaterally. Also the replacement of the central Ca atom 
by Mg atom shortens the bond lengths between the central atom and sur-
rounding oxygen atoms and shrinks the structure [116]. When Mg ions are 
simultaneously incorporated into the HA coating with F ions, this defor-
mation may not only destabilize the apatite structure, but also influence the 
ordered structure formed by the F incorporation in the apatite structure. 
It is well known that the solubility of HA coating can be decreased by the 
substitution of OH− with F− in the HA lattice [7,15,83]. In the HA crystal 
structure, H+ in a OH− can bond with O2− from different directions along 
the c-axis; once an OH− is replaced by a F−, a stronger hydrogen bond forms 
between the F− and the nearby OH−, forming a more ordered structure, 
especially at a 50% substitution [15]. Thus, the replacement of Ca2+ by Mg2+ 
results in the increased solubility of MgxFHA coating (x > 0) in comparison 
with FHA coating.
The release of Mg2+ ions from the coating into the solutions is also mea-
sured. Taking FMA3 as an example, the Mg2+ concentration increases with 
the soaking time, shown in its typical dissolution behavior in Figure 3.42. 
As shown in the inset of Figure 3.42, the Mg2+ concentration of different 
coatings exhibits the same trend as that of the Ca2+ concentration after 
soaking in the TBS solution for 28 days. The dissolution behavior of Mg2+ 
can be explained in terms of coating composition, which is measured by 
XPS (Figure 3.27). Excessive Mg distributes on the surface of the coatings, 
and the measured Mg concentration increases with the increase in the 
designed Mg in the sol. Therefore, the coating with higher Mg concen-
tration releases more Mg2+ ions into the solution (FMA1 < FMA2 < FMA3); 
however, FMA4 (the highest Mg concentration) releases less Mg2+ than 
FMA3. This might be due to the extra Mg ions on the surface of the coat-
ing, which protect the coatings from dissolution because the vacancies or 
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tangling bonds that are active in dissolution are filled with Mg ions, thus 
leading to slower dissolution.
After the dissolution test, the surface morphologies of the dissolved 
MgxFHA coatings have no significant difference, as shown in Figure 3.43. 
A rough and porous surface is observed on both FMA3 and FMA4, and the 
pore diameter is 2–3 μm. As a result of different solubility of different phases 





































Dissolution behavior of FMA3 in the TBS solution: Mg2+ concentration as a function of soaking 
time (inset: total Mg2+ concentration after 28 days). (From Cai, Y., Zhang, J., Zhang, S., Mondal, D., 
Venkatraman, S.S., and Zeng, X., Osteoblastic cell response on fluoridated hydroxyapatite coat-
ings: The effect of magnesium incorporation, Biomed. Mater., 5, 054114, 2010. With permission 
from Institute of Physics.)
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Figure 3.43
Surface morphology of MgxFHA coatings on Ti6Al4V substrates after soaking in the TBS 
solutions for 28 days: (a) FMA3 and (b) FMA4.
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a porous morphology with the dissolution-resistant phases (HA or FHA) 
within the coating.
Since the initial dissolution of the coating is beneficial to the healing pro-
cess as well as the osseointegration [117], the current dissolution behaviors 
of different coatings are promising. When a synthetic HA ceramic was 
exposed in vivo, a small amount of the ceramic was phagocytized, but the 
major remaining part acted as a secondary nucleator as evidenced by the 
appearance of a newly formed mineral [118]. The initial sharp dissolution 
of the coating increases the concentrations of calcium and phosphate ions 
to create a locally supersaturated environment, causing the precipitation 
and growth of biological apatite crystals from the surface of the initial syn-
thetic crystals with simultaneous incorporation of various ions presented 
in the biologic fluid. This is favorable to speed up the formation of links 
between the implant and the bone. On the other hand, it is easier for 
osteoblast cells to attach and grow on a rough and porous surface and 
then form new bone.
3.4.3.2  Adhesion Strength
The adhesion strength between the coating and the substrate is mea-
sured by the pull-off test. The typical morphology of rupture surfaces of 
the Mg2FHA coating after the pull-off test is shown in Figure 3.44. It can 
be seen that both the adhesive and cohesive failures are present. Figure 
3.44a shows the typical adhesive failure where a piece of the coating is 
detached from the substrate. Cohesive failure can be observed in Figure 
3.44b. It happens within the coating and is spot flaking around the sur-
face of the coating. “Pull-off adhesion strength” test is conducted on the 
coatings (data shown in Figure 3.45), but it is not able to distinguish the 
failure modes. Without Mg incorporation (FMA0), the pull-off adhesion 
20 kV
(a) (b)
×100 100 µm 17 25 SE I 20 kV ×100
Cohesive failure
100 µm 17 25 SE I
Adhesive failure
Figure 3.44
Typical morphology of rupture surfaces of the Mg2FHA coating: (a) adhesive failure and 
(b) cohesive failure.
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strength is about 12 MPa. When Mg is incorporated, it increases signifi-
cantly (p < 0.05) to about 18 MPa. However, there is no significant difference 
between different Mg concentrations.
Both the mechanical interlocking and the chemical bonding contribute 
to the adhesion between the coating and the substrate. In this work, all 
the substrates were polished to grade #1200 of SiC sandpapers to achieve 
the same finish. Moreover, Blackwood et al. proved that the adhesion 
became independent of surface finish at levels smoother than #600 [119]. 
Therefore, the mechanical interlocking is considered as identical among 
all the samples, thus the main contribution to the adhesion strength is the 
chemical bonds at the interface of the coating and substrate formed during 
the coating deposition process, especially at the firing stage. During the 
firing process, the elements of the coating and the substrate diffuse toward 
each other. As can be seen in Figure 3.30, all the elements are present in the 
transitional region (Rt). Without Mg incorporation, chemical bonds between 
Ti, O, Ca, P, and F atoms are formed at the interface, such as Ca-O-Ti bonds, 
which could contribute to higher adhesion strength [8]. When Mg ions 
are incorporated, Mg-O-Ti bonds form at the interface as well as Ca-O-Ti 
bonds, which would make the chemical bonds even stronger and result in 
much higher adhesion strength. Since more Mg ions are abundant on the 
surface of the coating, Mg concentration near the interface might be not 
significantly different among MgxFHA coatings, thus there is no significant 
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Figure 3.45
Pull-off adhesion strength between MgxFHA coatings and Ti6Al4V substrates: Mg incorpora-
tion enhances the pull-off adhesion strength significantly (p < 0.05), but no significant differ-
ence between different Mg concentrations.
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3.5	 	Effect	of	Fluorine	Substitution	in	Magnesium-Containing	
Hydroxyapatite	Coatings*
Fluorine ions are incorporated into magnesium-containing HA coatings 
to enhance the long-term stability. The as-deposited coatings are denoted 
by MgFyHA (Ca9Mg1(PO4)6Fy(OH)(2−y), y varies from 0 to 2). The correspond-
ing samples were labeled as MFA0, MFA1, MFA2, MFA3, and MFA4, or the 
corresponding coatings as MgF0HA, MgF0.5HA, MgF1HA, MgF1.5HA, and 
MgF2HA for further discussion.
3.5.1 Co-Substitution of Mg and F ions in the MgFyHa Coatings
3.5.1.1  Phase Evolution
GIXRD patterns of as-deposited MgFyHA coatings are shown in Figure 3.46. 
Without F incorporation (MFA0), β-TCMP is detected as the main phase, and 
HA phase exists as the secondary phase. Due to the presence of Mg ions, the 
transformation temperature from apatite to β-TCMP can be 100°C lower than 
pure β-TCP (700°C–800°C). Furthermore, Ca ion vacancies in the ideal β-TCP 
* With kind permission from Springer Science+Business Media: J. Mater. Sci. Mater. Med., 
Cai, Y., Zhang, S., Zeng, X., and Sun, D., Effect of fluorine incorporation on long-term stability 
of magnesium-containing hydroxyapatite coatings, 22, 2011, 1633.
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GIXRD patterns of as-deposited MgFyHA coatings on Ti6Al4V substrates. (With kind per-
mission from Springer Science+Business Media: J. Mater. Sci. Mater. Med., Cai, Y., Zhang, S., 
Zeng, X., and Sun, D., Effect of fluorine incorporation on long-term stability of magnesium-
containing hydroxyapatite coatings, 22, 2011, 1633.)
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structure are too small to accommodate Ca ions, but allow for the inclusion 
of Mg ions, which thereby stabilizes the structure resulting from the differ-
ence in size of Ca2+ ions (0.99 Å) and Mg2+ ions (0.69 Å) [102,120]. Since the 
designed (Ca, Mg)/P ratio in MgF0HA is 1.67, which exceeds the stoichiomet-
ric molar ratio of 1.5 for β-TCP, Mg ions preferentially incorporate into β-TCP 
lattice and the excess of Ca ions form HA phase.
When F is incorporated, FHA becomes the main phase in all the MgFyHA 
coatings (y > 0), confirmed by the slight shifting of the main diffraction peaks 
toward higher degrees compared with that of HA [91]. Furthermore, it is wor-
thy of noting that when F concentration increases from 0 to 0.5, i.e., MgF0.5HA 
(MFA1), β-TCMP is detected only with weak intensity; as F concentration 
further increases, no more β-TCMP forms. This is a clear indication of F ions’ 
suppression ability of β-TCMP formation. In other words, F promotes the 
substitution of Ca2+ with Mg2+ in the HA lattice, in agreement of our previous 
findings (Section 3.4.1.1) as well as other researches [96].
3.5.1.2  Co-Substitution of Mg and F Ions in the MgFyHA Coatings
The shift of (211) and (300) peaks and the shrinkage of a-axis take place 
when fluorine ions are incorporated into the HA crystal structure [69–71]. In 
the MgFyHA coatings, the two-theta of (300) peak and calculated a-axis are 
listed in Table 3.3. As F concentration increases from 0 to 1.0, the (300) peak 
shifts toward higher degree due to the substitution of larger OH− (1.68 Å) 
with smaller F− (1.32 Å). However, at F concentration of 1.5, the two-theta of 
(300) peak remains the same with that of 1.0. When F concentration increases 
further to 2.0, (300) peak shifts a little to higher degree. The same trend is 
also observed from the change of a-axis. The gradual shrinkage of a-axis 
along with the increase of F concentration indicates the replacement of OH− 
groups by F− ions in the HA crystal structure. As mentioned in Section 
3.4.1.2, the shift of (002) peak and the decrease in c-axis are indications of 
Mg substitution in the HA lattice. In pure HA, the two-theta of (002) is 25.88° 
and c-axis is 6.88 Å as shown in PDF#09-0432. In the MgFyHA coatings, the 
(002) peak shifts to a higher degree of 26.02° or 26.04°, and calculated c-axis 
is ∼6.84 Å. Since the designed Mg concentration is the same among the 
MgFyHA coatings, there is no obvious difference between the c-axis values.
Table 3.3
Two-Theta of (300) Peak and Calculated a-Axis 
of MgFyHA Coatings
Sample MFA0 MFA1 MFA2 MFA3 MFA4
Two-theta (°) 33.00 33.16 33.22 33.22 33.24
a-axis (Å) 9.39 9.35 9.33 9.33 9.33
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XPS analysis of MgFyHA coatings (chemical states and F concentration) 
are shown in Figure 3.47. The survey scans (Figure 3.47a) present the exis-
tence of all the elements in MgFyHA coatings including C 1s, which is the 
contaminant. Since F concentration varies in MgFyHA coatings, F incorpo-
ration and concentration in the coatings are analyzed. Only one peak is 
detected in the F 1s narrow scans (Figure 3.47b) of the coatings. The binding 
energy is 684.3 ± 0.1 eV, which is the fingerprint of F in FHA or FA structure 
[8,75]. The result indicates the incorporation of F ions into the HA crystal 
structure. Moreover, the intensity of F 1s peak increases when F concentra-
tion increases, indicating that more F ions are incorporated. Figure 3.47c 
exhibits the comparison of the designed and the measured F concentra-



















































































Designed F concentration in the sol (y)
Figure 3.47
XPS analysis of MgFyHA coatings: (a) XPS survey scans of MgFyHA coatings, (b) XPS nar-
row scans of F 1s, (c) fluorine concentration in MgFyHA coatings (straight line: designed; solid 
square: measured).
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the designed F in the sols are completely incorporated into the HA crystal 
structure. The data points are F concentrations determined by XPS in the 
as-deposited coatings. There is a discrepancy between the designed and 
measured F concentrations, especially at higher levels. The loss of fluorine 
might be due to the formation of HF during the sol–gel dip-coating pro-
cess [75]. Fluorine concentration in the coating is measured in the range of 
0.39–1.16 mol F−/mol apatite. Besides F incorporation, Mg 2p at 50.3 eV is 
also detected (not shown here), which confirms the substitution of Mg in 
the HA lattice.
Figure 3.48 shows FTIR spectra of MgFyHA coatings. The typical peaks of 
phosphate group (PO43−) are in the range of 1000–1200 cm−1 due to the triply 
asymmetric v3 stretching vibration and between 960 and 970 cm−1 caused 
by v1 symmetric stretching vibration [103]. Two weak peaks between 1400 
and 1500 cm−1 ascribe to the v3 stretching vibration of carbonate (CO32−) 
[104]. Without F incorporation (MFA0), there is a peak at 3570 cm−1 due to 
the stretching vibration of free OH groups. When F ions are incorporated, 
the stretching peak of OH shifts to a lower frequency at 3540 cm−1 due to the 
stretching of OH-F band when the OH groups are partially replaced by the 
F ions [38,69]. Moreover, the intensity of the peak at 3540 cm−1 decreases as 
F concentration increases, implying that more F ions are incorporated into 
HA lattice. It is worthy of noting that this peak is still present in MFA4 with 
weak intensity, meaning the existence of OH–F band in the coating. In other 
words, F− ions do not completely replace OH− groups when the designed 
fluoridation degree is 2.0, because the OH stretching band disappears in 
the case of pure FA [38]. This is in agreement with the measurement of 





















FTIR spectra of MgFyHA coatings on Ti6Al4V substrates.
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3.5.1.3  Surface and Interface
Surface and cross-sectional views of MgFyHA coatings are similar to those 
of MgxFHA coatings, thus not shown here. The elemental distribution from 
the coating to the substrate is acquired by GDOES. A typical GDOES depth 
profile is plotted in Figure 3.49, showing the distribution of Ca, P, O, Mg, 
F, Ti, and Al along the depth direction. Three regions are identified at the 
cross section along the depth direction: the coating region (Rc), the tran-
sitional region (Rt), and the substrate region (Rs). Tangent method is used 
to determine the boundaries between two adjacent regions. In the coating 
region Rc, most of the elements in the coating are stable. At the bound-
ary of Rc and Rt, the concentration of Ca, P, Mg, and F begins to decrease, 
whereas there is an abrupt increase in O concentration followed by a sharp 
decrease. The increase in O might be due to the presence of F ions because 
nc-CaF2 formed in the dipping sol could be easily absorbed on the sub-
strate surface through hydrogen bonds, which could attract more O near 
the interface [8]. In the region of Rt, all the elements of the coating as well 
as the substrate are present. Also the width of the Rt is about 500 nm. Thus, 
it is speculated that the mutual diffusion of the elements in the coating 
and the substrate takes place during the coating deposition process. At the 
boundary between the Rt and the Rs, Ti and Al stabilize, and Ca, P, O, Mg, 
and F disappear.
XPS narrow scans near the interface of the MgF1.5HA coating and the 
























GDOES depth profile of MFA3 (Mg20: 20 times of Mg concentration; F100: 100 times of F con-
centration). (With kind permission from Springer Science+Business Media: J. Mater. Sci. Mater. 
Med., Cai, Y., Zhang, S., Zeng, X., and Sun, D., Effect of fluorine incorporation on long-term 
stability of magnesium-containing hydroxyapatite coatings, 22, 2011, 1633.)
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are analyzed. Figure 3.50a shows Ti 2p spectrum. Only Ti4+ is detected, Ti 
2p3/2 at 458.5 eV and Ti 2p1/2 at 464.2 eV, the typical binding energy in tita-
nium dioxide (TiO2) or titanate group (TiO32−) [105,106]. Ca 2p spectrum in 
Figure 3.50b contains two different states: Ca 2p3/2 at 347.4 eV is the typical 
binding energy of Ca2+ in HA or FHA; Ca 2p3/2 at 346.7 eV can be attributed 
to CaTiO3 [105,107]. Since the elemental interdiffusion takes place during 
the firing stage, it is speculated that CaTiO3 forms near the interface of the 
coating and the substrate, i.e., Ca-O-Ti bonds form at the coating/substrate 
interface. O 1s spectrum is shown in Figure 3.50c. The main component 
at the binding energy of 529.9 eV can be assigned to O2− species in TiO2/
TiO32− and that at 531.3 eV corresponds to O2− in HA or FHA [105,107]. P 2p 
locating at 133.4 eV (not shown here) is attributable to PO43− in HA or FHA 
[107], further proving the apatite formation. Figure 3.50d presents Mg 2p 
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XPS spectra of Ti 2p (a), Ca 2p (b), O 1s (c), and Mg 2p (d) near the interface of the MgF1.5HA 
coating and the substrate. (With kind permission from Springer Science+Business Media: 
J. Mater. Sci. Mater. Med., Cai, Y., Zhang, S., Zeng, X., and Sun, D., Effect of fluorine incorpora-
tion on long-term stability of magnesium-containing hydroxyapatite coatings, 22, 2011, 1633.)
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energy of Mg2+. Since Mg2p of pure Mg metal is around 49.8 eV, the peak 




After soaking in the SBF solutions for 28 days, the phases are indentified by 
GIXRD, shown in Figure 3.51. The GIXRD profiles are different from that of 
as-deposited MgFyHA coatings (Figure 3.46). A broad peak is seen around 
32° on all the samples, indicating a poorly crystallized apatite. Also main dif-
fraction peaks of Ti6Al4V substrate are not observed, which should be at 40.5°, 
38.5°, and 35.4°. The absence of the diffraction peaks of the substrate also sug-
gests the formation of a new layer on the as-deposited coatings because the 
thickness of the detected layer is over the detection limit of GIXRD (usually 
several micrometers). Besides the apatite phase, β-TCMP is present in MFA0. 
Since β-TCMP is the main component of as-deposited MgF0HA, it still exists 
after soaking in the SBF solution. Since the poorly crystallized apatite forms 
on all the MgFyHA coatings, it suggests comparable bioactivity of MgFyHA 
coatings regardless of the fluoridation degree.
Formation of new apatite phase is also supported by the surface 
morphology observation. Figure 3.52 shows typical surface morphologies 



















GIXRD profiles of MgFyHA coatings on Ti6Al4V substrates after soaking in the SBF for 28 days.
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After soaking, the surface is quite flat and homogeneous. From the high 
magnification (Figure 3.52b), this newly formed layer has submicroscale 
network structure, which is the typical microstructure of bone-like apatite 
grown in the SBF solution.
3.5.2.2  Cell Response
Typical SEM images of MG63 cells after cultured on MgFyHA coatings for 
3 days are shown in Figure 3.53. Taking MFA1 and MFA3 as examples, no 
significant difference is observed in cell morphology on different coatings 
(Figure 3.53a and b). All cells spread well and grow favorably on the coat-
ing surface. Cells attach tightly on the coating surface with their filopodium 
and lamellipodium (Figure 3.53c and d), suggesting good viability on all the 
coatings regardless of F concentration.
Cell proliferation is quantified through cell numbers at each cell culture 
period. Figure 3.54 shows cell proliferation on MgFyHA coatings in terms of 
cell density. During the whole cell culture period, no significant difference is 
observed among different coatings (p < 0.05). However, cell numbers increase 
sharply after incubation for 5 days, over five times compared with the initial 
seeded cell density. It indicates that all the coatings, regardless of the fluori-
dation degree, have favorable viability with MG63 cells.
ALP is an important intracellular enzyme and is considered as a prereq-
uisite for normal skeletal mineralization. ALP activity is the most widely 
recognized early marker of osteoblastic cell differentiation [121]. In this 
work, ALP activity was measured to evaluate the early cell differentiation, 
as revealed in Figure 3.55. Significant increase (p < 0.05) in ALP activity is 
observed for all the coatings except for MFA0 in the first 2 weeks. Both MFA2 
and MFA3 have a significantly higher ALP activity than MFA0 after 14 days. 
Then, a downregulation is seen on most of the coatings. This trend in ALP 
20 kV ×1,000 10 µm 17 25 SE I 20 kV ×8,000 2 µm 17 25 SE I
(a) (b)
Figure 3.52
SEM images of MgF1HA coating on Ti6Al4V substrates after soaking in the SBF for 28 days ([b] 
is the higher magnification of [a]).
115Simultaneous Incorporation of Mg and F Ions in HA Coatings
20 kV ×300 50 µm 19 25 SE I
(a)
20 kV ×300 50 µm 19 25 SE I
(b)
20 kV ×1,000 10 µm 19 25 SE I
(c)
20 kV ×700 20 µm 19 25 SE I
(d)
Figure 3.53






























(See	color	insert.) Cell proliferation on MgFyHA coatings in terms of cell density: no signifi-
cant difference is observed on different coatings (p < 0.05).
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activity indicates that F ions stimulate early cell differentiation mostly at the 
2nd week with a designed fluoridation degree of 1.0–1.5 (the measured one 
of 0.72–0.97).
OC is the predominant noncollagenous protein of bone and dentin 
and plays roles in bone formation and remodeling [122]. Late cell 
differentiation is assessed by OC expression, as shown in Figure 3.56. At 
day 7, MFA2 exhibits a significantly higher OC expression than all the 





























Intracellular ALP activities of MG63 cells cultured on MgFyHA coatings over the culture 

































Intracellular OC expression of MG63 cells cultured on MgFyHA coatings over the culture 
period: *MFA2 has a significantly higher OC expression than all the other coatings (p < 0.05).
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among different coatings after 14 and 21 days. Although comparable levels 
of OC expression are found on different coatings after 14 and 21 days, 
the fastest entry of MFA2 to the late differentiation stage suggests that 
F incorporation in the coating can accelerate cells to late differentiation 
stage when the designed fluoridation degree is around 1.0 (the measured 
F concentration is 0.72).
It is well known that fluorine can directly stimulate cell proliferation and 
alkaline phosphate activity [123]. In our previous studies, when only F ions 
were incorporated into HA coatings, a significantly higher (p < 0.05) cell 
proliferation was observed on FHA coatings at the fluoridation degree of 
0.8–1.1 [15]. However, this stimulation effect of F incorporation is not shown 
when Mg ions are co-substituted into HA coating. It might be due to the 
presence of Mg ions. Mg ions were proved to accelerate osteoblast cell adhe-
sion on FGMgCO3Ap–collagen composite [6]. Also in Section 3.4.2.2, Mg ions 
were shown to have more profound stimulation effect on cell proliferation 
than on early cell differentiation. Therefore, when F ions were co-substituted 
into HA with Mg ions, the effect of Mg ions on cell proliferation might over-
shadow that of F ions. Consequently, no significant difference is observed on 
cell proliferation with varied F concentrations.
The stimulating effect of fluorine is dose dependent as a higher dosage 
might cause toxic effect [123,124]. Generally, a moderate level of F content 
(Ca10(PO4)6F∼1.0(OH)∼1.0) is recommended in clinical application. For example, 
in Cheng et al.’s work, when x is in the range of 0.67–1.68 (Ca10(PO4)6Fx(OH)2−x), 
sol–gel derived FHA coating is the most suitable for implantation [91]. 
Wang et al. further optimized the fluoridation degree, and they found that 
FHA coating exhibited the best dissolution resistance and cell activities 
at the molar level of fluorine ions from 0.8 to 1.1 [15]. Also in the case of 
electrochemical deposition, FHA coating with fluoridation degree from 1.0 
to 1.25 had the most positive stimulating effects on cell proliferation and 
ALP activities [66]. In our study, the coatings with a measured fluoridation 
degree of 0.72–0.97 exhibit the most predominant stimulating effect on cell 
differentiation (ALP activity and OC expression), which is in agreement with 
the study mentioned earlier.
Moreover, it seems that the effect of F ions on cell behaviors varies at dif-
ferent stages. Inoue et al. investigated in vitro response of osteoblast-like 
and odontoblast-like cells to unsubstituted and substituted apatites, and 
they found that F ions contributed more to differentiation rather than to 
proliferation in the early period [125]. Similar results were also reported by 
Kim et al. They studied the effect of fluoridation of HA in hydroxyapatite–
polycaprolactone (HA–PCL) composites on osteoblast activity and found 
that the proliferation of MG63 cells on FHA–PCL composite was at a similar 
level to those on HA–PCL composite. However, the ALP activity and OC 
production were increased significantly by the increase in fluoridation of 
HA [126]. Our study presents similar results: there is no significant difference 
on cell proliferation, but the stimulating effect is observed on both early and 
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late stages of cell differentiation (significantly higher ALP activity and OC 
expression at the measured fluoridation degree of 0.72).
3.5.3 long-Term Stability
Fluorine substitution in magnesium-containing HA coatings is expected to 
improve the long-term stability of the implant. In this part, the long-term 
stability of the MgFy HA coatings is investigated in detail. The dissolution 
behavior is monitored by the change of Ca2+ concentration in the TBS solu-
tion, and the adhesion strength between the coating and the substrate is 
measured by the pull-off test.
3.5.3.1  Dissolution Rate
The substitution of foreign ions into the HA lattice disrupts the crystal struc-
ture and, in turn, alters the dissolution properties of the materials in solu-
tion. In other words, the dissolution rate can be traced by the appropriate 
substitution of foreign ions into the HA lattice. The dissolution behavior 
of MgFyHA coatings with the fixed Mg content and the varied fluoridation 
degree is monitored by the change of Ca2+ concentration in the TBS solution, 
as shown in Figure 3.57. All the coatings release more Ca2+ ions with the 
increasing soaking time. However, MgF0HA coating without F incorpora-

































Dissolution behaviors of MgFyHA coatings in the TBS solution: Ca2+ concentration as a 
function of both soaking time and F concentration. (With kind permission from Springer 
Science+Business Media: J. Mater. Sci. Mater. Med., Cai, Y., Zhang, S., Zeng, X., and Sun, D., Effect 
of fluorine incorporation on long-term stability of magnesium-containing hydroxyapatite 
coatings, 22, 2011, 1633.)
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fastest dissolution rate (Figure 3.58). When more F ions are incorporated, less 
Ca2+ ions are released from MgF0.5HA, and the least Ca2+ ions from MgF1HA, 
MgF1.5HA, and MgF2HA coatings. The dissolution behavior of MgFyHA 
coatings reveals that MgF0HA coating has the highest dissolution rate, and 
MgF1HA, MgF1.5HA, and MgF2HA coatings have the lowest but compara-
ble dissolution rate. The dissolution rate is dependent on the solubility of 
the phases in the coating. From Figure 3.46, the phases of MgFyHA coat-
ings are detected as follows: most β-TCMP and little HA in MgF0HA, most 
FHA and little β-TCMP in MgF0.5HA, single FHA in MgF1HA, MgF1.5HA, 
and MgF2HA. Although β-TCMP is more stable and less soluble than β-TCP, 
and even that with 10.1 mol% Mg has a lower solubility than that of HA 
below pH 6.0, it is still more soluble than HA at pH 7.4 [127,128]. Thus, it is 
more soluble than FHA because the incorporation of F ions in the HA lat-
tice lowers the solubility of HA [7,15]. Also it is reported that the resorption 
of calcium phosphates as implants takes place in this order: FHA < Mg-TCP 
(β-TCMP) < HA < β-TCP < α-TCP [129]. Therefore, MgF0HA coating releases 
the most Ca2+ ions, less in MgF0.5HA coating, and the least in MgF1HA, 
MgF1.5HA, and MgF2HA coatings.
Surface morphology of MgFyHA coatings after the dissolution test is 
observed (Figure 3.59). After soaking in the TBS solution for 28 days, all 
the coatings exhibit a rough surface caused by the rapid dissolution of 
more soluble phases leaving less soluble phases in the coating. However, 
different dissolution characteristics are found when F concentration var-
ies. For example, large pores or grooves are seen in MgF0HA (without F 



































Dissolution rates of MgFyHA coatings in the TBS solution as a function of both soaking time 
and F concentration.
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The difference between the surface morphology is also reflected by the sur-
face roughness (Rq). The Rq of MgF0HA and MgF2HA after the dissolution 
test is 0.845 ± 0.013 μm and 0.429 ± 0.032 μm, respectively. These kinds of 
dissolution characteristics correspond to the dissolution behaviors of 
MgFyHA coatings mentioned earlier. The prior dissolution of β-TCMP in 
MgF0HA leaves large grooves and pores on the coating, and slow dissolu-
tion of FHA in MgF2HA only induces small pores.
The dissolution kinetics and mechanism of FHA have been widely studied 
at different temperature and pH values [130–134]. It was found that the dis-
solution rates of FHA are pH independent at neutral and basic conditions 
(7 ≤ pH ≤ 10). The dissolution seems to be initiated by the relatively rapid 
removal of F and/or OH and Ca near the surface. After the initial prefer-
ential release of F, OH, and Ca, stoichiometric release of Ca, P, and F takes 
place [132]. For pure HA, the presence of water induces the onset of dissolu-
tion through the escape of hydroxyl groups from the surface of apatite. The 
surface calcium ions also show the onset of dissolution at a lower extent: 
the bonds between calcium and lattice oxygen ions are lengthened by the 
surface water molecules. However, when fluorine ions replace hydroxyl 
groups partially in HA lattice, hydroxyl groups may dissolve, but fluorine 
ions at the surface remain in the crystal. Moreover, the surface calcium ions 
are anchored on the surface by the strong interaction with fluorine ions [67]. 
Therefore, the incorporation of fluorine ions into HA lattice makes the mate-
rial more dissolution resistant. It can be explained from the change of HA 
crystal structure. In pure HA lattice, there is a certain degree of disorder 
with randomly oriented OH groups because OH groups are diatomic and 
located off-center from the symmetry position in the c-direction. When OH 
groups are replaced by F ions, there will be no elastic strain caused by the 
substitution of OH groups by F ions because F− (1.32 Å) ion is smaller than 
OH− group (1.68 Å). Also F ions can locate on the symmetry positions in HA 
20 kV ×1,000 ×1,00010 µm 18 25 SE I 20 kV 10 µm 18 25 SE I
(a) (b)
Figure 3.59
Surface morphology of MgFyHA coatings on Ti6Al4V substrates after soaking in the TBS solu-
tions for 28 days: (a) MFA0 and (b) MFA4.
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lattice [67]. The substitution of OH group by F ions stabilizes randomization 
of OH groups in the columns by the reversion of the OH alignment within 
the column [135]. Moreover, fluorine is very electronegative and has an even 
greater capacity than oxygen in forming hydrogen bonds. Hydrogen bonds 
formed between F ions and adjacent OH groups further stabilize the crystal 
structure. Therefore, the crystal structure of FHA is more stable than HA, 
resulting in lower dissolution rate than that of HA. This is also supported 
by the calculated excess heats of solid solution that the replacement of OH 
groups in HA by F ions is an exothermic process [135].
3.5.3.2  Adhesion Strength
After the pull-off test, the surface morphology is observed by SEM as shown 
in Figure 3.60. Typical adhesive failure is seen on MFA0 (without F incorpo-
ration) (Figure 3.60a): big pieces of the coating are torn from the substrate. 
While on MFA3 (with F incorporation) (Figure 3.60b), the coating still adheres 
well on the substrate without or with only a little detached coating. The frac-
tion of the adhesive failure on the whole surface of the coating is estimated 
by the Image-Pro Plus 6.0 after capturing the images of the whole coating, 
listed in Table 3.4. The percentage of the adhesive failure in MFA0, MFA1, 
and MFA2 is more than 20% but that in MFA3 and MFA4 is less than 10%. 
Thus, it can be speculated that the adherence of the coating on the substrate 
of MFA3 and MFA4 is stronger than that on others.
Correspondingly, the pull-off adhesion strength is compared in 
Figure 3.61. Without F incorporation (MFA0), the pull-off adhesion strength 
is about 16 MPa. When F is incorporated at the fluoridation degree of 
0.5–1.0, no significant difference is observed. However, in the range of 
1.5–2.0, the pull-off adhesion strength increases significantly (p < 0.05) to 29 
and 24 MPa. It suggests that F incorporation into Mg-containing HA coating 
enhances the adhesion strength at higher F concentration. The trend of the 
20 kV
(a) (b)
20 kV×50       500 µm ×1, 00017 25 SE I 10 µm 16 25 SE I
Figure 3.60
Surface morphology of MgFyHA coatings after the pull-off test: (a) MFA0 and (b) MFA3.
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calculated pull-off adhesion strength quite matches that of the fraction of 
the adhesive failure. Moreover, the adhesion strength between the coating 
and the substrate should be much higher if the area of the adhesive failure 
is considered.
The influence of F incorporation on the adhesion strength between the 
coating and the substrate owes to the changes of HA crystal structure, the 
incorporated F concentration, the reduction of the coefficient of thermal 
expansion, and the chemical bonding. The incorporation of F ions into 
HA lattice stabilizes the crystal structure by reversing the OH alignment 
within the column and forming hydrogen bonds between OH groups and 
nearby F ions. Theoretically, the structure is the most stable at around 
50% substitution due to the alternating arrangement of the F ions between 
each pair of OH groups [68]. The fluorine concentration measured by XPS 
is shown in Figure 3.47c. There is a discrepancy between the measured 
























MFA1 MFA2 MFA3 MFA4
Figure 3.61
Pull-off adhesion strength between MgFyHA coatings and Ti6Al4V substrates: significantly 
higher pull-off adhesion strength on MFA3 and MFA4 (p < 0.05). (With kind permission from 
Springer Science + Business Media: J. Mater. Sci. Mater. Med., Cai, Y., Zhang, S., Zeng, X., and 
Sun, D., Effect of fluorine incorporation on long-term stability of magnesium-containing 
hydroxyapatite coatings, 22, 2011, 1633.)
Table 3.4
Fraction of Adhesive Failure on MgFyHA Coatings after the 
Pull-Off Test
Sample MFA0 MFA1 MFA2 MFA3 MFA4
Adhesive failure (%) 23.4 ± 4.9 24.1 ± 8.6 30.1 ± 7.8 2.7 ± 4.3 9.0 ± 7.5
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F concentration is around 1.0 or nearly 50% substitution, thus they have 
the most stable crystal structure. Correspondingly, significantly higher 
pull-off adhesion strength is observed in MFA3 and MFA4. Another 
effect of F ions is the reduction of the coefficient of thermal expansion. 
The coefficient of thermal expansion of pure HA, pure FA, and Ti6Al4V 
is 15 × 10−6/K, 9.1 × 10−6/K, and 8.9 × 10−6/K, respectively. The substitution 
of F ions in HA lattice reduces the coefficient of thermal expansion, so 
does the thermal mismatch between the coating and the substrate, thus 
the residual stress in the coating is reduced [8]. Furthermore, the chemical 
bonds among Ti, O, Ca, Mg, P, and F at the interface formed during the 
drying and firing process, such as Ca-O-Ti and Mg-O-Ti bonds, also con-
tribute to the enhancement of the adhesion strength between the coating 
and the substrate.
3.6	 Mg1.5FHA/MgF1.5HA	Bilayer	Structured	HA	Coating
As discussed in Sections 3.4 and 3.5, MgxFHA and MgFyHA coatings exhib-
ited distinct properties in the short-term osseointegration and the long-term 
stability. Mg incorporation in MgxFHA coatings took a great effect on the 
short-term osseointegration, but not significant on the long-term stabil-
ity. Ca8.5Mg1.5(PO4)6F(OH) (Mg1.5FHA) showed the best in vitro bioactivity 
and cellular response, i.e., the best short-term osseointegration. However, 
F incorporation in MgFyHA coatings enhanced the long-term stability 
much, but the effects on the short-term osseointegration were comparable. 
Ca9Mg1(PO4)6F1.5(OH)0.5 (MgF1.5HA) presented the lowest dissolution rate and 
the highest adhesion strength, i.e., the long-term stability. Therefore, a bilayer 
structured HA coating was developed on the basis of systematical investiga-
tion of both MgxFHA and MgFyHA coatings, i.e., Mg1.5FHA was selected as 
the upper layer and MgF1.5HA as the bottom layer. This bilayer structured 
HA coating is denoted by BHA coating. The physical and chemical proper-
ties as well as the short-term osseointegration and the long-term stability 
were evaluated compared with pure HA coating.
3.6.1 Physical and Chemical Properties
Phase comparison between pure HA and BHA is done by GIXRD and 
shown in Figure 3.62. Typical diffraction peaks of HA are detected on pure 
HA deposited sample: main peaks of (211), (112), (300), and (002) locate at 
31.7°, 32.2°, 32.8°, and 25.9°. On the other hand, for BHA, only FHA phase 
is detected. Compared with HA, all the main diffraction peaks of BHA 
shift a little to higher degree: (211) at 32.0°, (300) at 33.2°, and (002) at 25.94°. 
124 Hydroxyapatite Coatings for Biomedical Applications
The shifting of diffraction peaks to higher degree corresponds to the shrink-
age of a- and c-axes as calculated in Table 3.5, indicating the incorporation of 
Mg and F ions in the HA lattice as discussed in Sections 3.4.1 and 3.5.1.
The phase formation of BHA coating is illustrated by comparing the 
phases of bottom layer with MFA3 (MgF1.5HA) (Figure 3.63a), and BHA with 
FMA3 (Mg1.5FHA) (Figure 3.63b). Since the designed composition of bottom 
layer is the same as that of MFA3 (MgF1.5HA) and the only difference is the 
deposition times, the phases of the bottom layer and MFA3 are identical as 
shown in Figure 3.63a. In other words, the phase formed on the substrate is 
independent of the thickness of the coating. When the upper layer is depos-
ited on the bottom layer to form BHA coating, a little difference in phases 
is observed in Figure 3.63b): a weak peak of β-TCMP detected in FMA3 is 
not present in BHA. This is because the gradient of Mg concentration in the 
upper and bottom layers from Mg1.5 to Mg1.0. Mg diffusion during the fir-
ing process results in a lack of Mg to form β-TCMP, thus only FHA phase 



























Phase comparison between HA and BHA by GIXRD.
Table 3.5
Calculated a-Axis and c-Axis 
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The chemical states of the main elements in the coatings are measured by 
XPS, as shown in Figure 3.64. HA and BHA coatings have the same peaks of 
Ca 2p and P 2p, respectively. The binding energy of Ca 2p1/2, Ca 2p3/2, and 
P 2p locates at 350.7 ± 0.1, 347.2 ± 0.1, and 133.3 eV, which are the typical bind-
ing energy of Ca 2p and P 2p in HA and FHA [105,107]. In BHA coating, Mg 
2p and F 1s are detected at the binding energy of 50.6 and 684.3 eV, indicating 
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Figure 3.63
Illustration of phase formation of BHA coating. (a) Comparison of MFA3 and bottom layer of 
BHA. (b) Comparison of FMA3 and BHA.
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FTIR spectra identify the chemical groups in HA and BHA coatings, 
shown in Figure 3.65. In pure HA coating, there are three peaks belong-
ing to the phosphate group (PO43−) at 959, 1005, and 1086 cm−1. The peaks of 
PO43− in BHA coating are very close to those of pure HA coating, located 
at 966, 1012, and 1093 cm−1, indicating the formation of apatite structure 
[103]. The weak peaks in the range of 1400–1500 cm−1 ascribe to carbonate 
(CO32−) [104]. In pure HA coating, the stretching vibration of OH group is at 
3570 cm−1; however, this peak shifts to 3540 cm−1 in BHA coating due to the 
vibration of OH–F, suggesting the partial substitution of OH groups with F 
ions in the HA crystal structure [38,69].
Figure 3.66 shows surface morphology and cross-sectional view of 
BHA coating. The surface of the coating is very homogeneous without 
any cracks or pores (Figure 3.66a). The cross-sectional view (Figure 3.66b) 



































































XPS narrow scan spectra of Ca 2p (a) and P 2p (b) in HA and BHA coating, Mg 2p (c) and F 1s 
(d) in BHA coating.
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any delamination. Also it is observed that the coating thickness is about 
1.5 μm. The depth profiling of BHA is carried out by GDOES, as shown in 
Figure 3.67. As analyzed in MgxFHA and MgFyHA, the coating region (Rc), 
the transitional region (Rt), and the substrate region (Rs) are divided. In the 
coating region Rc, it is roughly set to the upper layer (Ca8.5Mg1.5(PO4)6F(OH)) 
and the bottom layer (Ca9Mg1(PO4)6F1.5(OH)0.5) according to the deposition 
times though there is no obvious boundary between them. Mg concen-
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Figure 3.65
FTIR spectra of HA and BHA coatings.
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(a) Surface and (b) cross-sectional view of BHA coating on Ti6Al4V substrate.
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exhibits the contrary trend, which are in accordance with the designed 
Mg and F concentrations in the upper and bottom layers. In the region 
of Rt, all the elements of the coating as well as the substrate are present, 
demonstrating the mutual diffusion of the elements in the coating and the 
substrate. At the boundary between Rt and Rs, Ti and Al stabilize, and Ca, 
P, O, Mg, and F disappear.
3.6.2 Short-Term Osseointegration
3.6.2.1  In Vitro Bioactivity
In vitro bioactivity of HA and BHA coating is evaluated by immersing the 
samples in the SBF solution for different days. After 7 days, the phase evolu-
tion is examined by GIXRD (Figure 3.68). A broad peak is observed around 
32° on both HA and BHA due to the formation of poorly crystallized apatite. 
Moreover, the absence of the diffraction peaks of Ti6Al4V substrate suggests 
that the total thickness of the newly formed layer and the primary coating 
is more than the detection depth of GIXRD (usually several micrometers). 
Since similar phase evolution happens on both HA and BHA, it suggests 


















































GDOES depth profile of BHA (Mg20: 20 times of Mg concentration; F200: 200 times of F 
concentration).
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Surface morphology observation is another proof to demonstrate the 
formation of new apatite layer. Figure 3.69 shows surface morphologies of 
BHA and HA coatings after soaking in the SBF solution for 7 days. Many 
cracks are seen in Figure 3.69a and b. Some pieces of the layer are peeled off 
from the primary coating as shown in Figure 3.69c and d, revealing that the 
thickness of the peeled layer is around 10 μm, much thicker than the primary 
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Figure 3.68
GIXRD profiles of HA and BHA coatings on Ti6Al4V substrates after soaking in the SBF for 
7 days.
20 kV ×1,000 21 25 SE I
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Figure 3.69
SEM images of BHA (a) and HA (b) coatings on Ti6Al4V substrates after soaking in the SBF for 
7 days ([c, d] the cross-sectional views of [a, b]).
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formed apatite layer as detected in Figure 3.68. The cracks and peeling off are 
due to the shrinkage upon drying as well as the stress relief during dehydra-
tion. They will not appear in the moist body environment [136]. Moreover, 
the coating is further dehydrated during pumping process of gold sputter-
ing for SEM observation, and the stress released leads to further cracking of 
the coating.
3.6.2.2  Cell Response
Figure 3.70 shows SEM images of MG63 cells after cultured on BHA and HA 
coatings for 3 days. No significant difference is observed in cell morphology 
between the coatings. All cells spread well and grow favorably on the coat-
ing surface. Cells attach tightly on the coating surface with their filopodium 
and lamellipodium, suggesting good viability on both BHA and HA coat-
ings. Cell numbers on HA and BHA coatings at each cell culture period are 
compared in Figure 3.71. On the first and second day, there is no significant 
difference between the coatings. After incubation for 3 and 5 days, the cell 
numbers on the BHA coating are significantly higher than those on the HA 
coating. It suggests that the BHA coating stimulates cell proliferation more.
15 kV 15 kV ×1,000 14 20 SE I×1,000 14 20 SE I10 µm 10 µm
15 kV 15 kV ×200 14 20 SE I×200
(a) (b)
(d)(c)
14 20 SE I100 µm 100 µm
Figure 3.70
Cell morphology after cultured on BHA (a, c) and HA (b, d) coatings for 3 days.
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3.6.3 long-Term Stability
3.6.3.1  Dissolution Rate
Dissolution behaviors of HA and BHA coatings are compared by the change 
of Ca2+ concentrations in the TBS solution, as shown in Figure 3.72. Ca2+ 
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Figure 3.71
Cell proliferation on HA and BHA coatings in terms of cell density: significantly higher cell 
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Figure 3.72
Comparison of dissolution behaviors of HA and BHA coatings in the TBS solution: Ca2+ 
concentration as a function of soaking time.
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Ca2+ ions during the whole period, indicating a higher dissolution rate. The 
average reduction of the coating thickness after soaking in the TBS solution 
for 28 days is estimated to be about 0.5 and 0.4 μm in HA and BHA coatings, 
respectively, according to the dissolution amount, coating area, and coating 
density (using the density of pure HA, 3.16 g cm−3 [137]). Thus, the dissolu-
tion is limited in the upper layer of BHA (about 0.6 μm thick theoretically), 
and the comparison of dissolution rate between HA and BHA becomes that 
between HA and the upper layer. Although the designed Mg concentration 
in the upper layer is higher than that in the bottom layer, β-TCMP is not 
detected (Figure 3.68), and only FHA phase forms. Since FHA has lower dis-
solution rate than HA as discussed in Sections 3.4.3.1 and 3.5.3.1, BHA coat-
ing releases less Ca2+ ions.
3.6.3.2  Adhesion Strength
Figure 3.73 compares the pull-off adhesion strength between HA and 
BHA coating on Ti6Al4V substrates. Without distinguishing the adhesive 
and cohesive failures, the pull-off adhesion strength between HA coat-
ing and Ti6Al4V substrate is about 10 MPa, and about 20 MPa for BHA 
coating, which is nearly two times higher. Compared with MFA3 (the 
designed composition of the bottom layer, of which the pull-off adhesion 

























Pull-off adhesion strength between HA and BHA coating on Ti6Al4V substrates: the pull-off 
adhesion strength of BHA is two times higher than that of HA.
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It is caused by the elemental interdiffusion during the drying and firing 
process, thus the elemental concentrations in BHA coating are not identi-
cal to the designed ones. Although it is much lower than that of MFA3, 
it is still significantly higher than that of pure HA, a lot more than the 
minimum 15 MPa stipulated by ISO standards (ISO 13779) for biomedical 
applications [88].
3.7	 Summary
In this work, a bilayer structured magnesium (Mg) and fluorine (F) ions 
co-substituted HA coating on Ti6Al4V substrate is developed to achieve an 
integration of short-term osseointegration and long-term stability. GIXRD, 
XPS, and FTIR spectroscopy results indicate that Ca ions and OH groups 
in HA crystal structure are substituted with Mg and F ions, respectively. 
Table 3.6 summarizes the compositional dependence of co-substitution of 
Mg and F on in vitro bioactivity, cell response, dissolution rate, and adhesion 
strength. Details are as follows.
High Mg concentrations (1.0 ≤ x ≤ 2.0) in the MgxFHA coatings improve the 
in vitro bioactivity a lot. However, F concentration does not influence the 
bioactivity of the MgFyHA coatings. MG63 cells attach and spread well on 
all the MgxFHA and MgFyHA coatings. In the MgxFHA coatings, Mg ions 
show a significant stimulating effect on cell proliferation and late cell differ-
entiation when x is 1.5. F concentration studied does not affect cell numbers 
grown on the MgFyHA coatings. However, it maintains a positive stimulat-
ing effect on cell differentiation.
The incorporation of Mg increases the dissolution rate of MgxFHA coating 
in the TBS solution, and the maximum is achieved at x = 1.5. F incorpora-
tion decreases the dissolution rate of MgFyHA coating in the TBS solution, 
especially at the measured fluoridation degree of 0.72–1.16. Mg substitution 
enhances the adhesion strength, but comparable among different Mg con-
centrations. Greatly enhanced adhesion strength is achieved by F incorpora-
tion at the measured F concentration around 1.0.
Finally, Mg1.5FHA/MgF1.5HA bilayer structured HA coating is developed. 
Single FHA phase forms in the coating with the substitution of Mg and F 
ions in HA lattice. It shows comparable in vitro bioactivity with pure HA 
coating, but more significant cell proliferation. The long-term stability of the 
bilayer structured HA coating is much better than pure HA coating, exhib-
iting lower dissolution rate and higher adhesion strength. Thus, a combi-
nation of both the short-term osseointegration and the long-term stability 
is achieved in this one coating/substrate system, which will have potential 
applications in the biomedical fields.
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Zinc- and Fluorine-Doped HA 
Coatings via Sol–Gel Method
Kui	Cheng	and	Wenjian	Weng
4.1	 Introduction
Hydroxyapatite (HA)-coated metallic implants have been widely investigated 
due to their fast integration with bone compared with pure metal [1,2]. In 
order to improve their holistic performance in vivo, researches have focused 
on the following respects: (1) inducing active interaction between the film 
and tissue through promotion of osteoblast cell attachment, proliferation, 
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and differentiation, resulting in fast new bone formation and osteointegra-
tion [3,4] and (2) making films more dissolution resistant through reduction 
of intrinsic solubility of the film materials, so that better long-term effective-
ness of the implants could be obtained [5,6].
Compared with HA, fluoridated hydroxyapatite (FHA) has proven to have 
a stronger dissolution resistance and comparable biocompatibility [7–12]. 
FHA can therefore be applied as a thinner coating, reducing the risk of 
coating delamination frequently observed with thicker coatings [13], thus 
providing a longer-term stability in osseointegration. However, significant 
improvements in HA coatings are still necessary in early bone–implant 
osseointegration processes to promote rapid physiologic loading and to 
further improve the repair quality of an implant. Osseointegration of an 
implant into a bone site depends primarily on the activity of the bone cells 
or their precursors. The ability of bone cells to migrate to the implant and 
to adhere, proliferate, and differentiate on the implant surface is a major 
factor in determining the success of osseointegration. Attempts have been 
made to combine bone-promoting pharmaceuticals with the implants, and 
the release of these pharmaceuticals directly at the bone–implant interface 
has high therapeutic efficiency. A possible approach is to apply osteoin-
ductive coatings that are supplemented with beneficial trace elements that 
promote early osseointegration [14–16]. The pharmaceutical effects of many 
trace elements on bone cells, such as Sr, Si, and Zn, have been widely studied 
[17–19]. Zinc is well established as an essential trace element that has stimu-
latory effects on osteoblast activity and bone formation at low concentration 
[20–22]. Several studies have revealed that the pharmacological performance 
of Zn-containing implants can be significantly influenced by the mode of 
Zn release. In general, slow and sustained release of the Zn-incorporated 
implant material promoted the best bone formation around the implant [23].
To satisfy both the requirements of dissolution resistancy and bone for-
mation stimulatory, fluorine- and zinc-substituted HAs could be a good 
alternative, if they could be incorporated in an appropriate manner. In this 
chapter, the incorporation of fluorine and zinc as well as the effects of such 
incorporation are introduced and discussed.
4.2	 Sol–Gel-Derived	Fluorine-Doped	Hydroxyapatite	Coatings
Although many methods have been developed to prepare HA coatings, 
sol–gel method remains one of the most prevalent. Compared with other 
methods, sol–gel preparation possesses many advantages, such as low cost, 
simple equipment, and easy control of chemical composition. Generally, the 
coating material or its precursors are first transformed into sol and then 
coated on the substrate surface uniformly; the rapid solvent evaporation and 
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subsequent condensation reactions will lead to the formation of the gel film. 
After drying and calcining, the required film is finally prepared.
The pioneer work of sol–gel preparation of bioactive materials was actu-
ally carried out by Hench on bioglass [24]. In the past decades, owing to the 
excellent performance of apatite and the development of bioactive films, 
the sol–gel technique has begun to be widely used in the preparation of 
HA films.
According to the type of sol, the sol–gel technique can be divided into two 
categories. First, HA particles are directly prepared and mixed with proper 
solvent to form HA sol after dispersion. Second, calcium- and phosphorus-
containing reagents are dissolved to be Ca and P precursors, respectively, 
and then gelation happens as a result of solvent evaporation and probably 
some polycondensation reactions. HA films will be obtained after calcining 
of the dried gel.
Mavis et al. prepared the HA films using HA particles [25]. The process 
was as follows: first, HA fine powder was obtained through coprecipitation 
method and calcined to improve crystallinity; then the HA powder was 
ultrasonically dispersed into water to form HA sol. After dip coating and 
840°C heat treatment, HA films with thickness of about 25 μm and bonding 
strength of about 30 MPa were finally obtained. By this method, although 
the size of HA particles is much smaller than that prepared through plasma 
spray, the corresponding films are still thick, which may affect the bonding 
strength and long-term stability. In fact, many researchers prefer the precur-
sor ways to prepare HA films instead of directly using HA particles. Given 
the characteristics of the technique itself, the differences between various 
methods mainly lie in the choice of precursors. It is rather important to find 
the most suitable sol system for the preparation of bioactive apatite coatings 
although a variety of sol–gel systems have been developed.
4.2.1 basics of Sol–gel-Derived Films
4.2.1.1  Dip Coating
Dip coating is the most commonly used technique to prepare films or coat-
ings utilizing a sol–gel process. The substrates were first immersed in the 
precursor solution and then vertically pulled upward with a constant pull-
ing speed [26]. During this process, the sol attaches to the substrate to be a 
liquid sol film. There are two liquid layers in the sol film: the outer layer of 
the liquid flows back into the sol pool, and the inner layer remains on the 
substrate after the solvent evaporates. The liquid film is similar to a wedge, 
the starting point of which begins with a clear-cut line called the drying line. 
If the downward speed of the drying line is equal to the substrate pulling 
speed, then the film deposition process is relatively stable.
In the presence of inorganic materials, the inorganic is the first to move 
from the sol to the drying line and then precipitates owing to the evapora-
tion of the solvent. The deposition time depends on the thickness of the film 
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and evaporation rate. For a precursor solution that usually contains ethanol, 
the steady state stays only a few seconds.
4.2.1.2  Drying of Films
The dip-coating process accompanies the drying of films. That actually 
determines the shape of the liquid film. The drying process increases the 
concentration of the liquid and leads to the formation of an elastic or vis-
coelastic gel. Further evaporation results in the capillary pressure, which 
balances with the surrounding solid phase pressure and further contracts.
Scherer divided the drying process into two phases [27]: constant phase 
(CRP) and deceleration. In the constant phase, mass transferring rate depends 
on the surface convection and the speed of gas taken away; in deceleration 
phase, mass transferring rate depends on the internal permeation of the gel. 
According to this theory, most of the drying process belongs to constant one 
that proves the wedge shape of the film.
4.2.1.3  Calcination of Films
After drying, the films may need calcinations to discharge the residual 
organic and then crystallize. In this process, as films have lost mobility, it 
is prone to stress and cracks. In fact, this process has already begun in the 
drying stage. The film shrinks with drying. However, when attached to the 
substrate, the shrinkage is restrained. That means the volume contraction 
can only be achieved by the reduction of film thickness. As a result, tensile 
stress in the substrate surface will occur. Theoretically, if the film adheres to 
the substrate well, the critical thickness of the cracks that begin to proliferate 













KIC is the critical stress intensity factor
σ represents the ratio of elastic modulus of the film and the substrate
For films less thick than hC, the energy required for crack extension is smaller 
than that required for the crack released from the vicinal stress, and the film 
remains crack-free.
4.2.2 Systems for Fluorine-Doped Hydroxyapatite Films
HA films made by sol–gel technique have been much improved compared 
with traditional methods. However, due to the fact that the composition is 
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still mainly HA, the bioactive film dissolves rather quickly when implanted, 
which affects the long-term stability of the implant or even leads to complete 
failure of implantation. Thus, it is extremely necessary to adjust components 
of the film. As fluorine can improve the solubility of HA and play an impor-
tant role in biological mineralization as well, FHA (fluorine-doped HA) 
has attracted widespread concern. Fluorine can be introduced into the film 
via fluorine-containing reagents, such as trifluoroacetic acid (CF3COOH), 
hexafluorophosphoric acid (HPF6), and ammonium hexafluorophosphate 
(NH4PF6). Depending on the chosen fluorine-containing compound, they 
could be divided into different systems.
4.2.2.1  Ca(NO3)2–PO(OH)x(OEt)3–x–CF3COOH System
In this system, a designed amount of triethanolamine (N(CH2CH2OH)3 or 
N(EtOH)3 is always added to reduce the acidity of precursor solution caused 
by CF3COOH. The effect of N(EtOH)3 on the solutions containing CF3COOH 
can be described as follows.
When N(EtOH)3 is added into CF3COOH solution, being an organic base, 
it will react with the organic acid, CF3COOH. The reaction tendency leads 
to the complete transformation of dimeric CF3COOH species to monomeric 
CF3COOH species and enhances the dissociation of monomeric CF3COOH 
species to form trifluoroacetate or an organic salt (Equation 4.1):
 
CF COOH N EtOH CF3COO HN EtOH







( ) ( )
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When Ca(NO3)2·4H2O is added into CF3COOH solution, the H2O coming 
along with Ca(NO3)2 will increase the polarity of the solvent. The polarity 
increase leads to the formation of monomeric CF3COOH species and further 
causes the monomeric CF3COOH species to be dissociated into CF3COO− and 
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Under an acidic condition, the CF3COO− does not have a strong ability to coor-
dinate with Ca ion by replacing nitrate group. Hence, free CF3COO− could 
be dominant in the solution. When the basicity of the solution increases, 
Equation 4.2 is greatly enhanced, leading to a high concentration of the com-
plex species, Ca(OOCF3C)x(NO3)2−x, as the dominant species in the solution.
To form FHA finally, the mixed solution needs to be dried and fired. If 
a mixed solution containing CF3COOH but without N(EtOH)3 is heated, 
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the species in the solution are concentrated during the evaporation of the 
solvent, and the decrease of the solvent will lower the dissociation degree 
of CF3COOH. Since the boiling point of CF3COOH is 72.4°C, it is easy to 
be evaporated. As a result, very little amount of fluorine-containing spe-
cies could remain to take part in the formation reactions of apatite. Hence, 
FHA can be hardly formed. If N(EtOH)3 is added into the mixed solution, 
upon drying and firing, the Ca(OOCF3C)x(NO3)2−x species could remain 
during drying because N(EtOH)3 has a higher boiling point of 277°C and 
keeps Ca(OOCF3C)x(NO3)2−x stable. Hence, fluorine-containing species will 
effectively take part in the formation reactions of FHA.
Besides promoting FHA formation, the existence of N(EtOH)3 with high 
boiling point will react with decomposed products of nitrates to produce 
a flame. During the flaming, FHA could be directly formed. Moreover, 
according to Equations 4.1 and 4.2, ammonium nitrate may be produced as 
follows:
 HN CH CH OH  NO  NH CH CH OH NO2 2 3 3 2 2 3 3( ) ( )
+ −+ →
In the fast drying process, NH(CH2CH2OH)3NO3 will oxidize and decom-
pose, leading to the release of large amounts of gas. That may result in loose 
and cracked film.
4.2.2.2  Ca(NO3)2–PO(OH)x(OEt)3–x–PF6− System
When HPF6 is added into the initial mixed precursor solution, the resulting 
reactions could be mainly alcoholysis and hydrolysis, and the reactions are 
proposed as follows:
 HPF EtOH OEt POF HF6 2+ ⇔ +( )  (4.3)
 ( ) ( )OEt POF EtOH OEt POF HF2 + ⇔ +  (4.4)
 ( ) ( )OEt POF H O HPO OEt F HF2 2 2+ ⇔ +  (4.5)
 PO OEt OH F EtOH PO OEt OH HF2 3( ) ( ) ( ) ( )− −+ ⇔ +x xx x  (4.6)
In addition, Ca species have a strong tendency to react with HF to form CaF2. 
The HF produced in reactions (4.3) through (4.6) is rapidly consumed by Ca 
species in the previous refluxing mixture to form fine CaF2 nanoparticles. 
The formation of CaF2 nanoparticles causes the mixture to be cloudy or even 
sedimentated.
During refluxing, the increase in temperature and the formation of solid 
CaF2 as a reaction product will promote and lead to the completion of 
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alcoholysis and hydrolysis reactions (Equations 4.3 through 4.6), resulting 
in the refluxed mixture (dipping sol) containing only the solid CaF2 particles 
and the soluble PO(OEt)3–x(OH)x species as the detected reaction products. 
Since the solid CaF2 particles are very fine, the sol could be kept stable for a 
long time period, if sedimentation did not take place within 4 months.
Adding NH4PF6 to the initial mixed precursor solution would lead to simi-
lar alcoholysis and hydrolysis reactions to those suggested in the case of 
HPF6 with the formation of fine CaF2 particles. However, compared with the 
mixtures with HPF6, the substitution of H+ for NH4+ decreases the acidity 
of the mixture, which could favor reactions (4.3) through (4.6), and further 
accelerates the reaction between Ca and F. Hence, a faster precipitation pro-
cess occurs and CaF2 particles grow more easily in the mixture with NH4PF6 
than in that with HPF6. Besides, a decrease in acidity will also favor the 
formation of apatite precipitates. As a consequence, the dipping sol is less 
stable against sedimentation.
Since dipping sols with HPF6 or NH4PF6 contain fine and non-evaporable 
CaF2 particles, the incorporation of fluorine into HA film becomes easy. 
As the amounts of HPF6 or NH4PF6 in the initial mixed precursor solution 
increase, the resulting sols become rich in F-containing products (CaF2), and 
the F content in the films tends to increase. In addition, the incorporation of 
F into HA enhances the development of the apatite phase. Compared with 
Ca(NO3)2–PO(OH)x(OEt)3–x–CF3COOH system, gas released during the heat 
treatment is much less, which is also favorable for high-quality films. For the 
morphology of films, the film prepared by HPF6 is dense and smooth, while 
that prepared by NH4PF6 is dense but contains many embedded particles 
with a few hundreds of nanometers.
4.2.3 Microstructures of FHa Coatings
The formation of FHA films can be described as follows: first, a liquid layer 
containing Ca(NO3)2 or CaF2, PO(OH)x(OEt)3–x, and solvent (C2H5OH) attach 
to the substrate, and second, a series of reactions occur in the subsequent 
drying and calcining process: the film loses mobility after solvent evapora-
tion, and then its composition transforms into Ca(NO3)2 or CaF2 crystal phase 
and a large amount of amorphous calcium phosphate as the oxidation of 
the organic matter in PO(OH)(OEt)3–x occurs. As the calcining temperature 
increases, the nucleation and growth of FHA begins. Eventually a crystalline 
FHA film forms.
Figure 4.1 shows the x-ray diffraction (XRD) patterns of HA films 
prepared by sol–gel method at different calcining temperature without 
any F-containing compound added. As is shown in the figure, all samples 
contained apatite phase. Increased calcining temperature (Figure 4.1) led 
to a better developed apatite crystalline phase. However, films treated 
at 800°C had a small amount of β-TCP phase, which was a result of the 
decomposition of HA.
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When HPF6 was added in the preparation, as discussed previously, FHA 
films were obtained. Figure 4.2 shows the XRD results of films prepared 
at different calcining temperatures but with the same amount HPF6. As 
demonstrated earlier, the intensity of the XRD peaks belonging to apatite 
enhances with the increase of calcining temperature. Nevertheless, no trace 
of CaO, CaF2, or other calcium phosphate phase presented (Figure 4.2). With 
the increase of HPF6 (Figure 4.2), a small amount of rutile titanium dioxide 
phase appeared.
FHA films could also be obtained if NH4PF6 was added instead of HPF6 
(Figure 4.3). All films showed to be apatite, just as those with HPF6 addition. 
Among them, the intensity of the XRD peaks belonging to apatite was 
enhanced with the increase of calcining temperature. With the increase in 
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Figure 4.1
XRD patterns of films without fluorine (HAA series). (Reprinted from Cheng, K., Solgel 
preparation of fluoridated hydroxyapatite films and their in vitro properties, PhD 
dissertation.)
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Figure 4.4 shows the FTIR spectra of typical HA and FHA films. All the 
spectra show the existence of apatite, whether HPF6 or NH4PF6 was added: 
PO43− group of ν1 (965 cm−1), ν3 (1019 cm−1, 1087 cm−1), and ν4 (597 cm−1, 560 
cm−1) stretching bands and CO3− group of ν2 (879 cm−1) stretching band. HA 
film shows the OH librational band ρOH at 632 cm−1 and stretching band 
νOH at 3571 cm−1, while the ρOH and νOH of other films (FHA) shift to 748 
and 3540 cm−1, respectively. According to existing FTIR results on HA, such 












































XRD patterns of the FHA films with HPF6 addition. (From Cheng, K. et al., J. Biomed. Mater. Res. 
B Appl. Biomater, 69B, 33, 2004; Cheng, K. et al., Mater. Res. Bull., 38, 89, 2003.)
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These results demonstrate that pure FHA film could be obtained through 
this method, and the film remains stable up to 800°C. Also, it is obvious that 
active chemical reactions take place between the film and substrate as the 
rutile phase is present. This will be discussed later.
Many factors may have an effect on the microstructure of FHA films. 
Among them, calcining temperature and F content play important roles. 
Generally speaking, the calcining temperature affects the crystallinity, phase 
composition, and morphology of the films.
With the increase of calcining temperature, it is more likely for amorphous 
gels to crystallize into HA phase, resulting in the increase of the relative 
content of the crystalline phase. However, a small amount of β-TCP, which is 
a product of apatite decomposition, also appears with increasing calcining 
temperature, just as indicated in Figures 4.1 through 4.3.
The surface morphology of the films is shown in Figure 4.5. For HA films, 
the surfaces were very smooth, virtually no pores and cracks. When the 
calcining temperature increased to 600°C, there was basically no change 
























[PF6–]/Ca = 1/30 
[PF6–]/Ca = 1/30 
[PF6–]/Ca = 1/30 
[PF6–]/Ca = 1/90 
[PF6–]/Ca = 1/45 
[PF6–]/Ca = 1/30 
[PF6–]/Ca = 1/30 
Figure 4.3
XRD patterns of the FHA films with NH4PF6 addition. (From Cheng, K. et al., Mater. Res. Bull., 
38, 89, 2003.)
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in morphology; when the calcining temperature continued to increase, a 
small amount of pores and cracks appeared and grew in number. While for 
FHA prepared with the addition of HPF6, the films were basically smooth 
with a small amount of pores and cracks when treated at 500°C and 600°C. 
There were many cracks and pores when the temperature increased to 
700°C and 800°C. For FHA prepared with the addition of NH4PF6, there 
were a large amount of pores and cracks although the calcining tempera-
ture was only 500°C. Further increase of the calcining temperature led to 
a significant jump in the amount of crack and further deterioration of the 
morphology.
In conclusion, with the increase of calcining temperature, the morphology 
of the films becomes more porous with more cracks. The possible reason 
is that the stress caused by film densification becomes stronger when the 
temperature increases, and the release of stress leads to cracking. Thus, the 
higher the calcining temperature, the more cracks the films have. Moreover, 
films with NH4PF6 addition showed even poorer morphology; that is simply 
because the existence of NH4+ will release gas during film formation, which, 
in turn leads to the generation of pores and cracks.
500






















FTIR reflectance spectra of the FHA. (From Cheng, K., Sol–gel preparation of fluoridated 
hydroxyapatite films and their in vitro properties, PhD dissertation, 2003.)
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Besides the calcining temperature, the concentration of PF6− in the precur-
sor solution has a considerable effect on the crystallinity and morphology of 
the FHA films. Table 4.1 shows the relative crystallinity of the different films.
As shown previously, at the same calcining temperature, the relative crys-
tallinity of pure HA coatings was the lowest. With the increase of fluorine 
content, the relative crystallinity significantly increased. This phenomenon 
HA on Al2O3
fired at 500°C 
IMT697      25.0 kV        ×3.00 K         10.0 µm
IMAT51    25.0 kV        ×3.00 K         10.0 µm
HA on Al2O3
fired at 600°C 
IMT704     25.0 kV       ×3.00 K         10.0 µm
HA on Al2O3
fired at 700°C 
(c)
HA on Al2O3 
fired at 800°C 
IMT713 25.0 kV ×3.00 K 10.0 µm
FHA on Al2O3
fired at 500°C 
HPF6/Ca = 1/30
IMAT 1 25.0 kV ×3.00 K 10.0 µm
FHA on Al2O3
fired at 600°C 
HPF6/Ca = 1/30





SEM micrographs of films with and without adding PF6−. (a) HA fired at 500°C, (b) HA fired 
at 600°C, (c) HA fired at 700°C, (d) HA fired at 800°C, (e) FHA fired at 500°C with HPF6/Ca = 1/30, 
(f) FHA fired at 600°C with HPF6/Ca=1/30. 
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FHA on Al2O3
fired at 700°C 
HPF6/Ca = 1/30
IMAT12 25.0 kV ×3.00 K 10.0 µm
FHA on Al2O3
fired at 800°C 
HPF6/Ca = 1/30
IMAT10 25.0 kV ×3.00 K 10.0 µm
FHA on Al2O3
fired at 500°C 
NH4PF6/Ca = 1/30





fired at 800°C 
NH4PF6/Ca = 1/30
M6FE34 25.0 kV ×3.00 K 10.0 µm
FHA on Al2O3
fired at 700°C 
NH4PF6/Ca=1/30
M6FE05 25.0 kV ×3.00 K 10.0 µm
FHA on Al2O3
fired at 600°C 
NH4PF6/Ca = 1/30
M6FE13 25.0 kV ×3.00 K 10.0 µm
Figure 4.5 (continued)
SEM micrographs of films with and without adding PF6−. (g) FHA fired at 700°C with 
HPF6/Ca = 1/30, (h) FHA fired at 800°C with HPF6/Ca = 1/30, (i) FHA fired at 500°C with NH4PF6/
Ca = 1/30, (j) FHA fired at 600°C with NH4PF6/Ca = 1/30, (k) FHA fired at 700°C with NH4PF6/
Ca = 1/30, (l) FHA fired at 800°C with NH4PF6/Ca = 1/30. (From Cheng, K., Sol–gel preparation of 
fluoridated hydroxyapatite films and their in vitro properties, PhD dissertation, 2003.)
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could be explained by the formation of the FHA phase. In the case of no 
addition of HPF6, most Ca2+ ions in the gel coordinated to phosphate groups, 
while others remained “free” to crystallize into Ca(NO3)2. These Ca(NO3)2 
further reacted with PO43−-containing groups to form HA. In this case, the 
observed apatite formation temperature is around 500°C [30], even though 
the decomposition temperature of pure Ca(NO3)2 is 561°C [31]. In the case of 
HPF6 addition, the formation of nanocrystalline CaF2 consumed Ca2+ ions, 
thus reducing or totally depriving the amount of crystalline Ca(NO3)2 in the 
gel. This facilitated the formation of apatite due both to the high reactivity 
of nanoscale CaF2 and to the reduction or even total absence of Ca(NO3)2. 
As a result, even pure fluorapatite (FA) (Ca10(PO4)6F2) appeared at much lower 
temperature of 400°C in the system contained HPF6 (Figure 4.6).
Therefore, the increase in the amount of HPF6 in the precursor solution is 
favorable for the formation of the FHA phase with high crystallinity.
Table 4.1
Relative Crystallinity of the Films at Different Calcining Temperatures (%)








Crystallinity (%) 51.2 54.1 55.5 60.8 68.0










Crystallinity (%) 63.4 61.2 51.4 60.0 63.4
Source: Cheng, K., Sol–gel preparation of fluoridated hydroxyapatite films and their in vitro 
properties, PhD dissertation, 2003.
nc-CaF2 PO(OH)(OEt)2 PO(OH)2(OEt)
Figure 4.6
Schematic of gel formation through bonding of F in nc-CaF2 and H in P-containing groups. 
(From Cheng, K. et al., J. Sol–Gel Sci. Technol., 38, 13, 2006.)
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F also affects the morphology of the films (Figure 4.7). Pure HA film sur-
face was smooth, with little pores and cracks; with the presence of fluorine, 
the surface became rough, and many pores were observed; while the surface 
morphology improved with the increase of fluorine content, some pores still 
showed up; even higher fluorine content led the film to be more smooth. 
However, since then, further increase of HPF6 led to increased pores and 
HPF6/Ca = 0
IMAT15 25.0 kV ×3.00 K 10.0 µm
CS07DL 25.0 kV ×3.00 K 10.0 µm
HPF6/Ca = 1/90
CS07DL 25.0 kV ×3.00 K 10.0 µm
HPF6/Ca = 1/45
HPF6/Ca = 1/30
CS07DL 25.0 kV ×3.00 K 10.0 µm
HPF6/Ca = 2/45
CS07DL 25.0 kV ×3.00 K 10.0 µm
HPF6/Ca = 1/18





SEM micrographs of films with different fluorine concentration. (a) HPF6/Ca = 0, (b) HPF6/
Ca = 1/90, (c) HPF6/Ca = 1/45, (d) HPF6/Ca = 1/30, (e) HPF6/Ca = 2/45, (f) HPF6/Ca = 1/18.
(continued)
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cracks and thus resulted in a rather rough surface. As for NH4PF6 addition, 
the effects of fluorine on the morphology of films were rather similar to that 
of HPF6. It is noteworthy that the morphology was even rougher, which was 
actually the effect of NH4+, as discussed earlier.
How does the amount of HPF6 content affect the morphology of the 
films? When HPF6 is added into the precursor solution continuously, the 
transparency of the solution reduces, proving that the size of CaF2 particles 
HPF6/Ca = 1/15
CS07DL 25.0 kV ×3.00 k 10.0 µm
NH4PF6/Ca = 1/45
PZT2_5 25.0 kV ×1.50 k 20.0 µm
(i)
NH4PF6/Ca = 1/90
PZT2_7 25.0 kV ×1.50 k 20.0 µm
NH4PF6/Ca = 1/30





SEM micrographs of films with different fluorine concentration. (g) HPF6/Ca = 1/15, (h) NH4PF6/
Ca = 1/90, (i) NH4PF6/Ca = 1/45, (j) NH4PF6/Ca = 1/30. (From Cheng, K. et al., Biomaterials, 26, 
6288, 2005.)
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increases. The increase of CaF2 particle size will lead to the reduction of 
particle number and finally affects gel formation. As a result, the quality 
of the film obtained deteriorates, and the amount of pores and cracks 
also increases. On the other hand, however, with the increase of HPF6 
content, Ca(NO3)2 in the gel decreases, resulting in the decrease of gas 
released in the subsequent calcining process, which then improves the 
microstructure. Considering these two factors, the microstructure of films 
initially improves with increasing content of F and then deteriorates with 
even higher F content.
For films in the case of NH4PF6 addition in preparation, the corresponding 
precursor solution did not possess excellent ability of gelation. In addition, a 
relatively large amount of gas would be released due to the existence of NH4+, 
making the film morphology even worse.
4.2.4 Solubility of FHa Coatings
As F is smaller than the OH group in size, the corresponding lattice of FHA 
is smaller, compared with pure HA. The lattice constant of FA (a = 9.3684A, 
c = 6.8841A) is smaller than that of HA (a = 9.418A, c = 6.884A). As a solid 
solution of FA and HA, the structure of FHA is more compact, and the 
solubility of FHA is relatively lower. That would be very important for HA 
films showing lower solubility and longer lifetime.
Many scholars have studied the dissolution process of FHA films at differ-
ent pH value and proposed many mechanisms of dissolution. Most of them 
have admitted that the introduction of F is an important factor for the stabil-
ity of FHA.
The solubility of the films was usually measured by immersing them in 
covered containers with Tris solution buffered at pH 7.25, held in a 37°C 
water bath. Tris buffer solution can provide the same pH as the body envi-
ronment and does not contain any additional ions except H+ and Cl−, which 
eliminates the influence of the deposition of other minerals. Therefore, the 
appearance of metal ions and anions after film immersion and the variation 
of their concentrations can be considered as the result of the dissolution of 
the thin film and thus can be utilized to evaluate the relative stability.
Figure 4.8 depicts how the fluorine content affects the solubility of the 
films. As shown in the figure, the greater the fluorine content, the more 
slowly the films dissolve. On the other hand, calcination had an effect on 
the solubility of the film as well, even though the F content did not alter, as 
shown in Figure 4.9. Besides, calcination also affected the dissolution of pure 
HA (Figure 4.10).
In order to explain this phenomenon, it is necessary to clarify the dissolution 
process of the FHA films. Generally [34], the solubility of calcium phosphate 
varies in the following order: ACP > HA> FA. Since FA is less soluble than 
HA, the substitution of F in the structure of HA, which makes FHA, would 
make the solubility somewhere between HA and FA. Therefore, the order 
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of solubility should be ACP > HA > FHA > FA. In the immersion test, due to 
the films that usually contain some poorly crystallized calcium phosphate, 
which is rather similar to ACP, these calcium phosphate will dissolve 
first, after which the concentration of Ca, PO43− increases and dissolution–
precipitation equilibrium is achieved. As shown in Figure 4.11, the Ca and 
P concentrations in Tris solution varied with immersion time. After a rapid 
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Dissolution amount of FHA calcined at different temperatures. (From Cheng, K., Sol–gel prepa-






























Dissolution amount of films with different fluorine content after 2 weeks. (From Cheng, K. 
et al., J. Biomed. Mater. Res. B Appl. Biomater., 69B, 33, 2004.)
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The solubility product constant (Ksp) in the Tris solution after soaking was 
calculated, and it was found that the concentration of Ca2+, PO43−, and OH was 
much greater than the saturation concentration of HA, which meant that HA 
had saturated in the Tris solution. Due to the much slower growth process of HA 
compared with other phosphate, however, it is unlikely to produce HA directly 
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Dissolution amount of pure HA films calcined at different temperatures. (From Cheng, K., 
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Figure 4.11
Ca and P concentration in the Tris solution versus different soaking time. (From Cheng, K., 
Sol–gel preparation of fluoridated hydroxyapatite films and their in vitro properties, PhD dis-
sertation, 2003.)
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in solution containing Ca, PO43− was as follows: ACP phase first precipitated 
spontaneously and then converted into OCP, which turned to HA phase finally 
after further hydrolysis. Similarly, in the case of apatite films, the reactions dur-
ing immersion can be described as follows: the uncrystallized calcium phos-
phate, which could be regarded to be similar to ACP, dissolved in the solution 
and saturated with the remaining ACP; the remaining ACP then transformed 
into OCP and eventually into HA. As a result, the content of HA in the film 
increased and that of ACP decreased at the same time. Comparing the XRD 
patterns of films before (Figures 4.1 and 4.2) and after immersion (Figure 4.12) 
in the Tris solution, it was found that the crystalline phase increased after 
immersion. In the final solution, there was still a considerable amount of Ca2+, 
PO43− produced as the ACP dissolved, leading to weight loss of films.
With the increase of F content in the films, the relative content of crystal-
line phase in the films without immersion increased correspondingly (see 
Table 4.1), and soluble amorphous phase content reduced in the meanwhile. 
Moreover, some fluorine might be present in ACP, which would improve the 
stability of ACP [34,35]. As a result, less Ca2+ and PO43− dissolution, as well as 
less weight loss of the films were observed.
Defects (such as cracks and pores) will increase the actual contact area 
of films and solution, which benefits the dissolution of ACP. Therefore, for 
high-temperature calcining of the films, there are two opposite effects: the 
amount of amorphous phase decreases so that the films dissolve less, while 
the contact area increases so that the films dissolve more. As a result of these 
two opposite effects, the film weight loss may differ against the variation of 
calcining temperature, as shown in Figures 4.9 and 4.10.
In the immersed solution, the existence of F ions (as the amorphous phase 
of fluorine-containing films contains a certain amount of F, which may pro-
duce F ions when dissolved in the solution) is favorable for the transforma-
tion from OCP phase to HA. Figure 4.13 shows the morphology of films after 
immersion in the Tris solution (the insets show the morphology before soak-
ing). With the increase of the calcining temperature, HA films showed sig-
nificant changes. Surfaces of HA films with 500°C calcining turned rough 
and were composed of a number of grains. For films treated with high tem-
perature, there were many pores on the surface; with higher temperature, 
the film surface became very rough and even discontinuous.
The morphology variation of FHA films after immersion is basically the 
same as that of HA films (Figure 4.13). Compared with the HA films, the 
FHA film after 800°C calcining was relatively flat but with larger pores. With 
different fluorine content, the morphology of films after immersion also had 
some changes. Films with lower fluoride content became rougher, and more 
grains were observed on the surface, while films with higher fluorine content 
appeared rather smooth.
In conclusion, fluoride-containing films are much more advantageous with 
respect to stability. This advantage is due to the fact that the introduction of 
F not only reduces the dissolution of the crystalline phase but also increases 
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the content of crystalline phase in the films. As a result, the overall stability 
of the bioactive films has been improved.
4.2.5 adhesion Strength of FHa Coatings
Adhesion strength between the film and substrate is a critical factor in suc-
cessful implantation and long-term stability of any coated implant. The 
introduction of F into HA films has some influence on the adhesion strength 




























[PF6–]/Ca = 1/30 
[PF6–]/Ca = 1/30 
[PF6–]/Ca = 1/30 
Figure 4.12
XRD patterns after soaking in Tris solution. (From Cheng, K., Sol–gel preparation of fluori-
dated hydroxyapatite films and their in vitro properties, PhD dissertation, 2003.)
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as well. The most commonly used methods employed to evaluate adhesion 
strength of bioactive coatings on metallic substrate include the tensile test 
(pull-out test) [36,37] and scratch test [38,39].
Figure 4.14 shows how to evaluate the adhesion strength through the 
tensile test. First, on one side of the metal substrate, bare metal is exposed 
HA on Al2O3
fired at 500°C
IMAT28        25.0 kV       ×3.00 K            10.0 mm
HA on Al2O3
fired at 600°C















IMAT17    25.0 kV       ×3.00 K          10.0 mm
IMAT16   25.0 kV       ×3.00 K          10.0 mm
IMAT22   25.0 kV       ×3.00 K          10.0 mm
Figure 4.13
SEM micrographs of the films after 2 week immersion in Tris solution. (a) HA fired at 500°C, 
(b) HA fired at 600°C, (c) HA fired at 700°C, (d) HA fired at 800°C, (e) FHA fired at 600°C with 
HPF6/Ca = 1/90, (f) FHA fired at 600°C with HPF6/Ca = 1/45.
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through polishing, and then two aluminum rods with the same diameter 
and length are stuck to both sides coaxially, and the tensile strength test is 
carried out with a universal testing machine. The force at which fracture 
occurs as the film side is divided by the contact area, and the result is consid-
ered as the bonding strength between film and substrate.




















SEM micrographs of the films after 2 week immersion in Tris solution. (g) FHA fired at 500°C 
with HPF6/Ca = 1/30, (h) FHA fired at 600°C with HPF6/Ca = 1/30, (i) FHA fired at 700°C with 
HPF6/Ca = 1/30, (j) FHA fired at 800°C with HPF6/Ca = 1/30. (From Cheng, K., Sol–gel prepara-
tion of fluoridated hydroxyapatite films and their in vitro properties, PhD dissertation, 2003.)
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Figure 4.15 shows the bonding strength of films with different content of 
fluorine. Obviously, FHA films showed stronger adhesion than pure HA 
films. When F content was relatively low, adhesion increased rapidly with 
increasing F content. With even higher F content, the adhesion strength 
tapered off gradually.
However, as shown in the morphology of the films, there are pores and 
cracks in the film. That will lead to inevitable glue infiltration, which may 
eventually result in inaccuracy in the pull-out test [41,42]. Comparatively, 
a scratch test may avoid such adverse influences. In this test, the adhesion 
strength between the film and the substrate was evaluated using a scanning 
scratch tester. For example, in a typical test, a spherical Rockwell C diamond 
stylus of 15 μm radius with a progressive load from 0 to 1000 mN was used. 
The stylus scanned the film surface at a speed of 2 μm/s while maintained 
scanning amplitude of 50 μm perpendicular to the scratching direction. The 
load at which the first damage is made in the film is called the “lower critical 
load,” and the load at which the total peeling-off of the film from the sub-
strate occurs is referred to as the “upper critical load.” In hard films, usually 
the “lower critical load” is used to measure the cohesion of the film. To evalu-
ate the film/substrate adhesion, the “upper critical load” was chosen as an 
indication of the adhesion strength.
A typical scratch track of the film is shown in Figure 4.16, and the cor-










Schematic diagram of the bonding strength characterization. (From Cheng, K. et al., Thin Solid 
Films, 517, 5361, 2009.)
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function of load. Increasing voltage corresponded to increasing coeffi-
cient of friction. Figure 4.17 is that for HA and FHA fired at 600°C. At the 
beginning of the scratch, the coefficient of friction increased as the load 
increased due to cohesive failure because of the “soft” nature of the film. 
Before point 1 (Figures 4.16 and 4.17), there were fluctuations as a result 
of the surface roughness. After point 1, the indenter started to plow into 
the film, resulting in a steeper increase in the coefficient of friction. As the 








0.4 0.8 1.2 1.6 2.0




















Scratch track of an HA coating. (From Zhang, S. et al., Surf. Coat. Technol., 200, 6350, 2006.)
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completely peeled off the film and scratched onto the substrate causing 
an abrupt increase in friction. This load was taken as an indication of the 
adhesion strength for the film. Curve b records that for FHA. After the 
indenter digs into the film (note the change of the slope in the curve), 
there is no abrupt increase in friction until the indenter reaches the sub-
strate at about 470 mN. Comparing curves a and b in Figure 4.17, b appears 
smoother (less fluctuation in friction before the indenter digs in) and the 
film adheres to the substrate better (slower slope after the indenter digs in 
and lack of abrupt increase). The abrupt increase of friction signals meant 
a sudden and brittle peeling-off of the film from the substrate. The lack of 
this abrupt change demonstrated that b has more ductile interface and thus 
better film–substrate bonding [43].
Figure 4.18 summarizes the adhesion strength (“upper critical load”) of all 
the FHA films with different F content as a function of fluorine and firing 
temperature. Both fluorine content and firing temperatures had significant 
effect on the adhesion strength: with increasing fluorine concentration or 
firing temperature, there was an obvious increase of the critical load. For the 
same fluorine content films, higher firing temperatures gave rise to jumps in 
adhesion strength. At the same firing temperature, the general trend was that 
adhesion increases with fluorine content. However, the increase was more 
profound at higher temperatures. At 500°C, the critical load only increased 
marginally with fluorine content, but at 600°C and 700°C, the curves went up 
rapidly with fluorine content. In addition, only when the F content was rela-
tively low, the adhesion strength increased rapidly. If the F content exceeded 
a certain value, the increase of strength was not so obvious.
100
Tip radius: 15 µm
Scratch speed: 2 µm/s




























Coefficient of friction in terms of relative voltage as a function of normal load while scratching 
(a) pure HA coatings and (b) FHA coating on Ti6Al4V substrate. (From Zhang, S. et al., 
Surf. Coat. Technol., 200, 6350, 2006.)
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Films adhere to substrates through either mechanical interlocking or 
chemical bonding or both. Since all substrates have the same finishing, 
mechanical interlocking is deemed identical; thus, the increase in adhesion 
strength is attributed to stronger chemical bonds developed at the film–
substrate interface during firing.
Figure 4.19 shows the interface microstructure of an FHA film fired at 
600°C. The cross section micrograph showed dense and uniform structure, 
and no delamination and/or cracks at the interface were observed.
Figure 4.20 shows a typical EDS cross-sectional elemental distribution of 
Ca, O, F, and P in an FHA fired at 600°C. Three regions were marked: the 
substrate (Rs), the film (Rc), and in between was the transition (Rt). Within 
the transitional region, the Ca and P concentrations decreased significantly 
toward the Ti substrate, while the F and O decreased slowly and gradu-
ally from the film to the substrate. In other words, there existed relatively 
large amount of F and O in the transition region. It showed that, along the 
cross section, certain Ti–P–Ca–O–F chemical bonds formed at the interface 
[37,44,45] that could contribute to the increase in adhesion. The formation of 
chemical bonds at the interface may be also responsible for the change in 
failure mode (from brittle to more ductile).
Figure 4.21 shows the cross-sectional HRTEM image of an FHA film. 
There are multiple sets of fringes, representing the different lattices of 
apatite crystals. As seen from the image, the grain size is about several 
nanometers to several tens of nanometers. Some typical apatite lattices, 
such as [211], [112], and [111] could be found in the high-resolution images. 
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Adhesion strength of pure HA and fluoridated HA coatings on Ti6Al4V substrate as indicated 
by upper critical load in scratch test. Firing temperatures are indicated. (From Zhang, S. et al., 
Surf. Coat. Technol., 200, 6350, 2006.)
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Figure 4.22 is the electron diffraction diagram (r = 0.29 μm) of the cross 
section. The value of R12:R22:R32:R42:R52 basically equaled to 3:4:7:9:12, which 
was consistent with the increase of R2 of {hk0} lattices in the hexagonal 
system. That proves that the grains belonged to the hexagonal system. As 
FHA is hexagonal, the result is in well agreement with the presence of 
lattice fringes shown in Figure 4.21. In addition, the presence of diffraction 

















EDS element analysis of the cross section of FHA fired at 600°C. (From Zhang, S. et al., Surf. 
Coat. Technol., 200, 6350, 2006.)




Cross section of a typical FHA coating. (From Zhang, S. et al., Surf. Coat. Technol., 200, 6350, 
2006.)
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As discussed previously, there might be some chemical bonds formed at 
the interface; the HRTEM image of the interface between the film and the 
substrate in Figure 4.23 gives more direct evidence. The interface showed 
that the film and substrate bond together closely without any gap. Part 
of the lattice fringes of the apatite can be found in Figure 4.23, such as 
[002]. More important, from the microdiffraction photo of a typical grain, 
R12:R22:R32:R42:R52:R62:R72 = l:2:4:5:8:9:10 could be calculated. That indicated such 
grains were tetragonal. Considering the previous XRD and EDS results, the 
grains were rutile TiO2.
According to the previous analysis, the structure of the films can be 
described as follows, as shown in Figure 4.24: crystalline FHA layer with 
thickness of about 1.5 μm, FHA with low fluoride content, and the transition 
layer containing fluorine and titanium dioxide.
The formation of this structure may be explained as follows: First, chemi- 
and physisorption process occurred during dipping and drying. Since native 
oxide (TiOy, y ≤ 2) forms spontaneously on titanium and titanium alloy sur-









Cross-sectional HRTEM photo of the film. (From Cheng, K. et al., Surf. Coat. Technol., 198, 
242, 2005.)
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by Ti cations that lead to the formation of Ti–OH bonds on the outermost 
surface [46]. XPS depth profiling confirmed a 5–8 nm titanium oxide layer 
as soon as the Ti6Al4V substrates were prepared. In dipping sols, fluorine 
ions released by F-precursor react with Ca2+ to form nanocrystalline CaF2 
[29]. The F in nc-CaF2 easily forms hydrogen bond with H in the OH group, 
i.e., O–H⋯F–Ca–F [44]. Therefore, when the Ti6Al4V substrate is immersed 
into the dipping sol, nc-CaF2 could be easily adsorbed onto the substrate 
surface through the formation of hydrogen bond. The higher the fluorine 
concentration in the dipping sol, the more nc-CaF2 forms and adsorbs on 
the substrate surface. It has been reported that the adsorbed nc-CaF2 on 
the titanium alloy substrate surface attracts more O near the interface [44]. 
On the other hand, due to the amphoteric property of Ti–OH, the substrate 
surface is positively charged in current dipping sol (pH < 1). Thus, surface 
adsorption of electronegative groups, such as NO3−, PO43− groups, will follow. 
Following the adsorption, an important step is the diffusion during firing 
when the surface-adsorbed nc-CaF2, PO43− groups, etc., react with titanium 
to form certain chemical bonds if the temperature is high enough to acti-
vate the formation process. The diffusion of fluorine and oxygen from the 
film into the transition region encourages this reaction and results in the 
accumulation of O and F in this region (Figure 4.20). Since higher fluorine 
content in the dipping sol attracts more O near the interface [44], firing in an 







Selected area electron diffraction pattern of the film at cross section. (From Cheng, K. et al., 
Surf. Coat. Technol., 198, 242, 2005.)
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TiO2 or even complex Ti–P–O–F–Ca bonds may be formed in the transitional 
region that helps improve the adhesion strength. Higher firing temperature 
obviously promotes diffusion of fluorine and oxygen as well as provides 
activation for the chemical bonding process, thus leading to higher adhesion 
strength. Previous studies by Filiaggi et al. [47] also indicated that similar 
interactions at the interface of the substrates and the dipping sol have great 
influence on the ultimate adhesion property.
Residual stress at the interface resulting from the deposition process 
may exert adverse effect on adhesion strength. The difference in the ther-
mal expansion coefficient for the film and substrate results in thermal mis-
match that in turn contributes negatively to adhesion strength via increased 
residual stress [48]. The incorporation of fluorine ion into apatite structure 
decreases the coefficient of thermal expansion (CTE) from 15 × 10−6/°C to 
9.1 × 10−6/°C when HA is changed to FA. The latter is much closer to that of 
the Ti-alloy substrate (8.9 × 10−6/°C). In fact, the mismatch in CTE between 
HA and Ti-alloy is 68.5% while only 2.2% between FA and Ti6Al4V. As a 
result, the incorporation of fluorine in HA reduces the thermal mismatch and 










HRTEM photo of the film–substrate interface. (From Cheng, K. et al., Surf. Coat. Technol., 198, 
242, 2005.)
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thus residual stress and consequently improves the adhesion strength. The 
reduction in residual stress also contributes to better ductility [49].
Both tensile test and scratch test reveal that the film adheres to Ti-alloy 
substrate better as the fluorine concentration increases in the film. This adhe-
sion enhancement is much more profound at higher firing temperature. The 
increase in adhesion likely comes from the formation of chemical bonding at 
the interface and the relief of thermal mismatch stress due to the incorpora-
tion of F into the HA structure. As a result, the film and substrate interface 
becomes more ductile.
4.2.6 in Vitro and in Vivo evaluations
From cell proliferation point of view, pure HA is preferred because large 
dissolution of HA leads to increases of Ca and P ion concentrations that favor 
cell activities [50,51]. Although long-term stability (dissolution resistance) 
and enhanced cell attachment are achieved on FHA films, cell proliferation 
is compromised because release of Ca and P ions is impaired [33]. To strike 
a balance between these two polarities, FHA films with moderate F content 
FHA layer 







Schematic photo of the cross-sectional structure of the film. (From Cheng, K., Sol–gel prepara-
tion of fluoridated hydroxyapatite films and their in vitro properties, PhD dissertation, 2003.)
177Zinc- and Fluorine-Doped HA Coatings via Sol–Gel Method
are tested and they do demonstrate good performances both in vitro and 
in vivo [52].
Here cell attachment and proliferation on different FHA films (the molec-
ular formula of some typical FHA films were obtained and tabulated in 
Table 4.2) and cell culture in leaching out solutions were measured and 
assayed. The experiment process is conducted as follows.
The cells used in the culture test were the osteoblast progenitor cells derived 
from adult rabbit bone marrow, extracted from adult rabbit back shank. The 
cells were washed twice in phosphate buffer solution (PBS) and collected 
via centrifugation. In the standard incubation condition (5% CO2, 37°C), 
they were incubated for about 1 week in different cultural media contain-
ing Dulbecco’s Modified Eagle’s Medium (DMEM), dexamethasone, vita-
min C, and β-sodium glycerol-phosphate. Finally, the cells developed into 
osteoblast-like cells. After sterilization in 120°C water steam for 20 min, the 
samples were placed in 24-well plates for osteoblast-like cell implantation at 
a set density of 1 × 104 cells/cm2.
After implantation, the films were taken out and the osteoblast-like cells 
attached on the films were fixed and observed with an SEM. As shown in the 
typical SEM micrographs (Figure 4.25), the cells attached well on the film sur-
face. They spread well, and the filopodia were clearly seen, indicating good 
Table 4.2
Sample Annotation and F Content in the Coatings
F0 F067 F148 F190 F200


































Typical morphology of cells attached on the films: (a) F148 and (b) F0. (From Cheng, K. et al., 
Biomaterials, 26, 6288, 2005.)
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livelihood. The cell numbers were evaluated by hemocytometer. Figure 4.26 
plots the cell density as a function of culture time for films with different F 
content but the same initial cell implanting density of 1 × 104 cell/cm2. In the 
pure HA film (F0), the cell concentration reached about 5 × 104 cell/cm2; for 
F067 and F148, only about (3–4) × 104 cell/cm2; for F190, it also reached about 
5 × 104 cell/cm2, which is similar to pure HA; as for F200, the concentration 
reached 11 × 104 cell/cm2.
Flow cytometry analysis indicated (Table 4.3) the percentage of cells in 
different cell cycles (G0G1: pre-DNA synthesis or resting; S: DNA synthesis 
phase; G2M: post-DNA synthesis and mitosis). The percentage of the cells in 


























Cell growth curve of cells attached on coatings with different F content. (From Cheng, K. et al., 
Biomaterials, 26, 6288, 2005.)
Table 4.3
Cell Cycles of Cells on Different Coatings at Different Time Periods
Period	of	Cell	Cycle G0G1	(%) S	(%) G2M	(%) Proliferation	Index	(%)
F190, 4 day 50.2 ± 4.8 49.8 ± 3.2 0 50.2 ± 4.5
F148, 4 day 60.0 ± 5.2 34.4 ± 2.6 5.6 ± 0.3 65.6 ± 5.4
F0, 4 day 86.5 ± 6.8 11.2 ± 1.3 2.3 ± 0.2 88.8 ± 5.7
F190, 7 day 32.9 ± 2.1 67.1 ± 5.3 0 32.9 ± 2.9
F067, 7 day 56.4 ± 4.3 34.8 ± 2.6 9.7 ± 0.6 66.1 ± 6.5
F0, 7 day 88.2 ± 5.6 11.8 ± 1.3 0 88.2 ± 5.1
Control 99.5 ± 6.3 0 0.5 ± 0.1 100 ± 6.4
Source: Cheng, K. et al., Biomaterials, 26, 6288, 2005.
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were found in the S period when they are cultured on the films than those on 
the control. Compared to the control, the difference is significant.
For effects of leaching out of the film, the samples were immersed in DMEM 
solution at 37°C for 4 days at a ratio of 10 mL/cm2 (DMEM volume per unit 
film area). The immersed solution was used for the incubation of osteoblast-
like cells. Untreated DMEM solution was also processed as the control. The 
MTT statistics (at p < 0.05) of the cells cultured for 1–5 days are shown in 
Figure 4.27. At first, all the cells showed relatively low absorbance, indicating 
the cells were adapting to the new environment. Thus, the number of living 
ones fell below that of the control. After 3 days, the absorbance increased 
drastically on all the films, meaning the number of living cells increased, i.e., 
the cells proliferated. At this moment, leaching out from films with different 
F content showed significant difference (considering at p < 0.05) in cell pro-
liferation: pure HA and FHA with less F content (F0, F067, and F148) showed 
even better cell proliferation than control (higher absorbance). On film with 
very high F content or pure FA (F190 and F200), less cell proliferation was 
seen than the control.
When the osteoblast cells are cultured on the FHA film, there are two 
different ways in which F affects the behavior of the cultured cells. First, sur-
face property variations due to F existence in FHA films could have a direct 
influence on interactions between the cell and the film; second, changes 
in the leaching outs of the films due to the F incorporation could have an 
influence on cell growth by means of ion concentration changes in the cul-
ture medium. As such, the cell behavior will be affected. Considering these 

















MTT results of cells cultured in leaching-out solutions of the coatings (considered at p < 0.05). 
(From Cheng, K. et al., Biomaterials, 26, 6288, 2005.)
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Based on the dissolution results obtained in a pH condition similar to that 
of the cell culture media, the maximum depth involved can be estimated 
through calculation based on weight loss. The depth is calculated to range 
from about 170 to 68 nm, inversely proportional to the F content.
Apparently, all the films showed good biocompatibility because osteo-
blast-like cells could attach and spread well on the films, as shown in the 
SEM results (Figure 4.25). In the cell growth curve (Figure 4.26), when the 
films had low F content (F067 and F148), less cell attachment was observed as 
compared to pure HA. Only when the concentration was high (to the extent 
of F190), did it show positive effect on cell attachment: F190 had a cell attach-
ment similar to that of pure HA, while F200 produced the maximum. Further 
cell cycle analysis results are tabulated in Table 4.3. With the increasing F 
content in the film, the percentage of cells in S period increased, indicating 
that the cells attached on the film seemed to become more active in the DNA 
replication process. From both the cell attachment and cell cycle results, it 
can be concluded that it is quite clear that the variations of cell behaviors are 
greatly affected by the F content in the films.
As widely accepted, rough surfaces promote cell attachment. However, even 
F067 and F148 have rougher surfaces than all the other films and the number 
of cells attached is still less (Figure 4.26). The same situation happened to F190 
and F200, where F190 seems to have rougher surface than F200, but the cells 
attached on F190 are significantly less than F200. Obviously, the cell attach-
ment differences here are not mainly induced by the roughness variations.
The aforementioned cell behavior variations could have resulted from the 

























Zeta potential of FHA coatings after different times of immersion in Tris solution. (From 
Cheng, K. et al., Biomaterials, 26, 6288, 2005.)
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potential results for 3-day and 6-day soaking. The tendency of the zeta poten-
tial against the F content coincided with the trend of the cell attachment as a 
function of F content: roughly lower potential corresponded to higher num-
ber of attachment. The variation of zeta potential may influence the adsorp-
tion of Ca2+ ions, which, in turn, affects the adsorption of extracellular matrix 
(ECM, including osteocalcin and osteopontin) [53]. Consequently, the attach-
ment of the cells is affected because osteoblast-like cells actually attach on 
the ECM preadsorbed on the surface of the sample.
The influence of F on surface potentials can be attributed to the FHA 
film’s different dissolution behavior. According to the apatite self-inhibition 
dissolution model [54,55], after the initial dissolution of a small portion of 
apatite, a steady calcium-rich layer consisting of Ca2+ ions and their anionic 
counterparts will first form and then control the further dissolution of apatite. 
If this “calcium-rich layer” is regarded as the “compact layer” in the double 
layer theory of colloids, the exact content of the “calcium-rich layer” will 
affect the zeta potential of apatite. With the F existence in the surface layer of 
apatite, more Ca2+ ions will be attracted in the “calcium-rich layer” due to the 
strong electronegativity of F, leading to increase of the zeta potential (F067 
and F140). However, even higher F content will result in solubility decrease, 
which will in turn produce a low Ca2+ concentration in the solution, leading 
to decrease of the zeta potential (F190 and F200).
When a film exists in the body, the dissolution of the film will affect the 
surface potential as mentioned earlier, as well as the long-term stability 
[5,6]. The dissolution also produces ion concentration variations around the 
vicinity of the film in the initial time after implantation. This could influ-
ence new bone formation. One approach to getting insight into the influence 
could be an in vitro test through observing behavior of osteoblast-like cells in 
a culture medium with leaching out, which is prepared by soaking the film 
in the medium.
The MTT measurement demonstrates that the leaching outs of the differ-
ent films do have different effects on cell proliferation. The number of living 
cells (or percentage of absorbance) for pure HA is rather similar to that of 
FHA with low F concentration, while for film with high F concentration, the 
number of living cells is significantly lower than pure HA.
Based on the relation between F content and dissolution, the maximum 
concentration of F ions is estimated to be ∼6.3 × 10−6 mol/L, which falls 
below the determination limit of normal measurement methods such as 
ion-selective potentiometry. In such a low concentration, it is impossible 
for F ions in the culture medium to play a significant role in affecting the 
behavior of osteoblast-like cells [56]. Comparing the Ca2+ dissolution with 
that of the MTT result (Figure 4.27), it is seen that as the concentration of Ca2+ 
increases, the number of living cells increases in cell culture experiments. 
This is in agreement with the report where the existence of Ca2+ benefits 
osteoblast cell proliferations [57]. The aforementioned variation of the F 
content with cell proliferation could be attributed to Ca2+ ion concentration 
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changes that depend on the F content in FHA film, i.e., an increase in 
F content in the film leads to a decrease in Ca2+ release, which, in turn, 
decreases cell proliferation.
Although the situation for the cell growth in the body is different from that 
in the culture media, the aforementioned analysis may help in understanding 
influences of the films as comprehensive as possible. The cell culture results 
demonstrate that the F content in FHA films affects the behaviors of cultured 
cells in different ways: high F content produces a low surface potential, which 
favors cell attachment, but at the same time, a reduction in Ca2+ release in a 
culture medium could inhibit cell proliferation. Previous work shows that 
high F content in FHA films has low solubility in SBF, which is good to guar-
antee long-term stability; also, a certain F content promotes apatite deposition 
in SBF [11]. From the film design point of view, all these effects of F content do 
not necessarily function in line with one another. However, all these effects 
are important in clinical applications and thus need to be taken into consider-
ation simultaneously and holistically. Based on the experimental data, FHA 
films with moderate F content, Ca10(PO4)6F0.67–1.48(OH)0.52–1.33, may have a more 
promising potential. Savarino [52] also showed that the Ca10(PO4)6F1.0(OH)1.0 
film in the in vivo test was better than both Ca10(PO4)6(OH)2.0 and Ca10(PO4)6F2.0 
films. The aforementioned analysis on F influences and optimized F content 
serves well in explaining Savarino’s results.
In general, FHA films with different F content prepared by sol–gel method 
show good cytocompatibility. F in the FHA films results in low zeta poten-
tial that promotes cell attachment. High F content also results in decreased 
Ca2+ release in culture media due to reduced solubility, and, as a result, cell 
proliferation is inhibited. For clinical application, it is suggested that a mod-
erate content of F, such as Ca10(PO4)6F0.67–1.48(OH)0.52–1.33, is most suitable as a 




In vitro and in vivo studies revealed that reactions such as dissolution, 
precipitation, ion exchange, and structural rearrangement occurred at the 
material–tissue interface [58], where the released ions can create solution-
mediated effects on cellular activity. As an essential trace element in the 
body, zinc is found to have positive roles in promoting bone formation and 
inhibiting bone resorption [59–61]. Several studies have been carried out 
on bulk zinc-containing materials based on coprecipitated HA [62–64], and 
the dissolution or biodegradation of zinc-containing HA could release zinc 
ions and show beneficial effects on bone formation. Therefore, based on the 
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previous discussion, the incorporation of Zn into FHA film may show even 
better effect on cellular responses.
4.3.1 Direct or Composite Doping
The easiest way to prepare Zn-doped FHA films on Ti-alloy is to incorporate 
Zn-containing compounds into the sol, so that the stimulating effect of Zn 
and the low solubility of FHA could be imparted into one film [65]. It is 
found that Zn can easily be enriched on the surface of the films or exists in 
grain boundaries. Although such Zn distribution favors the initial Zn release 
in vivo to act as an agent for enhancing bone formation, large amount of 
Zn incorporation renders undesirable porosity. Moreover, the fast release 
of Zn is rather uncontrollable and therefore would not have the desired 
pharmacological effect.
In contrast, Zn ions can directly locate within the crystal structure of 
β-tricalcium phosphate (β-TCP), which can then serve as an ideal slow 
release carrier of Zn. Ito and colleagues [66,67] have reported that low levels 
of Zn can be incorporated into β-TCP (ZnTCP) ceramics to enhance bone 
formation. However, these ZnTCP ceramics lack sufficient mechanical and 
chemical stability needed for osseointegration and therefore cannot be 
directly used as coating materials.
In order to compromise Zn release, bioactivity, and long-term stability 
in a coating, a bilayer coating that consists of a chemically stable FHA bot-
tom layer coupled with a top layer with Zn-releasing ability was proposed. 
The top layer, Zn-releasing fluoridated hydroxyapatite (ZTFHA) coating, 
was prepared by sol–gel method, in which nanosized ZnTCP particles were 
dispersed as Zn carriers within an FHA matrix [68].
In such coating, nanosized ZnTCP particles acted as Zn carriers and Zn 
mainly existed in the β-TCP phase dispersed among FHA matrix. ZTFHA 
coatings demonstrated slow and sustained release ability because soluble 
ZnTCP particles were involved. Preliminary cell culture results showed an 
obvious increase in cell viability on the ZTFHA coatings compared with 
an FHA coating without Zn, indicating that capacity for Zn release ability 
clearly had a stimulatory effect on osteoblast cells. In vivo testing showed 
that the osseointegration was obviously improved with the ZTFHA coating 
compared with an FHA coating. This novel ZTFHA coating shows promise 
for establishing early cementless fixation of orthopedic implants.
4.3.2 Sol–gel Preparation of Zinc-Containing FHa Coatings
In a typical sol–gel preparation of ZnFHA films [69], Zn(NO3)2·6H2O was 
dissolved in absolute ethanol to form 0.1 M/L solution, and then designed 
amount of Zn(NO3)2 solution was added into the typical sol of FHA to form 
a series of dipping sols. Extra ethanol was added to adjust the Ca ionic 
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concentration to be the same in different dipping sols and was used for film 
preparation. As for ZTFHA films, the sol–gel preparation is even simpler, 
just add designed amount of nano-ZnTCP powder into the typical sol of FHA 
and then use the obtained sol for film preparation. It is noteworthy that after 
nano-ZnTCP addition, the sol transforms into a much thicker “colloid sol,” 
and as a result, the times of coatings could be reduced to once or twice to a 
film thickness of 1–2 μm.
4.3.3 Microstructures of Zinc-Containing FHa Coatings
Figure 4.29 shows the SEM micrographs of the ZnFHA films [65]. The mor-
phology (Figure 4.29a) of the FHA film was dense. As Zn was incorporated, 
the film became porous and more porous with increasing Zn content. As for 
the films with composite Zn doping, all of the ZTFHA films (Figure 4.30) 
exhibited heterogeneous and rough morphology [69]. Most parts of the coat-
ing were covered by island-like ZnTCP agglomerates, which were embedded 
in the FHA matrix and existed stably. The morphology of the resulting coat-
ing showed a more heterogeneous and rougher surface than that of an FHA 
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Figure 4.29
SEM micrographs of the 600°C fired films with different Zn content. (a) Zn/Ca = 0, (b) Zn/
Ca = 0.0046, (c) Zn/Ca = 0.0077, and (d) Zn/Ca = 0.0093. (From Miao, S. et al., Surf. Coat. Technol., 
198, 223, 2005.)
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coating. The surface tension driving force during the solidification of the 
liquid layer may cause the accumulation of the particles on the surface. The 
accumulation degree is closely related to the particle size of ZnTCP, which 
decreases with increasing Zn content in ZnTCP. This leads to a relatively 
smooth surface morphology and a uniform Zn distribution in the ZTFHA-3 
coating (Figure 4.30c).
4.3.4 Zinc release behavior
Zn has been shown to be capable of increasing osteoblast proliferation, 
biomineralization, and bone formation [59,70]. However, the pharmacologi-
cal performance of zinc ions is dependent on the release behavior. Generally, 
the initial burst release of ions in the body may induce adverse reactions. 
Yamamoto evaluated the cytotoxicity of zinc salts using the colony forma-
tion method and found that the 50% inhibitive concentration of zinc for 
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Figure 4.30
Scanning electron microscopic micrographs of ZTFHA coatings: (a) ZTFHA-1, Zn/(Zn+Ca) = 
0.03; (b) ZTFHA-2, Zn/(Zn+Ca) = 0.06; and (c) ZTFHA-3, Zn/(Zn+Ca) = 0.09. Zn/(Zn + Ca) means 
the amount of Zn in ZnTCP; the amount of ZnTCP added was fixed at 67.2 mg/mL. (From Miao, 
S. et al., J. Am. Ceram. Soc., 94, 255, 2011.)
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MC3T3-E1 cells cultured in a modified Eagle’s medium + 10% fetal bovine 
serum (FBS) was about 5.85 mg/L [71]. Thus, the release process should be 
well adjusted to a slow and sustained rate, which is required during bone 
tissue regeneration.
The soaking test results (Figure 4.31) proved that the ZnFHA films are 
able to release zinc [72]. The zinc release profile of the ZnFHA films showed 
that Zn initially released fast within the first 16 h and then slowed down. 
The zinc concentration of ZnFHA-2 in Tris solution was higher than that of 
ZnFHA-1, which was consistent with the designed amount. This indicates 
that the release of zinc can be controlled by zinc amount in the films. After 
soaking for 168 h, the zinc of ZnFHA-1 was almost released out, while the 
ZnFHA-2 could still release zinc.
Zn release from ZTFHA coatings was time and load dependent, according 
to the Zn concentration variation in the Tris-buffered solution (Figure 4.32) 
[69]. The Zn release process took place slowly and was sustained up to 275 h. 
The release process could be regulated by changing the Zn content of the 
ZnTCP particles. In the ZTFHA-3 coating, the Zn content was about 1.7 times 
that of the ZTFHA-2 coating, while Zn release was only 1.1 times higher than 
that from the ZTFHA-2 coating. Hence, the ZTFHA-3 coating had a slower 
and more sustained Zn-releasing capacity.
For ZTFHA films, Zn release was realized through the dissolution of 
the ZnTCP phase. Thus, the variation in Zn content of the ZnTCP can 
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Figure 4.31
In vitro zinc release profile of ZnFHA coatings. (From Miao, S. et al., J. Mater. Sci. Mater. 
Med., 18, 2101, 2007.)
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direct incorporation of Zn into FHA coatings [59,73], the Zn release pro-
cess of ZTFHA coating is slower and more sustained and therefore more 
desirable.
In a more detailed comparative immersion test, ZTFHA film showed 
quite different Zn-releasing behavior from the control ZnFHA film [74]. 
In Figure 4.33a, during the first 96 h, for ZnFHA film, the Zn concentra-
tion increased rapidly during the initial 48 h and then tapered off. For 
ZTFHA films, however, the 24 h initial release of Zn was rather slow for 
films with CaZnTCP/CaFHA (R) of 1/8 and 1/4, but became similar to ZnFHA 
when R reached 1/2 and 3/4. During the first 96 h, ZTFHA films showed 
almost linear increases of Zn content. The end concentrations of Zn after 
each 96 h cycle were also compared in Figure 4.33b. Obviously, ZnFHA 
film released most of the Zn during the first 96 h, and after that, dur-
ing the rest cycles, very few Zn ions were leached. While ZTFHA films 
showed quite different behaviors: for those with R equal to 1/8, 1/4, and 
1/2, almost unchanged Zn concentrations were observed at the end of each 
cycle. But an obvious concentration decrease was recorded for that with R 
equal to 3/4.
The corresponding Ca/Zn ratios are also plotted in Figure 4.33c; for 
ZnFHA film, the Ca/Zn ratios kept almost unchanged at the ends of each 
cycle. While for ZTFHA films, the Ca/Zn ratios varied greatly; for coatings 
with R of 1/8, 1/4, and 1/2, the ratios after the first 96 h were rather similar, 
while they increased greatly after the second cycle and dipped a little after 
the third cycle. Particularly, for that with R of 3/4, Ca/Zn ratios remained 



































In vitro Zn release profiles for ZTFHA coatings. (From Miao, S. et al., J. Am. Ceram. Soc., 94, 
255, 2011.)






















































































Immersion results of ZTFHA coatings. (a) Zn concentration variations during the first 96 h, 
(b) Zn concentrations after different immersion cycles, and (c) Ca/Zn ratio variations after dif-
ferent immersion cycles. (From Cheng, K. et al., Thin Solid Films, 519, 4647, 2011.)
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Comparing with ZnFHA, ZTFHA films (except that R = 3/4) show quite 
different Zn release behavior: the concentrations of Zn increase slowly but 
steadily in the first 96 h (Figure 4.33a), and the concentrations after each cycle 
remain almost unchanged, while that with R = 3/4 shows similar Zn release 
behavior to ZnFHA, which is a rather fast release during the first 96 h and 
significantly decreased release in the remaining 96 h cycles.
In fact, as shown in Table 4.4, the Zn contents in ZTFHA films with R of 1/4 
and 1/2 are actually higher than that in ZnFHA films, and their Zn-releasing 
behaviors actually mean that a slower and more sustained Zn release is 
achieved.
The reason for such release is attributed to the different Zn chemical 
state: both the surface state and interfacial state of Zn are rather instable 
and thus more soluble, which makes the majority contribution to the 
initial rapid release of Zn. After that, since β-TCP is more soluble than 
FHA, Zn in ZnTCP releases at a medium rate. When there is a proper 
amount of ZnTCP (e.g., R equals 1/8, 1/4, or 1/2) in the composite coatings, 
the release of Zn is actually controlled by β-TCP dissolution since most of 
Zn exists in that phase (Figure 4.34). Further increased ZnTCP amount (R 
equals to 3/4) may lead to more interfacial Zn, which results from chemical 
reaction between ZnTCP and FHA precursor sol. These interfacial Zn ions 
are released rather quickly during the first immersion cycle (Figure 4.33a). 
Such analyses coincide well with the Ca/Zn ratio results in Figure 4.33c: 
in the first cycle, all the coatings show relatively low Ca/Zn ratio since the 
Zn is actually released from those soluble surface or interface phase; after 
that, the increased Ca/Zn ratios are in well agreement with Zn content 
in the ZnTCP phase; particularly, for biphasic coating with R = 3/4, since 
there is much interfacial phase, the Ca/Zn ratios remain low during the 
whole process.
Obviously, a composite Zn incorporation route could easily realize a slow 
and sustained Zn release.
The morphological evolution of the film also confirms that Zn is released 
through ZnTCP dissolution. In the typical SEM micrographs in Figure 4.35a 
Table 4.4







FHA 1.0 N/A 0 1.0
ZTFHA, R = 1/8 0 6.0 1/8 0.7
ZTFHA, R = 1/4 0 6.0 1/4 1.3
ZTFHA, R = 1/2 0 6.0 1/2 2.1
ZTFHA, R = 3/4 0 6.0 3/4 2.7
Source: Cheng, K. et al., Thin Solid Films, 519, 4647, 2011.
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[74], the original rough surface, which contained many microscale islands 
(ZnTCP particles), transformed into one with many microscale pores; such 
morphological change meant that many ZnTCP particles were dissolved. As 
for the ZnFHA coatings, except sporadic pores, few changes were observed. 
Obviously, for the ZnFHA coating, very few parts were dissolved, since this 
phase is much more dissolution resistant [73].
Obviously, Zn release behavior of ZTFHA film was slow and sustained for 
up to tens of days. Moreover, the zinc release process could be regulated by 
varying both the zinc content in ZnTCP and the amount of ZnTCP coating. 
The controllable release behavior of Zn ions therefore could be a promis-
ing candidate for orthopedic implants, as it is well accepted that Zn ions 
could influence the surrounding bone tissue in a sustained way. This will be 
confirmed in the in vivo test.
4.3.5 in Vitro and in Vivo evaluations
As discussed earlier, slow and sustained Zn release, which is desired for 
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Detail scan spectra of Zn2p3/2 peaks. (a) ZnTCP/FHA coating with R = 1/4, (b) ZnTCP/FHA 
coating with R = 3/4, (c) FHA coating, and (d) ZnTCP powder. (From Cheng, K. et al., Thin Solid 
Films, 519, 4647, 2011.)
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Therefore, it is reasonable to consider such coatings could show good perfor-
mance in the in vitro test and in vivo test.
The MTT results of cell cultured on ZTFHA films are shown in Figure 4.36. 
Based on the MTT results (Figure 4.36) [69], ZTFHA coating showed a 
statistically significant increase in cell viability compared with the control 
FHA coating at days 1 and 5. Zn has been shown to have stimulatory effects 
on bone formation and the stimulatory effects when the Zn concentration 
reached 65.3 μg/L in vitro. Nevertheless, the adverse effects caused by 
increased Zn ion concentration should also be considered. A 50% inhibition 
of MC3T3-E1 cell culture growth has been reported at Zn concentrations 
of 5.85 mg/L. The results shown in Figure 4.32 suggest that Zn released 
from ZTFHA films is below the toxic range. Therefore, the enhanced cell 
viability on ZTFHA films is attributed to the pharmacological effects 
resulting from proper Zn release. Osseointegration is the essential and 
pivotal requirement for the long-term success of the implant to maintain 
the mechanical stability with the surrounding bone tissue. Some researches 
[75,76] have demonstrated that pure Ti implant may sometimes lead to the 
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Figure 4.35
SEM morphological comparisons of the coatings before and after immersion. (a) ZTFHA coat-
ing with R = 3/4 and (b) ZnFHA coatings. (From Cheng, K. et al., Thin Solid Films, 519, 4647, 2011.)
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press-fit condition. However, Takatsuka et al. [77] and Yan et al. [78] also 
reported that Ti alloys did not have the ability of bonding to bone directly. 
That means in many cases, the implant surface of Ti alloy was in poor 
contact with bone tissue, and a typical layer of fibrous tissue was often 
observed at the interface.
To further investigate the effect of composite route of Zn incorporation, 
a comparison of cell growth between β-TCP/FHA and ZTFHA films were 
carried out (Figure 4.37) [68]. Both of these layers were able to support 
cell growth as the number of viable cells on the layers increased with cul-
ture time. A significant difference could be seen at days 1 and 5 when 
comparing the β-TCP/FHA and ZTFHA layers. When the cell responses 
were compared at each time point, the ZTFHA layer showed a statistically 
significant increase in cell viability in comparison with the β-TCP/FHA 
layer. In addition, cells growing on the ZnTCP/FHA layer showed a higher 
growth rate with culture time. Considering the similar dissolution of 
β-TCP and ZnTCP, it is reasonable to ascribe the increased cell activity to 
the existence of Zn.
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MTT results of different coatings (#significantly different from the controls [ANOVA, LSD 
Po0.05]; ZTFHA sample was that with Zn/(Zn+Ca) = 0.09). (From Miao, S. et al., J. Am. Ceram. 
Soc., 94, 255, 2011.)
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After 5-day culture [68,69], the cells showed a spherical morphology on 
a Ti alloy surface (Figure 4.38a). In contrast, irregularly spread cells were 
observed on both the FHA and ZTFHA films (Figure 4.38b and c), and the 
cells appeared to be confluent and overlapped with each other. Cells were 
more widely spread and extended on ZTFHA films, while on FHA films, 
some relatively spherical cells could often be seen. The cells on ZTFHA 
coatings therefore appeared more viable than those on Ti or the FHA 
coating.
Figure 4.39 shows the toluidine blue–stained histological images of the 
bone at the implant interface [69]. There were few contact areas of new bone 
with the implant surface in the Ti group. In some cases, a typical layer of 
fibrous tissue could be identified between the bone and Ti implant interface, 
suggesting poor long-term osseointegration of titanium (Figure 4.39a and d). 
Both FHA and ZTFHA coating groups showed mature cortical or trabecular 
bone growth in contact with the implants, while fibrous tissue at the bone–
implant interface was absent (Figure 4.39b and c). A higher amount of bone 
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MTT results of cells cultured on the TCP/FHA and ZTFHA coatings at days 1 and 5. (Values 
represent the mean + SD of triplicate measurements. *Significantly different from the TCP/FHA 
coating [p < 0.05].) (From Miao, S. et al., Acta Biomater., 4, 441, 2008.)
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tissue and direct bone contact occurred in the ZTFHA group compared with 
that seen in the FHA group. The latter consistently showed a gap between 
the implant and the bone tissue. The newly formed bone tissue in contact 
with the ZTFHA implant appeared highly mineralized and had a similar 
structure to that of the lamellar bone with organized osteon groups and a 
Haversian canal (Figure 4.39f).
The white arrow refers to the tetracycline fluorescent band, indicat-
ing active new bone formation [69]. Results of fluorescence microscopy 
are depicted in Figure 4.40. Tetracycline labels, which were adminis-
tered 2 and 1 weeks before animal sacrifice, were clearly observed as thin 
yellow lines, indicating the newly formed bone tissue. An intensive new 
bone formation was clearly observable at the bone–implant interface in 
both the FHA and ZTFHA groups, indicating active bone formation near 
the implants.
In conclusion, ZTFHA films with a composite Zn doping route exhibit 
excellent osteointegration performance. It is believed that the Zn existence 
plays an important role in osteointegration.
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Figure 4.38
In vitro cell biocompatibility of different coatings: (a) Ti, (b) FHA, and (c) ZTFHA. (From Miao, 
S. et al., J. Am. Ceram. Soc., 94, 255, 2011.)



















Light microphotographs of the bone–implant interface at 12 weeks after implantation in Ti alloy 
group (a and d), FHA group (b and e), and ZTFHA group (c and f). The black arrows indicate 
osteocytes (toluidine blue staining; original magnification: (a through c) ×4, (d, e, and f) ×10). 













Fluorescence microphotographs of the bone–implant interface at 12 weeks after implantation 
in the Ti alloy group (a), FHA group (b) and ZTFHA group (c). (From Miao, S. et al., J. Am. 
Ceram. Soc., 94, 255, 2011.)
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Confocal fluorescence microscopy of nuclear DNA (stained blue), actin cytoskeleton (stained 
green), and vinculin plaque (stained red) in HOB cell as revealed with multiple labeling 
using TOTO-3, FITC conjugated phalloidin, and Texas red conjugated streptavidin on (a) S1, 
(b) S2, (c) uncoated Ti substrate (control), (d) S3, and (e) S4. (Reprinted from Biomaterials, 26, 
Thian, E. S., Huang, J., Best, S. M., Barber, Z. H., and Bonfield, W., Magnetron co-sputtered 
silicon-containing hydroxyapatite thin films—An in vitro study, 2947–2956, Copyright 2005, 
with permission from Elsevier; Biomaterials, 27, Thian, E. S. et al., The response of osteoblasts to 
































Cell proliferation on MgxFHA coatings in terms of cell density: *At day 3, FMA1 and FMA3 
have a significantly higher cell number than that on FMA0 (p < 0.05). **At day 5, cell num-
bers on FMA3 are significantly higher than all the other coatings (p < 0.05). (From Cai, Y., 
Zhang, J., Zhang, S., Mondal, D., Venkatraman, S.S., and Zeng, X., Osteoblastic cell response 
on fluoridated hydroxyapatite coatings: The effect of magnesium incorporation, Biomed. Mater., 
5, 054114, 2010. With permission from Institute of Physics.)


























Intracellular ALP activities of MG63 cells cultured on MgxFHA coatings over the culture 
period: no significant difference between Mg-incorporated coatings (from FMA1 to FMA4) 
and Mg-free one (FMA0). (From Cai, Y., Zhang, J., Zhang, S., Mondal, D., Venkatraman, S.S., 
and Zeng, X., Osteoblastic cell response on fluoridated hydroxyapatite coatings: The effect of 

































Intracellular OC expression of MG63 cells cultured on MgxFHA coatings over the culture 
period: *FMA3 has a significantly higher OC expression than all the other coatings (p < 0.05). 
(From Cai, Y., Zhang, J., Zhang, S., Mondal, D., Venkatraman, S.S., and Zeng, X., Osteoblastic 
cell response on fluoridated hydroxyapatite coatings: The effect of magnesium incorporation, 






























Cell proliferation on MgFyHA coatings in terms of cell density: no significant difference is 
observed on different coatings (p < 0.05).
Mineral on film
20 25 30 35 40 45 50
2θ










Scanning electron microscopy of bioresorbable polymer films (a) before incubation and (b) after 
biomimetic incubation in a modified simulated body fluid (mSBF). Films were composed of the 
bioresorbable polymer poly(ε-caprolactone) (PCL). Incubation of films in mSBF resulted in the 
formation of a continuous mineral layer that displayed a nanoporous, plate-like morphology. 
(c) A profilometric analysis of the films demonstrated as well the formation of a continuous 
mineral coating. (d) Characterization of mineral phase by x-ray diffraction confirmed the for-















Biomimetic HAP coatings with different extent of carbonate incorporation (represented in 
black, blue, and green) allow for control over mineral dissolution and associated release of 




Sustained release of growth factors from HAP mineral coatings can influence cellular activities 
that lead to the formation of various tissue types, such as blood vessels and bone. Sustained 
release of recombinant human vascular endothelial growth factor (VEGF) induced new blood 
vessel formation in vivo. Arrows pointing dark brown stained lumens represent blood vessels 










































Schematics of HA coating formation on PLGA microspheres. (From Zhang, Z. et al., Nanosci. 
Nanotechnol. Lett., 3(4), 472, 2011.)
(a) (b)
Figure 6.28





Nondecalcified histological cross section of apatite-coated NiTi implant at 6 weeks after 
implantation. (a) Using a light microscope, showing direct contact of bone and coated implant 
(original magnification × 100). (b) Using a fluorescent light microscope, showing active trans-
formation of bone (osseous tissue is red and zones signed by Achromycin are yellow, origi-
nal magnification × 75). (Reprinted from Mat. Sci. Eng. C, 24, Chen, M.F., Yang, X.J., Hu, R.X., 
Cui, Z.D., Man, H.C., Bioactive NiTi shape memory alloy used as bone bonding implants, 497, 
Copyright 2004, with permission from Elsevier.)
(a) (b)
150 µm 150 µm
Figure 7.25
Nondecalcified histological cross section of apatite-coated NiTi implant at 13 weeks after 
implantation. (a) Using a light microscope, showing a new bone layer contacting with coated 
implant (original magnification × 100). (b) Using a fluorescent light microscope, showing a 
green bone layer between the marrow and the coated implant (original magnification × 75). 
(Reprinted from Mat. Sci. Eng. C, 24, Chen, M.F., Yang, X.J., Hu, R.X., Cui, Z.D., Man, H.C., 




















Nondecalcified histological cross section of apatite-coated NiTi implant at 26 weeks after 
implantation. (a) Using a light microscope, showing a mature bone layer. (b) Using a fluores-
cent light microscope, showing pink osteoid on apatite-coated NiTi implant. (c) Formation of 



















Nondecalcified histological cross section of uncoated NiTi implant at 26 weeks after implantation. 
(a) Using a light microscope, showing a new bone layer between bone and NiTi implant. (b) Using 
a fluorescent light microscope, showing new bone and mineralizing osteoid. (c) Noncontinuous 



























Nondecalcified histological cross section of apatite-coated NiTi and uncoated NiTi implants at 
53 weeks after implantation. Using a light microscope, showing a mature bone layer encom-
passes apatite-coated NiTi implant (a), and absorbable bone at one end of uncoated NiTi implant 
(b and c); using a fluorescent light microscope, showing rough interface between host bone and 
apatite-coated NiTi implant (d), and smooth interface between host bone and uncoated-NiTi 
(e). N, NiTi; B, bone; M, marrow; A-B, absorbable bone.
Figure 7.59
Collagen distribution in the coating on NiTi alloy after soaking in 0.5 g/L 1.5CSBF for 3 days.
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5.1	 Introduction:	Apatites	in	Biology	and	Medicine
Biomimetic principles seek to imitate or reproduce key elements of biological 
systems using synthetic techniques. In biomineralization, inorganic materials 
are often designed, structured, and optimized to replicate functions of 
nature’s minerals for a desired application. Biomimetic approaches can also 
provide a simple, deconstructed surrogate for biological function in the case 
of complex biological archetypes that are difficult to replicate ex vivo [1]. For 
more complicated biological systems, staged addition of features may be used 
to increase model sophistication as needed. Thus, biomimetic principles can 
potentially illustrate a biological system, explore its functionality, and exploit 
benefits to improve upon natural limitations.
Biomineralization is a classic example of a process that can be mimicked for 
multiple technological applications. Biomineralization is a natural process in 
which organisms synthesize and regulate growth of over 60 minerals for a 
number of critical functions [2]. Hydroxyapatite (HAP), a naturally occurring, 
hexagonal mineral crystal with the formula Ca10(PO4)6OH2 is synthesized 
by a myriad of organisms and is an important constituent of hard tissues 
such as vertebrate teeth and bones [3–5]. HAP comprises roughly 70% of the 
material found in cancellous bone by weight, with the other 30% coming 
from organic materials including collagen. In nature, HAP is the most stable 
of the calcium phosphate minerals at physiological pH [6], and other calcium 
phosphate mineral phases can transition to HAP in physiological buffer 
conditions [7,8]. Because bones and teeth are hard materials that degrade and 
wear over time, development of biomimetic substitutes for these materials 
has been prevalent during the past three decades.
In nature, HAP provides strength, support, and external coverage for 
critical body parts such as shells and bones and also facilitates an organism’s 
basic functions by maintaining calcium concentrations in the blood [9]. 
Therefore, there is a strong motivation for the use of HAP as a high-
strength biomaterial and as a bone implant. Interestingly, pure synthetic 
HAP is not typically attractive as a stand-alone orthopedic implant, as 
it demonstrates brittle mechanical properties and low material strength. 
This distinction between natural HAP-based hard tissues (e.g., bone) 
and pure synthetic HAP provides a simple illustration of the value of 
biomimetic approaches. One specific distinction is that biological apatites 
found in bones, teeth, and antlers are more calcium deficient and contain 
carbonate ions in lieu of phosphates when compared to pure synthetic 
HAP [10]. Therefore, perhaps the simplest example of biomimetic mineral 
synthesis involves creating calcium-deficient or otherwise “substituted” 
versions of HAP. This type of substitution renders HAP more soluble by 
influencing the crystal size and crystallinity, making the material slower to 
grow and faster to dissolve and release mineral ions. A number of ions can 
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substitute within the basic calcium phosphate mineral structure at either 
the hydroxyl or phosphate ion sites Ca10(AX)BY (A, AB, or B substitution), 
resulting in a change in crystal structure and mineral stability. Examples of 
variations of stoichiometric HAP include carbonated apatite, fluorapatite, 
and chlorapatite [11,12]. Each of these variations in HAP synthesis has 
functional consequences that can be useful for particular technological 
applications.
Another fundamental property of natural HAP exploited in technological 
applications is its well-characterized ability to bind to biological molecules (e.g., 
proteins, DNA). As a result, HAP materials have made strong contributions 
to the fields of chromatography and therapeutic drug delivery. HAP has a 
high affinity for proteins and DNA because of its elemental composition, 
which can be used to selectively separate proteins or DNA passed through 
a column [13–15]. Further, HAP-based drug delivery applications have 
exploited the controllable electrostatic interactions of the inorganic mineral 
with a variety of drug molecules, including DNA, peptides, proteins, and 
small molecules for subsequent delivery in vivo.
In essence, the fundamental properties of HAP and its prevalence in 
nature’s hard tissues have led to the widespread development of HAP-
based biomaterials with biomimetic functions. These biomaterials have 
continued to gain widespread use as components of metallic and polymeric 
medical devices to improve osteoconduction and deliver proteins and other 
drug molecules, thereby improving osteoinduction (Figure 5.1) [16–18]. This 
chapter will discuss the contemporary use of HAP-based biomaterials for 
therapeutic drug delivery, with a particular emphasis on their fabrication, 
stability, dissolution, and interaction with drugs (e.g., proteins). The focus 
will be on introducing key HAP properties of relevance to drug delivery 
and describing examples in which HAP biomaterials have been used in 
biomedical applications.
T = 37°C
t = 7 days
HAP coating
Incubation of devices in SBF
Devices
Figure 5.1
Biomimetic coating of medical devices. Hydroxyapatite (HAP) nucleation from aqueous 
solution (e.g., simulated body fluid [SBF]) can be used to coat a wide array of devices. The 
process is highly adaptable and can be used with complex geometries and a variety of template 
materials. Devices such as bone screws, sutures, scaffolds, and injectable particles have been 
successfully coated for localized drug delivery applications.
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5.2	 Introduction:	Localized	Therapeutic	Delivery
Local therapeutic delivery vehicles have emerged as an alternative to 
systemic drug delivery in some biomedical applications. Generally, the 
minimal requirements for successful localized drug carriers include 
(1) biocompatibility—avoidance of adverse biological reactions after in 
vivo implantation; (2) ability to chemically or physically incorporate drug 
molecules; (3) biodegradability into byproducts that are not detrimental 
to the patient locally or systemically; and (4) implantability or injectability 
into desired in vivo locations. In addition to these base requirements, 
emerging localized release approaches must either improve upon efficacy 
of a particular drug molecule or decrease side effects caused by systemically 
administered therapy. Calcium phosphate biomaterials such as HAP-based 
biomaterials are particularly interesting vehicles for localized therapeutic 
delivery, as they have a long tenure as osteoconductive bone graft substitutes 
in orthopedic, dental, and plastic/reconstructive surgery applications [19–21] 
and are therefore known to be biocompatible and implantable. The ability of 
biomimetic HAP biomaterials to degrade over time and incorporate/release 
various drug molecules has extended their use beyond bone graft substitutes 
into a variety of controlled delivery applications for proteins, peptides, and 
small molecules (Figure 5.1).
A wide variety of drug carrier materials have been used for localized 
therapeutic delivery, and they can be generally classified into naturally 
derived organic biomaterials, synthetic organic biomaterials, and inorganic 
biomaterials. Common examples in clinical applications include deminer-
alized, inactivated, or insoluble bone matrix, autolyzed antigen-extracted 
allogeneic bone, collagen types I and IV (e.g., sponges, gels, or membranes), 
fibrin, synthetic poly (α-hydroxyacids) (e.g., polylactic acid, polyglycolic acid) 
[22], titanium, and calcium phosphates [23]. HAP is a particularly attractive 
candidate for use as a therapeutic delivery carrier not only for its space 
filling ability but also for its ability to bind and release biological molecules. 
In view of the widespread applicability of HAP biomaterials in biomedical 
applications, the following section will introduce common methods that are 
used to synthesize this class of materials, with an emphasis on properties that 
are of relevance for drug incorporation and release.
5.3	 Common	Methods	to	Form	Hydroxyapatite	Biomaterials
As a group, calcium phosphate minerals vary individually based on the 
number of calcium ions present, the presence of water, and the fabrication 
method. The presence of impurities and the spatial arrangement or ratio of 
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elements during fabrication influence the mineral properties, which can in 
turn influence degradability and drug release [24]. Pure HAP has a calcium/
phosphorous (Ca/P) ratio of 1.67 and a low level of degradability over time, 
while biomimetic HAP retains the Ca10(PO4)6OH2 formula but is calcium 
deficient and its Ca/P ratio ranges from 1.55 to 1.67 [25]. The degradation 
characteristics of HAP are important, as they substantially influence release 
of drugs from HAP biomaterials. Matusmoto et al. were among the first to 
demonstrate that changing the degradation of pure HAP via changes in 
sintering temperature influences the release rate of bound proteins, with 
faster degradation kinetics leading to more rapid protein release [26]. HAP 
properties (e.g., degradability, osteoconductivity) can also be influenced by 
porosity, which is affected, for example, by the presence of water molecules 
during HAP sintering. Pores of a sufficient size can allow for bone ingrowth, 
creating a macroporous, osteoconductive interface with a large surface area 
to promote new tissue formation [27,28]. Likewise, pores can be used to 
increase drug binding capacity and facilitate drug release. Microporous and 
macroporous HAP each show promise in their ability to deliver proteins and 
other drug molecules. The purpose of this section is to introduce common 
fabrication methods used to form the types of HAP that have been used to 
achieve sustained, localized drug delivery in therapeutic applications.
HAP is fabricated via a variety of methods, including solid state reactions, 
precipitation from solution, hydrothermal processing, electrospraying [29], 
electrospinning [30–32], flux cooling [33], rapid combustion [34], flame spray 
pyrolysis [35], ultrasound [36], mechanochemical processing [37], microwave-
assisted precipitation [38], microemulsion/surfactant-assisted precipitation 
[39–41], hydrolysis of metal organic precursors [42–44], chemical vapor 
deposition, and plasma deposition [45]. Though varied, these methods can be 
categorized based on the temperature ranges at which they form materials: 
physiological (low temperature) and elevated (high temperature) [6]. The 
following subsections briefly introduce common types of HAP fabrication 
methods.
5.3.1  Fabrication of Calcium Phosphate 
Minerals: effects of Temperature
Temperature is a key element of calcium phosphate mineral formation 
and strongly influences the mineral phase produced. Precipitated HAP or 
“low-temperature HAP” is obtained by aqueous precipitation of calcium 
and phosphate ions homogeneously (i.e., precipitation via nucleation in 
solution) or heterogeneously (i.e., precipitation via nucleation upon a solid 
phase substrate). High-temperature HAP is produced by thermal reactions 
greater than 800°. Sintering, which is the process of removing air spaces from 
CaP materials, typically heats minerals to temperatures in excess of 1200°C, 
producing highly crystalline pure HAP with a Ca/P molar ratio of 1.67 and 
little to no degradability in aqueous solution [46]. Low-temperature calcium 
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phosphate minerals can be decompensated or calcinated [47] to change the 
phase of the material to form stable α- or β-tricalcium phosphate (TCP) or 
high-temperature HAP. Calcium phosphate cements are a mix of calcium 
phosphate formulations—with mixing at 40°C–80°C, the CaP formulations 
dissolve and mix into a less soluble, rigid CaP cement that sets to form 
precipitated HAP at pH > 4.2 or brushite at pH ≤ 4.2 [48]. Cement processing 
varies based on the volume of the cement and the ratio of particles to liquid, 
and these parameters dictate cement rigidity and toughness.
5.3.2 Sintered Calcium Phosphate Ceramics
The initial calcium phosphate crystals introduced into a sintering process 
can be nucleated from a supersaturated solution or grown on an organic 
platform before being sintered at high, supra-physiological temperatures. 
Sintering heats HAP particle suspensions of low density to form more dense 
masses, causing a decrease in specific surface area and porosity. Sintering 
can also combine two different calcium phosphate phases, such as HAP and 
TCP, and progress across three morphologic stages to form a new material. 
The characteristic setup of the initial phase allows for particles to be in close 
contact to one another before they merge, allowing numerous small particles 
to become fewer larger ones. At the conclusion of the intermediate stage, the 
contact area between particles grows larger, leading to the final stage, when 
the pore spaces are distributed between isolated closed pores that begin to 
shrink over time [47]. Sintering is a critical element of preparing ceramic 
HAP, as it imparts the material with strength and resistance to erosion. It is 
greatly influenced by the initial CaP phases present and the ratio of ions. For 
example, too much TCP and too little HAP can cause a coarser surface and 
altered morphology of the resulting sintered ceramic.
5.3.3 Calcium-Deficient Hydroxyapatite
HAP phases can also be prepared at lower temperature. For example, HAP 
can be produced by combining exact stoichiometric quantities of calcium and 
phosphate salts at basic pH, then boiling for several days with CO2 extraction, 
filtration, and drying. This process, and other similar aqueous processes, is extre-
mely sensitive to the presence of additives, and often results in the formation 
of calcium deficient hydroxyapatite (CDHA). CDHA is nonstoichiometric in 
its Ca/P ratio and known to have a large number of defect sites. It is often 
highly substituted and poorly crystalline, for example, ion substitutions 
such as carbonate substitution for phosphate can influence the crystal lattice 
parameters, morphology, crystallinity, solubility, and thermal stability [6]. 
Heating CDHA with a Ca/P ratio between 1.5 and 1.67 above 700°C creates 
a biphasic calcium phosphate, which contains both β-TCP and HAP phases. 
This biphasic calcium phosphate has been used in a variety of bone void filling 
applications discussed elsewhere [49,50], but will not be discussed in detail here.
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5.3.4  Calcium Phosphate Particles: Toward 
Drug incorporation and release
A variety of applications have also led to the development of HAP 
microparticles and nanoparticles. Solid HAP particles have a limited surface 
area for drug binding and therefore have poor drug incorporation efficiency. 
Incorporating porogens can increase surface area and facilitate better drug 
integration. Cosijns et al. fabricated porous HAP tablets by eccentrically 
pressing a mixture of milled HAP and a 50% (w/w) pore former, then 
sintering the final product at 1250°C. The investigators discovered the 
upper limit of pore incorporation and the sintering temperature at which 
tablets maintained their stability. Interestingly, these tablets could be used 
to efficiently incorporate proteins, and the rate of protein release was 
proportional to the pore size. Indeed, protein release kinetics could be 
accelerated by up to 26-fold via an increase in pore size [51].
Hollow HAP particles in spherical or rod-like structures provide an 
alternative vehicle to encapsulate therapeutic agents [52]. Hollow HAP 
microspheres spray dried at 180°C or calcined at 500°C for 1 h resulted 
in porous surface microspheres ranging from 1 to 10 μm. Immersed in a 
simulated body fluid (SBF), the mass of the particles decreased initially 
until day 8, suggesting particle dissolution, but then increased over time, 
suggesting new apatite precipitation on the microsphere surface. The 
slight changes in mass between days 8 and 21 were attributed to a shift 
from amorphous HAP to crystalline HAP, and after 21 days a dissolved, 
porous structure remained. As a delivery vehicle, hollow spheres are able 
to incorporate and release insulin into phosphate-buffered saline (PBS) 
at physiological temperature and pH over a 7 h timeframe. The hormone 
release kinetics followed a burst release trajectory over the first 3 h, followed 
by a linear release. Because the insulin was released prior to significant HAP 
dissolution, the authors proposed that the release was dependent on sphere 
porosity and the insulin–microsphere binding affinity [53]. This study is 
representative of a series of studies that have used micro- or nanoscale HAP 
materials for protein incorporation and release.
5.3.5 Calcium Phosphate Cements
Self-hardening in situ calcium phosphate cements are attractive for in vivo 
applications because they form HAP adjacent to existing bone, contouring to 
the geometry of a defect more closely than premolded implants. The setting 
process is often a result of HAP dissolution and precipitation, and the cement 
hardens as the precipitated HAP particles interlock. Cements are advantageous 
over other preparations because they are injectable and microporous and can 
set at low temperatures allowing for incorporation of biologically active drugs 
such as protein growth factors [54]. Cement base materials are composed 
of a variety of minerals, including tetracalcium phosphate and anhydrous 
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calcium phosphate. When they form crystalline apatite, CaP cements are 
osteoconductive with respect to the surrounding bone [21]. However, cements 
have a lower compressive modulus and failure strength than typical sintered 
HAP ceramics, which substantially limits their applicability in load-bearing 
sites. Some studies have used composite cements to increase the load-bearing 
capabilities with some success. Regardless of their material properties, these 
cements are potentially good candidates for use as drug carriers, provided 
that the drug remains active within the hardened cement.
5.4	 “Bioinspired”	Calcium	Phosphate	Synthesis
Biomineralization constitutes the formation of inorganic minerals within 
biological systems, which typically involves induction, nucleation, and 
mineral growth facilitated by the presence of an organic matrix and cellular 
activity [55]. Organisms including bacteria, protozoa, and mollusks produce 
minerals with complex architectures in extracellular spaces, directed by 
an organic extracellular matrix which is critical in dictating the structural 
framework [55]. The intricate organization and adaptability of natural 
biomineralization processes has led to widespread interest in biomimetic or 
“bioinspired” mineralization processes ex vivo, which seek to replicate some 
of nature’s mineral properties. In particular, bioinspired HAP synthesis 
proposes to simplify and deconstruct apatite biomineralization and thereby 
create a material that retains critical functions of native HAP. Critical 
HAP functions, as suggested by Legeros et al., include protein adhesion, 
interconnecting porosity, biodegradability, bioactivity, osteoconduction, and 
the ability to elicit a pro-osteogenic cellular response [56].
5.4.1 Heterogeneous Mineral Nucleation in Simulated body Fluid
There are myriad of ways in which HAP has been produced in simulated 
physiological conditions to form a crystalline mineral. The most common 
is by incubating a substrate material (e.g., an orthopedic implant) in an 
SBF to encourage heterogeneous nucleation. Using this approach, Kokubo 
et al. initially demonstrated that an HAP film can be formed on a silicate 
bioglass immersed in a circulating SBF containing mineral ions present in 
the blood [57,58]. The resultant mineral coating has a carbonate-substituted, 
calcium-deficient HAP phase, nanoscale porosity, and a lower stability 
than sintered, stoichiometric HAP. We and many others have extended 
the Kokubo approach to enable synthesis of numerous calcium phosphate 
mineral compositions on a broad spectrum of materials, and the mineral 
properties are generally dictated by the characteristics of the SBF (Figure 5.2). 
For example, Lu and Leng describe the formulation of different HAP phases 
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based on the composition of the SBF and its relationship to the ions found 
in human blood plasma [59]. Interestingly, crystallinity of HAP depends 
on its synthesis temperature, and low-temperature synthesis yields low 
crystallinity. For example, Matsumoto et al. demonstrated that a difference 
of 20°C has a direct influence on crystal size and an inverse relationship with 
crystal surface area [26].
One of the common themes in biomineralization, and by extension in 
biomimetic mineralization, is heterogeneous nucleation. This type of 
nucleation occurs when nuclei are energetically stabilized on an organic 
surface. The saturation of mineral ions in the surrounding solution serves 
as the driving force for the rate of mineral formation, as well as dissolution. 
The greater the concentration of ions in a supersaturated solution, the higher 
the driving force for mineral precipitation. Mineral precipitation is delayed 
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(See	 color	 insert.) Scanning electron microscopy of bioresorbable polymer films (a) before 
incubation and (b) after biomimetic incubation in a modified simulated body fluid (mSBF). 
Films were composed of the bioresorbable polymer poly(ε-caprolactone) (PCL). Incubation of 
films in mSBF resulted in the formation of a continuous mineral layer that displayed a nano-
porous, plate-like morphology. (c) A profilometric analysis of the films demonstrated as well 
the formation of a continuous mineral coating. (d) Characterization of mineral phase by x-ray 
diffraction confirmed the formation of hydroxyapatite (HAP). The blue trace represents the 
diffraction patterns associated with pure HAP.
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in solutions with insufficient supersaturation, as less saturated solutions can 
exist in metastable states that may need to be seeded or “doped” with calcium 
phosphate seeds or other charged moieties to induce mineral nucleation [60]. 
Undersaturated solutions are counterproductive to the mineral nucleation 
process and encourage mineral dissolution, by decreasing the size of the 
HAP crystals. Because there is no energy barrier limiting the dissolution 
process, it can occur frequently even in the midst of the mineral nucleation 
process. This dissolution/precipitation dynamic is less volatile as the level of 
supersaturation remains high, but does still typically occur.
The precise mechanism by which calcium phosphate minerals nucleate in 
nature has been debated for many years, and several studies have postulated 
that anionic functional groups serve to concentrate clusters that contain 
inorganic cations, creating a local supersaturation that promotes nucleation. 
Similarly, spontaneous nucleation can occur in vitro from supersaturated 
solutions, forming crystals of varying shapes and sizes. Weiner describes 
two methods to control biomimetic growth of large crystals by either 
slow cooling the substance onto a crystal seed or using a crystal seed to 
nucleate crystal formation in a supersaturated solution. In contrast, natural 
organisms create crystals of equal size along a determined trajectory and 
orientation and are not able to withstand the temperature increases needed 
by the slow cooling approach. Moreover, it has been determined that solid 
mineral deposits in nature are often organized randomly or amorphously, 
which then transform into organized apatite crystals as mineralization 
progresses [61]. Mann et al. determined that the key to controlling the crystal 
product is the ability to create an inorganic–organic interface that recognizes 
molecules and incorporates them into the growing crystal lattice. Proteins 
that recognize specific crystal surfaces can also control mineral growth and 
dissolution by determining the surface topology of the crystal face [62].
Mineral formation is also often achieved within or upon an extracellular 
matrix, including self-assembled matrices and planar substrates (e.g., 
Figure 5.2). Cui et al. used self-assembly to prepare mineralized collagen 
nanofibrils, noting that the self-assembled collagen nanofibrils served as a 
template for HAP precipitation. The fibrils were manipulated by changing 
the composition of collagen monomers and placing them into solutions with 
varying calcium and phosphate ion concentrations. The crystal lattice formed 
on the surface of the fibrils had a higher density than the interior mineral. 
Importantly, HAP crystals were formed in the gap zones between collagen 
fibrils, and the hexagonal crystals were oriented with their c-axis along the 
longitudinal axis of the fibrils. These data suggested that the fibrils served 
as a template for oriented HAP crystal growth, and further data from Cui 
et al. showed that negatively charged side groups on the collagen molecules 
served as nucleation sites for HAP [63]. Importantly, this type of mineralized 
collagen matrix bears key similarities to natural bone, which is a composite 
of organic collagen fibrils and oriented inorganic apatite, and this composite 
leads to bone’s unique structural and mechanical properties.
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5.4.2 biomolecule incorporation during bioinspired HaP Formation
Apatites formed via heterogeneous nucleation in simulated physiological 
conditions have several desirable features, as they can allow for mineral 
formation on a variety of geometries, with mineral properties that can be readily 
modified during formation by varying solution characteristics. Therefore, 
biomimetic HAP formation can create a biocompatible mineral interface on 
the surface of a variety of material types fashioned in variable geometries. 
HAP formation in SBFs also allows for protein incorporation during mineral 
growth, which can add biological activity to a mineral interface. HAP coatings 
on materials can then be used for delivery of “encapsulated” proteins, small 
molecules, DNA, and other drugs to a particular region of interest.
In one approach, investigators have examined incorporation of biological 
molecules (e.g., proteins) into a growing mineral coating. For example, bovine 
serum albumin (BSA) has been incorporated into an SBF solution during the 
formation of an HAP coating on the surface of a poly(lactic-co-glycolic acid) 
material. This study explored a variety of processing variables, including 
co-precipitation time and subsequent protein adsorption [64]. The results 
showed that co-precipitation leads to higher incorporation of protein than 
adsorption to a preformed mineral layer, as well as seemingly higher protein 
retention after scaffold rinsing. The authors also observed that protein 
co-precipitation changes mineral morphology, leading to decreased crystal 
size and crystallinity. This study also demonstrated that BSA incorporation 
influences mineral properties, as there was a correlation between BSA 
incorporation and mechanical strength. Although this study did not focus 
on the mechanism of protein incorporation or discuss biological activity of 
the protein, it did demonstrate that protein can incorporate into a growing 
mineral and influence resultant mineral properties. Other studies have 
co-precipitated HAP and BSA onto titanium surfaces to achieve efficient 
protein loading. They have found that loading efficiency varies with protein 
concentration, as expected, and that subsequent protein release kinetics 
depends on the strength and number of bonds that form between the mineral 
and BSA as the coating increases its porosity.
Importantly, the presence of protein during crystal growth can affect 
the nucleation and growth of the mineral in several ways. It is important 
to consider the potential influence of proteins, as there is the potential for 
undesirable trade-offs between efficient protein incorporation into a growing 
mineral and soluble protein effects on the growing mineral. The presence 
of proteins in SBF can inhibit or promote mineral nucleation and growth 
depending on the concentration of protein included. In the presence of 
albumin, the interfacial energy of mineral nuclei is decreased, stabilizing the 
smaller nuclei that grow at a slower rate. As a result, the higher the albumin 
concentration, the longer it takes for the crystal to form. Likewise, a high 
protein concentration also limits diffusion of ions to the crystal surface. In 
contrast, if there is not sufficient protein concentration to coat the surface 
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of mineral nuclei, then crystal growth occurs at a faster rate. Over time, 
as more protein adsorbs to the surface, the solution protein concentration 
decreases and eventually less stable mineral nuclei form. Importantly, since 
the protein can incorporate into the crystal lattice, the mineral may have a 
protein-dependent morphology, composition, or crystallinity. Each of these 
parameters is critical, as they can alter subsequent mineral dissolution and 
associated protein release kinetics.
5.5	 Therapeutic	Delivery	from	Hydroxyapatite	Biomaterials
HAP typically serves as an inexpensive, nontoxic, minimally resorbed 
material that is able to facilitate appositional bone growth. Thus, HAP 
has been extensively used as a bone substitute and a coating material on 
orthopedic and dental implants. It has more recently been appreciated that 
HAP also serves as an outstanding carrier for biological molecules, and it 
is widely applicable to a number of small molecules, proteins, and nucleic 
acids. A number of therapeutic proteins (e.g., growth factors) have been 
shown to enhance tissue regeneration and bone graft healing, but their 
effects are short lived when directly injected into open defects. Since HAP 
biomaterials are inserted directly into a defect site, they can provide local 
therapeutic delivery and circumvent some limitations of systemic therapies. 
Contemporary therapeutic delivery systems require compatibility with 
clinical settings as well as the capacity to efficiently incorporate and 
release therapeutic agents with controllable dosage and timing. The high 
binding affinity of HAP for a broad range of proteins and nucleic acids 
is well documented and provides an adaptable mechanism for drug 
incorporation and release. The following sections will introduce a series of 
specific therapeutic applications that have been explored to date using HAP 
biomaterials as drug carriers.
5.5.1 antibiotics against bacterial infection
Because of the high incidence of HAP in bone implant coatings, a large 
amount of work has focused on incorporating antibiotics onto HAP at the 
time of implantation to prevent infection. Implant-associated infections pose 
a serious impediment in adult orthopedic implant procedures including total 
joint replacements and fracture fixation. The number of implant-associated 
infections has continuously increased due to growing demands for surgical 
implantation and remains a primary cause of postoperative complications. 
Without proper treatment, implant-associated infections often necessitate 
additional surgical procedures such as simple debridement and implant 
removal, followed by reimplantation. It is during this window between 
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removal and reimplantation that antibiotic delivery carriers have often been 
used to improve therapy.
Osteomyelitis is a particularly severe infection found mostly in the 
metaphysis of long bones. It may be secondary to injury or joint replacement. 
Common bacterial strains involved in osteomyelitis include Staphylococcus 
aureus, Pseudomonas aeruginosa, and Escherichia coli. A majority of S. aureus 
pathogens are methicillin sensitive (60%–80%) and 10% are methicillin 
resistant (termed methicillin resistant S. aureus or “MRSA”), but in the United 
States, resistance is as high as 40%–50%. In many cases, antibiotic treatment 
must be initiated before susceptibility testing is obtained, treatment 
includes surgical debridement and systemic antibiotics for several weeks. 
Acute osteomyelitis can transform to chronic osteomyelitis if left untreated, 
causing changes to the bone architecture. Bone grafts are often necessary 
to reconstruct the bone loss caused by chronic osteomyelitis and prevent 
substantial limb deformity and risk of amputation. Thus, there is substantial 
motivation to develop therapeutic approaches to treat implant-associated 
infections and osteomyelitis.
Current approaches for systemic, intravenous antibiotic therapy can lead 
to significant complications, including systemic toxicity, low efficiency, 
and need for hospitalization. Localized antibiotic treatment has the 
potential to decrease systemic side effects and offers the potential to ease 
the administration of dosing (less parenteral administration), decrease the 
number of hospitalizations, and provide significant cost savings. Localized 
antibiotic delivery from HAP-based implants has been proposed as a 
treatment of skeletal infection or a prophylactic strategy. Local delivery 
provides a higher antibiotic concentration at the site of infection without 
systemic toxicity and better dead area management [65].
HAP deposition on implants has a long and well-established history of 
osteoconductivity, combined with HAP coatings that can be used to deliver 
antibiotics locally will potentially provide great advantages in orthopedic 
applications. Traditional HAP or β-TCP ceramics can also be readily processed 
into blocks, scaffolds, or granules and used as antibiotic carriers. In addition 
to overcoming systemic side effects, various geometries of HAP-based bone 
void fillers such as microspheres [66–68], nanoparticles [52], porous scaffolds 
[69,70], and self-setting cements [71–73] have been adopted to incorporate 
and release antibiotic drugs. For example, self-setting HAP bone cement was 
used as an antibiotic carrier to replace poly(methylmethacrylate) (PMMA) 
beads, which required a secondary surgery to remove the nondegradable 
PMMA increasing the propensity to induce a local foreign body reaction. 
HAP cement designed to release vancomycin in a sustained manner 
reduced infection by S. aureus, methicillin-resistant S. aureus (MRSA), 
and S. aureus with small colony variant (SCV) in a rabbit tibia model of 
chronic bone infection. HAP cylinders designed to release vancomycin in 
a continuous fashion also disrupted a biofilm of S. aureus tested in vitro. 
Because of the superior bactericidal activity of vancomycin, its biologically 
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active release from cylindrical HAP scaffolds is promising for bone void 
filling applications [74].
Interestingly, several strategies to control the antibiotic release rate have 
been proposed, including encapsulating the antibiotic inside an HAP block, 
incorporating it into biomimetic HAP coatings, or creating protective polymeric 
coatings on HAP implant surfaces. A clinical study incorporated antibiotic 
within HAP blocks and showed that the local antibiotic level in the wound 
was significantly higher than normal serum levels and was able to treat MRSA. 
Seven osteomyelitis patients were free of infection without complication [75]. 
Block HAPs may be more advantageous when compared to bone cements as 
they are simpler to remove if complications occur. However, they are limited 
by their brittle mechanics and their inability to conform to defect geometry.
Stigter and coworkers successfully incorporated various antibiotics into 
carbonated HAP coatings via co-precipitation during coating growth. For 
all released antibiotics tested, antibacterial activity was confirmed against 
S. aureus. This method allowed for a greater incorporation of antibiotics and a 
longer time period of release when compared to the adsorption of antibiotics 
on plasma-sprayed HAP coatings. Interestingly, the incorporation efficiency 
and release kinetics were dependent on the molecular characteristics of the 
antibiotic. Antibiotics containing carboxylic acid groups showed higher 
incorporation efficiency and slower release, likely due to their interaction 
with calcium in the HAP coatings [76,77].
Shinto et al. incorporated three different antibiotics—gentamicin, 
cefoperazone, and flomoxef—into the cavity of porous HAP blocks and 
observed the most rapid release from flomoxef and the slowest from 
gentamicin. Gentamicin released from the cavity of porous HAP blocks was 
still effective against S. aureus at 12 weeks in vitro and, when implanted in 
rat proximal tibia, a similar release profile was detected [78]. In subsequent 
clinical studies, these HAP blocks have demonstrated efficacy in preventing 
infection recurrence after treatment in chronic osteomyelitis patients [65,79].
Some studies have generated multicomponent materials to further control 
antibiotic release. For example, HAP combined with calcium sulfate and 
chitosan provided a stable, sustained release of gentamicin. In this case, the 
advantages of each of the three materials can be leveraged to provide optimal 
antibiotic delivery. Calcium sulfate dissolution creates an environment that 
neutralizes cytotoxicity and slows down antibiotic release, while chitosan/
HAP provides an additional structural support and scaffolding that alleviates 
the need for additional bone graft material. The result yields a biodegradable 
composite bone graft substitute that gradually releases gentimycin and 
limits cytotoxicity [80].
5.5.2 Silver Particles
Silver particles are often used as a natural antibiotic against a broad 
range of bacterial strains and provide an alternative method to decrease 
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nonspecific or antibiotic-resistant bacterial infections commonly observed 
in osteomyelitis. Silver is well-known as a reliable antimicrobial agent for 
wound healing [81], and silver agents have been shown to be minimally toxic 
to human cells on biomedical implants [82], including HAP implants. For 
example, investigators have efficiently incorporated silver into brushite and 
HAP minerals. HAP-bound silver particles showed minimal release and 
reduced antibacterial activity when compared to the brushite materials that 
showed sustained release. However, the addition of silver to HAP cement 
decreased the compressive strength by 50% [83]. In another study, silver-
doped HAP coatings on titanium disks disrupted S. aureus and S. epidermidis 
biofilms initially after device implantation. Fortunately, this coating did 
not alter the behavior of osteoblast precursor cells when compared to the 
HAP-coated samples without silver [43]. A similar study conducted by 
the same authors sputter coated silver and HA onto titanium targets that 
were then heated to 400°C. The authors reported antibiotic effects against 
S. aureus and S. epidermidis and no significant difference in the water contact 
angle of the coating surface with the addition of silver, supporting its benign 
use as an antimicrobial [30].
5.5.3 growth Factors
Healing of substantial skeletal defects can take place on the order of months 
and is often complicated by the formation of reactive fibrous tissue (i.e., scar 
tissue) instead of the desired tissue. After bone injuries, multiple endogenous 
growth factors are expressed and work in concert to orchestrate proper 
bone repair. Exogenous growth factors have been administered during the 
healing process to accelerate and actively guide tissue regeneration. To date, 
collagen, chitosan, and other naturally derived materials, as well as synthetic 
poly(α-hydroxyesters) and other synthetic polymer carriers, have been used 
to deliver recombinant human bone morphogenetic protein-2 (rhBMP-2), 
rhBMP-7 (OP-1), and other members of the transforming growth factor beta 
(TGF-β) superfamily of growth factors for bone and soft tissue regeneration 
[22,84–88]. Collagen carriers are plagued by rapid growth factor release at 
supra-physiological dosage, which has raised safety concerns, including 
potential for heterotopic bone formation, edema, and increased cancer risk. 
In this context, HAP biomaterials represent a promising candidate for growth 
factor delivery, as they offer excellent protein binding and retention while 
maintaining protein biological activity. In addition, they provide the potential 
to control the rate of growth factor release by controlling the dissolution rate 
of the mineral (Figure 5.3). The following paragraphs introduce a subset of 
the studies that have used HAP-based materials to deliver growth factors, 
and paragraphs are separated based on the specific growth factors delivered.
Bone morphogenetic proteins (BMPs) can induce osteogenic differentiation of 
mesenchymal stem cells and other osteoprogenitor cells to direct bone ingrowth 
and new bone formation in bone defects. Thus, there has been widespread 
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interest in delivering BMPs from bone void filling materials such as HAP-based 
materials. Liu and coworkers incorporated rhBMP-2 either on biomimetic 
HAP coatings by surface adsorption or into biomimetic HAP coatings by 
co-precipitation and found that in each condition the released rhBMP-2 induced 
ectopic bone formation in vivo [89]. Similarly, Schnettler et al. demonstrated 
ectopic bone formation and also accelerated bone ingrowth throughout an 
HAP-coated titanium implant with rhBMP-2 [90]. Levine et al. showed that 
when HAP implants were placed in an anterior muscle, BMP-treated implants 
induced greater vascularity and bone formation than untreated controls 
[91]. Ripamonti and coworkers have reported that BMP-7, also referred to as 
human osteogenic protein-1 (hOP-1), loaded on sintered porous HAP promoted 
heterotopic and orthotopic bone formation in adult primates [92].
Bone regeneration in large bone defects requires not only bone induction 
but also other growth factor-dependent processes such as angiogenesis, 
which is the formation of blood vessels from a preexisting vascular supply. 
Blood vessels are a source of key osteoprogenitor cells and mesenchymal 
stem cells, as well as the nutrients and oxygen to feed the developing 
tissue. Lack of functional vasculature often leads to delays in the healing 
process and can result in fibrous nonunions. Therefore, local delivery of pro-
angiogenic growth factors has been a subject of recent research interest from 
our group and others (e.g., Figures 5.4 and 5.5). Vascular endothelial growth 
factor (VEGF) is among the most potent pro-angiogenic growth factors, and 
it is known to be expressed at elevated levels for nearly a week after bone 
fracture. It was previously shown that rhVEGF efficiently bound to various 
HAP-based bone implant materials, including bone cement, porous blocks, 
biomimetic coatings, and solvent dehydrated human bone grafts. The 














(See	color	insert.) Biomimetic HAP coatings with different extent of carbonate incorporation 
(represented in black, blue, and green) allow for control over mineral dissolution and associ-
ated release of drugs. Higher carbonate incorporation leads to higher dissolution rates and 
therefore faster release kinetics.
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biological activity [93,94]. Another study reported that rhVEGF released from 
polymer scaffolds coated with a biomimetic HAP layer increased both blood 
vessel density and bone formation in a rat cranium critical defect [95,96]. 
More recent studies from our group have demonstrated that VEGF can be 
efficiently bound to HAP coatings (Figure 5.4) and released in a controllable 
manner to induce angiogenesis within porous scaffolds in vivo (Figure 5.5). 
These studies emphasize the potential use of HAP as a component in tissue 
engineering strategies, in which combinations of biomaterials, molecules, 
































Release of vascular endothelial growth factor (VEGF) mimetic peptide from β-TCP granules 
coated with an HAP mineral layer. HAP coatings were formed by incubation of granules in a 
modified simulated body fluid (mSBF) for 7 days. Release of the VEGF mimetic peptide was 
sustained for over 40 days.
Angiogenesis Osteogenesis
Figure 5.5
(See	color	insert.) Sustained release of growth factors from HAP mineral coatings can influ-
ence cellular activities that lead to the formation of various tissue types, such as blood vessels 
and bone. Sustained release of recombinant human vascular endothelial growth factor (VEGF) 
induced new blood vessel formation in vivo. Arrows pointing dark brown stained lumens 
represent blood vessels based on von Willebrand factor immunostaining.
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Basic fibroblast growth factor (bFGF, also known as FGF-2) is another 
pro-angiogenic growth factor, which can promote blood vessel formation 
by stimulating endothelial cell proliferation and migration. Schnettler et al. 
found that bFGF-loaded HAP implants enhanced angiogenesis and bone 
ingrowth, which was comparable to autologous bone grafts. Plasma-sprayed 
HAP coatings have also been used to release bFGF for 10 days, resulting in 
a significant increase in new bone formation and improved biomechanical 
properties three months after implantation in ovariectomized rats. Midy 
et al. compared the ability of carbonate substituted HAP or stoichiometric 
HAP to bind and release bFGF, and results demonstrated that HAPs with 
similar structure can exhibit different binding and release characteristics 
[97]. In another study, Lee et al. [98] coated high-strength Orthocord sutures 
with a nanoporous HAP mineral to facilitate growth factor binding. Coated 
sutures bound proteins efficiently, and the suture material maintained its 
integrity and ability to release multiple proteins over more than 30 days 
in a sustained fashion in a sheep infraspinatus tendon. This approach was 
then used to release biologically active bFGF in a sheep model of rotator 
cuff repair. Six weeks postoperatively, histological analysis demonstrated 
that bFGF-releasing sutures promoted higher levels of angiogenesis and 
increased tissue formation in the healing rotator cuff. This result supports 
the use of HAP coatings as growth factor delivery platforms not only for 
bone void filling applications but also in soft tissue healing applications.
Transforming growth factor-β1 (TGF-β1) and platelet-derived growth 
factor (PDGF) are multifunctional regulators for a broad range of cellular 
and biological processes. In particular, TGF-β1 plays an important role in 
bone formation by stimulating angiogenesis, osteogenic cell proliferation 
and differentiation, and extracellular matrix production. TGF-β1 mixed with 
HAP bone cement has been shown to stimulate osteogenic differentiation of 
rat pre-osteoblastic cells in vitro and increase the bone volume in rat calvarial 
bone defects in vivo [99]. Arm et al. released PDGF from the surface of HAP 
in the presence of albumin and measured its effects on bone ingrowth. 
Although the released PDGF was found to be biologically active, release 
from the surface was minimal over the course of three weeks [100,101], and 
there was no significant effect on bone ingrowth.
5.5.4 Hormones
Insulin injections provide life-sustaining medications for type 1 diabetics 
and a growing number of type 2 diabetics. Limited by low patient compliance 
for repeated dosing, investigators continue to seek new delivery approaches 
for sustained insulin release, including oral administration, subcutaneous 
pumping, and extended release injections. Insulin encapsulated into 
poly(ethylene glycol)-modified calcium phosphate nanoparticles has been 
shown to prevent release at gastric pH and sustain release over eight hours 
in the intestine to facilitate drug absorption [102]. Circular dichroism spectra 
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of insulin conformation before and after release were not changed during 
the nanoparticle fabrication or functionalization process [91]. This work is an 
extension of the previous work from the same group, in which insulin was 
encapsulated into porous HAP microspheres via solvent evaporation and 
coated with poly(ethylene vinyl acetate) for sustained release. Their results 
demonstrated a 2 day release of 92% of the encapsulated insulin, including 
a burst release and a gradual plateau [103] The released, biologically active 
insulin had a relatively low duration of action due to low initial incorporation 
efficiency, suggesting the need to repeat studies in other animal models 
or with other CaP biomaterials as a better model for scale-up to human 
use. HAP materials have also demonstrated controlled release of other 
biologically active hormones that regulate bone formation, including growth 
hormone and parathyroid hormone. For example, Yu et al. demonstrated a 
bioactive release of parathyroid hormone related protein (PTHrP). PTHrP 
was incorporated into an HAP-coated titanium surface via a co-precipitation 
in modified SBF and released in a sustained manner [104].
5.5.5 bisphosphonates
Bisphosphonate, an osteoclast inhibitor, is clinically used for the treatment 
of peri-prosthetic osteolysis, osteoporosis, and similar degenerative bone 
diseases. Current treatment regimens involve oral administration or 
intravenous injection, which can each lead to side effects including fever [105], 
bone pain, rigors [106], gastrointestinal ulcer [107], osteonecrosis, and ocular 
inflammation. Bisphosphonates incorporated within HAP materials exploit 
the strong affinity between the Ca2+ ions in HAP and the two phosphonate 
groups attached to a single carbon atom [108]. This mechanism ideally provides 
two modes of therapy: (1) inhibiting bone resorption activity of osteoclasts 
to prevent the loss of bone mass via the effects of the bisphosphonate 
and (2) promoting implant osteointegration to native bone tissue via the 
osteoconductive HAP coating. A HAP coating on an implant surface can 
connect the bisphosphonate to the implant and plausibly decrease implant 
loosening as the appositional bone may be more substantial [109]. Taken 
together, HAP-bisphosphonate delivery provides potential to improve in vivo 
osteointegration while inhibiting natural bone resorption.
Peter et al. adsorbed the bisphosphonate, zoledronate, onto HAP-coated 
titanium implants and sought to determine the optimal concentration to 
increase mechanical fixation. Results showed a decrease in osteoblast function 
and impaired mineralization with elevated zoledronate concentration, 
as evidenced by a decrease in implant–bone pullout force [110]. Gao et al. 
delivered the bisphosphonates, zoledronate, ibandronate, and pamidronate, 
and demonstrated positive effects on promoting bone–implant fixation 
in demineralized, osteoporotic bone [111]. Although the mechanism of 
action is not yet clear, Gao et al. hypothesized that the bisphosphonates 
are bound directly to HAP and are released slowly into the new bone 
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mineral, causing osteoclast apoptosis and supporting bone formation and 
associated bone–implant fixation. Due to their success in these and other 
bone healing applications, local HAP/bisphosphonate delivery has been 
hypothesized for use in more rare etiologies, including Gorham Stout 
syndrome and childhood hemangioma. Gorham Stout syndrome is thought 
to be a debilitating degenerative disease with abnormal osteoclast activity, 
analogous to osteoporosis. Current treatments include vitamin D, sodium 
fluoride, and systemic bisphosphonates. Sun et al. hypothesized that 
zoledronate released from HAP at a precise time and concentration could 
enhance bone reconstruction [112]. In another study, Yu et al. hypothesized 
that bisphosphonates bound to HAP and released locally could promote 
anti-angiogenic effects for children with unresolved hemangiomas. Benign 
hemangiomas can have severe side effects in some cases, including cartilage 
damage, congestive heart failure, or airway obstruction. Slow released 
zoledronate is known to inhibit serum bFGF and VEGF, but systemic or 
toxic levels of administration may impair skeletal maturity. The researchers 
hypothesized that sustained drug release from a bioresorbable carrier locally 
implanted could treat congenital disease with minimal side effects and high 
efficacy [113]. These emerging applications of HAP/bisphosphonate therapies 
may ultimately show substantial clinical impact.
5.5.6 anticancer and anti-inflammatory Drugs
Several types of antineoplastic agents have been incorporated within HAP 
carriers with demonstrated release. Barroug et al. demonstrated that cisplatin 
adsorbed on the surface of HAP nanoparticles was released gradually over 
20 days and the released cisplatin exhibited dose-dependent cytotoxic 
effects against a murine osteosarcoma cell line [114]. When mixed with HAP 
bone cement, 6-mercaptopurine was released over 4–25 days with release 
kinetics dependent on the porosity of the HAP cement [115,116]. Paclitaxel 
adsorbed on an HAP disc also proved effective against osteosarcoma cells 
and metastatic breast cancer cells [117].
Cisplatin, a widely used antitumor agent, binds more favorably to HAP 
as the crystallinity of the material decreases, resulting in slow drug release 
during HAP dissolution. For example, Palazzo et al. compared binding and 
release of cisplatin, alendronate, and di(ethylenediamineplatinum)medronate 
(DPM) to HAP surfaces. Specifically, they created HAP in either plate-like or 
needle-shaped morphologies, and the needle-like mineral showed a lower 
Ca/P ratio and lower crystallinity than the plate-like mineral. Additionally, 
the plate-like mineral had a slightly larger surface area and potentially 
higher drug binding capacity relative to the needle-shaped mineral. 
However, in this case, the less crystalline needle-shaped surface resulted in 
a higher amount of cisplatin and alendronate binding. This result may be 
partially explained by the chemistry of drug–HAP binding. In some cases, 
drug binding to a HAP surface can lead to ion exchange and an associated 
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decrease in the Ca/P ratio, and in the case of the Palazzo et al. study, the 
negatively charged alendronate likely elicited the exchange of two moles of 
phosphate for each mole of alendronate. Cisplatin is positively charged and 
could therefore bind to the phosphate-rich HAP surface. In contrast, DPM 
is neutral and was likely influenced less by the Ca/P ratio of the mineral. In 
general, the drug concentration and the Ca/P ratio and crystallinity likely 
had a substantial effect on drug binding by varying the presentation of drug 
binding sites on the surface. Within 16 days, 45% and 21% of the cisplatin and 
alendronate were released, while nearly 85% of the DPM was released over 
the same timeframe. Taken together, the Palazzo et al. results demonstrated 
that the HAP surface area and Ca/P ratio influenced drug delivery from 
HAP more strongly than the specific morphology of the HAP crystals [118].
Nonsteroidal anti-inflammatory drugs (NSAIDS) are widely used in clinical 
applications but can have side effects on the gastric mucosa, kidneys, and 
platelets when therapeutic doses are delivered systemically. Therefore, there 
is a motivation to develop localized delivery systems for NSAIDS, including 
HAP-based systems. Tvala et al. demonstrated that ibuprofen bound to calcium 
phosphate granules could be released gradually into a simulated physiological 
environment over 2 days. Melville et al. revealed that ibuprofen adsorbed on 
HAP particles had a release rate dependent on the crystal size and surface 
area, which were readily controlled during HAP particle preparation [119]. 
Otsuka et al. loaded the NSAID indomethacin homogenously within HAP 
bone cement, and the drug was released gradually over 3 weeks. They also 
found that in vivo release was slower than in vitro release, likely because the 
proteins and cells present in vivo altered the indomethacin–HAP interaction 
or the properties of the HAP cement surface.
5.5.7 Other Drug Classes
In addition to proteins and small molecules, HAP can also be used as a vehicle 
to deliver nucleic acids such as DNA and glycosaminoglycans (GAGs) such 
as heparin. Although these drug classes are not discussed in detail here, 
several previous studies have detailed the well-characterized polyanion–
HAP interaction (e.g., DNA–HAP interaction) and its use for nonviral 
transfection, siRNA delivery, and shRNA delivery. In one recent example, 
Choi et al. demonstrated sustained, localized release of plasmid DNA from 
CaP mineral coatings and the DNA release controlled by carefully tailoring 
the coating properties [120]. The results demonstrated uniquely high levels 
of substrate-mediated transfection of stem cells, restricted to the cells in 
contact with the mineral coating. This approach may find widespread use 
in clinical applications that call for efficient gene delivery. For GAG delivery, 
Bajpai et al. developed a calcium phosphate system to continuously release 
heparin to rats, resulting in a dose-dependent increase in blood clotting time 
[121]. The carrier material was optimized to provide an effective dose without 
heparin overdose, which would have substantial clinical consequences.
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5.5.8 Cells
Mesenchymal stem cells (MSCs) are multipotent progenitor cells that 
can differentiate into multiple mature cell types, including osteoblasts, 
chondrocytes, and adipocytes. Natural bone healing processes involve 
recruiting osteoprogenitor cells such as MSCs from the periosteum and bone 
marrow. These cells then differentiate into bone-forming osteoblasts. Based 
on their well-characterized ability to form calcified bone tissue, MSCs are 
being extensively developed for bone repair and regeneration. Bruder and 
coworkers isolated, cultured, and implanted autologous MSCs within porous 
biphasic calcium phosphate blocks (HAP:β-TCP = 65:35) in canine critical-
sized segmental defects. The MSC-loaded groups formed rapid integration 
at the bone–implant interface and produced a larger total quantity of bone, 
while the untreated groups had nonunion with limited bone formation [122]. 
Using the same HAP carriers, they also tested culture-expanded human 
MSCs by implanting in critical-sized segmental defects in the femurs of adult 
athymic rats [122]. The results indicate that the groups treated with cells had 
increased bone formation with improved biomechanical strength. Quarto 
et al. reported the human clinical use of autologous bone marrow–derived, 
culture-expanded osteoprogenitor cells combined with macroporous HAP 
scaffolds to treat large bone defects [123]. All three patients treated showed 
good bone–implant integration and bone formation throughout the scaffold, 
including a fracture callus without any complications up to at least 15 months. 
This study and others suggest a strong potential for use of MSCs combined 
with HAP-based implants in large bone defect healing applications. It is 
interesting to note that the osteogenic activity of MSCs has also been shown 
to be dependent on the geometric characteristics of HAP carriers, such as 
pore size and porosity [124].
5.6	 Foundational	Properties	of	Hydroxyapatite
The previous sections have described the ways in which HAP has been used 
in clinical applications and introduced scenarios in which HAP has been 
used as a versatile carrier for drug delivery. A series of foundational material 
properties of HAP have enabled the aforementioned clinical applications, 
as well as its tremendous potential in drug delivery. Indeed, HAP materials 
provide inherent benefits not only as orthopedic implants and implant 
coatings but also as chromatographic agents for purification of biological 
molecules and bulking agents in some clinical applications (e.g., vocal fold 
healing). This section will introduce some fundamental properties of HAP 
that are of relevance to its clinical and scientific applications, particularly 
therapeutic drug delivery.
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5.6.1 background: The Need for HaP implants/Coatings in Orthopedics
One of the particular advantages of HAP as a drug carrier is its already 
widespread use in orthopedic applications. Thus, it is worthwhile to consider 
the manner in which HAP is used in current orthopedic applications.
Large bone defects caused by trauma, cancer, or congenital defects are most 
often replaced with autologous or allogeneic bone grafts [125]. Autologous 
cancellous bone is readily revascularized and can be rapidly incorporated 
into the recipient site. However, while autologous cancellous bone grafts 
fill the defect, they do not provide substantial structural support and may 
be limited by tissue availability. Autologous cortical bone grafts provide 
better structural support but are similarly limited by tissue availability and 
associated donor site morbidity. Allogeneic and xenogeneic grafts are less 
limited in terms of the tissue availability, but may be capable of transmitting 
bacterial or viral agents that lead to infection or disease, and can also 
be immunogenic. Demineralized bone matrix represents an attractive 
alternative to fit well-circumscribed defect areas that do not require load-
bearing structural support, but these matrices are limited by batch-to-batch 
variability in properties.
Creating an osteoconductive surface on a durable, implantable material 
represents an alternative to autologous and allogeneic bone grafts. A suffi-
ciently osteoconductive material can promote healing via osteoprogenitor 
cell adhesion, proliferation, and differentiation, which can improve biocom-
patibility and biological activity. Perhaps the most widely used material to 
confer medical implants with osteoconductivity is the HAP mineral. HAP was 
first introduced into orthopedic implants as the major component by weight 
of natural bone tissue, with a surface area that facilitates strong cell/molecular 
interactions [9]. HAP has a well-known biological interaction with bony 
tissues and can be secured into a bone interface when osteoblasts colonize 
the biocompatible surface [126]. Initially, plasma-sprayed HAP coatings were 
commonly used to accelerate peri-implant bone formation and to thereby 
decrease the time needed for implant fixation. After extensive investigations, 
HAP-coated implants have been shown to not only improve implant stability 
and bone–implant interface strength but also facilitate mineralized tissue 
formation, improve bone ingrowth, and decrease implant migration [127, 128]. 
HAP coatings also increase fatigue resistance, which improves long-term 
fixation of metal implants such as titanium implants [129]. Unmodified HAP is 
a brittle material [130] and has suboptimal mechanical properties that include 
poor tensile strength and low resistance to impact [131]. Therefore, coating 
structurally superior materials with HAP and keeping the HAP coating 
thickness low reduces the likelihood of interfacial fracture.
HAP on its own does not support load bearing and therefore does not 
serve as a structural implant in large bone defects. Instead, HAP biomaterials 
typically serve as bone spacers or fillers in non-load-bearing sites [20] or are 
used to encourage appositional bone formation as coatings on titanium alloys 
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and other structural implants [132]. Plasma spraying, high-velocity oxygen 
fuel spraying, electrophoretic deposition, sol–gel deposition, hot isostatic 
pressing, frit enameling, ion-assisted deposition, pulsed laser deposition, 
electrochemical deposition, and sputter coating are all common methods by 
which HAP is coated onto implants or fabricated into stand-alone implants. 
These methods do not allow for protein incorporation during processing 
due to harsh material processing conditions. Thus, the amount of drug 
incorporated within common HAP-based implants is limited, and the drug 
release is often rapid since the drug is only bound to the nonporous outer 
surface.
5.6.2 HaP Chromatography and HaP–Protein binding
Therapeutic drug delivery from HAP-based materials is critically dependent 
on the characteristics of drug–HAP interactions, and this concept is perhaps 
most directly illustrated by HAP–protein binding. In general terms, protein 
adsorption occurs almost instantaneously when a protein in an aqueous 
solution is exposed to solid materials such as HAP. Due to what is referred 
to as the “Vroman effect,” proteins circulating in the plasma adsorb as a 
monolayer based on their size and affinity, with larger proteins often 
displacing smaller proteins from the surface. As proteins relax on a surface, 
they can undergo conformational changes and may not regain their original 
conformation upon desorption. In particular, an adsorbed protein may 
undergo conformational changes in which an increase in net surrounding 
charge decreases protein conformational stability, yielding unfolding and 
an extended conformation on the surface [133]. The typical stages of protein 
adsorption include transport of the protein from the bulk solution to the 
interface, attachment at the sorbent surface, and finally relaxation of the 
protein on the surface. Once the protein is bound to the solid surface, it will 
not typically desorb via simple dilution but can be displaced if a protein with 
more favorable binding energy on the surface is introduced. In this process, 
the protein cycles between the adsorbed and dissolved conformations. 
Adsorption of proteins to the surface also depends on several aspects of the 
surrounding environment, including the buffer osmolarity, ionic strength, 
ion composition, temperature, pH, and functional groups present on the 
protein and the substrate.
Proteins bind to pure, stoichiometric HAP via a mechanism that is based 
on the polar or charged side chains of the protein molecule interacting with 
calcium and phosphate ions in the HAP crystal. Amine and carboxylate 
groups are the major side groups implicated during protein binding to the 
HAP surface. This mechanism of protein binding has been used for protein 
purification for decades, with HAP and the more stable mineral fluorapatite 
used as resins for protein or DNA purification. Described by Tiselius 
et al. in 1956, HAP chromatography provides separation of protein mixtures 
containing medium to high molecular weight proteins [14]. At a constant pH, 
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BSA, lysozyme, ovalbumin, hemocyanin, and other proteins (MW range: 
14 × 103 to 8.9 × 106 Da) can be successfully separated by eluting protein fractions 
in solutions with a linear increase in soluble phosphate ion concentrations. 
This ion exchange mechanism allows for versatile purification of a broad 
range of proteins. HAP chromatography differs from common separations 
based on ion exchange, as separation of the protein from the resin particles 
depends primarily on the phosphate buffer concentration used for elution 
rather than the electrostatic properties of the molecules themselves.
Protein–HAP binding is also significantly influenced by the HAP crystal 
structure. Most proteins bind to calcium phosphate minerals in solution, and 
the binding strength depends in part on the isoelectric point of the protein 
and the solution pH. Ca2+ ions in the HAP crystal interact with carboxylate 
or other negatively charged (acidic) groups on the protein, whereas PO4− 
ions interact with positively charged (basic) amino acid side chains. Protein 
binding to HAP can be complex, as it can be influenced by both anionic 
and cationic exchange processes that vary according to the organization 
of the protein’s amino acid side chains and the environmental pH. The 
hexagonal HAP crystal also has two types of adsorbing surfaces—the 
a-axis and the c-axis. Typical needle-like crystals of HAP are thought to 
be primarily a-axis surfaces. In an aqueous solution, calcium ions on the 
a-axis surface present the hydroxyl group of HAP to the exterior particle 
surface, facilitating suspension of the mineral in aqueous solution [134]. 
These exposed hydroxyls are then flanked by calcium ions, creating a 
putative adsorption site for acidic molecules, termed as “C” site. In contrast, 
“P” sites are deficient in calcium ions and bind to basic molecules. Because 
the HAP surface is heterogeneous with “C” and “P” sites, its composite 
surface charge depends on the ratio of calcium to phosphate ions as well as 
the solution pH—the higher the pH, the more negative the surface charge. 
Likewise, because pockets of “C” sites or “P” sites can occur, proteins bind 
to HAP in a variety of conformations and they bind nonuniformly across 
the surface. Therefore, proteins with multiple binding sites can switch 
between stable conformations, facilitating intermolecular interactions 
between proteins.
The isoelectric point of a protein and its regions of hydrophobicity fur-
ther complicate the HAP–protein binding phenomenon, and proteins may 
be able to cooperate to maximize binding to the surface. Depending on the 
solution conditions, cooperative binding or competitive repulsion can be 
facilitated, depending on the ions in solution and the ability of proteins to 
bind to the HAP crystal lattice. Within a crystal, C sites are arranged in a 
rectangular manner while P sites are arranged on c-axis surfaces in a hex-
agonal manner. Kawasaki et al. systematically varied the HAP form and 
the protein chemistry to demonstrate that acidic and basic proteins adsorb 
to different surfaces of HAP [135]. In addition, protein–HAP interactions 
are a function of the protein’s net charge, as single amino acids have a poor 
affinity to HAP.
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Although electrostatic interactions between complementary charges on 
protein side chains and HAP crystal constituents are commonly thought to 
dominate protein–HAP interactions, there is evidence of greater complexity 
in this interaction. For example, amine-terminated side chains can also 
hydrogen bond to phosphate and hydroxyl groups on the HAP surface. 
Previous studies have shown that blocking basic amino acids within basic 
proteins inhibits binding, while some acidic proteins are not affected by 
this blockage [136]. Changing a carboxylate to a sulfonic acid maintained 
the charge but significantly reduced the retention of all proteins other than 
acidic proteins to negligible levels [137]. The simple assertion that basic 
proteins bind via amino groups and acidic proteins bind via carboxylates 
is also more generally an incomplete mechanistic description, as basic 
protein adsorption has been shown to be affected by carboxylate blocking. 
Gorbunoff et al. support that both carboxylate and amino groups are critical 
for binding, irrespective of the protein’s isoelectric point, because a higher 
molarity phosphate was needed for elution of all proteins after carboxylate 
blocking.
In HAP chromatography methods, acidic and basic proteins vary in the 
eluents used for protein desorption as well as their molar concentrations 
[136,138]. Elution of both acidic and basic proteins occurs at a relatively 
low phosphate ion molarity by either competitive displacement or charge 
screening, respectively. Acidic proteins cannot be eluted from the HAP 
surface by calcium ions, whereas basic proteins are displaced by divalent 
cations such as calcium at low molar concentrations. Because of the carboxyl 
groups found on acidic proteins, there is a strong interaction between the 
carboxyl and apatite calcium ions. Additional soluble calcium ions can 
increase the number of bridges of acidic proteins to the apatite surface, 
as calcium-bound carboxylate groups can interact electrostatically with 
phosphate sites on HAP [138].
5.6.3 Factors influencing Mineral Dissolution
Since a variety of studies have demonstrated a correlation between mineral 
dissolution and the release kinetics of incorporated or adsorbed drugs, it is 
worthwhile to consider the mineral dissolution process and the parameters 
that influence this process. Mineral dissolution depends on two principle 
phenomena: (1) the creation of “pits” also referred to as “active sites” and 
(2) the rate of step movement from the active site. The dissolution process 
can be accelerated by the presence of more pits on a mineral surface, which 
in turn leads to accelerated drug release from HAP. Surface pitting occurs for 
a variety of reasons and has been attributed to undersaturation of mineral 
ions in solution, the presence of hydronium ions in solution, and the inherent 
existence of point defects on the crystal surface. Dissolution proceeds via a 
similar process to nucleation, but in reverse, without the need for a to form 
critical nucleus [60].
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A series of models have been proposed to describe HAP dissolution 
behavior. The “polynuclear model” is based on the work by Christofferson 
et al. and describes nucleation as a function of calcium ion activity, both 
in the saturated solution and on the surface. It assumes that the linear 
growth or dissolution perpendicular to a surface has the same rate for 
all crystal surfaces and is often used to describe dissolution at neutral or 
slightly acidic pH. According to the polynuclear model, a crystal surface 
has concave and convex components, and the convex components continue 
to grow while the concave components are outgrown. During dissolution, 
the convex components disappear while concave components grow larger. 
The polynuclear mechanism has been explored experimentally in buffered 
solutions, and results indicate that the rate-limiting step during mineral 
dissolution is the dissolution of mineral particles at the surface [139].
Another well-cited model is described by the “self-inhibition” theory, 
which asserts that once nuclei reach a critical size the calcium and phosphate 
ions detach from the surface, move into the solution, and dissolve. At some 
point in time, the ions may readsorb to the apatite surface and form a calcium 
rich layer. This dissolution phenomenon tends to occur at more acidic pH 
3.7–6.9, where the rates of calcium release are coupled with hydrogen ion 
uptake. The step movement of ions along the crystal surface depends on the 
size of the mineral nuclei and whether they have reached their critical size. 
A nucleus smaller than the critical size can diffuse toward or away from the 
apatite material. When the nucleus is larger than its critical size, it transports 
in a manner that is dominated by convection rather than diffusion [139].
Mineral dissolution in vivo is significantly influenced by the surrounding 
environment and the mineral crystal composition. In undersaturated 
conditions of the surrounding solution, changes in temperature, ionic 
strength, pH, and other variables can facilitate mineral dissolution. Calcium 
phosphate mineral dissolution typically increases with a decrease in pH, and 
the rate of dissolution is mineral phase dependent. In vivo HAP dissolution 
characteristics are often similar to HAP dissolution observed in vitro at 
low pH, suggesting that a low pH may drive the in vivo HAP dissolution 
process [140]. Other environmental factors present in vivo can also influence 
HAP dissolution. Factors that accelerate HAP dissolution can function by 
modifying mineral solubility, influencing mineral surface charge, or blocking 
new crystal formation. For example, citric acid can inhibit HAP dissolution in a 
concentration-dependent manner by adsorbing to the dissolving surface [141]. 
Interestingly, this concentration-dependent behavior is not reproduced for 
other calcium phosphate phases. Binding the crystal surface at the active site 
not only decreases the rate of dissolution but also has an effect on free edge 
energy. It is also noteworthy that HAP is not pure in natural tissues and often 
contains other elements that strongly affect dissolution [4]. For example, natural 
apatites such as those in vertebrate bones and teeth are calcium deficient, 
which leads to high specific surface area and an abundance of stoichiometric/
crystallographic imperfections that enhance mineral dissolution [142].
228 Hydroxyapatite Coatings for Biomedical Applications
5.7	 Concluding	Remarks
The fundamental properties of HAP and other calcium phosphate minerals 
are advantageous for a variety of applications, including therapeutic drug 
delivery. The ability to readily process HAP biomaterials with a range of 
physical and structural properties has led to widespread use as medical 
implants in applications that range from bone regeneration to vocal fold 
healing. Further, HAP biomaterials have emerged as an ideal carrier for 
drug delivery, as they are adaptable to suit virtually all drug classes and 
in vivo locations. Although HAP has been used as a drug carrier primarily 
in orthopedic applications, new HAP processing methods and composite 
biomaterials are extending its use into a broader range of clinical scenarios. 
In addition, some specific drug delivery applications not emphasized here 
(e.g., gene delivery) benefit from not only drug release but also the associated 
release of mineral ions such as calcium and phosphate. Indeed, previous 
studies and emerging research directions suggest that HAP biomaterials 
have only begun to reach their extensive clinical potential in therapeutic 
drug delivery.
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6.1	 Introduction
The trend in biomaterial research mimics very closely to any other type 
of “conventional” material research: from bulk to thin film/coating, 
from single constituent to composite, and from macro- to micro- or even 
nanoscales. Hydroxyapatite (HA) demonstrates an excellent example of 
this trend that a material can be applied in different forms to solve various 
biomedical problems. This chapter is devoted to address a unique way 
that HA is used: as a coating material on polymeric scaffolds. Polymeric 
scaffolds, especially biodegradable ones, are extensively studied in recent 
years for guided tissue regeneration. Adhesion between the newly formed 
tissue and the promotion of cellular proliferation on the scaffold are 
important properties despite the general requirement of biocompatibility. 
It is well known that cellular proliferation and adhesion on biomaterials 
are both determined by cell type and biomaterial surface property. 
Studies are being conducted to improve those properties by material level 
modification and drug incorporation (e.g., growth factors). When it comes 
to musculoskeletal tissue regeneration, the material approach has a greater 
role to play because the major component of natural bone can be artificially 
synthesized with ease and high similarity. The nature already designed 
the musculoskeletal system in such a way that osteoblasts proliferate well 
on the existing tissue and the newly formed tissue integrates into the 
existing ones well. Therefore, the job left to researchers becomes relatively 
easier: provide an artificial interface between the scaffold and the tissue 
nearby so that in the eyes of the proliferating tissue the scaffold is of no 
difference to other host tissues. HA as the major mineral component of the 
natural bone serves this purpose well. The major drawback of HA when 
it is used alone is its poor mechanical strength; hence, it is often used as a 
coating material on substrates, especially metallic ones to improve the bone 
growth and adhesion, which is beneficial and crucial to bone replacement 
applications (e.g., hip and knee replacement surgery). In cases where repair 
is preferred rather than replacement, biodegradable polymer scaffolds are 
often used to provide the mechanical strength and allow new tissues to 
be formed. On the other hand, HA binds well to proteins, and HA itself is 
biodegradable as well. Those properties enable HA to be studied more than 
just as an artificial interface but also to deliver therapeutic agents locally 
for anti-inflammation or antibiotic purposes using polymer microspheres/
nanospheres as drug carriers.
This chapter will introduce some of the commonly used biodegradable 
polymers as substrate first, followed by HA coating techniques on them. 
Properties of the HA-coated polymers will be illustrated in different practical 
applications as each application requires different properties.
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6.2	 Biodegradable	Polymers
Biodegradable polymers, either synthetic or natural, are capable of being 
hydrolyzed into biocompatible small molecular byproducts through 
chemical or enzyme catalysts and do not induce an inflammatory reaction 
in the body; therefore, they are of great interest in the application of scaffold 
and fabrication of microspheres. Table 6.1 shows the list of popularly used 
biodegradable polymers in biomedical application.
6.2.1 Natural
Polysaccharides form a class of materials that have generally been 
underutilized in biomaterials. Apart from their biological activity, one of the 
more important properties of polysaccharides in general is their ability to 
form hydrogels. Hydrogel formation can occur by a number of mechanisms 
and is strongly influenced by the types of monosaccharide involved as well as 
the presence and nature of substituent groups. Polysaccharide gel formation 
is generally of two types: hydrogen bonded and ionic. Hydrogen-bonded 
gels are typical of molecules such as agarose (thermal gelation) and chitosan 
(pH-dependent gelation), whereas ionically bonded gels are characteristic of 
alginates and carrageenans. Natural hydrogel such as alginate and chitosan 
are also widely used to prepare microspheres by means of the ionic cross-
linking method due to their good biodegradability, biocompatibility, and 
high mucoadhesive properties.1–17
Table 6.1
List of Biodegradable Polymers in Biomedical Application
Classification Polymer
Natural polymer Protein-based polymers
Polysaccharides
Collagen, albumin, gelatin
Agarose, alginate, carrageenan, hyaluronic acid, 
dextran, chitosan, cyclodextrins
Synthetic polymer Polyester Poly(lactic acid), poly(glycolic acid), 
poly(hydroxy butyrate), poly(ε- caprolactone), 
poly(α-malic acid), poly(dioxanones)
Polyanhydrides Poly(sebacic acid), poly(adipic acid), 
poly(terphthalic acid) and various copolymers





Others Poly(cyano acrylates), polyurethanes, polyortho 
esters, polydihydropyrans, polyacetals
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6.2.1.1  Alginate
Commercially used alginate is extracted from three kinds of brown algae 
including Laminaria hyperborea, Ascophyllum nodosum, and Macrocystis 
pyrifera.18 Sodium alginate is a water-soluble linear polysaccharide 
comprised of α-l-guluronic (G-block) and β-d-mannuronic (M-block) acid 
in alternate bond. Because of the particular structure of monomer units, 
the G-block and M-block regions exhibit completely different geometries. 
Two neighboring G-blocks create a diamond-shaped hole that is ready 
for conjugating with ions, as shown in Figure 6.1. Gelation of alginate is 
realized by a G-block cross-linked with divalent metal ions such as Ca2+, 
Sr2+, and Ba2+, except Mg2+.20 The gelation process is mainly achieved by 
chelation with divalent ions. The Na ions from the G-block exchange 
with divalent Ca ions, and these G-blocks aggregate to form the egg-box 
structure.21
Some studies demonstrate that the alginate microsphere has large sized 
pore and shows the physical and chemical instability under high pH 
environment.22 These limitations may lead to low drug encapsulation and 
quick release in drug delivery application.
6.2.1.2  Chitosan
Chitosan is the only cationic biodegradable polymer because of the amide 
groups in its chemical structure (Figure 6.2). It shows high drug encapsula-
tion and excellently sustained drug release, as well as good bioadhesive 
properties. The most widely used chitosan is α-chitosan from the chitin of 
crab and shrimp shell.23 It forms a gel with the popular ionic cross-linker 
pentasodium tripolyphosphate (TPP) in a mild aqueous environment. 
Glutaraldehyde is another agent chosen as a chemical cross-linker reacting 
with amide groups for gel formation.24 In contrast to ionic gelation, chito-


























Chemical structure of alginate. (From Coviello, T. et al., J. Control. Release, 119(1), 5, 2007.)
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6.2.2 Synthetic
Most synthesized polymers used to prepare microspheres are hydropho-
bic. Thus, a scaffold or film is prepared by solvent evaporation; emulsion-
evaporation method is commonly chosen for microsphere fabrication. This 
method also shows other advantages in the drug encapsulated microsphere 
process: it can maintain the chemical stability and bioactivity of the drugs, 
provide high encapsulation efficiency, and control the ideal size distribution 
of the microspheres.
Among the biodegradable synthesized polymers, the most commonly 
investigated in implant and drug delivery systems are the following poly-
mers: poly(ortho ester) (POE), polyanhydride (PAH), poly(ε-caprolactone) 
(PCL), poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and poly(lactic-co-
glycolic acid) (PLGA).
6.2.2.1  Poly(Ortho Ester)
Since the 1970s, POE as a biodegradable polymer has evolved into four 
species: POE I, POE II, POE III, and POE IV.26 The chemical structures of 
the species are shown in Figure 6.3. Compared to other polyesters that 
degrade homogeneously in aqueous solution throughout the polymer 
matrix, POE with high hydrophobicity and water impermeability performs 
degradation by surface erosion. The morphology of POE microspheres is 
shown in Figure 6.4, as reported by David.27 Depending on the rate of surface 
erosion, the drug-loaded POE scaffold or microspheres maintain constant 
drug release rate without a significant burst release.26 However, low pH 
environment could accelerate erosion rate due to the pH sensitivity of POE, 
which limits its application in drug delivery system.
6.2.2.2  Polyanhydride
PAH is a hydrophobic polymer that is linked with hydrolytically anhydride 























Chemical structure of chitosan. (From van der Merwe, S.M. et al., Eur. J. Pharm. Biopharm., 
58(2), 225, 2004.)
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Chemical structure of PAH. (From Sokolsky-Papkov, M. et al., Adv. Drug Deliver. Rev., 
59(4–5), 187, 2007.)
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monomer composition. Using the emulsion-evaporation method, PAH 
microspheres are harvested as shown in Figure 6.6.30 The degradation of 
PAH depends on the water uptake rate and undergoes surface erosion in 
aqueous solution, which is the same mechanism as POE, and performs 
the zero-order drug release profile as the microsphere drug carriers. Since 
degraded monomer acids are nonmutagenic and noncytotoxic byproducts, 
PAH shows the minimal inflammatory reaction in vivo. One drawback of 
PAH is that it is difficult to make storage in anhydrous condition because of 
the hydrolytic instability of the anhydride bond.
6.2.2.3  Poly(ε-Caprolactone)
PCL is a semi-crystalline hydrophobic polymer, and its chemical structure 
is shown in Figure 6.7. Stephen et al. used PCL microspheres for taxol 
release, and the morphology of drug-loaded PCL microspheres is shown in 
Figure 6.8.31 Due to its high crystallinity and hydrophobicity, the degradation 
of PCL is quite slow, which provides the drug for long-term delivery. 
0.5 µm
Figure 6.6
Micrograph of PAH microspheres. (From Lopac, S.K. et al., J. Biomed. Mater. Res.: Part B Appl. 





Chemical structure of PCL. (From Kopecek, J. and Ulbrich, K., Prog. Polym. Sci., 9(1), 1, 1983.)
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A new design developed in blending PCL with other biodegradable 
polymers to provide opportunities to change the drug release rate.32 There 
are two steps for biodegradation of PCL-blended polymers in vitro or 
in vivo. At first, the PCL-blended polymer maintains its morphology and 
mass. Degradation of the PCL-blended polymer starts with weight loss 
due to the continuous chain cleavage and small fragments’ diffusion out 
of the polymer matrix. Its byproducts from biodegradation are non-acidic, 
which is good for biomedical application since non-acidic fragments do not 
induce local pH change.
6.2.2.4  Poly(Lactic-Co-Glycolic Acid)
PGA, PLA, and PLGA are all in the hydrophobic polyester family, which 
biodegraded by hydrolysis of the ester linkages. PLGA is a copolymer that 
is synthesized by means of random ring-opening polymerization of glycolic 
acid and lactic acid. The chemical structures of PGA, PLA, and PLGA are 
shown in Figure 6.9.
PLGAs have been used as Food and Drug Administration (FDA)-approved 
therapeutic devices due to their biodegradability and biocompatibility. 
Depending on the ratio of lactide to glycolide chosen, various PLGAs are 
harvested. PLGAs are identified in regard to the monomers’ ratio: taking 
940128   BAR = 100 µM              004
Figure 6.8
Micrograph of PCL microspheres. (From Dordunoo, S.K. et al., Cancer Chemother. Pharmacol., 
36(4), 279, 1995.)
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PLGA (80:20) as an example, it is a copolymer comprised with 80% lactic 
acid and 20% glycolic acid. All PLGAs are amorphous and show a very low 
glass-transition temperature in the range of 40°C–60°C. In comparison 
with PGA and PLA, which show low solubility in some oil solvents, 
PLGA can be dissolved in most of common solvents such as chlorinated 
solvents, acetone, or ethyl acetate. PLGA as a member of polyester family 
also degrades as a result of the hydrolysis of ester linkages in the presence 
of water, which is the same as PLA and PGA. In general, the duration of 
the PLGA degradation is correlated to the ratio of glycolic acid and lactic 
acid. The PLGA with higher amount of glycolic acid performs the shorter 
duration needed for degradation. Therefore, widely used PLGA (50:50) 
exhibits faster degradation duration. Aside from the ratio of monomers, 
PLGA end-capped with carboxyl groups illustrates shorter degradation 
duration than that end-capped with ester groups.
Since the body can effectively deal with monomers of PLGA biodegradation, 
very minimal systemic toxicity was found to affect the application of PLGA 
in protein and DNA delivery.34 One commercially marked drug delivery 
device by PLGA is Lupron Depot®, commonly used for the treatment of 
advanced prostate cancer.
6.3	 Simulated	Body	Fluid
In 1991, Kububo proposed that the necessary requirement for artificial 
implants to adhere with bone cells is the formation of bone-like apatite or 
HA on their surface.35 Like apatite formed in vivo, it also can be produced in 
simulated body fluid (SBF), a solution with ion concentrations nearly equal to 
those of human blood plasma. Table 6.2 shows the ion concentrations in SBF 
solution and human blood plasma as a reference. Since SBF or concentrated 
SBF can supply with abundant calcium and phosphate ions, apatite formed 
on the surface of the implant in SBF solution becomes a classical method for 















Chemical structures of PGA, PLA, and copolymer PLGA. (From Park, J. et al., Molecules, 10(1), 
146, 2005.)
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6.4	 HA	Deposition	by	Biomimetic	Method
HA coating deposition by biomimetic method has been studied for quite 
a few years. It can trigger the deposition of apatite coating on different 
substrates, including polymer scaffolds, the surface of cement, ceramic, and 
metal film or rods. In order to better understand the coating deposition 
procedure in aqueous solution, Lu et al. summarized a theoretical analysis 
of HA coating precipitation.37
6.4.1 Driving Force of apatite Deposition
The thermodynamic driving force of apatite deposition is obtained based on 

















ln( )  (6.1)
where
∆G is the Gibbs energy of apatite (CaP) ionic units in solution
R is the universal gas constant (8.314 JK−1 mol−1)
T is the absolute temperature
n is the number of ion units in 1 mol of apatite
S is the ratio of the activity product of ion units of precipitates (Ap) to the 
corresponding solubility product (Ksp), defined as supersaturation
Table 6.2
Ion Concentrations of SBF in 














Source: Kokubo, T. and Takadama, H., 
Biomaterials, 27(15), 2907, 2006.
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Among all CaP products formed in the solution, HA is the most stable; other 
CaPs such as octacalcium phosphate or dicalcium phosphate dehydrate 
formed at the beginning tend to transform into HA. Therefore, only the 
equation of HA precipitation in aqueous solution is studied here:
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The corresponding supersaturation (S) is calculated as follows:
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where Ksp(HA) equals to 2.35 × 10−59.40
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where
A is the Debye–Hückel constant varying with temperature, 0.5211 at 37°C
zi is the charge of ions




i i= ∑12 2  (6.5)
where ci is the mole number of each ion unit.
SBF was often chosen as a source of Ca and P for apatite formation by the 
biomimetic method; the equation for the ionic activity calculations would take 
into account magnesium and other ions in SBF that could affect HA precipita-
tion.41–43 In that case, classic theories of thermodynamics and kinetics would be 
not easy to apply since all chemical reactions in the solution must be considered.
6.4.2 Nucleation rates
The CaP nanocrystal nucleation rate (J) can be calculated based on the 























k is the Boltzmann constant
T is the absolute temperature
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Depending on this equation, the nucleation rate (J) of apatite formation is 
proportional to the kinetic factor (K) and is determined by the activation 
energy of nucleation (∆G). Here, ∆G is primarily affected by the interfacial 
energy γ, the supersaturation S, and the contact angle function f(θ). ν is defined 
as the CaP molecular volume and is determined by the crystal structure. 
The kinetic factor (K) is proportional to the probability (P) that ion units of 
CaP form a nucleus in the solution, i.e., K = K’P. Boistelle et al. proposed the 



















![ ] [ ]
! ! [ ] [ ]
 (6.7)
Attained from their experiment, K’ value could be calculated as 
13.64 × 10−24 cm−3 s−1. Based on the studies by Wu and Nancollas, the interfacial 
energy (γ) is also experimentally calculated as 10.4 mJm−2 for HA.45,46
6.5	 HA	Coating	on	Polymer	Scaffold
Recently, porous and 3-D polymer scaffolds are developed as a substrate 
for cell growth and proliferation in tissue engineering, and cells can secrete 
an extracellular matrix to induce new tissue formation.47 Polymer scaffold 
is chosen as an artificial implant due to biocompatibility, biodegradability, 
high mechanical strength, and osteoconductivity. Biocompatibility and 
biodegradability are correlated with polymer nature and can be administrated 
by an appropriate choice of polymer. In order to improve mechanical strength 
and osteoconductivity, some researchers designed a layer of apatite coating 
on the surface of the polymer scaffold.
The polysaccharide chitosan with amino groups, as a natural biodegradable 
polymer, is widely applied as a porous 3-D scaffold.48,49 Manjubala et al. 
used the freeze-dried method to fabricate macroporous chitosan scaffold 
(Figure 6.10a and b).50,51 They designed a modified double diffusion chamber 
containing separate calcium and phosphate ions to induce apatite deposition 
on the chitosan scaffold. The CaP particles can be clearly observed on the top 
and cross section of the scaffold as shown in Figure 6.10c and d. Apatite layer 
formed on the surface of the chitosan scaffold results from the amino groups 
of chitosan. Positively charged amino groups can bind phosphate ions in the 
solution to supply the site for apatite nucleation. After the nuclei formation, apa-
tite starts to grow by consuming calcium and phosphate ions in the solution.
Aside from the amino group, the carboxyl group is another effectively 
negative-charged chemical group that can induce apatite formation by 
means of absorption of calcium ions.52 Alginate hydrogel by ionic or 
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chemical cross-linking is used as the scaffold material for tissue engineering 
due to its biocompatibility and biodegradability.21,53 Darilis et al. investigated 
the nucleation of HA on alginate scaffold for stem-cell-based bone tissue 
application,54 and HA nanoparticles fully covering the surface of the alginate 
gel were observed, as shown in Figure 6.11. Since the alginate gel was 
prepared by using CaCl2 as a cross-linker, phosphate ions in the solution 
were immediately absorbed on the surface of the gel; in addition, there 
are abundant carboxyl groups in the alginate structure that could absorb 
calcium ions in the solution simultaneously. Thus, HA particles exhibit rapid 
precipitation on alginate gel scaffold.
Recently, many researchers have shown interest in synthesized copolymer 
PLGA as a 3-D macroporous scaffold in tissue engineering since it is capable 
of controlling biodegradability by composition, in comparison to natural 
polymers. In order to increase cell bioadhesion and osteoconductivity, 
many efforts are made to deposit a layer of apatite on PLGA scaffold.55–63 
Murphy first reported HA coating on the PLGA scaffold by biomimetic 
method in SBF solution, as shown in Figure 6.12.57 Later, they modified the 





20 µm 20 µm
Figure 6.10
Micrographs of (a) and (c) top view of chitosan scaffold and mineralized scaffold, (b) and (d) 
cross section of chitosan scaffold and mineralized scaffold.
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hydroxyl and carboxyl groups and then immersed the scaffold into SBF 
solution for HA crystal growth.58 The presence of these increasing groups 
accelerates calcium ion binding to the polymer surface and improves mineral 
growth. The morphology of the mineral coated on modified PLGA is shown 
in Figure 6.13. Chou et al. carried out a two-step soaking method with 
30 µmControlt = 4 weeks
(a)
30 µmt = 4 weeks
(b)
Figure 6.11
Micrographs for (a) control alginate gel and (b) HA coated on the surface of alginate gel after 
4 weeks immersion in SBF.
062506 5 kV ×1.70 K 17.6 µm
Figure 6.12
Micrograph of HA crystal deposition on PLGA scaffold after 16 days of incubation. (From 
Murphy, W.L. et al., J. Biomed. Mater. Res., 50(1), 50, 2000.)
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supersaturated solution of 5× SBF (SBF1) and Mg2+ and HCO3− free 5× SBF 
(SBF2) for HA growth.61 Unlike the apatite precipitated from original SBF, 
the coating obtained by two-step soaking method is comprised of plate-like 
structured HA nanocrystals (Figure 6.14).
6.6	 HA	Coating	on	Micro-/Nanospheres
Depending on the nucleation and growth theory of HA formation on 
scaffold, it can be applied to microparticle or nanoparticle as a substrate. 
The difference between their structures determines their biomedical 
application: HA coating on scaffold is applied to improve the bioactivity 











Micrographs of apatite-coated PLGA scaffold by sequentially immersing in (a) SBF1 and (b) 
SBF2. (From Chou, Y.F. et al., J. Biomed. Mater. Res. B Appl. Biomater., 75(1), 81, 2005.)
500  µm08–AUG–00 am04 WD19am 25.0 kV ×80 10 µm01–MAR–00 WD15am 10.0 kV×3.0k
(a) (b)
Figure 6.13
Micrographs of HA deposited on NaOH-treated PLGA scaffold after 16 days of incubation in 
SBF (a: magnification ×80; b: magnification ×3000). (From Murphy, W.L. and Mooney, D.J., J. Am. 
Chem. Soc., 124(9), 1910, 2002.)
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carriers for bioactive molecular drug delivery since HA can provide 
strongly chemical bonding with protein and DNA.
6.6.1 Supersaturated Solution
6.6.1.1  SBF or Concentrated Modified SBF
SBF or concentrated modified SBF solution, as a calcium and phosphate 
source, is usually chosen as the supersaturated solution for apatite formation. 
Murphy et al. prepared HA-coated PLGA microspheres using SBF solution, 
which is similar to the classic method of biomimetic HA coating on 
scaffolds.64 After immersing PLGA microspheres in SBF solution for 7 days at 
37°C, HA coating on the surface of microspheres was successfully produced. 
The morphology of uncoated and coated microspheres is shown in Figure 
6.15. Mineral HA with a plate-like structure was clearly observed after 
microsphere soaking. It showed that the biomimetic method for HA coating 
formation is also suitable for particle as a substrate. The protein release 
rate from binding with HA and encapsulation in PLGA microspheres was 
also investigated (Figure 6.16). Both approaches showed sustained release; 
however, the total amount of bound protein release is significantly higher 
than the encapsulated protein after 30 days. Even more importantly, the 
bound protein release rate is nearly constant, as a linear kinetics showed 
in the release curve without a burst release stage. It demonstrated that the 
release of protein drug binding with HA coating did not result from surface 





































Schematic of mineral-coated PLGA microspheres and micrographs for uncoated microspheres.
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rate of HA coating determined the bound protein release kinetics. This study 
opens a new view to control protein drug release in drug delivery systems.
They also studied the effect of the amount of the nucleating agent and 
surfactant in the supersaturated solution on the growth of HA coating.65 
The morphology of HA-coated microspheres with the addition of different 
concentrations of microspheres as nucleating agents is shown in Figure 6.17. 
0.25% (w/v) of PLGA microspheres is the preferable amount added for HA 
coating growth without aggregation. During the growth of the mineral 
HA coating, the presence of surfactant (Tween 20) significantly inhibited 
the formation of the mineral and changed the surface morphology of the 
coating, as shown in Figure 6.18.
Kang et al. also chose PLGA microspheres, 150–300 μm in size, as substrates 
for HA growth.66 While SBF with inorganic ion concentrations three times that 
of human blood plasma was modified as a source of Ca and P. After different 
immersion times, the surface morphology of uncoated PLGA and HA-coated 
PLGA microspheres is shown in Figure 6.19. HA coating is successfully formed 
on the surface after an immersion of 5 days; however, some obvious cracks are 
observed on the surface of the coating. Poor coverage of the coating is mainly 
caused by Mg2+, HCO3−, and other ions in the SBF which are bonded with Ca2+ 
and PO43− to affect the nucleation and growth of HA on the microspheres.
Apart from negatively charged PLGA microspheres, positively charged 































(a) Comparison of cumulative release of BSA bound to HA-coated PLGA microspheres and 
BSA encapsulated in PLGA microspheres. Micrographs of (b) HA-coated microspheres and (c) 
coated PLGA microsphere after the 30-day release period. (From Jongpaiboonkit, L. et al., Adv. 
Mater., 21(19), 1960, 2009.)
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group of chitosan can bond with phosphate ions to induce apatite nucle-
ation in the solution. Jayasuriya et al. used chitosan as a template to prepare 
apatite-coated chitosan microspheres for the release of growth factor IGF-1.67 
The important point in their work is that they used 5 times the concentra-
tion of SBF for rapid biomineralization. Some researchers use an incubation 











Micrographs of HA-coated microspheres after 7-day soaking in SBF solution with different 
amount of addition of microspheres: (a) 0.25% (w/v); (b) 0.50% (w/v); (c) 0.75% (w/v); (d) 1.00% 




Morphology of the surface of microspheres formed (a) in the presence of 0.1% (v/v) Tween 20 
and (b) in the absence of Tween 20. (From Jongpaiboonkit, L. et al., ACS Appl. Mater. Interfaces, 
1(7), 1504, 2009.)
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in 1.5× SBF or 3× SBF solution. It is quite a long immersion duration for the 
preparation of drug delivery devices. Jayasuriya et al. increased the concen-
tration of SBF to five times to obtain a complete coverage of the HA coat-
ing in 24 h incubation. A thin layer comprising HA nanoparticles on the 
surface of chitosan is shown in Figure 6.20. However, the morphology of the 





Micrographs of (a, b) PLGA microsphere and (c, d, e, and f) apatite-coated PLGA microsphere 
incubated in SBF for (c, d) 3 days and (e, f) 5 days. The scale bars indicate 10 μm in a, c, and e 
and 1 μm in b, d, and f. (From Kang, S.W. et al., J. Biomed. Mater. Res. Part A, 85A(3), 747, 2008.)
258 Hydroxyapatite Coatings for Biomedical Applications
structure in SBF solution. Morphology difference is caused by the effect of 
high concentrations of Mg2+, HCO3−, and other ions in 5× SBF on the nucle-
ation and growth of HA.
Min Lee et al. modified Jayasuriya’s work and designed a two-step 
immersion process to prepare apatite-coated alginate/chitosan microspheres 
for osteogenic protein delivery.68 They first added alginate/chitosan micro-
spheres into 5× concentrated SBF (SBF1) for a 6 h nucleation process; apatite-
nuclei-coated microspheres were then poured into Mg2+ and HCO3− free 
SBF (SBF2) for 12 h of continuing growth. By a two-step method, an apatite 
coating with a plate-like structure is completely formed in less than 1 day, 
as shown in Figure 6.21b. The problem in this work is the high extent of 
aggregation that occurs (Figure 6.22a).




Morphology of chitosan microspheres before (a) and after (b) biomineralization. (From 
Jayasuriya, A.C. and Kibbe, S., J. Mater. Sci.: Mater. Med., 21(2), 393, 2010.)
NONE LEI 10.0 kV ×130 100 µm WD10.0 mm NONE SEI 10.0 kV ×4,000 1 µm WD 15.2 mm
(a) (b)
Figure 6.21
Micrographs of (a) alginate/chitosan microparticles after soaking in SBF1 and (b) after soaking 
in SBF2. (From Lee, M. et al., Biomaterials, 30(30), 6094, 2009.)
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6.6.1.2  Solution Containing Only Ca and P
A classic biomimetic method of HA coating formation is by immersing 
the substrate in SBF, but this usually takes up to several days to produce a 
complete coating. The other problems that need to be solved include high 
aggregation and poor coverage. The constant composition precipitation in 
the solution is a rapid method for HA particle formation, as first reported 
by Tomson and Nancollas,69 Xu et al. successfully applied this method to 
prepare an HA coating fully covered on the surface of negative liposomes.70 
In this work, a stable supersaturated solution with respect to HA was pre-
pared by mixing CaCl2 and KH2PO4 (Ca/P ratio 1.67), at 37°C and pH 7.8, as 
neutral and basic pH tend to induce the formation of HA.71 Then liposomes 
as nucleating agents were added to induce the nucleation and growth of 
HA nanocrystals. In order to monitor the whole process for HA precipita-
tion, a computer-controlled system was designed as shown in Figure 6.22. 
An ion meter was used to measure calcium ion activity and a pH meter 
was used to monitor pH changes in the solution and to maintain a pH of 7.8 
throughout the whole process by adding KOH. The titrants comprised of 25 
mM CaCl2 (Titrant 1), 15 mM KH2PO4, and 50 mM KOH (Titrant 2), which 
supplied Ca2+ and PO43− to maintain the concentrations of Ca and P in the 
solution as constants. By using this system, an HA coating is successfully 
grown on liposomes in 6 h (Figure 6.23). However, regarding commercial 











Diagram of computer-controlled constant composition method. (From Xu, Q. et al., Biomaterials, 
28(16), 2687, 2007.)
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Anitha Ethirajan et al. developed a novel two-step process for HA coating 
formation, as shown schematically in Figure 6.24.72 The addition of calcium 
ions for bonding with nanoparticles, then followed by a dropwise addition 
of phosphate ions, corresponds to the stoichiometric Ca/P ratio of 1.67 for 
HA formation. The concentration of Ca and P in the solution is very low: 
0.5 mM Ca2+ and 0.3 mM PO43−. The pH value in this work, maintained at a 
constant value of 10, leads to the generation of HA-coated nanoparticles. As 
a result, HA coating is formed after 24 h but is not fully covered, as shown 
in Figure 6.25. A pH of 10 throughout the whole experiment is not suitable 
for most biodegradable microspheres/nanospheres due to quick hydrolysis 
under alkaline condition.
In our lab, we created a novel two-step process under physiological tem-
perature and pH for HA growth (as illustrated schematically in Figure 6.26). 
At first, after the addition of microspheres into the calcium solution, calcium 
ions in the solution are partly absorbed on the surface of microspheres due to 
bonding with carboxyl groups. This process would supply a Ca-rich surface 
for apatite nucleation. Residual calcium ions in the solution provide a supply 
for HA continuing growth. Secondly, when phosphate ions are added to the 
suspension, they would interact with the calcium ions at the microsphere 
surface to form the very first layer of HA, and thereafter, HA growth would 
take place. The whole growth is carried out at 37°C as the biomimetic process.
The PLGA microspheres we used as substrates were prepared by means 
of the oil in water (O/W) emulsion-evaporation method. The scanning 
electron microscope (SEM) micrographs show uniform distribution and 






Bright field image and corresponding electron diffraction pattern of HA-coated liposome 
nanospheres. (From Xu, Q. et al., Biomaterials, 28(16), 2687, 2007.)
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The average particle size of PLGA microspheres is measured as 6.67 ± 
0.82 μm. The zeta potential of these microspheres is −27.0 ± 1.87 mV, which 
indicates the negatively charged surface caused by the carboxyl groups in 
the chemical structure of PLGA. It is an important point for choosing PLGA 



























Schematic illustration of HA deposition on carboxyl-functionalized nanoparticle by consecu-
tive addition of Ca2+ and PO43−. (From Ethirajan, A. et al., Chem. Mater., 21(11), 2218, 2009.)
100 nm 100 nm
(a) (b)
Figure 6.25
Micrographs of HA-coated nanoparticles, in bright field (a) and dark field (b) image modes. 
(From Ethirajan, A. et al., Chem. Mater., 21(11), 2218, 2009.)











































(See	color	insert.) Schematics of HA coating formation on PLGA microspheres. (From Zhang, 
Z. et al., Nanosci. Nanotechnol. Lett., 3(4), 472, 2011.)
10 µm×6003.0 kVSEI WD 7mm 1µm×6,0003.0 kVSEI WD 7mm
(a) (b)
Figure 6.27
SEM micrographs of negatively charged PLGA microspheres (a) ×600 and (b) ×6,000 
magnification. (From Zhang, Z. et al., Nanosci. Nanotechnol. Lett., 3(4), 472, 2011.)
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well pronounced for particles with a high amount of carboxyl groups.72 
Generally, calcium ions could be bonded with carboxyl groups on the surface 
of PLGA microspheres through electrostatic forces; followed by the addition 
of phosphate, HA crystals start to nucleate and grow on the microspheres.
The factors that affect HA formation are proposed as the amount of –COOH 
group, concentrations of Ca and P in the solution, and immersion time of the 
substrate. In our experimental design, we fixed the amount of the –COOH 
group on PLGA as a constant index. The study of HA growth focused on the 
ion concentration of the solution and immersion time of microspheres.
6.6.1.2.1  Effect of Concentrations of Ca and P in the Solution 
on the Formation of HA Coating
Two solutions containing Ca and P with different concentrations are shown 
in Table 6.3. We set the ratio of Ca and P as a constant of 1.67 with respect 
to HA for the two solutions. After directly mixing the Ca and P solution, 
Solution 2 shows a suspension with white particle precipitation, but Solution 
1 is still clear, as shown in Figure 6.28. It indicates that HA particles are 
formed without a nucleating agent from Solution 2 of high concentration 
once Ca and P ions touch each other in the aqueous solution.
The formation of HA coating was investigated after the addition of PLGA 
microspheres in the two solutions for 16 h incubation. After soaking in 
Solution 1, a complete apatite coating is fully covered on the surface of micro-
spheres (Figure 6.29a). From magnification images (Figure 6.29b and c), the 
surface of the coating on the microspheres shows a plate-like structure and 
the coated microspheres are still uniform without aggregation. In contrast 
to Solution 1, after soaking in Solution 2, the bare smooth surface of micro-
spheres and large particles with irregular shapes can be observed as shown 
in Figure 6.29d and e.
Samples were also scanned by Fourier Transform Infrared (FTIR) analysis, 
as shown in Figure 6.30. FTIR spectra show phosphate absorption peaks of 
HA in both solutions at 1041 cm−1 (stretching vibration of PO43−) and 601, 563 
cm−1 (deformation vibration of PO43−) in comparison to PLGA microspheres 
before immersion. It demonstrates that the coating with a plate-like structure 
in Solution 1 and large particles with irregular shapes in Solution 2 are both 
correlated with HA.
Table 6.3
Ca and P Solutions with Different Concentrations 
(Ca/P = 1.67)
Solution Ca2+	(mM) PO43−	(mM) Precipitation
1 1.25 0.75 No
2 2.5 1.5 Yes
Source: Zhang, Z. et al., Nanosci. Nanotechnol. Lett., 
3(4), 472, 2011.
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Depending on SEM images and FTIR spectra, HA particles formed in Solution 
2 could be quickly self-precipitated in the solution rather than on the surface 
of the microspheres due to the high concentration of Ca and P. Solution 1, with 
1.25 mM of Ca2+ and 0.75 mM of PO43−, has the preferable concentration for HA 
nanocrystal nucleation and growth on the microsphere substrate.
6.6.1.2.2 Effect of Immersion Time on the Formation of HA Coating
The effect of immersion time on HA coating growth was examined by FTIR 
based on samples at 1, 4, 8, 16, and 24 h, as shown in Figure 6.31. After the first 
hour of incubation, the peaks for stretching and deformation vibration of the 
phosphate groups are obtained, but are very weak. With lengthened immer-
sion time, the phosphate groups show stronger peaks at 1041, 601, and 563 
cm−1. The peaks around 3500 cm−1 derived from the hydroxyl groups are very 
weak for all the samples, hinting that the HA coating is poorly crystallized.74
The morphology of PLGA microspheres before immersion as a control 
is shown in Figure 6.32a. Some HA crystals can be observed only after 1 h 
incubation (Figure 6.32b). Combined with the FTIR spectra, it is not difficult 
to see that a rapid nucleation and growth of HA takes place in the first hour. 
However, resulting from the short duration, HA crystals only grow on some 
parts of the microsphere. After 4 h and 8 h of immersion, HA crystals are 
formed more areas of the microsphere surface (Figures 6.32c and d), but still do 
(a) (b)
Figure 6.28
(See	 color	 insert.) Photographs for Ca and P mixed solution with different concentrations: 
(a) Solution1 and (b) Solution2.
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not cover completely. Until 16 h, complete coverage is seen as shown in Figure 
6.32e. The coating is composed of HA crystals with plate-like structures on 
the surface of the microspheres. After soaking for 24 h, plate-like structures 
with sharp edges are clearly observed, as shown in Figure 6.32f.
Simultaneously, the size distribution of microspheres before and after coat-
ing is studied as shown in Table 6.4. After 16 h immersion, the thickness of 





SEI     3.0 kV    ×18,000      1 µm  WD 7 mm
SEI     3.0 kV       ×2,000       10 µm WD 7 mm
SEI     3.0 kV       ×5,000      1 µm  WD 7 mm
SEI     3.0 kV       ×1,000       10 µm  WD 7 mm
Figure 6.29
SEM micrographs of HA formation after PLGA microspheres immersed in Solution 1 (a through c) 
and Solution 2 (d and e). (From Zhang, Z. et al., Nanosci. Nanotechnol. Lett., 3(4), 472, 2011.)
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HA coating nearly reached 1.5 μm. However, there is a slight increase in 24 h 
incubation duration in comparison to 16 h. The reason is probably attributed 
to the consumption of Ca and P and decrease of ion concentration.
The phase analysis of the coating is carried out by x-ray diffraction (XRD) 
as shown in Figure 6.33. The strong characteristic peaks at 26° and 32° cor-
responding to HA are obtained for coated PLGA microspheres at different 
soaking times. The broadening and overlapping of peaks demonstrate that 
the coating is comprised of poorly crystallized HA, consistent with the FTIR 
result. Poor crystallization of HA coating contributing to higher dissolution 
rate may be exploited in controlling drug delivery.
Since HA is fully covered on the surface of PLGA microspheres after 16 h 
incubation, thermo gravimetric analysis (TGA) is used to analyze the weight 
of the HA coating after 16 h and 24 h, as shown in Figure 6.34. In the tem-
perature range of 300°C–400°C, a significant weight loss is obtained, which 
corresponds to the thermal decomposition of PLGA. After heating at 500°C, 
there is no weight at all for PLGA microspheres, indicating that all micro-
spheres were burned out. After 16 and 24 h incubations, 9.12% and 10.73% 
of HA remain on HA-coated microspheres, respectively. Depending on the 
data and spectra, there is a slight weight increase with incubation time from 
16 to 24 h. However, the increase is very small because most of the calcium 
and phosphate ions in the solution are consumed and the kinetic balance is 
found between HA and Ca/P in the solution.














FTIR spectra for PLGA microspheres (a), and HA-coated PLGA microspheres immersed in 
Solution 1 (b) and Solution 2 (c). * represents phosphate groups. (From Zhang, Z. et al., Nanosci. 
Nanotechnol. Lett., 3(4), 472, 2011.)
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6.6.2 Modified Chemical groups of Microspheres
Anitha Ethirajan et al. also investigated the effect of the amount and category 
of surface chemical groups on HA growth.72 They demonstrated that in the 
same incubation time, the amount of HA nanocrystals increased along with 
increases in the surface carboxyl groups of nanoparticles. Negatively charged 
surfactant (sodium dodecyl sulfate, SDS) present on the surface of nanoparticles 
can affect the bonding of calcium ions with carboxyl groups and inhibit HA 
growth. However, Xu et al. provided a different conclusion with respect to an 
SDS-modified microsphere template.75 They prepared negatively charged SDS-
modified PLGA microspheres with zeta potential of −79.1 mV in comparison to 
the commonly used poly(vinyl alcohol) (PVA) surfactant for PLGA preparation 
of only −10 mV. They illustrated that a complete HA coating could be formed 
on SDS-modified PLGA microspheres in 6 h immersion (shown in Figure 6.35), 
but there was almost no HA crystal observed on the PLGA microspheres with 
PVA surfactant. Thus, they concluded that SDS, as the polar and ionic head of 
–OSO3, was a strong chelating group for calcium ions.
Since chitosan itself has a low capability to induce HA formation in normal 
SBF solution, Leonor I.B. et al. prepared silica-treated chitosan microspheres 























FTIR spectra for HA-coated microspheres with different immersion times: (a) 1 h, (b) 4 h, 
(c) 8 h, (d) 16 h, and (e) 24 h. * represents phosphate groups. (From Zhang, Z. et al., Nanosci. 
Nanotechnol. Lett., 3(4), 472, 2011.)




SEI 3.0 kV ×18,000 1 µm WD 7 mm
SEI 3.0 kV ×18,000 1 µm WD 7 mm
SEI 3.0 kV ×18,000 1 µm WD 7 mm
SEI 3.0 kV ×18,000 1 µm WD 7 mm
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Figure 6.32
SEM micrographs for uncoated microspheres (a) and HA-coated microspheres with different 
incubation times: (b) 1 h, (c) 4 h, (d) 8 h, (e) 16 h, and (f) 24 h. (From Zhang, Z. et al., Nanosci. 
Nanotechnol. Lett., 3(4), 472, 2011.)
Table 6.4
Average Size of HA-Coated Microspheres with 
Different Soaking Times
Soaking time (h) 0 16 24
Size (μm) 6.67 ± 0.82 8.16 ± 1.34 8.41 ± 1.73










XRD spectra for uncoated PLGA microspheres (a) and HA-coated microspheres with different 
incubation times: (b) 1 h, (c) 4 h, (d) 8 h, and (e) 24 h (• represents HA characteristic peak). (From 
Zhang, Z. et al., Nanosci. Nanotechnol. Lett., 3(4), 472, 2011.)

















TGA spectra for (a) PLGA microspheres and (b) HA-coated PLGA microspheres after 16 h and 
(c) 24 h incubation.














Micrographs of negatively charged PLGA microspheres with SDS surfactant (a and b) and 
HA-coated PLGA microspheres under different soaking times: (c and d) 1 h, (e and f) 3 h, and 
(g and h) 6 h.
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as a template for HA growth.76 From the image in Figure 6.36, HA particle 
formation was observed within 1 day; after 7 days of immersion, the HA 
coating fully covered on two kinds of silica-treated chitosan microspheres.
6.7	 Protein	Drug/HA	Coprecipitation	on	the	Microspheres
6.7.1 Coprecipitation of Drug and Ha on the Metal or Scaffold
Using the biomimetic method, HA can be deposited on the templates from 
the solution at normal physiological temperature. This provides probability 
for coprecipitation of protein drug and HA because protein can maintain its 
bioactivity at normal physiological temperature. Many efforts were made to 
study the dissolution rate and crystal phase of drug/HA coprecipitation.77–82
Wen et al. investigated the effect of protein (bovine serum albumin, 
BSA) on the crystalline phase and morphology of coprecipitation coating 
on titanium alloy.80 HA coating with the absence of protein shows straight 
plate-like units with sharp edges, while coprecipitation coating shows link-
net-structured crystal plates with some organic-like substance (Figure 6.37).
Liu et al. focus on the dissolution rate of CaP/BSA coprecipitation in different 
bathing concentrations of BSA (Figure 6.38), which is directly correlated 
with the drug release rate.82 They demonstrated that coprecipitation coating 
showed lower dissolution rate than CaP coating without BSA. However, there 
is no obvious difference in dissolution from coprecipitation with various 
bathing concentrations of BSA.
6.7.2 Drug-Co-Deposited Ha Coating on the Microspheres
With the inspiration of drug/HA coprecipitation on metal, we adopted this 
coprecipitation method for microspheres to study the effect of drug on HA 
growth and drug release profile.
Bovine serum albumin (BSA), which is 66 kDa in molecular weight and 
3.5 ± 0.3 nm in size, is chosen as a model protein drug. The size distribution 
of BSA is shown in Figure 6.39.
The nanosized BSA loading on the HA coating usually takes place on the 
surface of the coating, and the loading efficiency has its limitation. Due to 
protein bonding with HA, drug-co-deposited HA on the microspheres can 
be formed at the time of the HA nanocrystal deposition. The advantages of 
coprecipitation are that there is no need to reload the drug after HA forma-
tion, and the drug release duration may be lengthened.
The two-step biomimetic method is still suitable for drug-co-deposited HA 
preparation, due to its mild condition and maintenance of drug’s bioactivity. 
This provides the possibility of studying drug-co-deposited HA coating on 
the polymer microspheres.
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6.7.2.1  Effect of Drug on HA Formation
We propose the hypothesis that the drug has little or no effect on the 
nucleation and growth of HA, and loading efficiency is improved by 
increasing the initial drug concentration for drug-co-deposited HA. The 
different concentrations of the drug were designed to study drug loading 
and HA growth. After 24 h of incubation, the amount of drug incorporated 
in the coprecipitation coating was calculated as data shown in Table 6.5. The 
results are completely different from our hypothesis. The concentration of the 
initial drug increases from 100 to 500 μg/mL, and the amount of precipitated 
drug increases quite a little (from 43.5 to 55.0 μg/mL). When the initial drug 
increases up to 1000 μg/mL, there is no drug on the microspheres (0 μg/mL). 
This strange condition hints that BSA may strongly affect the growth of HA 
crystals, since the amount of the deposited drug is related to HA formation.
In order to confirm the drug effect on HA growth, FTIR measurements 
were used to analyze the coated microspheres without or with BSA drug 
coprecipitation as shown in Figure 6.40. For Figure 6.40a spectra as a control of 








Micrographs of HA (a and b) and HA/BSA (bathing concentration 2 mg/mL) (c and d) coatings 
prepared on Ti alloy. (Wen, H.B. et al., J. Biomed. Mater. Res., 46(2), 245, 1999.)
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Figure 6.38
Release of Ca2+ ions (a) from CaP coatings prepared biomimetically in the absence or presence 
of BSA (bathing concentration of 1 mg/mL), (b) from CaP/BSA coprecipitated coatings with 
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Figure 6.39
Size distribution of BSA.
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associated with the phosphate groups. When 10, 100, and 500 μg/mL BSA 
were added for coprecipitation, additional peaks at 1648 and 1541 cm−1 in 
FTIR spectra were observed, which can be ascribed to the amide I and amide 
II band of the protein, respectively (Figure 6.40b through d). The amide I 
band represents the stretching vibrations of C=O in the backbone of the 
protein, while amide II results from the combination of C–N stretching and 
N–H bending vibrations. These peaks demonstrate the incorporation of BSA 
drug into the HA coating. However, the condition differs after a 1000 μg/mL 
addition for coprecipitation, as shown in Figure 6.40e. In the spectra, no 
characteristic peak that corresponded with either phosphate groups or amide 
Table 6.5
Concentration of BSA before and after Coprecipitation
Sample 1 2 3 4
Concentration of drug in phosphate 
solution (μg/mL)
10 100 500 1000
Concentration of drug precipitated 
in the coating (μg/mL)
NA 43.5 ± 2.5 55.0 ± 6.2 0










FTIR spectra for HA-coated microspheres (a) and coprecipitation of HA and BSA-coated 
microspheres with initial BSA concentration (b) 10 μg/mL, (c) 100 μg/mL, (d) 500 μg/mL, 
(e) 1000 μg/mL. (* represents phosphate groups; • represents amide groups.)
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groups is observed. It illustrates that drug-co-deposited HA or even only HA 
is not formed after 24 h incubation, as the spectra is similar to uncoated bare 
PLGA microspheres.
The morphology of drug-co-deposited HA coating on the surface of 
PLGA microspheres was observed by FESEM. The fully covered HA coat-
ing without BSA, as a control, is shown in Figure 6.41a and b. The coating 
is comprised of many straight plate-like structured HA nanocrystals with 
sharp edges. However, some significant differences were found between the 
distinct concentrations of BSA drug for coprecipitation. At a concentration 
of 10 μg/mL of BSA, a completely uniform HA layer on the microspheres 
is observed, but the partial areas show the organic net-linked structure 
lacking a sharp edge (Figure 6.41c and d). When higher concentration of 
100 μg/mL BSA was added, more net-linked structured coprecipitations 
appear, as shown in Figure 6.41e and f, and the coating is not as dense as 
the one obtained in the control. A marked difference appears when the 
concentration of initial BSA is increased to 500 μg/mL (Figure 6.41g and h). 
The surface of the microsphere is partially covered with apatite after 24 h of 
incubation. Moreover, all formed apatite shows organic net-linked structure, 
which is completely different from plate-like structured HA coating with-
out the addition of BSA. When up to 1000 μg/mL BSA is added, the smooth 
surfaces observed in Figure 6.41i prove that there is no apatite formation on 
the surface of PLGA microspheres after 24 h of immersion, which is consis-
tent with the FTIR spectra. These results demonstrate that BSA can strongly 
influence the duration and structure of HA formation by incorporating into 
the crystal lattice of HA.
6.7.2.2   Comparison of Loading Efficiency of Drug-Soaked HA and 
Drug-Co-Deposited HA Coating
The amount of the drug absorbed on the HA coating and incorporated in the 
coprecipitation of HA and BSA were measured and calculated in Table 6.6 
and Figure 6.42.
Depending on the positive calcium ion and negative phosphate ion of HA, 
protein drug can strongly bond with HA by electrostatic force between cal-
cium ion and carboxyl group, and phosphate ion and amino group, respec-
tively. Loading efficiency of “drug-soaked HA” is studied by soaking coated 
microspheres in the BSA solution with varying concentrations of 100, 500, 
and 1000 μg/mL. From Table 6.6 and Figure 6.42, the amount of bound BSA 
increases along with an increase in initial BSA amount, which is very clearly 
obtained for the initial amount increasing from 100 to 500 μg/mL. However, 
condition differs from 500 to 1000 μg/mL, since the HA coating has nearly 
reached its absorption limit at this point.
The “drug-co-deposited HA” on the surface of PLGA microspheres 
provides a one-step method for HA growth and drug loading without 
an additional absorption process. However, the protein drug BSA, as a 
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SEI 5.0 kV ×10,000 1 µm WD 10 mm SEI 5.0 kV ×20,000 1 µm WD 10 mm
SEI 5.0 kV ×20,000 1 µm WD  9 mm SEI 5.0 kV ×20,000 1 µm WD   9 mm





Micrographs of co-precipitation of HA and drug on the microspheres with BSA concentra-
tion (a) ([b] ×20,000 magnification) and coprecipitation of HA and drug on the microspheres 
with BSA concentration (c) 10 μg/mL ([d] ×20,000 magnification), (e) 100 μg/mL ([f] ×20,000 
magnification).
(continued)
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foreign polymer, can strongly influence the nucleation and growth of HA 
coatings. Thus, the loading profile of “drug-co-deposited HA” is different 
from that of “drug-soaked HA” because the amount of precipitated drug 
is related to HA formation. The amount of the precipitated drug in “drug-
co-deposited HA” is also shown in Table 6.6 and Figure 6.42. Compared 
to the loading profile of “drug-soaked HA,” there is little increase for the 
precipitated drug with the initial drug increasing from 100 to 500 μg/
mL, and non-precipitated drug is measured against 1000 μg/mL of the 
(g) (h) 
(i) 
SEI 5.0 kV ×10,000 1 µm WD 9 mm SEI 5.0 kV ×20,000 1 µm WD 9 mm
SEI 5.0 kV ×10,000 1 µm WD 9 mm
Figure 6.41 (continued)
Micrographs of co-precipitation of HA and drug on the microspheres with BSA concentration 
(g) 500 μg/mL ([h] ×20,000 magnification) and (i) 1,000 μg/mL.
Table 6.6
Amount of BSA from “Drug-Soaked HA” and “Drug-Co-Deposited HA”
Initial	Loading	(μg/mL) 100 500 1000
Absorbed on the surface of HA coating (μg/mL) 52.4 ± 7.8 325.1 ± 34.3 356.5 ± 25.2
Deposited in coprecipitation of BSA and HA 
coating (μg/mL)
43.5 ± 2.5 55.0 ± 16.2 0
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initial drug. These results illustrate that HA growth is inhibited by the 




In our work, BSA release profile from “drug-soaked HA” and “drug-
co-deposited HA” with the same initial concentration (500 μg/mL) of 
BSA was investigated, as shown in Figure 6.43. The release kinetics of 
“drug-soaked HA” display two stages: a burst release after first day incu-
bation and following a linear release until 30 days. After 1 day immer-
sion, 20% of BSA releases from the HA coating. The rapid release rate is 
caused by diffusion of BSA out of the HA coating. Since BSA is absorbed 
on the surface of HA, in the beginning of release, partially instable BSA 
diffuses by exchanging with ions in the medium. While, bound BSA in 
the HA coating releases at a constant rate, which is correlated with the 
dissolution of HA. After 30 days of incubation, cumulative BSA release 
achieves 76%. Compared with “drug-soaked HA,” BSA release from “drug-
co-deposited HA” shows a linear kinetics without burst release stage. In 
























Initial BSA amount (µg/mL)
100 500 1000
Figure 6.42
The amount of BSA from “drug-soaked HA” and “drug-co-deposited HA.”
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“drug-soaked HA.” After 30 days of incubation, cumulative BSA release 
from “drug-co-deposited HA” is obtained as 16%. It suggests that BSA is 
incorporated into the HA crystal lattice, which is consistent with the mor-
phology shown in Figure 6.41. This novel drug delivery device offers the 
probability for long-term release profile.
We also studied the BSA release from “drug-co-deposited HA” with 
different initial concentrations of BSA (100 and 500 μg/mL). As shown in 
Figure 6.44, no difference in the BSA release rate is observed as a function of 
initial BSA concentration. It demonstrates that BSA release profile of “drug-
co-deposited HA” is independent of the initial BSA concentration.
6.8	 Future	Research
HA coating on different substrates is well demonstrated in various studies. It 
is believed that the process-driven approach in current HA-scaffold coating 
research will be replaced by application-driven approaches: the focus is no 
longer on how to prepare HA coating on the substrates, rather the emphasis 
will be on what type of HA should be coated for a particular application. 
 Drug-soaked HA
 Drug-co-deposited HA


























Comparison of cumulative release of BSA from “drug-soaked HA” and “drug-co-
deposited HA.”
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This transition is critical because different application requires slightly dif-
ferent type of HA, hence modification of the HA coating itself is of more 
significance from the viewpoint of future application.
A classic example is the property difference between HA and doped 
HA coating by sol–gel method: fluorine-doped HA has a high dissolution 
resistance83 and Mg-doped HA showed better bioactivity and adhesion 
in vitro84 than pure HA. However, formation of HA is usually obtained at 
high temperature or serious condition, such as annealing, electrochemical 
deposition, liquid precursor plasma spraying, etc. It is not suitable for a 
polymer substrate due to polymer tends to chain cleavage under high 
temperature.
Biomimetic method for coating deposition was adopted involving mild 
conditions similar to those characteristic of biological environments and for 
the deposition of CaP coatings on many different objects. One of the main 
advantages of biomimetic deposition of coatings is the possibility of other 
ions being doped onto the CaP layer on a polymer substrate. Therefore, 
some researchers started the ion-doped HA coating study by biomimetic 
method. Carbonated HA, a popularly known anionic substituent, has 
a better physical attachment on the substrate. Barrere et al. studied 
apatite growth in the normal SBF solution and 3× HCO3− SBF solution.85 
Drug-co-deposited HA with initial BSA 500 µg/mL
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Time/day
Figure 6.44
Cumulative release of BSA from “drug-co-deposited HA” with initial BSA concentration of 100 
and 500 μg/mL.
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The results show that HCO3− can quickly induce CaP nucleation, as the 
HA crystal inhibitor makes a reduction of apatite crystal size. Apart from 
HCO3−, some cations, Mg2+, Mn2+, Sr2+, and Zn2+, by a partial substitution 
of Ca, also have an inhibitory effect, even greater than that of HCO3−.86–89 
These doped apatite coatings not only have an effect on crystallization 
structure but also display a remarkably beneficial effect on bone cells. Mg2+- 
and Sr2+-doped apatite coatings promote proliferation and expression of 
collagen. Also, the apatite formed from the relatively high content of Mn2+ 
in the phosphate has a high effect on osteocalcin production.88 Good in 
vitro results have also been obtained in the case of Zn-containing apatite 
layers. Zn-substituted HA displays a significant increase in fibroblastic 
proliferation, osteoblastic proliferation, and differentiation in vitro.89 
Until now, most substituted HA studies are obtained from HA coatings 
on metal substrates. According to the specific biomedical application 
and technical feasibility in terms of polymer substrate and biomimetic 
method, substituted HA will be more studied on polymer scaffolds or 
microspheres. Besides ion addition into SBF solution for the formation of 
substituted apatite, Ca, P, and doping ions induce the doped HA formation 
by stoichiometric ratio, which is another future study. It will be more 
directly obtain the influence of doped ion on nucleation and growth of 
substituted apatite. Some cation- and anion-substituted HA coatings have 
lower crystallization and smaller crystal size than pure HA coatings as 
previously mentioned, which could affect the dissolution rate of apatite. It 
inspires a novel idea on controlling the drug release rate in drug delivery 
systems. After soaking the drug, ion-doped apatites may show different 
drug release rates related to the degradation of apatite. In the future, 
substituted apatite coatings may be chosen to control the protein drug 
release rate by different ion substitutions.
6.9	 Summary
Hydroxyapatite is an important biocompatible ceramic. It has been successfully 
coated onto different biodegradable polymers. Processes to realize such 
coatings have been reviewed in this chapter. It is clear that the surface 
property of the substrate plays a critical role in the success of the coating. With 
the current understanding of the coating process, it is believed that future 
research should be focused on the modification of the property of HA coating 
itself. The findings from HA coating on metallic substrates should be applied 
and verified on polymeric substrates in the near future to allow HA coatings 
with various intrinsic properties to be coated on polymeric substrates for 
advanced applications, i.e., drug release rate control.
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Biofunctionalization of NiTi Shape 





Nickel titanium (NiTi, also known as nitinol) is a metal alloy of nickel and 
titanium, in which the two elements are present in roughly equal atomic 
percentages. It undergoes a phase transformation in its crystal structure 
when cooled from the stronger, high-temperature form (austenite) to the 
weaker, low-temperature form (martensite). This thermoelastic martensitic 
phase transformation in the material is responsible for its extraordinary 
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properties. These properties include shape memory effect and superelasticity 
(also called pseudoelasticity). Shape memory refers to the ability of NiTi to 
undergo deformation at one temperature and then recover its original, unde-
formed shape upon heating above its “transformation temperature.” The 
superelasticity occurs at a narrow temperature range just above its trans-
formation temperature; in this case, no heating is necessary to cause the 
undeformed shape to recover, and the material exhibits enormous elasticity.
The combination of shape memory effect, superelasticity, and good bio-
compatibility makes NiTi alloy especially suitable for biomedical applica-
tions such as catheter shafts, orthodontic guidewires, valve frames, stents, 
filters, and endoscopic guide tubes. The application of the shape memory 
device not only simplifies the operation techniques but also firmly secures 
the fracture area [1]. The superelasticity of NiTi alloy allows for the design of 
shape memory devices with a constant stress over a wide range of strains/
shapes, which can accelerate healing without applying undue forces during 
the operation process. However, there are still some concerns. One is that 
the potential release of nickel ions from NiTi implant may cause harmful 
allergic, toxic, or carcinogenic reactions [2]. Although equiatomic NiTi is 
an intermetallic compound with well-defined bulk and surface properties, 
nickel ions can still be dissolved from bulk material due to corrosion. The 
corrosion behavior of NiTi alloy depends on the surface topography and 
surface chemistry. In general, surfaces tend to be highly corrosion resistant 
with a good topographical finish (polished or electropolished) and homo-
geneous composition (free from second phase like Ni-rich particles, coarse 
carbides, and nitrides) [3]. Also, it is suggested to further improve the cor-
rosion resistance by chemical treatments, passivation, etc., to build up a 
protective TiO2 layer. Moreover, the good biocompatibility of NiTi alloy is a 
direct consequence of lower nickel ion release rate due to the protective TiO2 
layer. Another concern is the bioinert characteristic of NiTi alloy. After it is 
implanted into the living body, it is usually encapsulated by fibrous tissues 
that isolate the implant from the surrounding bone [4,5]. This results in small 
gaps between the natural bone and the implant and leads to movement at the 
implant–bone interface. Finally, it causes implantation failure, and revision 
surgery is needed to replace the loosened implant [6].
To make NiTi alloy more applicable as a hard tissue implant, one feasible 
solution is to coat bioactive ceramics on its surface, which can bond to 
and integrate with living bone spontaneously in the body. Since synthetic 
hydroxyapatite (HA) ceramic has chemical similarity to bone and teeth min-
eral, it has been used as coatings on metallic prostheses to provide bioactive 
fixation since the mid-1980s [7,8]. Many techniques have been developed for 
the preparation of HA coatings onto metallic implant surfaces. The meth-
ods applied on NiTi alloy include plasma spraying [9,10], radio-frequency 
magnetron-sputtered deposition [11], sol–gel deposition [12], electrodeposi-
tion [13], biomimetic growth [14–16], and so on. Each method has its own 
advantages and disadvantages with regard to the coating properties, such 
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as coating chemistry, phase composition, crystallinity, mechanical proper-
ties, and biological properties. A comparison of different methods applied 
on NiTi alloy is summarized in Table 7.1.
Although a HA-coated metallic implant combines both good biocom-
patibility of HA and excellent mechanical properties of a metal substrate, 
significant differences still exist between synthetic HA and natural bone. For 
example, the bioactivity, in vivo resorption, and degradation of synthetic HA 
and HA coatings are inferior to those of bone mineral. Thus, it is attractive to 
use a bone-like structure or composition on a metal substrate.
Chemical treatment technology is a low-temperature method to modify 
metals and prepare coatings from chemical routes, which is independent of 
substrate shape and harmless to substrate properties. Various types of bioac-
tive metals with different functions can be developed by the simple chemical 
treatment, for example, Ti, NiTi, Ti6Al4V, Ti-Zr-Nb-Ta, and so on [17–21]. 
Basically, the metal is treated with an acid or an alkali solution to create a 
micro- or nanoscale structure. Then, after soaking in a simulated body fluid 
(SBF) with ion concentrations nearly equal to those in human blood plasma 
[22], a bone-like apatite layer forms on the treated metal surface and thus 
facilitates the bonding to bone in the body [23,24]. In this chapter, NiTi alloy 
Table 7.1
Comparison of Different Methods for Hydroxyapatite Coating Formation 
on NiTi Alloy
Method Advantages Disadvantages References











Thin, dense, and 
pore-free coating on flat 
substrates
Higher Ca/P ratio of 
coating than synthetic 
HA; expensive; time 
consuming
[11]
Sol–gel deposition Low processing 
temperature; can coat 
complex shapes; thin 
coating; high purity and 
homogeneity; low cost
Some processes may 
require controlled 
atmosphere and high 
sintering temperature
[12]
Electrodeposition Rapid deposition rate; 




biological fixation to 
metal substrates
[13]
Biomimetic growth Low processing 
temperature; form 
bone-like apatite, can 





or control of pH value 
of simulated body fluid
[14–16]
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was first treated with an acid and alkali solution and followed by a precalcifi-
cation process. The ability to induce the formation of bone-like apatite coating 
was examined by soaking the NiTi alloy in the SBF. To further resemble 
natural bone, apatite/collagen composite coating was prepared on the NiTi 
alloy. In vitro and in vivo studies were performed to investigate both the bio-
logical and histological performances of bioactive apatite-coated NiTi alloys.
7.2	 Chemical	Treatment	of	NiTi	Alloy
As mentioned earlier, NiTi alloys have been used as orthopedic devices due 
to their shape memory effect, superelasticity, and biocompatibility. However, 
two factors restrict their applications: the bioinert surface is difficult to inte-
grate with bone, and the released nickel ions may cause toxic and allergic 
responses [25,26]. As such, surface modification is necessary to make it bio-
active and lower the nickel release rate. One of the most effective methods 
is chemical treatment. In this work, nitric acid (HNO3) and sodium hydrox-
ide (NaOH) solutions were employed in sequence to create a micro- or even 
nanostructured network on NiTi alloy followed by immersing in saturated 
disodium hydrogen phosphate (Na2HPO4) and calcium hydroxide Ca(OH)2 
solutions to induce the formation of bone-like apatite on NiTi alloy.
7.2.1 acid Treatment
Aqueous acid solution (HNO3) was adopted to increase surface roughness 
and form a dense TiO2 layer on NiTi alloy. In the aqueous HNO3 solution, Ni 
is active, while Ti is inert, thus NiTi alloy can be highly passivated when n is 
6 according to the n/8 principle. When NiTi alloy is immersed in the aqueous 
HNO3 solution, Ni atoms are dissolved due to the chemical reaction (1). At 
the same time, the surrounding Ti atoms are oxidized to form a layer of TiO2 
(2). The process is illustrated in Figure 7.1.
 3Ni 8HNO 3Ni NO 2NO H O3 3 2 2+ = ( ) + ↑ +  (7.1)
 3Ti 4HNO H O 3TiO H O 4NO3 2 2 2+ + = + ↑·⋅  (7.2)
The acid treatment creates a porous structure on NiTi surface, as shown in 
Figure 7.2. Numerous pores with the diameters of 1–2 μm are present on 
NiTi alloy after it is immersed in the aqueous HNO3 solution at 60°C for 20 h. 
The porous surface increases the surface roughness and provides numer-
ous nucleation sites for apatite as well as increases adherence between the 
coating and the substrate. Figure 7.3 shows x-ray diffraction (XRD) patterns 
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of NiTi samples before and after the acid treatment. After the acid treat-
ment, the main peaks of NiTi alloy at 39.80° and 60.84° shift toward a higher 
degree with increased width and weakened intensity. Also, the presence of 
typical peaks of TiO2 (39.98°, 61.28°, 36.76°, and 37.40°) indicates the forma-
tion of a thicker TiO2 layer on NiTi surface. The chemical states of NiTi alloy 
after the acid treatment were examined by X-ray photoelectron spectroscopy 
(XPS). Figure 7.4a shows the narrow scan of Ti 2p. The peaks at the binding 
energy of 455.1 and 458.8 eV are attributed to Ti2+ and Ti4+, of which the area 
percentage is 25.7% and 74.2%, respectively. The higher percentage of Ti4+ 
suggests the selective oxidation of Ti atoms in NiTi alloy. The narrow scan 
of Ni 2p is shown in Figure 7.4b. Only Ni0 at 852.9 eV is detected, meaning 







Schematic illustration of the formation of a protective TiO2 layer on NiTi alloy when etched 
with the aqueous HNO3 solution. (a) Atom arrangement of untreated NiTi alloy; (b) atom 
arrangement of corroding NiTi alloy; (c) atom arrangement of corroded NiTi alloy.
Acc.V     Spot  Magn    Det  WD 
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SEM images of NiTi samples treated by aqueous HNO3 solution for 20 h (b is the high magni-
fication of a).
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7.2.2 alkali Treatment
After the acid treatment, aqueous alkali solution (NaOH) was used to further 
activate NiTi alloy. Scanning electron microscope (SEM) observation reveals 
the effect of NaOH concentration on the surface morphology of NiTi alloy 
(Figure 7.5). Needle- or rod-like substances appear on the acid treated sur-
face after it is immersed in 0.5–5 M aqueous NaOH solution at 60°C for 24 h. 
Moreover, the higher the NaOH concentration, the bigger and the more rods 











































































XPS spectra of NiTi alloy after the acid treatment: (a) Ti 2p and (b) Ni 2p.
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it is almost the same as that after the acid treatment (Figure 7.2). After the 
treatment in the 1.0 M NaOH solution, a layer can be seen with the nee-
dle size of 100 nm (Figure 7.5b). When the concentration increases to 2 M, 
it becomes a network structure (Figure 7.5c). A nanoporous network in the 
order of 100 nm pore size covers the whole surface after the treatment in the 
5 M NaOH solution (Figure 7.5d).
XRD patterns of NiTi samples after the acid–alkali treatment are shown 
in Figure 7.6. Compared with that after the acid treatment (Figure 7.3, H), 
two new phases appear after the treatment in the 1 M aqueous NaOH solu-
tion, i.e., NaTi2O4 and Na2Ti3O7. When the concentration of NaOH solution 
increases to 5 M, Na5NiO4 forms together with Na2Ti3O7. However, there 
is no TiO2 peak detected, indicating that the previously formed TiO2 layer 
in the acid treatment reacts with NaOH to produce sodium titanate. XPS 
analysis was performed to further confirm the reactions during the alkali 
treatment [27]. The survey scan (Figure 7.7a) shows all the elements on 
the NiTi surface after the NaOH treatment, including Ni, Ti, Na, O, and C 
(due to contamination in air). In Figure 7.7b, the narrow scan of Ti 2p, the 
peak at 453.5 eV is ascribed to Ti–Ti bonding [28], and the peak at 458.9 eV can 
be assigned to Ti–O (Ti4+) bonding. Figure 7.7c shows the narrow san of Ni 2p. 
Acc.V     Spot  Magn   Det  WD 
(a) 
20.0 kV  3.4     5000×   SE    7.3
5 µm 
Acc.V     Spot  Magn   Det  WD 
20.0 kV  3.4     5000×  SE     7.3
5 µm 
(c) 
Acc.V     Spot  Magn   Det  WD 
20.0 kV  3.4     5000×  SE    9.6
5 µm 
Acc.V     Spot  Magn   Det  WD 




SEM images of NiTi samples treated in aqueous NaOH solution at different concentrations: 
(a) 0.5 M, (b) 1.0 M, (c) 2.0 M, and (d) 5.0 M, respectively.
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The peak at 856.8 eV is attributed to Ni–O (Ni3+) bonding [28], which corre-
sponds to the Na5NiO4 identified by XRD measurement.
In the initial stage of the alkali treatment, the following reactions happen:
 TiO +OH nH O HTiO nH O2 2 3 2
− −+ = ⋅·  (7.3)
 Ti 3OH =Ti(OH) +3+
− + 3e  (7.4)
 Ti OH e TiO H O 1/2H 4e3 2 2 2( ) + = ⋅ + +
+ ·  (7.5)
 Ti OH OH =Ti OH3 4( ) + ( )
+ −  (7.6)
 Ti OH OH TiO4 3( ) + = ⋅
− −H H O2 2  (7.7)
Because of high activation energy for homogeneous nucleation of apatite in 
human body fluid, it is necessary to introduce a type of functional group as 
an effective site for faster apatite nucleation on the material surface in the 
living body. Kokubo et al. [21,29] found that Ti–OH groups were capable of 
inducing apatite nucleation. After the alkali treatment, the sodium titanate 
transforms into hydrated titania by ion exchange, and many Ti–OH groups 
form on the surface of NiTi alloy. The Ti–OH groups play a role as effective 
nucleation sites by absorbing Ca2+ and PO43− ions in the SBF, and the ionic 
























F: Na2Ti3O7 G: Na5NiO4
Figure 7.6
XRD patterns of NiTi samples treated in aqueous NaOH solution at different concentrations: 
(a) 1.0 M and (b) 5.0 M.
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XPS profiles of NiTi alloy after the acid and alkali treatments: (a) XPS survey scan, (b) Ti 2p, and 
(c) Ni 2p. (Reprinted from Surf. Coat. Technol., 173, Chen, M.F., Yang, X.J., Liu, Y., Zhu, S.L., Cui, 
Z.D., Man, H.C., Study on the formation of an apatite layer on NiTi shape memory alloy using a 
chemical treatment method, 229, Copyright 2003, with permission from Elsevier.)
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activity product of apatite in the surrounding fluid is increased due to the 
increase in OH− ion concentration in the SBF. As a consequence of what was 
mentioned earlier, a large number of apatite nuclei form on the chemically 
treated NiTi surface.
Figure 7.8 presents the effect of the NaOH concentration on the forma-
tion of apatite on chemically treated NiTi alloy. After soaking in the SBF 
for 3 days, the needle-like substances formed in the acid treatment totally 
disappear; however, there is no precipitation on NiTi surface treated in the 
0.5 M NaOH solution (Figure 7.8a). NiTi samples treated in the 1.0 and 2.0 M 
NaOH solutions give quite different surface morphologies after 3 days, i.e., 
a layer of spherical particles are observed (Figure 7.8b and c). The network 
morphology after the samples are treated in the 5.0 M NaOH solution is 
preserved on NiTi samples after 3 days’ soaking (Figure 7.8d). Nine days 
later, precipitates are observed on all the samples with different morphology 
and coating thickness. Small particles disperse on the surface treated in the 
0.5 M NaOH solution (Figure 7.8e). Spherical particles cover the whole sur-
face of the samples treated in the 1.0 and 2.0 M NaOH solutions with a cer-
tain thickness (Figure 7.8f and g). Though spherical particles also completely 
cover the surface of those treated in the 5.0 M NaOH solution (Figure 7.8h), 
the particle sizes are relatively smaller than those in Figure 7.8f and g. The 
surface morphology observation suggests that it is not the higher the NaOH 
concentration, the faster the particles grow on the treated surface.
7.2.3 Precalcification Treatment*
After the acid and alkali treatment, apatite can be induced to grow on NiTi 
alloy as shown in Figure 7.8. However, it takes a relatively long period for 
apatite to cover the whole surface. As Kokubo et al. [30] suggested, the bioac-
tivity of implant material can be evaluated by the formation of apatite layer 
in body fluid and the growth rate of apatite layer as well. Therefore, a pre-
calcification process was adopted to accelerate the growth of apatite. In brief, 
the NiTi samples after the acid and alkali treatment were put into a saturated 
Na2HPO4 solution at 40°C for 15 h and then in a saturated Ca(OH)2 solution 
at 25°C for 10 h. After that, the surface elements and phases were identified 
[31]. Figure 7.9 shows the auger electron spectroscopy (AES) depth profile of 
the precalcified NiTi alloy. Ca and P signals come from the adsorbed Ca2+ 
and HPO42− ions on the precalcified NiTi surface. The percentages of Ca, P, 
and O elements decrease from the surface to the substrate. Moreover, the 
Ca/P ratio is more than 5 at the outermost surface of the precalcified sam-
ples. This result supports the suggestion that these components are present 
as ions on the surface, since there is no stable calcium phosphate with Ca/P 
* Source: Scrip. Mater., 54, Yang, X.J., Hu, R.X., Zhu, S.L., Li, C.Y., Chen, M.F., Zhang, L.Y., and 
Cui, Z.D., Accelerating the formation of a calcium phosphate layer on NiTi alloy by chemical 
treatments, 1457, Copyright 2006, with permission from Elsevier.
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Figure 7.8
SEM images of NiTi alloys after soaking in the SBF for 3 days (a–d) and 9 days (e–h). The 
samples were treated with 0.5 M (a and e), 1.0 M (b and f), 2.0 M (c and g), 5.0 M (d and h) 
aqueous NaOH solution before soaking in the SBF.
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ratio higher than 2 [32]. Figure 7.10 shows XRD patterns of the acid–alkali 
treated samples before and after the precalcification. No significant differ-
ence is found between the acid–alkali treated and the precalcified samples. 
The main phases on the surfaces of both samples are sodium titanate and 
titanium oxides (TiO2 and TiO).
The effect of precalcification treatment on the growth of bone-like apa-
tite was evaluated by immersing the precalcified samples in the SBF at 37°C 
for 12, 24, 36, or 48 h. After soaking in the SBF for 12 h, numerous gran-
ules appear in a network on the sample surface (Figure 7.11a). More gran-
ules form with increasing soaking time (Figure 7.11b and c). A relatively 
complete coating forms after 36 h (Figure 7.11c), and the sample surface is 
entirely covered by compact and uniform particles after 48 h (Figure 7.11d). 
Thus, the formation of a perfect coating is accelerated by the precalcification 
process. Figure 7.12 shows energy dispersive spectrometer (EDS) spectra of 
the precalcified NiTi alloy immersed in the SBF for various periods. The Ca 
and P peaks are detected during the whole immersion period, of which the 
percentages increase with immersion time. Also, the Ca/P ratio increases 
and reaches about 1.6 after 48 h immersion, which is very close to that of 
stoichiometric HA. The lower Ca/P ratio at the early immersion stage might 
be due to the presence of other calcium phosphates in the deposited layer. 
Figure 7.13 shows XRD patterns of the precalcified samples immersed in the 






























AES elements depth profile of the precalcified NiTi alloy. (Reprinted from Scripta Materialia, 
54, Yang, X.J., Hu, R.X., Zhu, S.L., Li, C.Y., Chen, M.F., Zhang, L.Y., Cui, Z.D., Accelerating the 
formation of a calcium phosphate layer on NiTi alloy by chemical treatments, 1457, Copyright 
2006, with permission from Elsevier.)
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crystallized HA, which is in good agreement with the EDS results. However, 
strong peaks of HA can only be detected after 24 h immersion.
Wen et al. [18] also used a precalcification step prior to immersion, and they 
found that calcium phosphate precipitation can be dramatically speeded 
up on the acid–alkali treated titanium surface. Meanwhile, Jonasova et al. 
[32] reported that only an inhomogeneous and nonuniform apatite layer is 
formed on the NaOH treated titanium even after 20 days immersion in the 
SBF. These findings reflect the fact that the applied treatment parameters 
before immersion in the SBF significantly influence the apatite formation. 
In our work, the unchanged surface phases after the precalcification indi-
cate that the surface features induced by the acid and/or alkali treatment 
remain, such as the microporous surface, nanosized porous network. They 
still contribute to the high nucleation efficiency of apatite due to increased 
surface area, pore size, and pore volume. The abundant adsorption of Ca2+ 
and HPO42− ions onto the microporous surface causes local supersatura-
tion of Ca2+ and HPO42− ions and thus increases the driving force for apatite 
nucleation [6,32]. On the other hand, the concentrated locations of Ca and P 
ions might act as the preseeded nuclei for the heterogeneous nucleation of 
apatite. Once in apatite nuclei form, they spontaneously grow by consuming 
Ca and P ions from the SBF to form a dense and uniform apatite layer [21]. 
The rapid formation of apatite layer on the precalcified NiTi alloy implies 
shortened time to establish the expected physical–chemical bond between 



























XRD patterns of the acid–alkali treated samples before and after precalcification. (Reprinted 
from Scripta Materialia, 54, Yang, X.J., Hu, R.X., Zhu, S.L., Li, C.Y., Chen, M.F., Zhang, L.Y., 
Cui, Z.D., Accelerating the formation of a calcium phosphate layer on NiTi alloy by chemical 
treatments, 1457, Copyright 2006, with permission from Elsevier.)
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7.3	 	Bioactive	Apatite	Coating	on	Chemically	
Treated	NiTi	Alloy
Chemical treatments are crucial for the biomimetic growth of apatite on NiTi 
alloy. The acid immersion is advantageous to increase the surface rough-
ness of NiTi alloy by producing many acid etched pits or grooves. The alkali 
treatment at the second step might have two concurrent effects on the acid-
etched surface. One is the formation of a microporous surface layer, and the 
other is the formation of more titanium oxides in this microporous layer 
including TiO2 and TiO. Each step of the treatment is important for acquiring 
the microporous titanium oxide surface, which cannot be produced by either 
acid or alkali treatment individually. The precalcification does not change the 
surface features of the acid–alkali treated surface but results in the abundant 
adsorption of Ca2+ and HPO42− ions onto the microporous surface. The local 
supersaturation of Ca2+ and HPO42− ions contributes to the faster nucleation 
and growth of apatite.
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SEM micrographs of the precalcified samples immersed in the SBF for 12 h (a), 24 h (b), 36 h (c), 
and 48 h (d). (Reprinted from Scripta Materialia, 54, Yang, X.J., Hu, R.X., Zhu, S.L., Li, C.Y., Chen, 
M.F., Zhang, L.Y., Cui, Z.D., Accelerating the formation of a calcium phosphate layer on NiTi 
alloy by chemical treatments, 1457, Copyright 2006, with permission from Elsevier.)
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It is important to understand the performances of both natural and syn-
thetic biomaterials for the development of new and more biocompatible 
implant materials. The evaluation involves both in vitro and in vivo assess-
ments. in vitro assessment uses cells and/or tissues derived from animals 
or humans and maintained in tissue culturing conditions. In vivo test uses 
animal models to evaluate histological responses to biomaterials in living 
animals. By obtaining the clinical data during the trial period and histologi-
cal data from the examination of postmortem tissues, we are able to assess 
the tissue responses to the implanted materials. In this section, the formation 
of apatite layer and the growth mechanism of apatite on chemically treated 
NiTi alloy are discussed, and also the in vitro and in vivo biological and 
histological performances are investigated.
7.3.1 biomimetic growth of apatite on Chemically Treated NiTi alloy
A series of optimal parameters of chemical treatments are selected: 




































EDS spectra of the precalcified samples immersed in the SBF for 12 h (a), 24 h (b), and 48 h (c). 
(Reprinted from Scripta Materialia, 54, Yang, X.J., Hu, R.X., Zhu, S.L., Li, C.Y., Chen, M.F., Zhang, 
L.Y., Cui, Z.D., Accelerating the formation of a calcium phosphate layer on NiTi alloy by 
chemical treatments, 1457, Copyright 2006, with permission from Elsevier.)
304 Hydroxyapatite Coatings for Biomedical Applications
saturated Na2HPO4 solution, 40°C, 15 h, saturated Ca(OH)2 solution, 25°C, 
10 h. Figure 7.14 shows surface morphologies of the chemically treated 
NiTi samples after soaking in the SBF for different periods. Before soak-
ing (Figure 7.14, 0 h), the sample surface preserves the microporous mor-
phology. After soaking for 9 h (Figure 7.14, 9 h), some particles with the 
size of 300–500 nm disperse on the surface. Later, these particles continu-
ously grow to be spherical and become bigger in size (Figure 7.14, 12 and 
18 h) and almost cover the whole surface of the sample after soaking in 
the SBF for 24 h (Figure 7.14, 24 h). These spherical particles connect with 
each other to form a complete coating (Figure 7.14, 72 h) when the soaking 
time is up to 3 days. The coating becomes thicker with some light cracks 
after 5 days (Figure 7.14, 120 h), and the particles grow to about 2 μm in 
diameter and more cracks appear in the coating after 14 days (Figure 7.14, 
296 h). EDS was used to identify the elements in the coating. Ca, P, and 
O are detected, of which the intensities increase with increasing soaking 
time. It means that the precipitated particles are calcium phosphates and 
the coating becomes thicker and thicker. The atomic percentages of Ca and 
P as well as the Ca/P ratio are listed in Table 7.2. In the initial period, the 
Ca/P ratio is low, only around 1.0. It increases with the soaking time and 
reaches 1.60 after 120 h, which is closer to that of HA. The cross-sectional 
views of the coated NiTi alloys are shown in Figure 7.15. The coating thick-
ness is about 5 μm after soaking in the SBF for 3 days and up to about 
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Figure 7.13
XRD patterns of the precalcified samples immersed in the SBF for different periods. (Reprinted 
from Scripta Materialia, 54, Yang, X.J., Hu, R.X., Zhu, S.L., Li, C.Y., Chen, M.F., Zhang, L.Y., 
Cui, Z.D., Accelerating the formation of a calcium phosphate layer on NiTi alloy by chemical 
treatments, 1457, Copyright 2006, with permission from Elsevier.)
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The phase evolution on the NiTi alloy during the immersion is shown in 
Figure 7.16. XRD pattern of pure HA powder is included as reference. From 
Figure 7.16, it can be seen that the (002) peak of the sample soaked in the 
SBF for 5 days is sharper than that for 3 days, while other diffraction peaks 
of HA, such as (112), (310), (213), and (004), are still broad. The broadness of 
12 h
24 h













SEM images of chemically treated NiTi samples after soaking in the SBF for different periods.
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the XRD diffraction peak depends on the crystal size and/or perfection or 
strain: the broader the peak, the smaller or less perfect or more strained the 
crystal. The broad peaks indicate the poorly crystallized HA with small size, 
while the sharp (002) peak shows the preferential orientation of HA crystals 
grown in the latter period.
Fourier transform infrared spectroscopy (FTIR) was used to identify 
the chemical groups in the coatings after soaking in the SBF for 72 h 
(HNBPS72) and 120 h (HNBPS120). The sample before soaking (HNBP) 
and pure HA powder were also examined for comparison, as shown in 
Figure 7.17. There is no chemical group on HNBP. However, similar peaks 
appear on both the samples after soaking in the SBF for 72 and 120 h. 
Compared with those of pure HA powder, the peaks at 1009, 599, and 
557 cm−1 are attributed to PO43− groups. It is noted that the peak of OH 
at 632 cm−1 in the pure HA does not exist in HNBPS72 but appears in 
HNBPS120. Moreover, the typical peaks of CO32− are also detected at 1483, 
1421, and 872 cm−1, meaning the formation of carbonated apatite that is 
also called bone-like apatite.
Table 7.2
Ca/P Ratio of NiTi Alloys after 
Soaking in the SBF for Different 
Periods
Soaking	Time	(h)
12 24 72 120
Ca (at%) 1.86 5.43 11.95 16.20
P (at%) 1.73 4.63 8.62 10.15
Ca/P 1.07 1.15 1.39 1.60
(a)
5 µm 10 µm
(b)
Figure 7.15
Cross-sectional views of the chemically treated NiTi alloy after soaking in the SBF for 3 days (a) 
and 14 days (b).













































XRD patterns of the chemically treated NiTi after soaking in the SBF for 0, 3, and 5 days; XRD 
pattern of HA powder is included for reference. (Reprinted from Surf. Coat. Technol., 173, Chen, 
M.F., Yang, X.J., Liu, Y., Zhu, S.L., Cui, Z.D., Man, H.C., Study on the formation of an apatite 
layer on NiTi shape memory alloy using a chemical treatment method, 229, Copyright 2003, 
















FTIR patterns of the chemically treated NiTi before and after soaking in the SBF for 72 and 
120 h; pure HA powder is taken as reference.
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Figure 7.18 shows the XPS spectra of chemically treated NiTi after soak-
ing in the SBF for 24 h (HNBPS24) and 72 h (HNBPS72). Pure HA powder 
was also measured as a reference. Ca 2p spectrum of HNBPS72 is almost 
the same as that of pure HA, but that of HNBPS24 shifts a little to lower 
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XPS spectra of the chemically treated NiTi after soaking in the SBF for 24 and 72 h; XPS 
spectrum of pure HA is included for reference: (a) HNBPS24, (b) HNBPS72, and (c) HA.
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peak is attributed to that at 347.1 eV (typical binding energy of Ca 2p in HA) 
[33,34], and the peak at 346.3 eV might belong to other calcium phosphate. 
Comparing P 2p spectra, the P 2p of HNBPS 24 also shifts a little to lower 
binding energy, of which 81.9% is due to PO43− (the binding energy is 133.1 eV) 
[34]. Again, in the spectra of O 1s, HNBPS24 shifts a little to lower binding 
energy compared with that in pure HA and HNBPS72. The peak at 531.1 and 
532.9 eV is attributed to O–H and O–P bonds, respectively. And the peak at 
529.0 eV belongs to that in metallic oxide, indicating the existence of non-
apatite phase on the chemically treated NiTi, which might be Ca2P2O7·4H2O 
as measured by XRD.
SBF is a kind of saturated solution containing Ca2+ and PO43− ions. Calcium 
phosphates can be precipitated homogeneously at certain conditions, but 
homogeneous nucleation generally occurs with much more difficulty: much 
higher energy and supersaturation. However, when the chemically treated 
NiTi alloy is immersed in the SBF, the bioactive surface provides a number 
of nucleation sites for heterogeneous nucleation of calcium phosphates, 
which can promote the precipitation of calcium phosphates. Assume that the 
following reaction takes place in the SBF:




1 4 6 2
0 0+ − −+ + ( ) ( )  (7.8)
The thermodynamic driving forces for hydroxyapatite precipitation are 
calculated based on the classical equation of free energy change in super-
saturated solutions [35]:
 




















R is the gas constant
T is the absolute temperature
Ap is the ionic activity product
Ksp,HA is the solubility product
Ap/Ksp is the supersaturation
a is the activity
When the chemically treated NiTi alloy is immersed in the SBF, the 
treated surface provides a number of nucleation sites that are beneficial 
for the heterogeneous nucleation of apatite. The Gibbs free energy of the 
heterogeneous nucleation is expressed as [35]




























∆G* is the free energy for the formation of an embryo of critical size
σ is the interface energy between the nucleus and the solution
f (θ) is a function of the contact angle between the nucleus and the substrate
As reported by Kokubo et al. [21,36], an amorphous sodium titanate 
hydrogel layer formed on the surface of titanium or titanium alloys by 
the alkali treatment. When exposed to the SBF, the alkali treated surface 
releases Na+ ions into the SBF via exchanges for H3O+ ions in the SBF. Thus, 
Ti–OH groups form on the surface and then induce the formation of apatite 
in the SBF. In our study, a microporous network is built on the NiTi surface 
after the alkali treatment, which contains most of the sodium titanate and 
a little amount of sodium nickelate. When the treated NiTi is immersed 
in the SBF, similar reactions take place. Since the release of Na+ ions into 
the SBF would cause the increase of pH, the changes in pH values in the 
SBF are monitored as shown in Figure 7.19. The increase in pH after 6 h 
indicates the beginning of the ion exchange between Na+ and H3O+ ion. 
The pH becomes stable until the apatite layer covers the whole surface of 
the substrate. The growth of the apatite layer on the treated NiTi can be 
explained by Equation 7.12. Firstly, the ion exchange between Na+ and H3O+ 
ions makes microscale concave surfaces with negative charges, providing 
numerous nucleation sites for the heterogeneous nucleation of apatite. 
Also, in the case of forming the crystal nucleus with same critical size and 
contact angle, it is the easiest to nucleate on the concave surface, followed 
by smooth and convex surface. Thus apatite nucleus prefers to be formed in 
the small concave sites. Furthermore, the negatively charged Ti–OH groups 
absorb Ca2+ and PO43− ions in the SBF, which decreases the contact angle 
between the nucleus and the substrate, i.e., decreases f (θ). Consequently, 
∆G* is decreased, and it is easier to form apatite crystals. Secondly, the 
precalcification results in abundant adsorption of Ca2+ and HPO42− ions onto 
the microporous surface and consequent local supersaturation of Ca2+ and 
HPO42− ions on the sample surface. The increase in the local supersaturation 
finally decreases ∆Gv. Once the free energy barrier is overcome, the apatite 
formation is favored.
According to the earlier EDS and XRD analysis, Ca2P2O7·4H2O firstly 
forms on the treated surface, which might be due to the increase in local 
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supersaturation. Generally, when the concentrations of Ca2+ and PO43− ions 
in the solution are low, and the pH is higher than 4.3, the solution is only 
supersaturated to HA. However, when both the concentration and the pH 
are high, the SBF is supersaturated to several kinds of calcium phosphates. 
In this case, the formation of Ca2P2O7·4H2O is preferred. Ca2P2O7·4H2O con-
tinues to grow, and the concentrations of Ca2+ and PO43− decrease. After about 
20 h, the supersaturation of the SBF is low enough to form HA. At the same 
time, the as-grown calcium phosphates act as the nucleation sites for HA 
formation. Thus, HA crystals nucleate and grow rapidly.
7.3.2 in Vitro biological Properties*
Biocompatibility of metallic implant plays an important role in the long-
term survival of prosthetic implant fixation [37], and cell attachment and 
spreading on material surface is a major indicator in implant technology [38]. 
Although cell culture studies cannot directly mimic the cellular response 
and the environment in vivo, the toxic effects of different materials can be 
well quantified in vitro [39]. The effects of bioactive surface treatment on 
* Source: Mater. Sci. Eng. C, 28, Cui, Z.D., Chen, M.F., Zhang, L.Y., Hu, R.X., Zhu, S.L., and 
Yang, X.J., Improving the biocompatibility of NiTi alloy by chemical treatments: An in 















Measured pH values during the soaking of the chemically treated NiTi in the SBF.
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the biocompatibility of NiTi alloy were investigated by in vitro cell culture 
tests. In this test, 3T3 human embryonic fibroblast cells were used because 
they are substrate-dependent, nonspecific cell lines [26]. The in vitro cell 
responses on the apatite-coated NiTi (NiTi/CaP), mechanically polished 
NiTi (MP NiTi), and pure Ni samples were studied to compare their biologi-
cal properties [40].
Figure 7.20 shows the light micrographs of fibroblasts cultured for 3 days 
near the samples of NiTi/CaP, MP NiTi, and Ni, respectively. Black areas at 
the corners of the images are the borders and shadows of the test samples. As 
shown in Figure 7.20a, the fibroblasts attach to the NiTi/CaP sample with the 
shape of a shuttle and/or elongated polygon, which are the normal individual 
form of the 3T3 fibroblast cells. Cell morphologies near the MP NiTi are 
similar to those near the NiTi/CaP, but the number of attached cells to the MP 
NiTi is slightly lower than that on the NiTi/CaP. Significant inhibition of cell 
attachment and growth is observed near the Ni sample. Most fibroblasts cul-











Light micrographs of fibroblasts cultured for 3 days on (a) NiTi/CaP, (b) MP NiTi, and (c) Ni. 
Black areas in the images are the borders and shadows of the test samples. (Reprinted from 
Mat. Sci. Eng. C, 28, Cui, Z.D., Chen, M.F., Zhang, L.Y., Hu, R.X., Zhu, S.L., Yang, X.J., Improving 
the biocompatibility of NiTi alloy by chemical treatments: An in vitro evaluation in 3T3 human 
fibroblast cell, 1117, Copyright 2008, with permission from Elsevier.)
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(Figure 7.20c) without any surface evaginations. The lower attachment and 
spreading on the Ni will finally lead to cell death. Figure 7.21 shows the SEM 
micrographs of the fibroblasts cultured for 3 days on the samples. Cells are 
well flattened on the NiTi/CaP. The lamellipodia presents and extends radi-
ally from the central area and strongly adheres to the substrate and draws the 
cellular body by cytoplasmic contraction (Figure 7.21a). Cells cultured on the 
MP NiTi are also well flattened, but the lamellipodia is still in the early stage 
without extending to adjacent areas (Figure 7.21b).
After 6 day culture, the cell morphologies near the NiTi/CaP and the MP 
NiTi samples are as shown in Figure 7.22. The fibroblasts attach very well to 
both the NiTi/CaP and the MP NiTi, but cell density near the NiTi/CaP is 
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SEM micrographs of fibroblasts cultured for 3 days on (a) NiTi/CaP and (b) MP NiTi. (Reprinted 
from Mat. Sci. Eng. C, 28, Cui, Z.D., Chen, M.F., Zhang, L.Y., Hu, R.X., Zhu, S.L., Yang, X.J., 
Improving the biocompatibility of NiTi alloy by chemical treatments: An in vitro evaluation in 








Light micrographs of fibroblasts cultured for 6 days on (a) NiTi/CaP and (b) MP NiTi. Black 
areas in the images are the borders and shadows of the test samples. (Reprinted from Mat. 
Sci. Eng. C, 28, Cui, Z.D., Chen, M.F., Zhang, L.Y., Hu, R.X., Zhu, S.L., Yang, X.J., Improving the 
biocompatibility of NiTi alloy by chemical treatments: An in vitro evaluation in 3T3 human 
fibroblast cell, 1117, Copyright 2008, with permission from Elsevier.)
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higher than that near the MP NiTi. Also, the fibroblasts on the NiTi/CaP are 
in more close contact with each other but grow slightly less close to the MP 
NiTi. Unhomogeneous cell distribution is observed near the MP NiTi sample, 
and the even worse case is that the cell-free region is found (Figure 7.22b). 
However, no evident membrane lesions and cytolysis are observed.
Cell proliferation on different surfaces is compared in terms of the cell 
density after culturing for different days (Figure 7.23). The mean cell number 
per area increases significantly after 3 and 6 day incubation but decreases 
after 8 and 10 day incubation for both the NiTi/CaP and the MP NiTi sam-
ples. The decrease in cell density is ascribed to the culture medium, which 
is not replaced over the specific incubation periods. However, there is no 
statistical difference in the optical density of cells between the NiTi/CaP and 
the MP NiTi at all the designated incubation points.
The aforementioned results are in agreement with previously published 
work. It is reported that the biocompatibility of NiTi alloy is promising and 
comparable to that of pure titanium [26,39,41], and NiTi is well tolerated by 
the 3T3 human embryonic fibroblasts. Moreover, the surface modification 
of NiTi alloy exhibits no major difference on cytotoxicity and cytocompat-
ibility. The 3T3 human fibroblasts show normal morphology and attach onto 
both the NiTi/CaP and the MP NiTi surfaces over the incubation periods. 
The biocompatibility of NiTi alloy is attributed to the thermodynamically 
and mechanically stable oxide layer composed mainly of TiO2 on its surface 
[38], and nickel ions are not easily released out of NiTi because of a strong 
interatomic bonding between nickel and titanium atoms [42].

























Cell numbers of fibroblasts cultured on NiTi/CaP and MP NiTi samples for various periods. 
(Reprinted from Mat. Sci. Eng. C, 28, Cui, Z.D., Chen, M.F., Zhang, L.Y., Hu, R.X., Zhu, S.L., 
Yang, X.J., Improving the biocompatibility of NiTi alloy by chemical treatments: An in vitro 
evaluation in 3T3 human fibroblast cell, 1117, Copyright 2008, with permission from Elsevier.)
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Surface treatment also has a critical importance for the biocompatibility of 
NiTi alloy [43]. Toxic and immunologic reactions of NiTi are generally due 
to inadequate surface treatment and a breakdown of the oxide layer under 
certain experimental conditions [42]. These may be responsible for the cell-
free regions observed on the MP NiTi incubated for 6 days (Figure 7.22b). In 
addition, Bogdanski et al. [41] reported that the toxic effects to cells could be 
a result of increasing nickel content and/or Ni-rich intermetallic phases in 
the NiTi alloy. They also observed cell-free areas on the high nickel sections 
of the functionally graded Ni-NiTi-Ti samples. NiTi containing more than 
60% Ni and Ni3Ti alloys may not be passivated as fast as titanium or NiTi 
with a layer of TiO2, in which local corrosion is enhanced and more nickel 
ions are released in the cell culture medium. As a result, they show a low 
biocompatibility, because locally concentrated nickel ions due to the corro-
sion of NiTi induce adverse tissue reactions or alter cellular functions such 
as cell proliferation [44].
The cell culture results reveal that the NiTi/CaP samples have an excel-
lent biocompatibility. When implants are implanted into the human 
environment, the implant surface makes the first contact with the living 
tissue [43], and the cell behaviors on implant surface depend upon the 
cell–implant interactions [38]. The nature of material surface directly influ-
ences the interactions between the living tissue and the implant material. 
In this work, chemical treatments are used to modify the surface of NiTi 
alloy to induce the deposition of a bone-like apatite layer on the alloy sur-
face. The good biocompatibility of this apatite layer is confirmed by the 
results of in vitro cell attachment and proliferation tests that the NiTi/
CaP samples are well tolerated by fibroblasts. The fibroblasts attach and 
spread very well on the NiTi/CaP with normally elongated shape, and an 
increased adherence of fibroblasts is observed throughout on the NiTi/
CaP samples compared with the MP NiTi samples. The increased cell 
adherence can be ascribed to the evolution in the surface chemistry of the 
treated samples because calcium phosphates have an intrinsic good bio-
compatibility [6,20,45]. Moreover, the changes in surface morphology asso-
ciated with the deposition of apatite layer such as the increased surface 
area also contribute to the increased cell adherence [24,46,47]. On the other 
hand, the apatite-coated NiTi alloy has beneficial properties including 
sealing against nickel release and absorbing bioactive molecules such as 
growth factors [44]. Consequently, the NiTi/CaP samples exhibit a better 
cytocompatibility as compared with the MP NiTi samples.
Redey et al. [48] reported that several surface requirements are necessary 
for a biomaterial to have osteoconductive properties. The material surface 
needs to be biocompatible and, if possible, similar with the chemical com-
position of the bone. Cell attachment and proliferation are important indices 
for osteoconductive biomaterials. An osteoconductive biomaterial allows 
osteoprogenitor cells to attach, proliferate, and differentiate at its surface 
and then induces the formation of an interface of mineralized collagenous 
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bone matrix between bone tissue and bulk implant. The critical param-
eter for achieving osteoconduction is the initial number of well-attached 
osteoblastic cells to the bone substitute. It has been well known that calcium 
phosphates such as HA are generally used to coat metallic implants to 
improve the osteoconductivity of the implants, because they have a similar 
chemical composition with the mineral component of the bone [20,49]. 
As shown in Figure 7.21, the fibroblasts cultured on the NiTi/CaP show a 
normally elongated form with radially extended lamellipodia. This is an 
indication of good adhesion according to Maitz et al. [45]. The cell density 
near the NiTi/CaP samples is higher than that near the MP NiTi samples 
(shown in Figures 7.20 and 7.22). These results reveal the osteoconductivity 
of the apatite-coated NiTi alloy.
In other words, pure nickel is strongly toxic to 3T3 human embryonic 
fibroblasts, and the mechanically polished and the apatite-coated NiTi alloy 
exhibit good cytocompatibility with the cells. Moreover, the apatite-coated 
NiTi has a better biocompatibility as compared with the mechanically 
polished NiTi and shows a good osteoconductivity.
7.3.3 in Vivo Histological Performances*
In vivo histological performances of apatite-coated NiTi alloy (48 h immersion 
in the SBF after the chemical treatments) were evaluated by rabbit models, 
with untreated NiTi implants as controls. China white rabbits, weighing 
2.5–3.0 kg, were prepared by intramuscularly injecting ketamine (15 mg/kg) 
and diazepam (0.5 mg/kg). Under sterile surgical conditions, the femur was 
exposed through a medical incision. Three slightly oversized holes (2.1 mm 
in diameter) separated by about 10 mm were made in the latered corex 
bone using a low-speed dental burr under saline irrigation. The implants 
(cylindrical shape, 2 mm in diameter, and 6 mm in length) were randomly 
inserted in the holes with light pressure. The long axis of the cylinder was 
perpendicular to the long axis of the femur. Three apatite-coated cylinders 
were implanted in one leg of the rabbit and three uncoated ones were 
implanted in the other leg as a paired control. The rabbits were sacrificed with 
the physical method, at 6, 13, 26, 53 weeks as well as 2 years postoperation, 
respectively, followed by the histological evaluations [50,51].
X-rays of the rabbit femurs were taken to confirm the stability of the 
implants at 6 weeks postimplantation. All implants remained seated at the 
original site, indicating a good interference fit. There was no abnormal behav-
ior, skin irritations, infections, or tumors in any of the test animals. Histology 
* Source: Mat. Sci. Eng. C, 27, Li, C.Y., Yang, X.J., Zhang, L.Y., Chen, M.F., and Cui, Z.D., In vivo 
histological evaluation of bioactive NiTi alloy after two years implantation, 122, Copyright 
2007, with permission from Elsevier. 
 Mat. Sci. Eng. C, 24, Chen, M.F., Yang, X.J., Hu, R.X., Cui, Z.D., Man, H.C., Bioactive NiTi 
shape memory alloy used as bone bonding implants, 497, Copyright 2004, with permission 
from Elsevier.
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shows that the osteoblasts directly contact with the apatite coating on the NiTi 
rod, without any intervention between the femurs and the firm implants at 6 
weeks after implantation (Figure 7.24a). The zones labeled by Achromycin are 
clearly seen in the microscope under fluorescent light, indicating active trans-
formation of bone and osseointegration in the front of the implants (Figure 
7.24b). At 13 weeks after implantation, more close direct contacts were found 
in the apatite-coated samples (Figure 7.25a) and a new bone layer, about 120 
μm, had formed. Furthermore, a green bone layer between the marrow and 
the coated implant was also seen by fluorescent microscope (Figure 7.25b). In 
contrast, a fibrous layer (red connective tissue) of variable thickness appeared 
between the new bone and the uncoated NiTi implants under fluorescent light 
(Figure 7.26a). Under SEM, the gaps between the implant and the fibrous layer 
were seen to be about 15–20 μm in width (Figure 7.26b). Some island osteohis-
tology, about 10% of surface area, were found on the surface of cleaved speci-
men with the uncoated NiTi implants. Some bulged cells, organic matrix, and 
a little collagen fibers were observed on the implants (Figure 7.27a), indicating 
certain proliferation of osteoblast. Osteoblast proliferation was very active on 
the surface of the apatite-coated implants. About 90% of the surface areas on 
the coated implants were directly covered with new bone. Some osteoblasts 
were present, and a large number of collagen fibers (about 0.1 μm in size) were 
around the cells (Figure 7.27b), which suggests that new bone was growing 
luxuriantly on the apatite-coated surface.
For metallic implants, it is important to examine whether the implant 
materials and metal ions or worn particles released from the surface have 
negative effects on bone formation. The in vivo results have shown that 




(See	 color	 insert.) Nondecalcified histological cross section of apatite-coated NiTi implant 
at 6 weeks after implantation. (a) Using a light microscope, showing direct contact of bone 
and coated implant (original magnification ×100). (b) Using a fluorescent light microscope, 
showing active transformation of bone (osseous tissue is red and zones signed by Achromycin 
are yellow, original magnification × 75). (Reprinted from Mat. Sci. Eng. C, 24, Chen, M.F., Yang, 
X.J., Hu, R.X., Cui, Z.D., Man, H.C., Bioactive NiTi shape memory alloy used as bone bonding 
implants, 497, Copyright 2004, with permission from Elsevier.)
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and lower activity of osteonectin synthesis than pure titanium or other tita-
nium alloys [53]. Though the NiTi implant with a mechanically ground sur-
face has no negative effects on the total new bone formation [54], attention 
must be directed to the fact that a fibrous layer forms between the implants 
and the bone (Figure 7.26a). An incontestable conclusion is that the interface 
between the uncoated implant and the bone is analogous to a fibrous capsule 
and bone. The fibrous encapsulation around the uncoated implants induces 
weak bone–implant interface. Therefore, gaps at the interface are produced 
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Figure 7.26
The gaps between new bone layer and uncoated implant. (a) Using light microscopy (original 
magnification ×100). (b) Using SEM. (Reprinted from Mat. Sci. Eng. C, 24, Chen, M.F., Yang, 
X.J., Hu, R.X., Cui, Z.D., Man, H.C., Bioactive NiTi shape memory alloy used as bone bonding 
implants, 497, Copyright 2004, with permission from Elsevier.)
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Figure 7.25
(See	 color	 insert.) Nondecalcified histological cross section of apatite-coated NiTi implant 
at 13 weeks after implantation. (a) Using a light microscope, showing a new bone layer con-
tacting with coated implant (original magnification ×100). (b) Using a fluorescent light micro-
scope, showing a green bone layer between the marrow and the coated implant (original 
magnification × 75). (Reprinted from Mat. Sci. Eng. C, 24, Chen, M.F., Yang, X.J., Hu, R.X., Cui, 
Z.D., Man, H.C., Bioactive NiTi shape memory alloy used as bone bonding implants, 497, 
Copyright 2004, with permission from Elsevier.)
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On the other hand, there are no gaps observed between the apatite-coated 
implants and the bone, indicating that the coated implants are integrated 
with the bone tissue after periodical implantation. This hypothesis is sup-
ported by previous in vivo studies [55–58]. Direct contact between the 
coated NiTi and the bone after 6 and 13 weeks of implantation is observed in 
our study. It is thought that some chemical interaction may occur between 
the apatite coating and the bony tissue. This chemical bonding provides a 
substantial union that can transmit all types of forces [58], so the bonding 
strength at the interface is high.
In contrast to the uncoated implant, faster osteoblast proliferation occurs on 
the surface of the coated implant at 13 weeks of implantation. It shows early 
bone remodeling on the apatite-coated implant. Apatite coating demonstrates 
its superiority to help the implant get stable quickly at the early period after 
implantation. This is due to the fact that apatite is the main inorganic constitu-
ent of hard tissues, and the free Ca and P ions can be used in metabolism, so 
apatite coating shows good osteoconduction. New osteoblasts with more pro-
jection directly adhere on the apatite coating, and their projection penetrates 
into the apatite crystals. At the same time, an important role of the osteoblast 
is to secrete osseous collagen fibers. The more active osteoblasts are, the more 
osseous collagen fibers are, and the faster new bone forms, as demonstrated 
in Figure 7.27. According to the size and distributed formation of osseous col-
lagen fibers, it is judged that the new bone layer shown in Figure 7.27b is 
woven bone that first forms on apatite-coated implants. After that, the parallel 
fibroid bone forms (see Figure 7.26a). Since there are big cavities in the woven 
bone, its strength is lower. The fragmentation occurs in the woven bone when 
the specimen is split into two parts along the long axis of the implant.
At 26 weeks after implantation, there is no obvious gap or interface between 
the apatite-coated implant and the host bone, and a mature bone–implant 
(b)(a)
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Figure 7.27
Surface morphologies of implants at 13 weeks after implantation. (a) A little bulged cell and 
collagen fibrous networks on uncoated NiTi implant. (b) A large number of bone cells and col-
lagen fibrous networks on apatite-coated NiTi implant. (Reprinted from Mat. Sci. Eng. C, 24, 
Chen, M.F., Yang, X.J., Hu, R.X., Cui, Z.D., Man, H.C., Bioactive NiTi shape memory alloy used 
as bone bonding implants, 497, Copyright 2004, with permission from Elsevier.)
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union is observed (Figure 7.28a). At the same time, pink osteoid still pres-
ents and undergoes mineralization (Figure 7.28b). This suggests that the new 
bone formation and remodeling take place simultaneously on the apatite-
coated implant. Moreover, a layer of green bone with a thickness of about 
100 μm forms at the interface of the apatite-coated NiTi implant and the med-
ullary cavity (Figure 7.28c), suggesting the transformation from stem cells 
in the medullary cavity into new bone directed by the apatite layer on NiTi 
implant after 26 weeks. Compared with the apatite-coated NiTi implant, the 
uncoated NiTi implant shows weaker ability in inducing the new bone forma-
tion. Although a new bone layer forms between the bone and the uncoated 
NiTi implant (Figure 7.29a), it is not continuous (Figure 7.29c). Also, the pink 
osteoid further indicates weaker osteoinduction ability of the uncoated NiTi 
implant than the apatite-coated one (Figure 7.29b). Figure 7.28d shows a spe-
cial case that the apatite-coated NiTi implant passes through the cortical 
bone and the medullary cavity at one side to reach the cortical bone at the 
other side. Thus, both the apatite-coated surface and the uncoated surface 
are exposed in the marrow. After 26 weeks, a new bone layer forms and cov-


















(See	 color	 insert.) Nondecalcified histological cross section of apatite-coated NiTi implant 
at 26 weeks after implantation. (a) Using a light microscope, showing a mature bone layer. 
(b) Using a fluorescent light microscope, showing pink osteoid on apatite-coated NiTi implant. 
(c) Formation of new bone layer in medullary cavity. (d) A special specimen. N, NiTi; B, Bone; 
M, Marrow; O, Osteoid; H, Haversian.
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uncoated surface. As such, the osteoinduction ability of apatite coating on 
the NiTi implant is clearly illustrated.
SEM was also used to observe the surface and interface morphologies after 
the implantation for 26 weeks. New lamellar bone forms on both the apatite-
coated and the uncoated NiTi implants (Figure 7.30a and b). Collagen fibers 
bundle together and arrange in the lamellar shape. Osteoblasts are embed-
ded in the matrix and mineralized to new bone. Although similar surface 
morphology is observed on the apatite-coated NiTi and the uncoated NiTi, 
they exhibit distinct interfacial views. The apatite-coated NiTi implant inte-
grates with the host bone closely without any gaps (Figure 7.30c); however, 
there is a clear gap between the uncoated NiTi implant and the host bone 
(Figure 7.30d). Though the gap might be caused by the specimen prepara-
tion, it still suggests the poor bonding between the metallic implant and the 
host bone without effective mechanical locking or chemical bonding.
After nearing 1 year’s implantation (53 weeks), both the apatite-coated 
and the uncoated NiTi implants are surrounded by new bone, as shown 
in Figure 7.31a and b. Cortical bone grows along the long axis of both the 


















(See	color	insert.) Nondecalcified histological cross section of uncoated NiTi implant at 26 weeks 
after implantation. (a) Using a light microscope, showing a new bone layer between bone and NiTi 
implant. (b) Using a fluorescent light microscope, showing new bone and mineralizing osteoid. 
(c) Noncontinuous new bone in medullary cavity. N, NiTi; B, bone; M, marrow; O, osteoid.
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Under the fluorescent light microscope, there is no fibrous layer (red connec-
tive tissue) on the uncoated NiTi implant as observed after 13 weeks’ implan-
tation (Figure 7.26a), but a new layer of green bone contacts with the implant 
(Figure 7.31e). However, the interface between the uncoated implant and the 
bone is quite smooth, which might be easily fractured. However, the apatite-
coated NiTi implant interlocks with the bone (Figure 7.31d), suggesting 
stronger bonding. It is worth noting that osteolysis happens at the interface 
of the uncoated NiTi implant and the bone (Figure 7.31b). Under higher mag-
nification (Figure 7.31c), the bone structure becomes unclear without obvious 
texture. However, there is no such osteolysis happening around the apatite-
coated NiTi implant.
It is well known that the hard tissue implant should have higher strength, 
bigger Young’s modulus, and stronger antifatigue property, because the 
metallic implants cannot regulate by themselves. But the huge differences 
between the bone and the implant would cause mismatch and stress concen-
tration. New bone formed around the implant would also change due to the 
applied forces on the host bone, and consequently, the internal bone structure 
would also change. In general, bone growth is promoted when tension force 
(a)
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Figure 7.30
SEM surface and interface morphologies at 26 weeks after implantation: lamellar bone on 
the surfaces of apatite-coated NiTi implant (a) and uncoated NiTi implants (b); the interface 
between apatite-coated NiTi implant and host bone (c), and the gap between uncoated NiTi 
implant and host bone (d).
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is applied, while bone resorption happens under compression force. When 
the uncoated NiTi implant is inserted into the femur of the rabbit, a vertical 
force generated by the normal load on the leg transmits onto the long axis of 
the implant. Since the implant is in cylindrical shape, the stress concentrates 



























(See	color	insert.) Nondecalcified histological cross section of apatite-coated NiTi and uncoated 
NiTi implants at 53 weeks after implantation. Using a light microscope, showing a mature bone 
layer encompasses apatite-coated NiTi implant (a), and absorbable bone at one end of uncoated 
NiTi implant (b and c); using a fluorescent light microscope, showing rough interface between 
host bone and apatite-coated NiTi implant (d), and smooth interface between host bone and 
uncoated-NiTi (e). N, NiTi; B, bone; M, marrow; A-B, absorbable bone.
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accumulated during 1 year finally exceeds the limit that natural bone can 
sustain; thus, osteolysis and bone resorption take place (Figure 7.31b and c). 
Consequently, the implant would be loosened or even detached from the 
host bone, which will cause implantation failure. It is good that there is no 
osteolysis or bone resorption around the apatite-coated NiTi implant (Figure 
7.31a), and the implant integrates well with the new bone, showing good 
osseointegration (Figure 7.31d). It is obvious that the apatite coating plays 
an important role in reducing the osteolysis and the bone resorption. On the 
one hand, the apatite coating acts as a buffer layer between the metal and the 
bone to transfer the stress in the implant or in the bone. Moreover, the rough 
surface of the apatite coating increases the surface area of the implant, which 
may transfer the longitudinal stress to the surrounding bones. As a result, 
the stress concentration is largely reduced, and the osteolysis or bone resorp-
tion does not happen.
After 2 years’ implantation, the animals still appeared to be in good 
health conditions throughout the experimental period. After the animals 
were sacrificed and the implantation area was exposed, it was found that 
all the implants were steady, and no signs of inflammation or adverse tis-
sue reaction were observed around the implants. Figure 7.32 reveals the 
undecalcified histological images. There are no significant differences 
between the apatite-coated NiTi and the uncoated NiTi implants. Complete 
osseointegration is observed in both the apatite-coated and the uncoated 
implants. The decalcified histological images of the apatite-coated NiTi 
implant are shown in Figure 7.33. The implant–bone interface shows com-
plete osseointegration, and mature bone structures including osseous 
lamellas and cement line formed at bone reconstruction in different time 
(Figure 7.33a). Among the osseous lamellas, there are a lot of blood ves-
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Figure 7.32
Optical-microscopic images of undecalcified sections (T, NiTi alloy; B, bone). (a) apatite-coated 
NiTi; (b) uncoated NiTi. (Reprinted from Mat. Sci. Eng. C, 27, Li, C.Y., Yang, X.J., Zhang, L.Y., 
Chen, M.F., Cui, Z.D., In vivo histological evaluation of bioactive NiTi alloy after two years 
implantation, 122, Copyright 2007, with permission from Elsevier.)
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uncoated NiTi implant. Compared with Figure 7.33a, the osseous lamella 
structure is less mature. There are some cell concentrated zones, blood ves-
sel, and mature marrow in the bone. SEM was performed to examine the 
implant–bone interface. Figure 7.34a shows the implant–bone interface of 
the apatite-coated NiTi. The implant–bone interface is completely osseoin-
tegrated including compact bone and osseous lamella structures. Fibrous 
tissue is absent. Compared with the apatite-coated NiTi, the implant–bone 
interface of the uncoated NiTi is also completely osseointegrated, but the 
osseous lamella structures are obscure. This is ascribed to the relatively 








Optical-microscopic images of decalcified sections (B: bone). (a) apatite-coated NiTi; (b) 
uncoated NiTi. (Reprinted from Mat. Sci. Eng. C, 27, Li, C.Y., Yang, X.J., Zhang, L.Y., Chen, M.F., 
Cui, Z.D., In vivo histological evaluation of bioactive NiTi alloy after two years implantation, 
122, Copyright 2007, with permission from Elsevier.)
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Figure 7.34
SEM micrographs of the implant–bone interface. (a) apatite-coated NiTi; (b) uncoated NiTi. 
(Reprinted from Mat. Sci. Eng. C, 27, Li, C.Y., Yang, X.J., Zhang, L.Y., Chen, M.F., Cui, Z.D., 
In vivo histological evaluation of bioactive NiTi alloy after two years implantation, 122, 
Copyright 2007, with permission from Elsevier.)
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implantation stage. As shown in Figure 7.26, there are gaps and fibrous 
layer at the interface between the bone and the uncoated NiTi implant. On 
the contrary, osteoblasts proliferate actively on the surface of the apatite-
coated NiTi implant after 13 weeks’ implantation, and a large amount of 
new bone directly contact with the host bone. The results described ear-
lier indicate the relatively lower biocompatibility of the uncoated NiTi and 
the significantly enhanced bioactivity of the apatite-coated NiTi, espe-
cially within the early stage of implantation. These are in good agreement 
with the results reported by another study on the use of HA-coated Ti 
implants at initial healing period [59]. The relatively lower biocompatibil-
ity of the uncoated NiTi within the initial stage of implantation could be 
ascribed to several factors including nickel ion release from the alloy, cell 
adhesion ability, and osteogenesis mechanism. Wever et al. [60] demon-
strated that nickel release from NiTi alloy in the SBF at 37°C measured by 
atomic absorption spectrophotometry reduced in time during the measur-
ing period with a high release rate to a level that could not be detected 
anymore after 10 days immersion. The released nickel ions with a high 
concentration might induce negative effects on the biocompatibility of the 
uncoated NiTi alloy during the initial implantation period. Apatite coat-
ing on the implant increases cell adhesion [9] and thus accelerates the new 
bone formation especially during the initial stage of osseointegration [61]. 
Therefore, the apatite-coated NiTi shows better biocompatibility at the 
early implantation stage. The function of two-direction osteogenesis of 
apatite coatings was verified by Weinlaender [62]. Bone matrix deposits not 
only from the implant bed to the surface of implant but also in the reverse 
direction simultaneously. In the case of the uncoated titanium implant, 
however, the bone matrix deposits only from the implant bed to the sur-
face of the implant. The osseointegration of titanium containing implants 
depends on the surface titanium oxide that absorbs calcium phosphate 
from the living body fluid. This process occurs at a slow speed and results 
in prolonged osseointegration [63].
In summary, HA or apatite coating on NiTi alloy plays an important role 
in new bone formation. HA coating achieves a strong bonding with liv-
ing bone in a relatively short period. The formation of the bone–implant 
bonding is schematically shown in Figure 7.35. Briefly, it can be described 
as follows: (1) initial dissolution of HA coating causes a rise of calcium 
and phosphate ion concentration in a local environment around the coat-
ing; (2) crystal precipitation on HA coating and ion exchange with sur-
rounding tissues; (3) formation of a carbonated calcium phosphate layer 
with the incorporation of a collagenous matrix and bone growth towards 
the implant; (4) bone remodeling in area of stress transfer by fast resorp-
tion of both carbonated HA in bone mineral and HA coating; (5) further 
bone ingrowth and remodeling at the bone–implant interface and bio-
logical fixation through the bidirectional growth of a bonding layer [64]. 
Although both the apatite-coated and the uncoated NiTi implants exhibit 
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good biocompatibility after 2 years’ implantation in this study, the apatite-
coated NiTi implants present better histological performances than the 
uncoated NiTi implants at the early implantation stage. Both the in vitro 
cell culture and the in vivo animal models indicate that the chemical 
treatment is an effective method to biofunctionalize NiTi alloy, and the 































Schematic diagram of the formation of bone–implant bonding. (a) Partial dissolution of HA 
coating causing an increase of Ca2+ and PO43– ion concentrations in the local area around the 
coating. (b) Precipitation of crystals on HA coating and ion change with surrounding tissues. 
(c) Formation of a carbonated calcium phosphate layer with the incorporation of a collageneous 
matrix and bone growth toward the implant. (d) Bone remodeling-osteoblasts resorb normal 
bone, creating a local pH of –4.8, leading to faster resorption of both carbonated HA in bone 
and the HA coating. (e) Bidirectional growth and formation of a bonding layer between bone 
and HA coating through further bone remodeling. (From Sun, L., Berndt, C.C., Gross, K.A., 
Kucuk, A.: Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite 
coatings: A review. J. Biomed. Mat. Res. 2001. 58. 570. Copyright Wiley-VCH Verlag GmbH & Co. 
KGaA. Reproduced with permission.)
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7.4	 	Self-Assembled	Apatite/Collagen	Composite	
Coating	on	Chemically	Treated	NiTi	Alloy
Bone is an organ naturally formed by c-axis oriented deposition of HA 
nanocrystals on a bundle of collagen with excellent mechanical properties. 
This nanostructure probably plays an important role in the bone metabolism 
and mechanical properties [65]. The current trend to resemble bone-like 
materials is not only mimicking the chemical composition of natural bone 
but also the hierarchical structure. Many approaches have been employed 
to synthesize HA/collagen composite materials, and promising results have 
been achieved by the co-precipitation reaction of HA nanocrystals in soluble 
collagen macromolecular matrices that act as template and orient mineral 
deposition [66–68]. The composite material showed better osteoconductive 
properties compared with HA and produced calcification of identical bone 
matrix. Also, they exhibited superior mechanical properties than individual 
components [69]. Therefore, on the basis of the apatite-coated NiTi alloy, 
collagen was introduced into the apatite coating on the chemically treated 
NiTi alloy to resemble natural bone both in the chemical composition and the 
structure. Two kinds of collagen were used, including animal-like collagen 
and recombinant human-like collagen. The effects of collagen on the physical 
and chemical properties of the composite coating were investigated [70–73].
7.4.1 effect of animal-like Collagen*
Water-soluble collagen type I powders were dissolved in the SBF to obtain 
1.0 g/L collagen simulated body fluid (CSBF). The chemically treated NiTi 
alloy was immersed in the SBF and CSBF for 3 and 7 days. Figure 7.36 shows 
the surface morphologies after immersion. After soaking in the SBF for 
3 days, some calcium phosphate particles begin to nucleate and grow, but 
they do not cover the whole surface of the sample. Whereas after soaking in 
the CSBF for 3 days, the calcium phosphate particles cover the whole surface 
of the sample uniformly with some colloidal and elliptic particulates that 
might be ascribed to the addition of collagen. This is demonstrated by the 
EDS analysis of the elliptic particulates in Figure 7.37. The main elements of 
* Source: With kind permission from Springer Science+Business Media: Front. Mater. Sci. China, 
Comparison of physical characteristics and cell culture test of hydroxyapatite/collagen 
composite coating on NiTi SMA: Electrochemical deposition and chemically biomimetic 
growth, 1, 2007, 229, Hu, K., Yang, X., Cai, Y., Cui, Z., and Wei, Q.
 Scrip. Mater., 54, Cai, Y., Liang, C., Zhu, S., Cui, Z., and Yang, X., Formation of bonelike 
apatite-collagen composite coating on the surface of NiTi shape memory alloy, 89, Copyright 
2006, with permission from Elsevier.
 Surf. Coat. Technol., 201, Hu, K., Yang, X.J., Cai, Y.L., Cui, Z.D., and Wei, Q., Preparation of 
bone-like composite coating using a modified simulated body fluid with high Ca and P con-
centrations, 1902, Copyright 2006, with permission from Elsevier.
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elliptic particulates are C and O, of which the weight per cents is more than 
50% of the total weight. The ratio of Ca/P is 1.94, which is much higher than 
that of normal calcium phosphate compounds. It could be concluded that 
the elliptic particulates might be a hybrid of collagen, calcium, and phos-
phate ions. When the soaking time is up to 7 days, spherical calcium phos-
phate particles uniformly spread on the surface (with some small cracks) of 
the sample soaked in the SBF, whereas a compact calcium phosphate coat-
ing with more colloidal and elliptic particulates forms after the biomimetic 
growth in the CSBF. As the isoelectric point of the collagen used in the exper-
iment is pH 5.9–6.4, which is lower than pH 7.4 of the CSBF, most collagen 
in the CSBF is negative. The terminal groups (–COO−) might absorb Ca2+ 
easily; consequently, the growth of calcium phosphate particles is promoted, 
especially in the initial growth period.
Figure 7.38a and b are the high magnification images of Figure 7.36a2 and 
b2 respectively, which reveal the nanoscale character of the coatings. In the 
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Figure 7.36
SEM micrographs of the coatings deposited in the CSBF (a), SBF (b) for 3 and 7 days (a1, b1 for 
3 days and a2, b2 for 7 days). (Reprinted from Scripta Materialia, 54, Cai, Y., Liang, C., Zhu, S., 
Cui, Z., Yang, X., Formation of bonelike apatite-collagen composite coating on the surface of 
NiTi shape memory alloy, 89, Copyright 2006, with permission from Elsevier.)
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lamella that connected with each other to form a network, the structure of 
which is similar to that of bone [74]. Whereas in the latter, calcium phosphate 
particles grow into clusters formed by small club-shaped and needle-like 
substances. The different micromorphologies of coatings after soaking in the 
CSBF and SBF suggest that collagen might affect the nucleation mode of cal-
cium phosphate particles (and in this way influence the micromorphology).
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Figure 7.37
EDS profile of elliptic particulates on the surface of sample. (Reprinted from Scripta Materialia, 
54, Cai, Y., Liang, C., Zhu, S., Cui, Z., Yang, X., Formation of bonelike apatite-collagen compos-
ite coating on the surface of NiTi shape memory alloy, 89, Copyright 2006, with permission 
from Elsevier.)
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Figure 7.38
SEM images of the coatings deposited in the CSBF (a), SBF (b) for 7 days. (Reprinted from 
Scripta Materialia, 54, Cai, Y., Liang, C., Zhu, S., Cui, Z., Yang, X., Formation of bonelike apatite-
collagen composite coating on the surface of NiTi shape memory alloy, 89, Copyright 2006, with 
permission from Elsevier.)
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Figure 7.39 shows the XRD patterns of human thighbone and coatings 
after the biomimetic growth in the CSBF as well as in the SBF for 7 days. The 
main phase of human thighbone (a) is apatite, of which the main peaks are 
(002) around 26° and the integrated peaks of (211), (112), and (300) between 
31° and 33°. The intensities, shapes, and positions of the peaks of (b) and (c) 
are almost the same, and the main peaks are the same as human thighbone. 
Broad peaks in spectra (b) and (c) indicate poorly crystallized HA with small 
particle sizes. From XRD patterns shown in Figure 7.39, it can be speculated 
that bone-like apatite is the main phases of the coatings after the biomimetic 
growth in the CSBF and SBF.
Figure 7.40a exhibits an IR spectrum of human thighbone that shows the 
typical peaks of phosphate at the positions of 1095, 1020, 602, and 561 cm−1. 
These bands are assigned to molecular vibrations of phosphate, of which 
1095 and 1020 cm−1 are PO43− v3 bands, and 602 and 561 cm−1 are PO43− v4 
bands [75]. It can be observed that the typical amide bands of proteins are 
present in spectrum (a): C═O stretching vibration at 1651 cm−1 is ascribed 
to amide I band (1600–1700 cm−1), C–N stretching vibration and N–H 
bending vibration at 1547 cm−1 to amide II band (1500–1550 cm−1), and 















XRD patterns of human thighbone (a), coatings deposited in the CSBF (b) and SBF (c) for 7 days. 
(Reprinted from Scripta Materialia, 54, Cai, Y., Liang, C., Zhu, S., Cui, Z., Yang, X., Formation 
of bonelike apatite-collagen composite coating on the surface of NiTi shape memory alloy, 89, 
Copyright 2006, with permission from Elsevier.)
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amide III band (1200–1300 cm−1) [76]. Moreover, weak bands at 1456, 1418, 
and 873 cm−1 are ascribed to CO32−, of which 1456 and 1418 cm−1 are carbon-
ate v3 bands (1400–1580 and 1350–1550 cm−1), and 872 cm−1 is the carbonate 
v2 bands (850–890 cm−1). IR spectra of coatings deposited in the CSBF and 
SBF are shown in Figure 7.40b and c, respectively. Compared with the peaks 
of human thighbone (Figure 7.40a through c), both show the main peaks 
of phosphate at the positions of 1030, 604, 563 and 1034, 600, 563 cm−1 and 
carbonate bands at 1508, 1420, 872 and 1473, 1420, 872 cm−1, from which it 
could be concluded that the coatings deposited in the CSBF and SBF have 
the same inorganic components as bone. Furthermore, there is a band at 1650 
cm−1 in spectrum (b), which is similar to that of bone and should be ascribed 
to amide I band of collagen; whereas the band at 1637 cm−1 in spectrum (c) 
should be assigned to absorbed and occluded water in the coating [77]. The 
lack of amide II band and amide III band in spectrum (b) might be related to 
the amount of collagen added to the CSBF or the fact that the vibrations of 
C–N and N–H are more liable to be obstructed by combination with ions in 
solution than those of C═O. The IR spectra indicate that the coatings depos-
ited in the CSBF not only have the inorganic component of bone but also 
the organic component, i.e., a bone-like apatite–collagen composite coating 
has been formed on the surface of NiTi alloy. This coating may be useful in 
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Figure 7.40
IR spectra of human thighbone (a), coatings deposited in the CSBF (b) and SBF (c) for 7 days: 
*, PO43−; •, CO32−; ♦, amide I; ♢, water. (Reprinted from Scripta Materialia, 54, Cai, Y., Liang, C., 
Zhu, S., Cui, Z., Yang, X., Formation of bonelike apatite-collagen composite coating on the sur-
face of NiTi shape memory alloy, 89, Copyright 2006, with permission from Elsevier.)
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To shorten the immersion periods while maintaining the proper concen-
trations and proportions of apatite and collagen, the SBF was modified by 
increasing the Ca and P ion concentrations and denoted by MSBF. The ion 
concentrations of the MSBF were identical to Kokubo’s SBF [17], but the [Ca2+] 
and [HPO42−] concentrations were increased fivefold (see Table 7.3). The pH 
of the MSBF was controlled at 6.13 with 1 M HCl. The water-soluble type I 
collagen powder was dissolved at a concentration of 0.556 g/L in the MSBF. 
In the process of biomimetic growth, the pH of the MSBF was adjusted by 
tris-hydroxymethyl aminomethane [(CH2OH)3CNH3] to rise slowly to 7.15 
within 24 h. The chemically treated NiTi samples were kept in the MSBF at 
50°C, and the MSBF was changed everyday.
Figure 7.41 shows the surface morphologies of NiTi alloy after the biomi-
metic growth in the MSBF for 3 days. A uniform coating forms on the surface 
of the substrate (Figure 7.41a). It could be seen that the coating is composed 
of many small spherical particles, forming a loose arrangement. The average 
diameter of the single particle is about 1 μm. There are colloid-like connections 
among the small particles (Figure 7.41b). The stability of the MSBF containing 
(a) (b)
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Figure 7.41
SEM micrographs of composite coating grown biomimetically for 3 days in the MSBF, (a) and 
(b) are at low and high magnifications, respectively. (Reprinted from Surf. Coat. Technol.,201, 
Hu, K., Yang, X.J., Cai, Y.L., Cui, Z.D., Wei, Q., Preparation of bone-like composite coating using 
a modified simulated body fluid with high Ca and P concentrations, 1902, Copyright 2006, with 
permission from Elsevier.)
Table 7.3
Ionic Concentration of SBF and MSBF Solutions, in Comparison 
with Those of Human Blood Plasma (HBP) (mM)
Na+ K+ Ca2+ Mg2+ HCO3− Cl− HPO42− SO42−
HBP 142.0 5.0 2.5 1.5 27.0 103.0 1.0 0.5
SBF 142.0 5.0 2.5 1.5 4.2 148.0 1.0 0.5
MSBF 142.0 5.0 12.5 1.5 4.2 159.8 5.0 0.5
Source: Hu, K. et al., Surf. Coat. Technol., 201, 1902, 2006.
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high calcium and phosphate concentration is due to the acidic condition 
(pH = 6.13) adjusted by HCl. It is known that the relationship between CaP 
precipitation in solution and CaP coating growth is competitive [22]. If the 
calcifying solutions reach their supersaturation point rapidly, it will lead 
to CaP precipitate into the solution and hold CaP coating back from grow-
ing on the substrate. The gradual controlled release of trishydroxymethyl 
aminomethane into the MSBF within 24 h delays the CaP precipitation in 
solution and ensures that a CaP coating forms simultaneously. On the other 
hand, the isoelectric point of collagen used in the experiment is pH 5.9–6.4. 
Accompanying the rising pH, collagen molecules assemble themselves into 
collagen fibrils and become negatively charged ions whose terminal groups 
are mostly –COO− that might absorb Ca2+. Therefore, a calcium phosphate–
collagen composite coating forms on the substrate.
The IR spectra of the coating and a mechanical mixture of pure HA and 
collagen are shown in Figures 7.42 and 7.43. Figure 7.42a and b exhibits the 
typical peaks of collagen. In the spectrum of mechanically mixed powder 
(Figure 7.42b), the typical bands are observed, such as the C═O stretching 
vibration at 1654 cm−1 of the amide group I, the N–H deformation vibra-
tion at 1521 cm−1 of the amide group II, and N–H deformation vibration at 
1284 cm−1 of the amide group III band. Normally, the amide I band is strong, 



























(a) IR spectra of composite coating, (b) a mechanical mixture of pure HA and collagen and 
(c) H2O. (Reprinted from Surf. Coat. Technol.,201, Hu, K., Yang, X.J., Cai, Y.L., Cui, Z.D., Wei, Q., 
Preparation of bone-like composite coating using a modified simulated body fluid with high 
Ca and P concentrations, 1902, Copyright 2006, with permission from Elsevier.)
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The band at 1638 cm−1, which combines with the peak 1654 cm−1 of the amide 
I to form a shoulder structure, is the typical peak of H2O (Figure 7.42c). The 
presence of H2O might be due to the fact that the specimen is affected by 
moisture in the experiment. In the spectrum of the coating (Figure 7.42a), it 
is noticed that there is also a similar shoulder between 1600 and 1700 cm−1. 
Besides the band at 1638 cm−1 for H2O, the other band at 1651 cm−1 could be 
confirmed as being the typical peak of amide I of collagen. It is believed 
that the “red shift” of amide I is caused by a covalent bond formation with 
Ca2+ ions of HA crystals [78]. The band of amide II at 1521 cm−1 is very 
weak, and the amide III band almost disappears. It is implied that HA 
crystals grow on the self-assembled collagen fibrils and block the vibration 
of organic groups such as carboxyl and carbonyl groups [79]. The amide II 
and III bands not only correspond to the C═O stretching vibration but also 
include the N–H bending vibration. For this reason, the effects of miner-
alization on the amides II and III are greater than for amide I. Figure 7.43a 
shows the typical peaks of inorganic groups in the composite coating. There 
are PO43− v1 mode at 964 cm−1, PO43− v2 mode at 474 cm−1, PO43− v4 mode at 562 
and 604 cm−1, and –OH band at 632 cm−1. These vibration bands could also 
be seen in the mechanical mixture of pure HA and collagen (Figure 7.43b). 
The 1037 cm−1 and 1096 cm−1 bands in Figure 7.43b are PO43− v3 mode and 
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Figure 7.43
(a) IR spectra of composite coating, and (b) a mechanical mixture of pure HA and collagen. 
(Reprinted from Surf. Coat. Technol.,201, Hu, K., Yang, X.J., Cai, Y.L., Cui, Z.D., Wei, Q., 
Preparation of bone-like composite coating using a modified simulated body fluid with high 
Ca and P concentrations, 1902, Copyright 2006, with permission from Elsevier.)
336 Hydroxyapatite Coatings for Biomedical Applications
asymmetric HA, respectively. However, both are very weak in the IR 
spectrum of composite coating (Figure 7.43a). Furthermore, we could see 
the CO32− v2 mode at 865 cm−1 and the CO32− v3 mode at 1461 cm−1 in the 
spectrum of composite coating. According to Chang and Tanaka [76], the 
CO32− v2 mode at 865 cm−1 indicates the formation of carbonate apatite with 
B-type substitution in the HA/COL composite coating. This substitution 
leads to a distortion of the crystallographic lattice, i.e., a-axis contraction 
and c-axis extension [80].
The crystallographic structure of the coating was investigated by XRD. 
Figure 7.44 shows the XRD patterns of the coatings after the biomimetic 
growth in the MSBF for 4 days as well as in the SBF for 7 days. Both solutions 
contain identical concentrations of collagen as mentioned earlier. The phases 
of the coating obtained in the MSBF have broader diffraction peaks, indicat-
ing that the coatings are poorly crystallized with small particle size. The 
main diffraction peaks could be assigned to HA as shown in Figure 7.44a. 
An acute diffraction peak at 26.2° possibly corresponds to the most intense 
diffraction line of CaCO3, which might be caused by carbonate substitution 
in HA/COL composite coating proved by IR results earlier. So it could be 












































XRD patterns of coatings after biomimetic growth in the MSBF for 4 days (a), and SBF for 7 days 
(b). ♦, Hydroxyapatite; ◾, NiTi. (Reprinted from Surf. Coat. Technol., 201, Hu, K., Yang, X.J., Cai, Y.L., 
Cui, Z.D., Wei, Q., Preparation of bone-like composite coating using a modified simulated body 
fluid with high Ca and P concentrations, 1902, Copyright 2006, with permission from Elsevier.)
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biomimetic growth in the MSBF. Compared with the coating formed in the 
SBF after 7 days (Figure 7.44b), the coating grown in the MSBF for 4 days has 
a higher degree of crystallinity, while high Ca and P concentrations cause 
the faster deposition of the coating in the solution.
Transmission electron microscopy (TEM) was employed to study the 
micromorphology and microstructure between HA and collagen fibrils. 
A plate-like particle grows in the middle of a collagen fibril of 800 nm 
in length and 20 nm in diameter (Figure 7.45a). At high magnification 
(Figure 7.45b), the particle shows a typical crystallographic structure, com-
pared with the amorphous structure of uncalcified collagen fibril. This 
suggests that the current method could favor the nucleation of calcium phos-
phate crystal particles on the fibril at the initial stage of mineralization. To 
investigate the relative orientation between HA crystals and collagen fibril, 
a mineralized collagen fibril is analyzed by electron diffraction (Figure 7.46). 
In the electron diffraction pattern, the ring shaped diffraction is ascribed 
to (211) of HA, and the two pairs of bright diffraction points are ascribed to 
(002) and (004) of HA. This means that the c-axis of HA crystals aligns from 
above-right to bottom-left, i.e., the c-axis is the preferential orientation and 
oriented parallel to the longitudinal direction of the collagen fibril. This 
special orientation could be observed more directly from high-resolution 
TEM images. As shown in Figure 7.47, HA crystals grown on the surface 
of a fully mineralized collagen fibril exhibit overall uniform lattice plane 
distribution. By virtue of the calculation of lattice plane spacing, the lattice 
plane of 0.2638 nm corresponds to the HA lattice plane 202 (0.2630 nm), 
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TEM micrographs of composite coating showing HA nuclei formed on the collagen fibril in 
the initial stage of mineralization at low (a) and high (b) magnifications. (Reprinted from 
Surf. Coat. Technol.,201, Hu, K., Yang, X.J., Cai, Y.L., Cui, Z.D., Wei, Q., Preparation of bone-like 
composite coating using a modified simulated body fluid with high Ca and P concentrations, 
1902, Copyright 2006, with permission from Elsevier.)






TEM micrographs of the mineralized collagen fibril in composite coating. The inset shows a 
selected area electron diffraction (SAED) pattern of the mineralized collagen fibril. (Reprinted 
from Surf. Coat. Technol.,201, Hu, K., Yang, X.J., Cai, Y.L., Cui, Z.D., Wei, Q., Preparation 
of bone-like composite coating using a modified simulated body fluid with high Ca and 





High-resolution TEM image of fully mineralized collagen fibril. (Reprinted from Surf. Coat. 
Technol.,201, Hu, K., Yang, X.J., Cai, Y.L., Cui, Z.D., Wei, Q., Preparation of bone-like composite 
coating using a modified simulated body fluid with high Ca and P concentrations, 1902, 
Copyright 2006, with permission from Elsevier.)
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and the plane of 0.2734 nm corresponds to the HA lattice plane 300 
(0.2720 nm). The (202) and (300) planes of HA crystal are ascribed to the 
〈010〉 zone axis, thus the 〈010〉 direction is perpendicular to the paper 
plane. Because the 〈001〉 direction of the HA crystal is perpendicular to 
〈010〉 direction and parallel to (300) lattice plane, the same conclusion is 
obtained that the c-axis of HA crystal aligns parallel to the longitudinal 
direction of the collagen fibril. Moreover, the measured lattice plane spac-
ing is shown in Figure 7.45b. By comparison, the (202) plane of HA is basi-
cally perpendicular to the longitudinal direction of collagen fibril, which 
is different from the situation of Figure 7.47. It means that there is an angle 
between the c-axis of HA and the longitudinal direction of collagen fibril. 
It is believed that the individual size of crystallite is smaller during the 
onset of mineralization, and the calcium phosphate crystals nucleate on 
the collagen fibril oriented at random (Figure 7.45b). With the develop-
ment of mineralization, the crystallites become larger and the c-axis of HA 
exhibits the preferential orientation (Figure 7.47). Gradually, the crystallite 
size along the c-axis of HA even grows beyond the size of the diameter of 
the collagen fibril. Therefore, the c-axis orients parallel to the longitudi-
nal direction of the fibril in the later period of mineralization by means of 
structural self-organization between HA and collagen fibril [65]. The TEM 
results confirm that the relative orientation between HA crystals and col-
lagen fibrils, similar to the nanostructure of calcified natural tissue [81,82], 
could be obtained in the composite coating by biomimetic growth in the 
MSBF. This meant that the composite coating has the microstructure simi-
lar to bone. Therefore, the coating is likely to possess bone-like properties 
and reaction at the implant site. The relative orientation maintained in the 
composite coating may benefit the chemically treated NiTi alloy to achieve 
better properties in hard tissue replacement.
Another method to shorten the formation period of apatite coating on the 
substrate is electrochemical deposition (ELD). In our studies, ELD was also 
employed to prepare HA/COL composite coating and compared with the 
biomimetic growth (BG) method. The first step of this work was preparing 
a HA/COL composite coating on chemically treated NiTi alloy by the ELD 
method. The electrolyte used was the MSBF with high Ca and P ion con-
centrations to maintain the proper concentrations and proportions of apatite 
and collagen in the solution. Then, the physical characteristics and in vitro 
biocompatibility of the two kinds of composite coatings were compared. To 
combine the two chemically prepared methods, the ELD coated samples 
were soaked in the MSBF again for further biomimetic growth for several 
days (it was called EBG method here), and the characteristics of this coating 
were also studied.
The different surface morphology for three methods is exhibited in 
Figure 7.48. The surface of ELD coating is relatively flat and smooth, which 
is composed of some strip-like crystals with 5–7 μm length and 1 μm width 
(Figure 7.48a). The BG coating exhibits a relatively rough surface composed 
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of plate-like crystals with about 3 μm in length (Figure 7.48b). The EBG 
coating shows a denser surface. Moreover, its morphology seems to be a 
transition from ELD coating to BG coating, and the length of EBG plate-like 
crystals also presents an intervenient size (Figure 7.48c). The XRD patterns 
of three coatings are shown in Figure 7.49. All the coatings have relatively 
typical diffraction peaks of apatite of which the peaks could match the 
major diffraction peaks of HA crystals. Except for the typical peaks of HA, 
the ELD coating also consists in the diffraction peaks of Mg(OH)2 crys-
tal. The phases of three coatings have broader peaks, indicating that the 
coatings are of low crystallinity with small particle sizes. The diffraction 
peak due to the NiTi substrate at 42° disappears in the EBG coating, which 
None Sei 10.0 kV ×10.000
(a) (b)
(c)
1 µm WD 82 mm None Sei 10.0 kV ×10.000 1 µm WD 6.7 mm
None Sei 10.0 kV ×10.000 1 µm WD 8.2 mm
Figure 7.48
SEM micrographs of composite coating (a–c) are ELD (electrochemical deposition), BG (bio-
mimetic growth), EBG (electrochemical deposition followed by biomimetic growth) coatings, 
respectively, and the insets are the morphology at low magnification. (With kind permission 
from Springer Science+Business Media: Front. Mat. Sci. China, Comparison of physical char-
acteristics and cell culture test of hydroxyapatite/collagen composite coating on NiTi SMA: 
Electrochemical deposition and chemically biomimetic growth, 1, 2007, 229, Hu, K., Yang, X., 
Cai, Y., Cui, Z., Wei, Q.)
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proves that EBG coating is thicker than the others. Figure 7.50 shows the 
x-ray intensity ratios of (002) to (211) planes of the HA in the XRD pat-
terns of three coatings. The standard intensity ratio of (002) to (211) planes 
is 0.4, according to random hydroxyapatite crystals (JCPDS No. 09-0432). 
The intensity ratios of the apatite coatings prepared are all larger than 
0.4, indicating that the crystallographic lattice of HA along the c-axis is 
extended. This preferential orientation in the ELD coating is the most evi-
dent (I(002)/I(211) = 0.955).
The TEM images of EBG coating are shown in Figure 7.51. The collagen 
fibrils in EBG coating are about 500 nm in length and 20 nm in diameter. 
In addition, it is found that the collagen fibril is fully mineralized at the 
high-resolution TEM image (the middle image). The mineralized collagen 
fibril as shown exhibits overall uniform crystallographic lattice plane dis-
tribution compared with the amorphous structure of pure collagen fibril. 
The inset is the selected area electron diffraction (SAED) pattern of the 
mineralized collagen fibril. The c-axis of HA crystals aligns from above-
left to bottom-right, according to the location of HA (002) and (004) diffrac-
tion spots. This means that the c-axis of HA is the preferential orientation 
in the mineralized process of composite coating and is oriented parallel 
to the longitudinal direction of the collagen fibril. Figure 7.51c shows a 


















XRD patterns of composite coatings prepared by the three methods: ELD (electrochemical 
deposition), BG (biomimetic growth), and EBG (electrochemical deposition followed by 
biomimetic growth). (With kind permission from Springer Science+Business Media: Front. 
Mat. Sci. China, Comparison of physical characteristics and cell culture test of hydroxyapatite/
collagen composite coating on NiTi SMA: Electrochemical deposition and chemically biomi-
metic growth, 1, 2007, 229, Hu, K., Yang, X., Cai, Y., Cui, Z., Wei, Q.)
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schematic diagram of the mineralized collagen fibril illustrating the rela-
tionship between HA crystals and collagen fibril as described. Similarly, 
TEM images of ELD coating are shown in Figure 7.52. The collagen fibrils in 
ELD coating exhibit shorter length and smaller diameter than those in EBG 
coating, indicating the difference in the self-organization of collagen fibrils 
(Figure 7.52a). The high-resolution image (Figure 7.52b) indicates that the 
mineralization occurs partly on the surface of collagen fibril. Some crystal-
lographic lattice planes with different directions and also some unmineral-
ized areas could be observed.
To study in vitro biocompatibility of HA/COL composite coating, OCT-1 
osteoblast-like cells were employed to evaluate cellular responses on the 
composite coatings. Figure 7.53 shows the morphology of OCT-1 osteo-
blast-like cells attached on HA/COL composite coatings. On BG coating 
(Figure 7.53a), the cells are well attached on the coating with filopodia. At 
low magnification (Figure 7.53b), the cells seem to form bridges mutually 
and look more globose and compact. On ELD coating (Figure 7.53c), the 
cells spread dispersedly and are relatively rounded and flat. Moreover, 
the length of OCT-1 cells spread on ELD coating (about 10 μm) is less than 
that of the cells on BG coating (about 80 μm) after being cultured for the 














X-ray intensity ratios of the HA (002) to the (211) plane in the three coatings: ELD (electrochemical 
deposition), BG (biomimetic growth), and EBG (electrochemical deposition followed by biomi-
metic growth). (With kind permission from Springer Science+Business Media: Front. Mat. Sci. 
China, Comparison of physical characteristics and cell culture test of hydroxyapatite/collagen 
composite coating on NiTi SMA: Electrochemical deposition and chemically biomimetic 
growth, 1, 2007, 229, Hu K, Hu, K., Yang, X., Cai, Y., Cui, Z., Wei, Q.)
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coating (Figure 7.53d). Figure 7.54 shows the number of cells after 4 and 8 
days of culture. The percentages of cell numbers in 4 and 8 days for the 
three groups (ELD, BG, EBG) are 37.0%, 39.4%, and 33.9%, respectively, and 
that of the controls is 43.6%. Compared with the DMEM controls, OCT-1 
cells cultured on BG coating show satisfactory results in cell proliferation 
and its growth trend is similar to that of the control group, both in the abso-
lute value and the percentage. It indicates that the HA/COL composite coat-
ing prepared by BG method has better properties for OCT-1 cell adhesion 
and proliferation.
It is known that the bioactivity of cells is strongly influenced by surface 
composition, topography, roughness, and porosity [83–85]. In the present 
study, BG coating is composed of plate-like crystals and presents an open 
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TEM micrographs of the composite coating for EBG (electrochemical deposition followed 
by biomimetic growth) method. (a) is the image at low magnification; (b) is a fully mineral-
ized collagen fibril and the inset is its SAED pattern; (c) is a schematic diagram illustrat-
ing the relationship between collagen fibril and HA crystals. (With kind permission from 
Springer Science+Business Media: Front. Mat. Sci. China, Comparison of physical charac-
teristics and cell culture test of hydroxyapatite/collagen composite coating on NiTi SMA: 
Electrochemical deposition and chemically biomimetic growth, 1, 2007, 229, Hu, K., Yang, 
X., Cai, Y., Cui, Z., Wei, Q.)
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porosity surface with higher roughness. Therefore, it could promote physi-
cochemical surface reactions and cellular attachment behavior. On the other 
hand, some studies demonstrated that the apatite coating prepared by BG 
method dissolved faster than that prepared by ELD method, and the disso-
lution ability of calcium phosphate played an essential role in cell adhesion 
and bone-bonding [86,87]. Thus, it might be another reason of influencing 
the protein adsorption of HA/COL composite coating. It is found that the cell 
number on EBG coating is slightly larger than that on ELD coating, which 
could be ascribed to the formation of a more open surface structure to the cell 
culture medium after soaking the ELD samples in the MSBF for further BG. 
Our studies proved that BG is a better method than ELD in preparing an 
active, cell-friendly HA/COL composite coating in the acid MSBF.
7.4.2 effect of recombinant Human-like Collagen*
For the consideration of bionics and biosafety, the recombinant human-like 
type I collagen produced in Escherichia coli containing human collagen’s 
cDNA transcribed reversely from mRNA should be a good choice to provide 
* Source: Mater. Sci. Eng. C, 29, Yang, X.J., Liang, C.Y., Cai, Y.L., Hu, K., Wei, Q., and Cui, Z.D., 
Recombinant human-like collagen modulated the growth of nano-hydroxyapatite on NiTi 
alloy, 25, Copyright 2009, with permission from Elsevier.
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Figure 7.52
TEM micrographs of the composite coating for ELD (electrochemical deposition) method. 
(a) is the image at low magnification; (b) is the high-resolution image of a collagen fibril. (With 
kind permission from Springer Science+Business Media: Front. Mat. Sci. China, Comparison of 
physical characteristics and cell culture test of hydroxyapatite/collagen composite coating on 
NiTi SMA: Electrochemical deposition and chemically biomimetic growth, 1, 2007, 229, Hu, K., 
Yang, X., Cai, Y., Cui, Z., Wei, Q.)
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a reliable source of purified human collagens. Moreover, recombinant human-
like collagen has special characteristics that are significantly different from 
animal collagen, such as processability, virus-free, water solubility, little 
immunogenic reaction, and so on. This new material has the potential to be 
used as bone substitution grafts, but its relatively weak strength limits its 
application as load bearing bone grafts, where titanium and its alloys can 
exert their advantages of mechanical properties. In this work, recombinant 
human-like collagen was firstly introduced into the SBF to investigate its 
modulation effect on the growth of apatite coating and to achieve a combi-
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Figure 7.53
SEM micrographs of OCT-1 osteoblast-like cells attached on HA/COL composite coatings after 
4 days culture: BG (biomimetic growth) coating (a) and (b); ELD (electrochemical deposition) 
coating (c); EBG (electrochemical deposition followed by biomimetic growth) coating (d). (With 
kind permission from Springer Science+Business Media: Front. Mat. Sci. China, Comparison 
of physical characteristics and cell culture test of hydroxyapatite/collagen composite coating 
on NiTi SMA: Electrochemical deposition and chemically biomimetic growth, 1, 2007, 229, 
Hu Hu, K., Yang, X., Cai, Y., Cui, Z., Wei, Q.)
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XRD was used to confirm the crystallographic structure of the coating on 
NiTi alloy after biomimetic growth in 0.5 g/L 1.5CSBF for 3 days, as shown 
in Figure 7.55. The diffraction peak of NiTi substrate can be seen around 42°. 
A broadened peak between 31° and 33° should be the integrated peak of 
(211), (112), and (300) of HA with small size of crystals; the sharp peak at 26° 
could be (002) of HA; and other weak peaks are also assigned to the diffrac-
tion peaks of HA. In addition, the background of the pattern is relatively 
complex with many small peaks that couldn’t be assigned to any certain cal-
cium phosphates. It might be due to the presence of recombinant human-like 
collagen in the solution that influences the crystalline behaviors of calcium 
phosphates in the process of crystal nucleation and growth.
Figure 7.56 shows the surface morphology of the coating on NiTi alloy 
after soaking in 0.5 g/L 1.5CSBF for 3 days. Different from earlier net-
work structure formed in animal collagen added SBF (Figure 7.36), uni-
form HA coating comprises numerous nanocrystal forms on the surface 
of NiTi alloy (Figure 7.56a), and some crystals have aggregated to form 
small clusters. Image-Pro Plus 5.0, a professional image analysis software, 
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Figure 7.54
OCT-1 osteoblast-like cell proliferation after 4 and 8 days of culture on HA/COL composite 
coatings for the three groups: ELD (electrochemical deposition), BG (biomimetic growth), 
and EBG (electrochemical deposition followed by biomimetic growth), and the control (The 
cells were used at an initial concentration of 2.4 × 104/mL). (With kind permission from 
Springer Science+Business Media: Front. Mat. Sci. China, Comparison of physical charac-
teristics and cell culture test of hydroxyapatite/collagen composite coating on NiTi SMA: 
Electrochemical deposition and chemically biomimetic growth, 1, 2007, 229, Hu, K., Yang, X., 
Cai, Y., Cui, Z., Wei, Q.)
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nanophase coating (Figure 7.56b). The average diameter of the crystals is 
45 nm with a standard deviation of 26 nm. The average size of crystals in 
this coating is relatively smaller compared with that of calcium phosphate 
particles formed on NiTi alloy in the SBF solution (Figure 7.36) without 
recombinant human-like collagen, which might be due to the addition of 






















XRD pattern of the sample after soaking in 0.5 g/L 1.5CSBF for 3 days. (Reprinted from Mat. 
Sci. Eng. C, 29, Yang, X.J., Liang, C.Y., Cai, Y.L., Hu, K., Wei, Q., Cui, Z.D., Recombinant human-
like collagen modulated the growth of nano-hydroxyapatite on NiTi alloy, 25, Copyright 2009, 





SEM micrographs of the coating on NiTi alloy after soaking in 0.5 g/L 1.5CSBF for 3 days (b is 
the high-magnification image of a). (Reprinted from Mat. Sci. Eng. C, 29, Yang, X.J., Liang, C.Y., 
Cai, Y.L., Hu, K., Wei, Q., Cui, Z.D., Recombinant human-like collagen modulated the growth of 
nano-hydroxyapatite on NiTi alloy, 25, Copyright 2009, with permission from Elsevier.)
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As discussed by Combes et al. [88], where adsorbent molecules are present 
in the solution, the interfacial tension will be altered due to the absorption 











Q is the quantity of adsorbed protein
C the solute concentration in solution
γCL the interfacial tension between crystal and liquid
When the chemically treated NiTi samples are soaked in collagen containing 
solution, the interfacial tension between crystal and liquid decreases due to 
the adsorption phenomena. Furthermore, the critical nucleus size of crys-
tal should be considered. The critical nucleus diameter L* corresponding to 
∆G = 0 is given next in the case of spherical nuclei:
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α is the degree of dissociation of the nuclei
v is the number of species in the precipitating phase
C/C0 the relative supersaturation ratio (C is the ionic product in the 
solution, and C0 is the solubility product)
γCL is the interficial tension at the crystal–liquid interface
As the interfacial tension is decreased as a result of collagen addition, the 
nucleus critical size would be decreased. At the same time, collagen may 
delay the crystal growth due to their presence at the solution–crystal inter-
face but not inhibit it completely. Thus the crystals continue to grow at a 
slower rate, and numerous small nuclei would be stabilized. Consequently, 
nanophase HA crystals would be formed on the surface of chemically treated 
NiTi alloy. A similar phenomena could be found when bovine serum albu-
min (BSA) was added into the solution to study the influence of BSA at vari-
ous concentrations on the kinetics of nucleation and growth of octacalcium 
phosphate (OCP). Higher concentrations of BSA led to bigger crystals than 
in the absence of protein, whereas smaller crystals were observed for lower 
BSA concentrations [88,89].
The possible structure and chemical interaction of HA and collagen in the 
coating were also characterized. Figure 7.57 exhibits IR spectrum of the coat-
ing on NiTi alloy after soaking in 0.5 g/L 1.5CSBF for 3 days. The bands at 
the position of 1027, 601, and 561 cm−1 are the typical peaks of phosphate. The 
peak at 1027 cm−1 is attributed to the stretching vibration of PO43−, whereas 
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the other two peaks at 601 and 561 cm−1 can be ascribed to the deformation 
vibration of PO43− [75]. Besides, the bands at the positions of 1650, 1524, and 
1226 cm−1 represent typical amide bands of proteins, respectively: amide I 
band at 1650 cm−1 is ascribed to C═O stretching vibration, amide II band 
at 1524 cm−1 to C–N stretching vibration and N–H bending vibration, and 
amide III band of C–N stretching vibration and N–H bending vibration at 
1226 cm−1. Also, the band at 2930 cm−1 should be the typical band of CH2 or 
CH3 of the collagen [76]. Compared with the IR spectrum of pure recombi-
nant human-like collagen in Ref. [90] that amide I band is at the position of 
1658 cm−1, red shift of amide I band to 1650 cm−1 is observed for the bonding 
between Ca2+ ions and C═O bands. This phenomenon suggests that the car-
bonyl groups on the surface of collagen molecules are the nucleation sites of 
calcium phosphate. Additionally, 1457 and 1414 cm−1 are carbonate v3 bands, 
which indicates the formation of carbonated apatite on NiTi alloy.
TEM analysis can provide us more detailed information about the micro-
morphology of coating and the orientation relationship between HA and 
recombinant human-like collagen. As can be seen in Figure 7.58a, bundles of 
mineralized fibrils are dispersed in the coating, and the length of fibrils is less 
than 100 nm, which is shorter than natural type I collagen fiber. It is because 
the molecular weight of recombinant human-like collagen used in the experi-
ment is about 90,000 Da, much smaller than that of natural type I collagen 
(300,000 Da). EDX analysis of the fibril in Figure 7.58c presents the elements 







































IR spectrum of the coating on NiTi alloy after soaking in 0.5 g/L 1.5CSBF for 3 days. (Reprinted 
from Mat. Sci. Eng. C, 29, Yang, X.J., Liang, C.Y., Cai, Y.L., Hu, K., Wei, Q., Cui, Z.D., Recombinant 
human-like collagen modulated the growth of nano-hydroxyapatite on NiTi alloy, 25, Copyright 
2009, with permission from Elsevier.)
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the copper grids used as the supporting membrane. Ca, P, and O elements 
should be assigned to HA; a little amount of C, O, N, and S elements might be 
attributed to recombinant human-like collagen; and the presence of Mg ele-
ment might be due to the substitution of Ca element in the formation process 
of HA. The high intensity of C might be partly attributed to collagen, partly 
due to the contaminants and carbonates in the calcium phosphate phase.
Figure 7.58b shows a HRTEM image of a collagen fibril after the mineral-
ization. The diameter of the mineralization collagen fibril is about 5 nm, and 
numerous parallel lattice planes are aligned vertically to the longitudinal 
direction of the collagen fiber. The average lattice plane spacing of 0.34395 nm 
corresponds to the HA lattice plane (002) (0.3440 nm), and the orientation of 
(002), i.e., the c-axis of HA, should be vertical to the lattice plane and parallel 
to the longitudinal direction of the collagen fibril, which is the same as that 

































TEM images of the coating on NiTi alloy after soaking in 0.5 g/L 1.5CSBF for 3 days (a) TEM 
image of the coating on NiTi alloy; (b) HRTEM image of a mineralized collagen fibril; (c) EDX 
analysis of a mineralized collagen fibril). (Reprinted from Mat. Sci. Eng. C, 29, Yang, X.J., Liang, 
C.Y., Cai, Y.L., Hu, K., Wei, Q., Cui, Z.D., Recombinant human-like collagen modulated the growth 
of nano-hydroxyapatite on NiTi alloy, 25, Copyright 2009, with permission from Elsevier.)
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The distribution of collagen in the coating directly influences the proper-
ties of the uncoated NiTi alloy; thus, it is examined by laser scanning confocal 
microscope (LSCM). The sample after biomimetic growth in 0.5 g/L 1.5CSBF 
for 3 days was washed with phosphate buffered saline (PBS), and then 50 μL 
of 10% BSA was added to block nonspecific antigen and incubated for 20 min 
at room temperature. About 1.5 mL of 1:200 rabbit anti-human collagen I was 
added as the primary antibody and incubated at 4°C for 12 h. After washing 
with PBS, 750 μL of 1:10 rhodamine (TRITC) labeled goat anti-rabbit antibody 
was added as the secondary antibody and then incubated at 4°C for 10 h. The 
distribution of collagen in the coating was observed at the excitation wave-
length of 557 nm and the emission wavelength of 576 nm after the sample 
was further rinsed with PBS. As can be seen in Figure 7.59, the coating exhib-
its uniform red color, indicating the uniform distribution of collagen in the 
whole coating because the collagen was labeled by red colored TRITC.
The amount of collagen in the coating was measured using the Bradford 
method. The coating after biomimetic growth in 0.5 g/L 1.5CSBF for 3 days 
was detached from the substrate and dissolved in 0.1 M HCl. Bradford 
protein assay was used following the standard protocol. BSA was used to 
prepare the standard curve of protein concentration, and the collagen con-
centration was calculated according the measured OD595. The measured 
results are shown in Figure 7.60. The collagen concentration in 0.1 M HCl is 
10–20 μg/mL and 0.3–0.6 wt.% in the coating.
Figure 7.59
(See	color	insert.) Collagen distribution in the coating on NiTi alloy after soaking in 0.5 g/L 
1.5CSBF for 3 days.
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In summary, apatite/collagen composite coating can be self-assembled 
on the chemically treated NiTi alloy. Collagen modulates the growth of 
HA crystals by means of influencing the nucleus critical size and the 
growth rate of crystals. The c-axis of HA is parallel to the longitudinal 
direction of the collagen fibril. These preferentially oriented HA nanocrys-
tals on collagen fibril would give strength, while flexible collagen fiber 
itself gives ductility to implants [91]. Consequently, the hybrid of nano-HA 
crystals and recombinant human-like collagen fibers on NiTi alloy might 
greatly improve the mechanical properties of the coating, especially the 
toughness of the coating. Moreover, the interface between the coating and 
the substrate would become more ductile, and the whole implant material 
would be more bending resistant when used as fracture fixing materials in 
the orthopedic field to exhibit its shape memory effect and bone conduc-
tion function.
7.5	 Conclusions
To make NiTi shape memory alloy bioactive and to use it as hard tissue 
implant, chemical treatment is employed to biofunctionalize NiTi alloy. The 
NiTi alloy is chemically treated by acid, alkali, and precalcification processes. 
Then biological apatite or apatite/collagen composite coatings are grown in 
simulated body fluids (SBF) without or with collagen. After the acid treat-
















Collagen concentration in the coating on NiTi alloy after soaking in 0.5 g/L 1.5CSBF for 3 days.
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An amorphous and fine crystalline sodium titanate layer produced in the 
alkali solution provides numerous nucleation sites for apatite crystals by 
absorbing Ca2+ and PO43− ions on Ti-OH groups in the SBF. More Ca2+ and 
PO43− ions are absorbed on the microscale network during the precalcification 
for accelerating the formation of apatite layer.
A biological apatite layer is grown in the SBF solution on the chemically 
treated NiTi alloy. The apatite-coated NiTi alloy facilitates the proliferation 
of 3T3 fibroblast cells and exhibits a better cytocompatibility than mechani-
cally polished one. Direct bony coverage is observed on apatite coated NiTi 
implants after 6 weeks of implantation, the nature of osteo-bonding forms 
after 13 weeks, and a complete implant–bone interfacial osseointegration is 
achieved after 2 years.
To make the coating resemble natural bone more closely, apatite/collagen 
composite coating is self-assembled on the chemically treated NiTi alloy 
in the collagen containing SBF (CSBF). Apatite crystals and collagen fibrils 
coprecipitate in the CSBF with the c-axis of apatite crystals parallel to the lon-
gitudinal direction of the mineralized collagen fibrils. Collagen modulates 
the growth of apatite crystals by means of influencing the nucleus critical 
size and the growth rate of crystals. Moreover, faster cell proliferation takes 
place on the composite coating grown in the CSBF than that prepared by 
electrochemical deposition.
The biofunctionalization of NiTi alloy by the chemical treatment improves 
its biocompatibility and promotes its osseointegration to host bone, which 
makes the coated NiTi alloy more applicable as bone implant material.
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Titanium (Ti)-based alloys have been widely used in biomedical fields for 
many years, especially commercially pure (CP) Ti, Ti-6Al-4V alloys, and TiNi 
alloys [1], due to their excellent mechanical property and biocompatibility. 
However, extensive medical application of Ti alloy has been hindered for 
a long time owing to its lack of surface biocompatibility [2]. Therefore, it is 
crucial to improve surface biocompatibility and anticorrosion properties 
of titanium and its alloys by activation surface technology for clinical 
applications in the biomedical field.
Bioactive hydroxylapatite (HA) coatings are commonly used to improve 
the biocompatibility and osteoinductivity of the titanium alloy. Titanium 
alloy coated with HA has the advantages of metal and ceramics and 
has been considered as one of the most promising bone replacement 
material. Recently, there has been a tendency to develop HA-contained 
composite coatings to obtain new type of coatings that satisfy the different 
requirements of clinical applications. One type of composite coatings is to 
incorporate biomacromolecules, and the other is to add inorganic materials. 
Different composites have different functions and applications. The addition 
of carbon nanotubes (CNTs) into HA coatings can improve the mechanical 
properties. The preparation of HA/TiO2 composite coating is helpful to 
the augment of corrosion resistance and bioactive properties of Ti alloy 
substrate. The introduction of biomacromolecules, such as collagen, gelatin, 
polyamidoamine, and chitosan, can promote the biological performance and 
exhibit the antibacterial, osteoblastic, and inorganic crystallization functions. 
In this chapter, the recent investigation and application of HA composite 
coatings, including biomacromolecules and inorganic components, on Ti 
alloy are summarized and introduced.
8.1	 HA/CNTs	Composite	Coating
Hydroxyapatite (HA, Ca10 (PO4)6(OH)2) is a very important biomaterial due 
to its structural and chemical similarities to the mineral components of 
natural bones. Because of the poor mechanical properties of HA, however, it 
is difficult to apply the load-bearing parts of the body. Therefore, HA coating 
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on metallic substrates is one of the most promising ways to develop new 
biological bone substitute materials.
In order to improve the mechanical properties of HA, a lot of materials are 
introduced to HA composite material as a strengthening phase, with CNT 
being one of the materials. CNT is a new family of crystalline carbon that has 
special electromagnetic, mechanical, thermal, and other properties. They 
have now become a hot topic since they were found especially in composite 
fields.
The mechanical properties of CNTs are quite prominent, such as high elastic 
modulus and high plasticity. Ti alloy coated with HA/CNTs appear to have 
good biocompatibility and can be used as a hard tissue implant material. The 
HA/CNTs composite coating on the titanium substrate surface combined 
with the advantages of Ti/HA/CNTs must obtain excellent mechanical 
properties and biological properties of complex biological materials and is 
expected as a novel high-performance embedded body material that can 
meet the requirements of weight-bearing parts of the body.
8.1.1 Structure and Properties of CNTs
CNTs were found in 1991 when S. Iijima of NEC Corporation of Japan was 
preparing C60 by arc evaporation of graphite electrodes [3]. Since then, its 
special structure and excellent performance have greatly attracted the interest 
of scientists from various countries. CNTs are typical one-dimensional 
nanostructures, as shown in Figure 8.1. According to the number of graphite 
layers, CNTs can be divided into multiwalled carbon nanotubes (MWCNTs) 
and single-walled carbon nanotubes (SWNTs). Their superior mechanical 
properties, large diameter ratio (typically greater than 1000), excellent 
chemical and thermal stability, and good optical performance enhance their 
application prospects in biosensors, hydrogen storage containers, super 
capacitors, electromechanical actuators, structural reinforcements, and 
other aspects.
CNTs made by a single layer of graphite are called single-walled carbon 
nanotubes (referred to as SWNTs), with a typical diameter and length 
of 0.75–3 μm and 1–50 μm, respectively. SWNTs have a high uniform 
consistency. As an important nanoelectronics material, they can be used 
as conductors, semiconductor materials, as well as microelectronic devices. 
The ones coiled by multilayer graphite are called multiwalled carbon 
nanotubes (referred to as MWNTs), with the number of layers ranging 
from 2 to 50. The stacking is close to ABAB, and the layer spacing is 
0.34 ± 0.01 nm, which is equal to the graphite layer. At the beginning of 
MWNTs formation, it is easy to capture a variety of defects between layers; 
for this reason, MWNTs are usually covered with small holes on the wall-
like defects, which result in a large surface area. In addition, MWNTs have 
many other merits such as high crystallinity, good conductivity, and holes 
diameter concentration [4].
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CNTs usually appear as a dark gray or blue powder-like substance. 
The excellent mechanical properties of CNTs are closely related to their 
microstructure. CNTs are composed of carbon atoms combined with 
strong covalent bonds. The four outermost electrons generate three tracks 
with same energy level by sp2 hybridization, which incorporate with other 
carbon atoms to form a strong binding of σ key. This microstructure makes 
allows CNTs good stability and high modulus of elasticity. According 
to theoretical estimates, the Young’s modulus and shear modulus are 
similar to those of diamond. The theoretical estimate of Young’s modulus 
of SWNTs is up to 5 TPa; according to test measurements, the Young’s 
modulus of MWNT is 1.8 Tpa, flexural strength is 14.2 Gpa, tensile strength 
is about 100 times that of steel, and density is 1/7–1/6 of steel. Although 
the tensile strength of CNTs is high, their brittleness is not as high as that 
of carbon fiber. The carbon fiber will break when the deformation is about 
1%, while the carbon will break in about 18% of deformation. The inter-
laminar shear strength of CNTs reached 500 Mpa, which is higher by an 





Electron micrographs of microtubules of graphitic carbon. (From Iijima, S., Nature, 354, 56, 
1991.) Parallel dark lines correspond to the (002) lattice images of graphite. A cross section of 
each tubule is illustrated. (a) Tube consisting of five graphic sheets, diameter 6.7 nm. (b) Two-
sheet tube diameter 5.5 nm. (c) Severn-sheet tube diameter 6.5 nm, which has the smallest 
hollow diameter (2.2 nm).
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Hui Hu [5] and others modified the surface of CNTs with a chemical 
method. Then, neurons were cultivated using chemically modified CNTs as 
a substrate at a physiological pH of 7.35. Compared with nonmodified CNTs, 
the neurons grow well according to SEM observation, which indicates that 
CNTs have excellent biological activity. Therefore, we can try to explore their 
use in biomedical materials.
8.1.2  Strengthening and Toughening Mechanisms 
of Ha/CNTs Composite
In terms of the nature of CNT/HA, they are nanofiber-reinforced ceramic 
matrix composites. In CNT-reinforced ceramic matrix composites, pulling 
out the bridging and steering mechanism of crack contributes a lot to the 
improvement of strength and toughness. With high axial strength and 
stiffness, CNT can be repeatedly bent and not be destroyed under extreme 
twisted conditions. When the crack propagation in composite materials is 
encountered with CNT, the crack gets blocked. With the improvement of 
applied stress level, CNT begins to pull out because of substrate and CNT 
interface dissociation and the higher strength of CNT than that of the 
substrate. Fracture appears when the pulling out length reaches a critical 
value. (The critical value depends on the interface bonding strength of 
their own strength and CNT.) Therefore, crack propagation must overcome 
the CNT pulling out power and the breaking power, resulting in high-
fracture toughness. In the fracture process, the main crack turns to different 
directions according to the different positions of the fiber breakage, which 
will increase the crack growth resistance (due to crack propagation path 
twists resulting in an increase in the crack surface area) and further enhance 
the toughness [6].
In addition to the increase in CNTs in nanoceramic matrix composites, 
CNTs can suppress nanoceramic grain growth to some extent and pro-
mote the improvement of ceramic density so that they further improve the 
mechanical properties.
8.1.3 Preparation and Characterization of Ha/CNTs Composite Coating
Recently, the formation of CNTs–HA composite coatings has been reported 
using a variety of different techniques, including plasma spraying, laser 
deposition, and electrophoretic deposition (EPD).
8.1.3.1  Plasma Spraying
Plasma spraying is an existing commercially viable technique and has been 
used by researchers to economically coat HA composite coating for real-life 
implants. In recent years, numerous investigations have been carried out 
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to fabricate HA coating or HA composite coating using a plasma spraying 
technique.
With plasma spraying, the powder is sent to plasma flame, heated to melt 
or semimolten state, and then sprayed to the surface from the nozzle at the 
speed approaching or exceeding the speed of sound. The sprayed particles 
deformed after violent collision with the substrate and deposited on the sub-
strate surface. Meanwhile, the coating layer is formed while quench cooling 
and rapid solidification.
The combination of plasma spray coating and the substrate is mainly based 
on mechanical combination. Melting powder particles enter into the surface 
separation and cool down quickly to combine with the substrate by pinning. 
At the same time, HA at high temperatures can react with titanium dioxide [7]:
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To some extent, it can improve the bonding force between the apatite coating 
and Ti substrates.
During the formation of HA composite coating, addition of CNTs aids the 
nucleation sites in the crystallization of HA, preserving its inherent crystal 
structure.
There are various advantages of plasma-sprayed HA coating such as a short 
time to obtain the coating, the high strength (up to 60 MPa) between coating 
and the substrate, etc. So plasma spraying has been the most extensively stud-
ied method of preparation of HA coating. Although plasma-sprayed HA coat-
ings have resulted in successful improvement in promoting bone attachment 
and integration of the implants, the long-term stability of these coatings is still 
a very challenging issue since these coatings tend to have uncontrollable disso-
lution and sometimes exhibit insufficient bond strength to the metal substrate. 
In Balani’s work [8], the coatings bonded well to the substrate and appeared 
uniform in thickness. CNTs are not damaged and are evenly distributed in 
the coating, as shown in Figure 8.2a. The cell growth on HA–CNT surface is 
observed in Figure 8.2b, indicating biocompatibility of this coating. It is impor-
tant to note that biocompatibility and toxicity of CNTs have been debated in 
terms of (i) cell growth and proliferation and (ii) free CNTs in the blood/body.
8.1.3.2  Laser Deposition
In this method, HA + CNT powder is used as preset materials on metallic 
substrates. Then, a laser device is utilized to synthesize composite coating 
with bioactive ceramic under a cladding process (ventilate Ar as protection 
gas) chosen by orthogonal design.
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The microstructure characteristics, hardness, and elastic modulus of the 
laser-surface-alloyed MWNT-reinforced hydroxyapatite composite coating 
have been reported in Chen’s research work [9,10], and the results showed 
that the addition of CNTs has a notable effect on the increase in hardness 
but no strong effect on the increase in elastic modulus, which contributes to 
a decrease in the modulus mismatch relative to the living bone issues under 
the condition of guaranteeing higher strength.
Meanwhile, metallurgical bonding between the HA and the metallic sub-
strate can be easily obtained using laser surface processing. This is very 
useful to improve the mechanical fastening between coating material and 
human bone tissue.
Although CNTs in mixed powders (CNTs mixed with hydroxyapatite 
powder) can form TiC with Ti component in substrates, there are still CNTs 
that are unique tubular or multiparietal structures in the coating.
The nanoindentation technique is used to test the hardness and elas-
tic modulus of HA/CNTs. Under the same pressing conditions, compared 
with HA coating, the plastic deformation of HA/CNTs composite coating is 
improved.
Also, with the increase in CNT in the preset powder, the hardness of 
HA/CNTs is significantly improved because of the residual CNTs and 
TiC in situ formation, especially the CNTs with unique structure in the 
coating. However, the amplitude of increase in elastic modulus is much 
lower than that of the hardness. This is mainly on account of a number of 
structural defects existing in MWNTs, which will result in a decrease in the 
elastic modulus.
In [9], high-quality CNT-reinforced hydroxyapatite composite coatings have 
been successfully deposited on the surface of Ti-6Al-4V substrate using laser 
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Figure 8.2
(a) Cross-sectional image of plasma-sprayed HA-CNT coating, and (b) cell growth, adhesion, 
and proliferation of human osteoblasts on plasma-sprayed HA-CNT coating. (From Balani, K. 
et al., Acta Biomater., 3, 944, 2007.)
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are all of metallurgical fusion bonding. In Figure 8.3, SEM images showed 
that the coatings have a rough surface with interlinking of pores, and TEM 
observation showed that a large amount of CNTs can be found with their 
original tubular morphology, even though some CNTs react with titanium 
element in the substrate during laser irradiation, as shown in Figure 8.4.
8.1.3.3  Electrophoretic Deposition (EPD)
In plasma spray and laser cladding, high temperature leads to a large 
number of HA decomposing to CaO and TCP, which affects the biological 
(a) (b)
050120 25kV ×300 80 µm 050120 25kV ×300 80 µm
(c)
050120 25kV ×300 80 µm
Figure 8.3
SEM micrographs showing the surface morphology of as-alloyed with a powder mixture of 
HA–5% CNTs (a), HA–10% CNTs (b), and HA–20% CNTs (c). (From Chen, Y. et al., Carbon, 44(1), 
37, 2006.)
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activity. Thus, it is necessary to prepare HA/CNT composite coating under 
mild conditions.
The EPD process is promising for producing composite coatings on dif-
ferent substrates for several reasons: simplicity, low equipment costs, lack of 
restrictions on substrate shape, and lack of requirements for binding materi-
als. Most importantly, EPD technology facilitates the fabrication of a homo-
geneous microstructure and porous coating surface, the latter of which is 
beneficial to successful biointegration by the penetration of bone tissue into 
a coating.
To date, there have been several publications that reported the coating for-
mation of CNTs/hydroxyapatite by EPD from suspensions containing CNTs 










TEM image showing the typical morphology of as-prepared CNTs (a), residual CNTs in laser 
surface alloyed coating (b), and the selected area diffraction pattern of HA in the direction of 
[0001] (c). (From Chen, Y. et al., Carbon, 44(1), 37, 2006.)
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According to Yu Bai’s research [11], CNTs and HA were successfully preas-
sembled and deposited onto a titanium substrate by electrophoretic deposi-
tion, as shown in Figures 8.6 and 8.7.
8.1.3.4  Biomimetic Growth
Simulated body fluids (SBF) with ion concentrations similar to those of the 
inorganic constituents of human blood plasma were able to act as a medium 
for the development of a poorly crystallized HA similar to that of bone on 
substrates of different materials. The MWNTs/HA composite material can 
be prepared through chemical biomimetic growth at 37°C chemistry forma-
tion of the composite material. The possible mechanism of the reaction is 
shown in Figure 8.8.
MWNTs with negative charge were achieved by refluxing MWNTs with 
nitric acid. After dispersion in SBF (37°C), MWNT-COOH was found to 
be efficient for the growth of HA from SBF. The high surface area of CNTs 
makes for the reaction of Ca2+, PO43−, and carboxyl-functionalized CNTs in 
SBF and promotes the formation of MWNTs/HA composites.
In Aryal’s work [12], synthesis of hydroxyapatite (HA) using carboxylated 
CNTs was investigated using SBF similar to physiological conditions and 
products tailored to have chemistry found to mimic natural bone. The result 
showed that the carboxylated CNTs were capable of nucleating HA from SBF, 




























Schematic representation of preparation and EPD process of CNTs–HA nanocomposites. 
(From Bai, Y. et al., Mater. Sci. Eng. C, C30, 1043, 2010.)
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Figure 8.6
FE-SEM image of CNTs–HA coatings, deposited at a deposition voltage of 20 V, with a 2 min 
deposition time; arrow shows HA particles loaded to the CNTs. (From Bai, Y. et al., Mater. Sci. 
Eng. C, C30, 1043, 2010.)
(b)
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XRD patterns of (a) as-prepared CNTs–HA nanocomposites and (b) CNTs–HA nanocomposites 
after hydrothermal treatment. (From Bai, Y. et al., Mater. Sci. Eng. C, C30, 1043, 2010.)
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8.1.3.5  Electrochemical Deposition
The preparation of ceramic materials by electrochemical deposition started 
late; we have not seen any related research literature until 1991. For the pur-
pose of simulating the environment of the human body, the SBF is adopted 
for electrochemical deposition. The biologically active apatite is prepared, 
and the formation mechanism of apatite is discussed further.
The basic principle of electrochemical deposition of calcium phosphate 
compounds is as follows: Ca2+, PO43− in electrolyte near the cathode will pre-
cipitate due to a certain degree of supersaturation in the higher pH environ-
ment. A number of factors have an effect on the crystallization process such 
as the electrode materials, electrolyte composition, deposition model, and its 
current and voltage parameters, as well as the deposition temperature, the 
electrode surface mass quality conditions, and deposition time. The initial 
crystal charge of calcium phosphate obtained by biomimetic deposition in 
SBF provides sites for the nucleation of HA. At the same time, under the 
load current, Ca2+, PO43− ions will attract the MWNT in solution to promote 
self-assembly of MWNTs to form a mesh structure on the substrate sur-

















































Schematic representation of hydroxyapatite growth on MWNTs-COOH matrix. (From Aryal, S. 
et al., Mater. Sci. Eng. A, 426, 202, 2006.)
















SEM micrographs of MWNTs-HA composites recorded after (a) 7, (b) 14, and (c) 21 days of reac-
tion under ambient conditions. Micrographs (d) 7, (e) 14, and (f and g) 21 days are of MWNTs-HA 
composites synthesized at 37°C. (From Aryal, S. et al., Mater. Sci. Eng. A, 426, 202, 2006.)
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Meanwhile, the mineralization reactions in solution are engaged and are 
beneficial for the formation of calcium phosphate. Calcium phosphate will 
grow up on the initial crystal grain on the substrate surface. There is a 
mutual promotion between MWNTs self-assembly and the formation of cal-
cium phosphate. They are both deposited on the substrate surface, and the 
calcium phosphate turns to the most stable structure of hydroxyapatite in a 
suitable current density and temperature condition. Finally, we get the HA/
MWNTs composite coating.
Bone-HA or high degree of crystallinity of pure HA is prepared by electro-
chemical methods under mild conditions. The mechanism of electrochemical 
methods is inconclusive because the electrochemical process and ion reaction 
are more complex. Whether there is a precursor or not in the electrodepo-
sition process is the focus of the debate. But one thing is certain: the pH 
directly affected the solution supersaturation of calcium and phosphorus, 
and thus the nucleation and growth of HA are affected.
In our research group, the HA/MWNTs composite coating is prepared on 
the surface of NiTi alloy by the electrochemical deposition method, as shown 
in Figures 8.10 and 8.11. We can conclude that the coating is uniform and 
dense, morphology is lamellar structure, and the crystallinity is good.
8.1.4 Property evaluation of Ha/CNTs Composite Coating
The main properties of HA/CNT composites are mechanical and biological. 
The mechanical properties determine materials bearing effect and durabil-
ity, while the biological properties determine the compatibility, bone con-
duction, and toxic reactions of implanted materials. These properties play a 
decisive role in determining the success of implanted materials.
NONE NONESEI SEI10.0kV 10.0kV×5,000 ×10,0001µm 1µmWD 8.2 mm WD 7.6 mm
Figure 8.10
Morphology of HA/MWNTs composite coating on the surface of NiTi alloy. (From Yu, W., 
Preparation of HA/MWNTs composite coating on the surface of NiTi alloy, Master degree 
thesis, Tianjin University, Tianjin, China, vol. 33, pp. 37–38, 2008.)
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8.1.4.1  Mechanical Properties
The mechanical properties involved in CNT/HA are very extensive, but 
most current studies focus on toughness, wear resistance, and coating 
bond strength. Han Huijuan et al. [14] have studied the bonding strength 
of MWNTs/HA composite coatings by bonding tensile test, whose results 
show that the bonding strength of MWNTs/HA composite coating and the 
substrate obtained by electrophoresis deposition increased significantly. 
Compared with pure HA, the bonding force of the composite coating and the 
substrate increased from 20.6 to 35.4 MPa. MWNTs in the HA coating play an 
extremely important role in toughening and strengthening.
Balani et al. [8] investigated the friction properties of the CNTs/HA coat-
ing in physiological solution. The results show that the wear rate of the com-
posite coating and the substrate significantly reduced than the pure HA and 
wearing capacity was low. As time increased, the amount of wear capacity 
increased very little. This indicates that HA-CNTs composite coatings have 
excellent wear resistance. The wear resistance was improved and attributed 
to not only the deformation of CNTs and self-lubrication but also the func-
tion of bridging and stretching.
Chen used the nanoindentation technique to study the variation of the 
mechanical properties, as shown in Figure 8.12. It shows that the load 
increases with increasing content of CNT in the powder mixtures, indicat-
ing that the higher the content of CNTs, the higher the hardness and the 
elastic modulus. After removal of the indenter tip, the plastic deformation 
of CNT-free coating is about 1480 nm, while it is 1290 nm for the HA–20% 
100  nm 10  nm
Figure 8.11
TEM images of HA/MWNTs composite coating on the surface of NiTi alloy. (From Yu, W., 
Preparation of HA/MWNTs composite coating on the surface of NiTi alloy, Master degree 
thesis, Tianjin University, Tianjin, China, vol. 33, pp. 37–38, 2008.)
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CNTs coating. This means the CNT-free hydroxyapatite coating undergoes a 
larger plastic deformation during nanoindentation experiments.
8.1.4.2  Biological Properties
The evaluation of biological properties commonly includes two stages of 
the in vivo and in vitro studies. At present, the studies of HA/CNT com-
posite coating biological properties are still in in vitro stage, while there 
is less investigation of long-term performance (including biological and 
mechanical properties) for HA/CNT composite coating materials implanted 
in animals.
Han Huijuan et al. [14] with others conducted an in vitro cell culture exper-
iment. The results show that cells can adhere well to the surface. Balani [8] 
simulated artificial bone cells in vitro of the CNTs/HA composite coating. 
They found that the osteoblasts grew limitlessly along the surface of CNTs 
and then embedded in the substrate, which indicates that the composite is 
nontoxic. HA precipitated and mineralized on the surface, and crystallinity 























Typical load–displacement curves of laser surface alloyed coating with different content of 
CNT. (From Chen, Y. et al., Carbon, 44(1), 37, 2006.)
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8.2	 HA/TiO2	Composite	Coating
Titanium and its alloys are very suitable materials for dental and orthopedic 
implants due to their excellent mechanical properties and biocompatibility. 
However, they also have some disadvantages, such as poor corrosion resis-
tance and bad bioactive properties.
For example, despite the satisfactory clinical use of NiTi alloy in biomedical 
applications, NiTi is still a controversial biomaterial for the possibility that 
Ni may dissolve from NiTi due to corrosion [15]. The Ni content in the alloy 
is of great concern with regard to its biocompatibility when its ion releases 
into the human body. In order to improve the corrosion resistance of the NiTi 
alloy, a protective nickel-free oxide layer can form on the surface of NiTi for 
improved biocompatibility.
In fact, the biocompatibility of titanium and its alloys is closely 
related to the properties of the surface oxide layer. The native oxide that 
spontaneously forms on the titanium surface in ambient air is amorphous 
and is known to be bio-inert. Crystalline phases of TiO2 occur naturally 
as rutile, anatase, and brookite. Rutile is the thermodynamically stable 
phase and can be formed on titanium by heat treatment [16]. Anatase and 
rutile have good apatite-forming ability. Therefore, titanium oxide (TiO2) 
coating has been considered to improve the corrosion resistance and 
restrain Ni release.
TiO2 coating on titanium alloys has recently shown promising in vivo cor-
rosion behavior, acting as a chemical barrier against release of metal ions 
from the implant. However, it is difficult to achieve chemical bond with bone 
and form new bone on the implant with only TiO2 surface at an early stage. 
In order to further improve bioactivity of the implant, it is necessary to pre-
pare hydroxyapatite (HA) on the TiO2-coated surface.
A double-layer HA–TiO2 coating on titanium or its alloys with HA as the 
top layer and a TiO2 coating as the inner layer should show a very good 
combination of good corrosion resistance and bioactive properties.
8.2.1 Duplex Treatments for Preparation Ha/TiO2 Composite Coating
TiO2 film can be prepared by methods such as heat treatment, chemical 
treatment, chemical vapor deposition, and sol–gel dip coating technique. 
Several coating methods such as plasma spray, electrophoretic, sol–gel, and 
electrochemical deposition are usually used to prepare HA coating on the 
implant surfaces.
8.2.1.1  MAO Combined with Other Treatments
Microarc oxidation (MAO), also called microplasma oxidation, has attracted 
more and more attention by virtue of its convenience and effectiveness in 
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preparing oxide ceramic coatings on the surface of titanium or its alloys [15]. 
By applying a positive voltage to Ti or its alloy substrate immersed in an elec-
trolyte, a microarc occurs, and a TiO2 coating on the surface is formed when 
the applied voltage is increased to a certain point. The formed TiO2 film is 
porous and beneficial for the biological performance of the implants. An 
advantage of MAO process is that the formed TiO2 coating is in situ formed 
on titanium surface and thus bonds to titanium substrate firmly. The MAO 
process also has the potential to prepare coatings on metal surfaces with 
complex geometry [17].
During the early beginning of the MAO process, a compact film forms in 
the electrolyte. With the increment of the voltage, microarcing appears due to 
electrical breakdown of the dielectric layer, resulting in a porous microstruc-
ture on the titanium surface. The surface morphology of the Ti after MAO 
in electrolyte containing calcium and phosphate is shown in Figure 8.13. 
Microspores, protuberant areas, and concave areas were observed on the film, 
which made the film rough. The pores are channels of microarc discharge in 
electrolyte. The MAO coating should act as a barrier to the release of metal 
ions to human body and avoid deleterious effects.
The titanic coating is mainly composed of anatase structure containing 
rutile (as shown in Figure 8.14). With the applied voltage increasing, some 
anatase may translate to rutile.
Another advantage of the MAO process is the possibility of incorporating 
element in the electrolyte into the coating by controlling the composition 
and concentration of the electrolyte. Titanium oxide coating containing Ca 
and P can form on titanium substrate by MAO in electrolyte containing 
(CH3COO)2Ca·H2O and NaH2PO4·2H2O. The XPS spectra of a sample 
subjected to MAO treatment reveal that the outer layer of the MAO sample 
25 µm
Figure 8.13
Surface morphology of the MAO sample. (From Liu, S.M. et al., Mater. Lett., 65(6), 1041, 2011.)
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contains Ca, P, C, and O elements (as shown in Figure 8.15). The porous 
coating containing Ca and P ions can enhance the bonding between the 
implants and the bone.
HA/TiO2 composite coating on titanium and titanium alloy can be 
prepared by MAO combined with subsequent treatment.




















































XRD pattern of the MAO samples. (From Liu, S.M. et al., Mater. Lett., 65(6), 1041, 2011.)
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XPS survey of the MAO coating. (From Liu, S.M. et al., Mater. Lett., 65(6), 1041, 2011.)
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8.2.1.1.1 MAO and Electrophoretic Deposition
X. Nie made efforts to improve implant biocompatibility and durability. 
Ti-6Al-4V was used as the substrate. A relatively thick and hard TiO2 coat-
ing can be produced by MAO treatment, and then a pure HA coating with 
an intermediate HA/TiO2 composite layer deposited on top of the TiO2 layer 
can easily be formed by hybrid MAO treatment and electrophoretic deposi-
tion. The porous TiO2 surface is helpful in anchoring the HA powder to the 
surface to allow sintering to occur [19].
The adhesive strength between the coating and substrate was assessed 
using scratch adhesion testing. The result indicated that the adhesion upper 
critical loads of the TiO2 coating and HA/TiO2 coating were 8 and 10 N, 
respectively. Relatively high adhesive strength was achieved.
8.2.1.1.2 MAO and Electron Beam Evaporation
For deposition, anodized surface and calcium phosphate deposition by 
electron beam evaporation methods were combined. Han Li prepared the 
titanium samples of microarc oxidized surface (anodized Ti) and anod-
ized surface deposited with calcium phosphate thin film (coated Ti) by 
this way [20]. The porous oxide layer of an anodized Ti surface is shown in 
Figure 8.16a. After deposition of calcium phosphate, no obvious differences 
of morphology were observed (as shown in Figure 8.16b).
The film consisted of HA, b-TCP, and calcium oxide (CaO) before heat 
treatment. After heat treatment, the particle grows larger and only HA was 
detected.
8.2.1.2  Heat Treatment and Biomimetic Deposition
In order to transform titanium surface into rutile, commercially pure tita-
nium plates were oxidized in a furnace. Small faceted crystals that describe 
the topography constitute the surface (Figure 8.17). X-ray diffraction analysis 
(a) (b)
10 µm 10 µm
Figure 8.16
Surface morphology of samples: (a) anodized Ti and (b) coated Ti. (Li, Y. et al., Biomaterials, 29, 
2025, 2008.)
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shows that the titanium surface has been transformed into rutile after the 
heat treatment (see Figure 8.18).
After cleaning the samples with agent and ethanol, they were exposed 
to phosphate-buffered saline (PBS) to deposit HA. PBS is a solution with 
pH and ion concentrations similar to those of human blood plasma. HA 
coating had formed on the rutile surface after immersion for 7 days (see 
Figures 8.19 and 8.20). When the rutile surface is exposed to body fluids, 
OH groups adsorb to the titanium ions in the oxide and negative Ti–O 
groups are formed over it. These negative sites attract Ca2+ ions from the 
body fluid. A layer of amorphous calcium titanate is formed, and the 
surface becomes slightly positively charged. It will then attract negatively 
charged phosphate ions and calcium phosphate is formed. This layer is 
then crystallized into bone-like apatite because it is thermodynamically 
more favorable in a wet environment [16].
A scratch test was used to evaluate the adhesion of the coating/substrate 
composite. The critical pressure for the coating to detach from the substrate 
was estimated to be 2.4 ± 0.1 GPa. When the critical pressure was reached, 
large pieces of the coating started to detach from the substrate.
8.2.1.3  Anodization and Electrodepositon
Anodization and electrochemical technique have been developed to form 
HA/TiO2 composite coating on a titanium substrate [21]. Initially, Ti substrate 
was anodized in an acidified fluoride solution to prepare TiO2 nanotubes 
(Figure 8.21a). Vertically oriented TiO2 nanotubular arrays acted as templates 
200 nm
Figure 8.17
Surface morphology of the oxidized sample; the sample is tilted 70°. (From Forsgren, J. et al., 
Acta Biomater., 3, 980, 2007.)
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Figure 8.18
XRD of oxidized titanium where all peaks correspond to rutile TiO2. (From Forsgren, J. et al., 
Acta Biomater., 3, 980, 2007.)
2 µm
Figure 8.19
Surface morphology of the HA deposited on rutile TiO2; the sample is tilted 70°. (From Forsgren, J. 
et al., Acta Biomater., 3, 980, 2007.)
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and anchorage for growth of the apatite nanocrystals during subsequent 
electrodeposition process (as shown in Figure 8.21b).
During the anodization process, phosphate ions can incorporate in the 
TiO2 lattice, which is proved by the peak at 133.8 eV (as shown in Figure 8.22). 
The presence of phosphate ions could facilitate nucleation of calcium phos-
phate within the nanotubes. Growth of HA inside the nanotubes would give 
anchoring effect to the electrodeposition, which will enhance the interfacial 
bond strength between TiO2 and HA coating.
Anodized sample was pretreated with NaOH solution subsequently. The 
result showed that a “ring-like” structure was observed at the neck of the 













XRD showing HA formation on rutile. (From Forsgren, J. et al., Acta Biomater., 3, 980, 2007.)
(a)
T8 1.0 kv SE(U) 500 nm
500 nm
CTi2 3.0 kv SE(U)4.9 mm ×80.0 k4.8 mm ×100k
(b)
Figure 8.21
Morphology of the TiO2 nanotubes: (a) top and (b) side views of the nanotubes. (From Kar, A. 
et al., Surf. Coat. Technol., 201, 3723, 2006.)
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rings (as shown in Figure 8.23). The sodium titanate was benefited to enhance 
the formation of the HA coating.
The morphology of crystalline HA on NaOH-treated anodized titanium 
after electrodeposition process is shown in Figure 8.24. The electrodeposi-

















P2p XPS spectrum of the TiO2 nanotubular sample anodized in phosphate solution. (From 









Full scale 1742 cts cursor: 0.000 keV keV
Figure 8.23
FESEM micrograph and EDAX analysis of the sodium titanate rings on the nanotubular TiO2. 
(From Kar, A. et al., Surf. Coat. Technol., 201, 3723, 2006.)
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temperature, so unwanted phase changes could be avoided. Complex shapes 
can be electrodeposited, and this process is relatively inexpensive.
The bond strength of the hydroxyapatite coating on the implant material 
is very important because it has to withstand bone growth stress. Heat 
treatment of the electrodeposited HA coating resulted in a bond strength of 
40 MPa.
8.2.2 One-Step Synthesis
Apatite/titania coating was prepared on commercial pure titanium by micro-
arc oxidation in electrolyte containing calcium and phosphate. Commercial 
pure titanium was used as the substrate material. The electrolyte containing 
(CH3COO)2Ca·H2O and NaH2PO4·2H2O was prepared [18].
Figure 8.25a shows the surface morphology of MAO-treated samples. 
The pores on the surface are probably caused by the oxygen bubbles pro-
duced in the anodic reaction during the MAO process. The porous surface 
of an implant is beneficial to bone tissue growth and enhanced anchorage of 
implant to bone. Furthermore, the microporous structure may be valuable 
as a depot for bioactive constituents and has the function of an enhanced 
cell proliferation. The cross section of the coated sample exhibits apparently 
three layers, which in turn are apatite, TiO2, and Ti substrate from the outside 
to inside (as shown in Figure 8.25b). No obvious discontinuity is observed 
among the three layers, indicating that the composite coating can be tightly 
adhered to the substrate. Such MAO films are expected to have significant 
applications as artificial bone joints and dental implants [22].
NaOH.HA 33.0 kV SE(U) 1/18/05 1.00 µm14.3 mm  ×45.0 k
Figure 8.24
Side view of crystalline HA deposition on NaOH treated anodized titanium. (From Kar, A. 
et al., Surf. Coat. Technol., 201, 3723, 2006.)
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The pattern of sample subjected to MAO treatment exhibits diffraction 
peaks of anatase and hydroxyapatite. Three peaks at 26°, 32°, and 49° are 
indexed as (002), (211), and (213) plane of hydroxyapatite (as shown in 
Figure 8.26).
FT-IR spectra of the powders scratched from the coating are shown 
in Figure 8.27. The CO32− absorption band is detected by the characteristic 
5.0 kV 11/28/2009 20 Out
(a) (b)
30 Out15.0 kV SE(M) 08 436/20/2009 15.1 mm ×1.50kTOCLS4800SE(M)10.3 mm ×2.00 k
Figure 8.25
(a) Surface morphology and (b) cross-sectional view of the MAO sample. (From Liu, S.M. et al., 
Mater. Lett., 65(6), 1041, 2011.)





















XRD pattern of the MAO sample. (From Liu, S.M. et al., Mater. Lett., 65(6), 1041, 2011.)
388 Hydroxyapatite Coatings for Biomedical Applications
stretching mode of CO32− group at 1450 cm−1, but the characteristic OH bands 
of hydroxyapatite at 3560 cm−1 are not clearly visible, indicating that carbonate 
incorporated to apatite and formed a carbonate apatite. The CO32− would be 
generated from decomposition of (CH3COO)− or absorption of atmospheric 
CO2 at ambient temperature.
8.2.3 evaluation of the Ha/TiO2 Composite Coating
8.2.3.1  Stability and Bioactivity of the Coating
It has been revealed that an essential requirement for an implant material 
to bond to living bone is via the formation of a bioactive bone-like apa-
tite layer on its surface in the body. Therefore, the in vitro apatite forming 
ability of the material surface is an important assessment to evaluate the 
bioactivity of the implants. In addition, the layer may be scratched during 
operation accidentally or dissolved after implantation by contacting with 
the body fluids. So a bioactive and stable coating for an implant material 
is prerequisite.
In order to evaluate the stability and bioactivity of coating, much efforts 
have been made to investigate the immersion behavior of coating in 
solutions, such as Hank’s balanced salt solution (HBSS), phosphate buff-
















2000 2500 3500 40003000
Figure 8.27
FT-IR spectra of the powders scratched from the coating. (From Liu, S.M. et al., Mater. Lett., 
65(6), 1041, 2011.)
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reproduce in vivo surface changes due to the same ion concentrations as 
those of the human blood plasma. For example, the SBF is usually prepared 
by dissolving reagent-grade mixtures of CaCl2, K2HPO4·3H2O, KCl, NaCl, 
MgCl2·H2O, NaHCO3, and Na2SO4 in distilled water and buffering at 
pH 7.40 with tris-hydroxymethyl aminomethane and hydrochloric acid 
(HCl) at 37°C. In order to accelerate the rate of apatite formation, 1.5 SBF 
is usually prepared. These in vitro studies are important in a practical 
sense in that they could give some indication of the in vivo behavior of 
the coating.
Han Li had immersed the anodized Ti and anodized Ti coated with cal-
cium phosphate (coated Ti) in DPBS solution for determined intervals [20]. 
The DPBS solution was prepared by dissolving Dulbecco’s PBS and reagent-
grade CaCl2 in ultra-pure water. The coated surface exhibited apatite for-
mation as shown in Figure 8.28. A newly formed homogeneous layer was 
observed on the coated surface after incubation in DPBS solution after only 
1 h and the bigger flake-like crystals appeared after 24 h of incubation, while 
no apparent changes appeared on the anodized surface of Ti until 24 h of 
immersion in DPBS solution. The XRD pattern also demonstrated the new 









Surface morphologies of sample anodized Ti after incubation in DPBS solution for (a) 1 h and (c) 
24 h, and sample coated Ti after incubation in DPBS solution for (b) 1 h and (d) 24. (From Li, Y. 
et al., Biomaterials, 29, 2025, 2008.)
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8.2.3.2  Corrosion Resistance
Nie investigated the corrosion resistance of the Ti alloy with HA/TiO2 
coating [19]. For comparison, the potentiodynamic polarization curves of the 
TiO2-coated Ti alloy and uncoated Ti alloy in the buffered physiological solu-
tion are also plotted in Figure 8.29. The HA/TiO2-coated Ti alloy possesses 
the lowest corrosion current. The TiO2-coated Ti alloy shows the highest cor-
rosion potential, while the uncoated Ti alloy gave the lowest corrosion poten-
tial and the highest corrosion current. This result showed that the duplex 
treatment of MAO and electrophoretic deposition could provide an anticor-
rosive HA/TiO2 composite coating on Ti alloys.
8.2.4 application of Ha/TiO2 Composite Coating
Han Li had implanted samples of anodized Ti and samples of anodized 
Ti coated with calcium phosphate (coated Ti) in four male minipigs for 
8 weeks [20]. Two groups of implants were placed on each side, respectively. 
Throughout the course of the study, all animals were healthy and tolerated 
all procedures well. At necropsy, no abnormal findings were found macro-
scopically. Radiographs of each mandible taken immediately after sacrifice of 
the animals were used to locate the implants. The implants contacted closely 
to the host bone (as shown in Figure 8.30). The typical sections comprising 
the implant and surrounding tissues are shown in Figure 8.31. Appositional 
bone formation occurs around the surfaces of the two groups of implants. 
Compared to the anodized implants, anodized implants coated with calcium 
phosphate have an improved characteristic of contact osteogenesis in soft bone. 
The calcium phosphate coating did not separate from the implant surfaces.
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Potentiodynamic polarization curves of samples. (From Nie, X. et al., Surf. Coat. Technol., 125, 
407, 2000.)
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8.3	 HA/Collagen	Composite	Coating
Human bone is a bioceramic composite that is mainly composed of calcium 
phosphate (69%), collagen (20%), and water (9%). Other organics, such as 
proteins, polysaccharides, and lipids, only account for a small percentage. 
Calcium phosphate exists in the form of a certain degree of crystallization 
HA, which can ensure the rigidity of the bone.
The main ingredient in the organic part is collagen fibers, which make the 
bone flexible and elastic. From the view of bionics, it is the best when the 
synthetic materials are designed on the basis of natural bone composition 
and structure. There is no doubt that nanohydroxyapatite/collagen composite 
materials must have good mechanical properties and biological characteris-
tics because the structure and chemical composition are similar to the natural 
bone. Compared to a pure HA layer, this organic–inorganic composite layer 
has a better application prospect. Therefore, in order to develop better sur-
face treatment technologies for implant materials, apatite/collagen composite 
coatings formed on the surface of titanium and its alloys have attracted many 
researchers’ attention.
Figure 8.30
Radiograph of implant sites. (From Li, Y. et al., Biomaterials, 29, 2025, 2008.)
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8.3.1 Collagen and its Characteristics
Collagen is a type of protein, mainly existing in animal skin, bone, cartilage, 
teeth, tendons, ligaments, and blood vessels. As a very important structural 
protein of connective tissue, it supports organs such as the heart, kidneys, 
liver, and lungs and protects organisms. Collagen is the most abundant 
protein present in mammals, composing 25%–30% by weight of body protein 
tissue [23].
Like other proteins, collagen has a quaternary structure, which plays a 
decisive role in determining its molecular size, shape, chemical reactivity, 
biological functions, and so on. Figure 8.32 gives the hierarchical design of 
collagen. The primary structure points to the arrangement of amino acids in 
the protein molecules. There is peptide bond between amino acids. It is the 
basic structure of protein, while the secondary structure, tertiary structure, 
and quaternary structure are three-dimensional structures of protein mol-
ecules as the high-level structure of protein molecules.
The structural features of collagen range from the amino acid sequence, 
tropocollagen molecules, collagen fibrils to collagen fibers.
(a) (b)
Figure 8.31
Light micrographs of the implant sites after 8 weeks of healing: (a) anodized Ti; (b) coated Ti 
(original magnification × 10). (From Li, Y. et al., Biomaterials, 29, 2025, 2008.)
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Collagen exists in the human body in the form of collagen fibers. The 
smallest unit of collagen structure is called tropocollagen molecules with 
diameters of about 1.5 nm, lengths of approximately 280 nm, and relative 
molecular mass about 300,000. Each procollagen molecule consists of three 
α-peptide chains, which have α-helix structure. Three α-peptide chains are 
entangled into a rope-like structure in parallel, right-handed forms and 
then formed collagen fibers by multistage polymerization in molecules. The 
three forces to stable collagen triple helix are the van der Waals force and the 
hydrogen bonds between spirals and the covalent cross-links [25].
Some of the basic physical and chemical properties of collagen are as fol-
lows: collagen is a poly-ampholyte, which is due to each peptide chain of 
collagen having a lot of acid or alkaline lateral groups, and both ends of each 
peptide chain are determined by α-carboxyl and α-amino. These groups 
have the ability to accept or give protons. In a certain pH, collagen solu-
tion has no charge, in the state of zwitterionic, meaning that it has the same 
positive charge and negative charge (zero charge). We defined the PH as the 
isoelectric point of collagen. The isoelectric point of collagen is pH 7.5–7.8, 
showing alkaline. The isoelectric point of collagen is quite different when it 
is prepared by alkaline and acid methods.
Collagen has colloidal properties in aqueous solution combined with water 
molecules by hydrogen bonding. There is a water membrane around the col-
lagen molecules, and then hydration occurs. If the temperature is increased 
and the water immersion time is extended, the collagen can further absorb 










The hierarchical design of collagen. (From Buehler, M.J., Curr. Appl. Phys., 8, 440, 2008.) The 
structural features of collagen ranges from the amino acid sequence, tropocollagen molecules, 
collagen fibrils to collagen fibers.
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collagen solution may freeze and precipitate. The denatured reaction is 
called collagen gel. The reactions of collagen with nitrite, formaldehyde, and 
ninhydrin can be used to determine amino acids. The ionic bond of collagen 
in salt solution will be opened, thus swelling.
The collagen-specific triple helix structure is responsible for many useful 
features of amino acids, such as high tensile strength, biodegradability, low 
antigen activity, low irritation, low cell toxicity, and promotion of cell growth. 
All these characteristics make it become an ideal biomedical material.
8.3.2 Preparation of Ha/Col Composite Coating
The aim of preparation of HA/COL composite coating on metal substrate is 
trying to combine the advantages of metal and coating to create a more useful 
hard tissue replacement materials. However, because collagen is a low melt-
ing point organic polymer, a lot of the traditional methods to prepare HA 
coating are no longer applicable (such as plasma spraying and laser coating). 
At present, the main methods of preparation of HA/COL composite coat-
ing on metal substrate includes biomimetic coating procedures, the electro-
chemical co-deposition method, and electrospray deposition (ESD) process.
8.3.2.1  Biomimetic Growth Method
Biomineralization is a process involving nucleation, growth, and phase 
transformation to obtain a biomineral material with a highly ordered struc-
ture. This process occurs when it is under certain conditions, in different 
parts of the organism, with a variety of different ways, and under the influ-
ence of the organic substance. The interaction of organic molecules and inor-
ganic mineral ions at the interface controls the precipitation of inorganic 
minerals at the molecular level, which gives the mineral a special high-level 
biological structure and assembly methods. Biomineralization has a special 
reaction medium.
The growth process of HA/COL composite coating on titanium surface is 
similar to the mineralization process in vivo, including the preorganization 
of organic molecules, the recognition of interface molecular, growth modula-
tion, and cell processing these four stages. Specifically, it is the accumulation 
of calcium and phosphorus ions in intracellular and extracellular matrix. 
When it is up to a specific saturation, it will become a nucleation in the matrix 
protein and then grow and form a hard tissue together with the substrate.
The collagen-specific three-dimensional configuration and certain chemi-
cal groups (lysine, hydroxyproline groups) can combine with phosphate to 
induce the crystallization of calcium phosphate so as to promote the calcifi-
cation process. Collagen plays the role of nuclei in the inorganic deposition 
process. It is a site of starting the crystallization. It has been proven that colla-
gen can covalently combine with a small amount of phosphate and the serine 
residues or carbonyl take the priority.
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In the process of bone formation, millions of collagen molecules self-
assemble into collagen microfibers through the interaction of side chains and 
the connection of end to end. The diameter is about 20–500 nm. The process 
of bone formation in hydroxyapatite nucleation sites on the collagen fibers is 
very similar to the cyclical nature of its mechanism of nucleation, which can 
be explained in Figure 8.33. Controlled nucleation and growth are accom-
plished within the fiber cell formed in the collagen matrix microstructure. 
Collagen molecules self-assemble into microfibrils. There are interspaces or 
holes with sizes of 40 nm at the terminals of two molecules. The microenvi-
ronment in holes contains free mineral ions and side chain groups among 
which there is a certain molecule period to promote heterogeneous nucle-
ation of mineralization phase. From Figure 8.34, obvious collagen fibers with 
a diameter of about 200–300 nm can be seen. The calcium and phosphorus 
compounds grow on and around collagen fibers whose diameter is about 
50 nm. The particles on collagen fibers grow periodically. And the interval is 
approximately 600–700 nm.
Cai Yanli et al. [28] prepared the HA/COL composite layer using the bio-
mimetic method on titanium surface, as shown in Figure 8.35. The morphol-
ogy of the composite coating was uniform and compact calcium phosphate 
particles with some colloidal and elliptical particulates, and the micromor-
phology of that was bone-like lamellar structure.





































































Schematic map of collagen compartments localizing a microenvironment which serves to 
nucleate the mineral phase heterogeneously. (From Qiyi, Z., The fabrication and bioactivity 
study of Ca-P coatings on titanium surface, Doctoral dissertation, Sichuan University, Sichuan, 
China, p. 110, 2003.)
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The formation mechanism is as follows. After acid–alkali treatment, there 
is a negatively charged microstructure on the sample surface. After precal-
cification process, the negatively charged surface gathered a large amount of 
Ca2+ and PO43− ions for the sake of static electricity, and the initial nucleation 
of calcium phosphate salt formed. Then under the control of the collagen, 
apatite crystals form nucleation on the organic/inorganic interface in the 
CSBF solution. With extension of growth time, the nuclei ultimately change 
into a HA/collagen composite layer under the influence of the transport rate 
and association rate of ions in solution.
8.3.2.2  Electrochemical Deposition
In the past researches, several different methods have been employed to 
deposit bone-like apatite coating onto metallic implant surface. Electro-
chemical deposition (ELD) is one of the most attractive methods because 
with it irregularly shaped substrates can be coated relatively quickly. 
Additionally, the corresponding devices for ELD are simple and convenient.
The possible mechanism for the present electrolytic deposition of HA/
collagen coating is understood as follows. First of all, the electroreduction 
of water molecules at the cathode surface leads to the pH increase due to 
the generation of OH− ions around Ti alloy and produced hydrogen gas, as 
shown in the following electrochemical half reaction:
 2 22H O 2e H OH2 + → +
− −
WD  9 .4 mm    5 .0 kV ×60k       500 nm
Figure 8.34
Micromorphology of composite coating on the surface of Ti alloy: (a) 0.5 g/L CSBF 12 h. (From 
Yanli, C., Formation of HA/COL composite coatings on the surface of Ti and NiTi alloy, Master 
degree thesis, Tianjin University, Tianjin, China, p. 22, 2005.)
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The hydroxide ions generated at the cathode surface then reacted with dihy-
drogen phosphate in MSBF to form PO43− in succession:
 
H PO OH H PO H O













The following reaction resulted in the formation of HA:




10 4 6 2Ca PO OH Ca PO OH+ − −+ + → ( ) ( )
At the beginning of the ELD process, Ca2+ ions are first attached to the cath-
ode as the nucleation of CaP. When the titanium surface is covered with Ca2+ 
ions, the surface tends to attract negative ions, and this hierarchical organi-
zation is growth of CaP. As the pH of the electrolyte is adjusted to the isoelec-
tric point of collagen or even lower, positively charged collagen molecules 






SEM micrographs of the coatings deposited in CSBF (a, b for 3 and 7 days) and SBF (c, d for 
3 and 7 days). (From Yanli, C. et al., Scripta Mater., 54(1), 89, 2006.)
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are drifted toward the titanium substrate and are deposited together with 
calcium phosphate.
The COL molecules experience a transformation from amphoteric ion 
balance to the electronegative molecules with the pH increase (P is peptide 
chain):
 − − − + → − − − +
+ − +OOC P NH OH OOC P NH H O23 2
It was believed that there were chemical interactions between the −COO− 
group in the COL molecules and HA crystal in the co-precipitation process. 
Thus, the formation of negative charge ion −COO− could induce the HA/
COL composite precipitate.
With the proceeding of the cathode reaction, more OH−ions gather around 
the Ti substrate, thus a pH gradient occurs around the titanium surface. 
Simultaneously, collagen is negatively charged when the local pH rises to the 
isoelectric point of collagen or even higher and is drifted away from cathode. 
If pH arrives at the isoelectric point of collagen, collagen fibril comes to its 
self-assembling process, which means the collagen fibril is fixed at the equi-
librium position accompanying the absorption of Ca2+ ions and phosphate 
group ions on itself. The mineralized collagen and the CaP layer combines 
with the ionic bond, which means the formation of the coating. The equilib-
rium position is determined by the voltage.
Collagen plays three roles in the formation of coatings: (1) increase the 
viscosity of the solution, which makes for generating relatively stable 
hydrogen bubbles to form a “bubble template,” promoting the growth of 
HA whiskers along the bubble wall. Finally, porous coating with nanomi-
cron secondary structure was prepared. (2) In the process of HA crystalli-
zation, it can play a part in inducing HA nucleation formation and growth 
and influencing the growth orientation of HA crystal and grain geometric 
scale. Fan Yuwei et al. [29] consider that the presence of calcium ions in solu-
tion will also promote collagen deposition at the cathode interface. (3) The 
protonized collagen and hydrogen phosphate may have chemical bonds 
and also participate in chemical co-deposition reaction on electrode sur-
face to make the organic–inorganic sediments cross-link with each other so 
as to help improve the mechanical strength in the co-deposition layer and 
the bonding strength between the deposition layer and metal substrate. In 
addition, the addition of collagen may greatly increase the degradation of 
hydroxyapatite.
In view of this, electrolytic deposition (ELD) has been used to generate 
homogeneous collagen-CaP (Col-CaP) composite coatings onto metallic 
implants [30–32]. Composite coating shows uniform and orderly distribu-
tion of the porous structure. It is a very obvious secondary structure, that 
is, nano-HA whiskers knot together in a certain orientation to constitute a 
relatively uniform micron-scale pore structure. Pore size is several microns, 
while the diameter of whiskers is about several tens of nanometers, which 
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looks thin and soft and is similar to natural bone microstructure. Composite 
coating consists of completely through holes as shown in Figure 8.36.
8.3.2.3  Spin Coating
Spin coating is a simple and effective technique for controlling the thickness 
of thin coatings. The spin coating process used to produce the HA/col com-
posite coating on Ti substrates is described in Figure 8.37.
Ultrafine HA particles were first prepared by the simultaneous titration 
of Ca(OH)2 and H3PO4 solutions. After the repeated centrifugation/ washing 
process, the HA precipitates so obtained were further centrifuged at high 
speed to remove as much of the water as possible. Subsequently, the gel-
like HA precipitates, without any dry treatment, were directly re-dispersed 
in the collagen/HFP (1,1,1,3,3,3-hexafluoro-2-propanol [HFP]) solution. 
2 µm
2.00 µmS4800-8018 5.0 kV 7.7 mm ×20.0 k SE(M)
Figure 8.36
SEM images of the HA/collagen coatings by electrochemical deposition. (From Sun, T. et al., 
Mater. Lett., 65(17–18), 2575, 2011.)
Precipitation Centrifugation Mixing Spin-coating Cross-linking
EDC/NHSCa(OH)2 H3PO4
HA COL + HA Ti
HFP
Figure 8.37
Schematic illustration of the processes used to produce the collagen/HA composite coating on 
the Ti substrates. (From Teng, S.-H. et al., J. Mater. Sci.: Mater. Med., 19, 2453, 2008.)
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A viscous, homogeneous composite sol was obtained by stirring the mixture 
for 24 h at room temperature. After the spin coating, the thin film that 
was obtained was cross-linked in EDC/NHS solution (ethanol containing 
N-(3-dimethylaminopropyl)-N0-ethylcarbodiimide (EDC) hydrochloride and 
N-hydroxysuccinimide (NHS) solutions) to ensure its chemical and structural 
stability, as presented in Figure 8.37.
In Teng’s study [34], a homogeneous collagen/HA nanocomposite sol was 
obtained by the biomimetic preparation and centrifugation of nanosized HA 
precipitates followed by mixing with collagen without any dry treatment. 
Subsequently, collagen/HA composite thin coatings with an approximate 
thickness of 7.5 µm were uniformly formed on Ti substrates through a spin 
coating process. The SEM results showed that the nanosized HA particles 
were well distributed within the collagen matrix, without any obvious 
aggregation, as shown in Figure 8.38.
8.3.2.4  Electrospray Deposition (ESD)
Using ELD or biomimetic, synthesis of Col-CaP coatings were time 
consuming and control over coating thickness was poor. The ESD 
process, on the other hand, is among the most promising techniques for 
generating organic–inorganic composite coatings on implant materials 
since its low processing temperatures allow for simultaneous deposition 
of both biomolecules and CaP. Using ESD, faster deposition rates and exact 
control over coating thickness can be achieved as compared to both ELD 
and biomimetic coating synthesis. As a result, the ESD technique offers 
the possibility to deposit coatings of nanometer thickness onto metallic 
materials.
Using the ESD technique, nanometer-thick col/CaP coatings were success-
fully deposited at a collagen/CaP ratio comparable to that of native bone 
tissue [35], of which the fibrous nanostructure resembled the structure of 
mineralized collagen in bone tissue. With increasing ESD times, the CaP 
particles and collagen became more tightly packed within the coating as 
compared to the relatively thicker composite coatings for the short spray-
ing times. The mechanical properties of the electrosprayed CaP coatings 
improved significantly upon co-deposition of collagen. Furthermore, both 
CaP and col-CaP coatings stimulated osteogenic behavior in vitro upon cell 
culture testing even though their thickness was reduced to below 100 nm. 
Figure 8.39 shows the SEM micrographs of the surface morphology of both 
CaP and col-CaP coatings.
8.3.3 Performance and application of Ha/Col Composite Coating
To comprehend that bone is apatite/collagen composite material in micro 
scale is the foundation of the preparation of bioactive ceramic/polymer 
bone biomimetic composite materials. The preparation of bone repair 
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and replacement materials by compositing hydroxyapatite has become 
one of the most useful methods of biomaterials investigation. The specific 
nano/microstructure hydroxyapatite/collagen composite coating on tita-
nium surface is prepared under mild conditions. Using the combination 















SEM morphologies of the coatings with different compositions on Ti substrates: (a) collagen; 
(b) COL-10%HA; (c) COL-20%HA; (d) COL- 30%HA; (e) COL-30%HA at high magnification; and 
(f) its cross section. (From Teng, S.-H. et al., J. Mater. Sci.: Mater. Med., 19, 2453, 2008.)
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composite coating was prepared to obtain bone substitute material with 
excellent biological and mechanical properties.
8.3.3.1  Biological Performance
The osteoblast responses to the collagen and collagen/HA composite coat-
ings were assessed using MC3T3-E1 cells in terms of the cell attachment, 
growth, and morphology [34]. The electron microscopy morphologies of the 
cells cultured on the uncoated- and coated-Ti substrates for 1 day are pre-
sented in Figure 8.40. The cell proliferation on these coatings after 3 days of 
incubation is presented in Figure 8.41.
As compared to both the bare Ti substrates and the conventional composite 
coatings with equivalent compositions, the collagen/HA nanocomposite 
coatings on the Ti substrates obtained with the present method showed 
much better cell proliferation behaviors and osteogenic potentials, thus 
confirming the improved activity of the cell functions that they afford. In 
conclusion, collagen/HA nanocomposites have great potential for use as 
a coating material for future medical applications in hard and soft tissue 
replacements.
(a) (b)
–100 nm –100 nm
–100 nm –100 nm
(d)(c)
Figure 8.39
Scanning electron micrographs of (a) CaPthin, (b) col-CaPthin, (c) CaPthick, and (d) col-CaPthick-
coated Ti disks. (From de Jonge, L.T. et al., Biomaterials, 31, 2461, 2010.)
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8.3.3.2  Mechanical Performance
Generally, the strengthening phenomena of collagen are obvious for 
hydroxyapatite coatings. Xu Yanli et al. [36] made a comparison of the pure 
HA and HA/col mechanical properties of composite coatings through bond-
tensile test. Experiments show that under the same conditions, the adhesion 
between HA/collagen composite coating and titanium substrate is doubled 
that of pure HA coating and substrate (5.02 MPa), approximately to 10.31 
MPa. In addition, the turn-off time of the coating with collagen is about 
60s, which is longer than the stretching time (about 37 s) of the pure coating 
indicating that both the coating adhesion and the flexibility are enhanced 
after adding collagen in the coating. Similarly, Keng-Liang Ou et al. [37] 
reported that the maximum indention depth under the same load decreased 
for the organic–inorganic composites obtained by introduced collagen into 
hydroxyapatite coatings, which are similarities between these HA/collagen 
and natural composite materials (Figure 8.42).
In Hu Kai study [38], the scratch method is used to evaluate the bonding 
properties of the coating and the substrate. The coating was prepared by 







The morphology of the MC3T3-E1 cells cultured on (a) titanium substrate, (b) collagen, 
and (c) COL-30%HA composite coatings. (From Teng, S.-H. et al., J. Mater. Sci.: Mater. Med., 
19, 2453, 2008.)









































Growth activity of the MC3T3-E1 cells on different coatings after 3 days. Pure Ti plates were 
used as a control, and differences at *P < 0.05 and **P < 0.01 with respect to pure Ti were consid-
















HA disk + collagen
3000 4000 5000
Figure 8.42
Relationship between the maximum indention depth and the loads for the sintered HA with 
or without collagen treatment. (Ou, K.-L. et al., J. Mech. Behav. Biomed. Mater., 4(4), 618, 2011.)
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The scratch method is based on the use of a diamond stylus under a con-
stant or continuous positive pressure, which engraves the coating surface 
with a certain speed till the damage of coating bonding ability. The criti-
cal load LC is the measurement of bond strength of the substrate/coating. 
According to the scratch morphology in Figure 8.43, it can be concluded that 
the coating surface roughness and crystal arrangement have a certain impact 
on the scratches. BG coating has a larger crystal spacing, is loosely arranged, 
has more apparent scratches, and the critical load is smaller (40N). The sur-
face roughness of ELD coating is relatively small, resulting in a small resis-
tance along the direction of scratches. The critical load is 50N. The results 
indicate that the combination performance of HA/COL prepared by electro-
chemical method is better than the coating prepared by chemical biomimetic 
growth method.
8.3.3.3  Clinical Applications
The water-soluble recombinant human-like collagen is applied to modulate 
the growth of hydroxyapatite on NiTi alloy so as to better biofunctionalize 




Montage of SEM micrographs of the scratch traces for the composite coatings. (From Kai, H., 
Study on preparing HA/COL composite coating by chemically biomimetic growth and elec-
trochemical deposition, Master degree thesis, Tianjin University, Tianjin, China, p. 38, 2007.)
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coating of hydroxyapatite and recombinant human-like collagen on NiTi 
alloy might improve the toughness of the coating and make the composite 
materials more applicable in the orthopedic field. Xiaolong Zhu et al. gave 
a characterization on hydroxyapatite/collage surfaces and described the 
cellular behaviors. The studies showed that the nano-HA/collagen surface 
favors cell spreading on the Ti alloy implant surface because of the collagen 
attraction to cells and cell motility on the surface by inducing well-developed 
cellular filopodia through nano HA (Figure 8.45), which enhanced cell 
adhesion to nano HA.
Jin Qiong et al. [41] investigated the efficacy of a new collagen-hydroxyapatite 
(COL-HA) composite membrane on bone regeneration of rat cranial defects. 
The research shows that COL-HA composite membranes can guide bone 
regeneration of rat cranial defects. As an absorbed membrane that can guide 
bone regeneration, the COL-HA composite film has a good prospect for clin-
ical application. The efficacy of bone regeneration of COL-HA double-layer 
500 nm 200 nm
(b)(a)
Figure 8.44
SEM micrographs of the coating on NiTi alloy after soaking in 0.5 g/L 1.5CSBF for 3 days ([b] is 




2 µm 2 µm
Figure 8.45
SEM of osteoblasts growing on nano HA (a) and nano-HA/collagen (b) films for 1 h. (From 
Zhu, X. et al., J. Biomed. Mater. Res. Part A, 79(1), 114, 2006.)
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membrane is superior to COL-HA single-layer dense membrane, because its 
property is more propitious to the adherence and proliferation of osteoblasts.
8.4	 HA/Gelatin	Composite	Coating
It is well known that an implant with a structure and composition simi-
lar to natural hard tissue can improve bone repair or substitute. Coatings 
on Ti and Ti alloy are managed to be designed as similarly as possible to 
natural bone structure. HA deposited on Ti alloy via various traditional 
methods has, in fact, little similarity to bone mineral in morphology, crys-
tallinity, composition, and trace element content [42]. Bone-like apatite is 
actually a needle-like nanocrystal with poor crystallinity containing CO32−. 
The nucleation and growth of these crystals are modulated by collagen 
fibrils, the other major component of natural bone [43]. Thereafter, com-
posite coatings combining collagen or collagen-like materials with HA are 
considered to modify the metal surface to either bridge the gap in HA 
coatings with poor mechanical properties or to simulate natural hard 
tissue [35]. On the other hand, thanks to the good cell adhesive property 
and osteointegration ability [44], collagen-like macromolecules can also 
function as carriers for releasing drugs, such as antibiotics and osteoinduc-
tive proteins, to enhance bone healing around the implant, and therefore 
implant fixation and osseointegration. Although collagen possesses many 
good properties as mentioned earlier, it is predominantly derived from 
natural sources, so there is some risk of allergy [45]. The drawbacks of 
high price and immune antigenicity limit its application [46]. Thus, there 
is a need for alternatives of collagen to fabricate HA composite coatings. 
Gelatin serves as one of the best choices.
8.4.1 Property of gelatin
Gelatin is the denatured state of collagen, sharing much similarity to col-
lagen molecules, and is always used instead of collagen because of the lower 
immune antigenicity and lower cost [46]. This macromolecule possesses 
arginine-glycine-aspartic acid (RGD) sequences reported to stimulate the 
adhesion of osteoblasts and improve the osteointegration [44].
Gelatin is actually a heterogeneous mixture of water-soluble proteins 
of high average molecular weights present in collagen. The proteins are 
extracted by boiling skin, tendons, ligaments, bones, etc., in water. There are 
two typical form of gelatin, Type A and Type B. Type A gelatin is mainly 
derived from acid-cured tissue, while Type B is derived from lime-cured tis-
sue. The structure of gelatin molecules is shown in Figure 8.46. Gelatin has 
70–120 mmol of free carboxyl groups per 100 g of protein. The charge on a 
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gelatin molecule is primarily determined by the ratio of free carboxyl groups 
to free amino groups on the side chains.
Gelatin is often used to improve cell attachment for a variety of cell types. 
Additionally, as a biocompatible polymer, gelatin has been used as a delivery 
vehicle for the release of bioactive molecules and in the generation of scaf-
folds for tissue engineering applications.
8.4.2 Preparation of Ha/gelatin Coatings
There are several methods to prepare HA/gelatin composite coatings on Ti 
and Ti alloy surfaces, including the dip coating method, biomimetic pro-
cesses, and electrochemical deposition.
8.4.2.1  Dip Coating Method
Dip coating methods are classified into two types: dip/spin coating and dip/
phase inversion process.
Rohanizadeh et al. used dip/spin coating method to obtain an oxidized 
Ti alloy surface, which was further immersed in a supersaturated calcium 
phosphate solution to allow apatite deposition [48]. Briefly, insoluble TiO2 
(rutile or anatase) powder was added into a gelatin solution with an ade-
quate viscosity for dip/spin coating to prepare TiO2 slurries. After that, the 
rutile and anatase slurries were stirred at 45°C to make them workable and 
ready for application to the Ti disks. The slurries were then placed onto the 
Ti disk, followed by spinning the slurry dipped disks at a fast speed. During 
the coating procedure, the slurry was stirred and kept in a water bath at 
45°C. Because of centrifugal forces during the spinning stage, the excess of 
slurry was removed from the surface. As a result, a homogeneous TiO2 film 
was achieved, and the disks were sequentially cooled to room temperature 
to evaporate the slurry. The treated Ti disks were incubated in a supersatu-
rated calcium phosphate solution containing CaCl2 and NaH2PO4 at pH 7.2 
for the formation of apatite.
Recently, Xiao et al. developed an asymmetric coating method that involves 
a dip coating and a phase inversion process [44]. In their method, HA nanopar-






























Chemical structure of gelatin. (Gaihre, B. et al., J. Mater. Sci.: Mater. Med., 20(2), 573, 2009.)
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solution was prepared by homogenously dispersing hydroxyapatite 
nanoparticles into deionized water by using ultrasonic cell disrupter and 
then dissolving gelatin in this solution and sonicating. Ti-6Al-4V alloy 
plates as substrate were etched to form a fresh titanium oxide surface. This 
substrate was immersed into the dipping solution for some time, followed 
by immersing into the quenching solution. Finally, asymmetric coatings 
composed of gelatin and hydroxyapatite were achieved by crosslinking in 
glutaraldehyde.
8.4.2.2  Biomimetic Processes
This method often involves SBF, which is prepared according to the inor-
ganic ion concentration of human blood plasma. SBF solution can mimic the 
ion components and their concentration of actual human body fluid to some 
extent. HA formed in SBF solution under human body temperature has the 
features of small size, low crystallinity, and high surface activity, very simi-
lar to the natural HA.
Bian et al. built a gelatin and HA composite coating on porous Ti alloy 
[49]. A titanium substrate treated by alkali and heat treatment was immersed 
in Na2HPO4 and Ca(OH)2 in advance. After that, it was put into SBF solu-
tion at 36.5°C, followed by immersing in a gelatin-containing die. However, 
the actual human body fluid contains not only the inorganic components 
but also some organic components, such as proteins, which have essential 
effects on the nucleation, polymorphism, growth, chemical composition, 
shape, and dimensions of apatite. Recently, Pan et al. employed a biomimetic 
process to form a HA/collagen-like protein coating on the alkali-heat treated 
Ti substrate in 1.5 times SBF (1.5 × SBF) with the addition of a recombinant 
collagen-like protein [45]. The composition of 1.5 × SBF is listed in Table 8.1 
[45]. Considering gelatin is also a kind of collagen-like protein, HA/gelatin 
may also be fabricated via this method.
8.4.2.3  Electrochemical Deposition
Low-temperature electrochemical deposition technique was also used to 
prepare HA/collagen composite coating on NiTi shape memory alloy [33]. It 
is expected in the near future that this technique could also be used to form 
HA/gelatin composite coatings as well.
Uncoated NiTi SMA disks were mechanically polished to a mirror 
finish, followed by ultrasonic cleaning in acetone and ethanol separately. 
Electrochemical deposition of coatings on metal disk was carried out at 
37°C in order not to denature protein. The metal disk served as the working 
electrode, and a pure platinum plate was used as the counter electrode. 
A double-strength simulated body fluid solution (2SBF) containing soluble 
collagen was used as the electrolyte. Composite-coated samples were gently 
rinsed with distilled water and dried after electrochemical deposition.
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8.4.3 Characterization of Ha/gelatin Coatings
The characteristics of HA/gelatin coatings formed on titanium vary in terms 
of the fabrication method employed. That is, the morphology, crystallinity, 
size, and chemical composition of HA, as well as the mechanical properties, 
adhesion strength to alloy substrate, and bioactive properties of the compos-
ite coatings, are related to the formation condition and mechanisms.
The fabrication process involving an SBF medium often leads to the forma-
tion of nanosized calcium-deficient carbonated HA with a poorly crystalline 
and flake-like structure [33,45]. As shown in Figure 8.47, nanosized apatite 
with the flake-like structure was obtained and was combined by the colla-
gen fibrils. The broadened peak of the XRD pattern indicated the low crys-
tallinity of HA. This characteristic of apatite may be due to the biomimetic 
chemistry mechanism resembling the biomineralization in vivo in the physi-
ological condition. A treated Ti or Ti alloy surface is able to bond OH− and 
form Ti–OH groups [50]. The Ti–OH groups were negatively charged and 
could selectively combine with the positively charged Ca2+ in SBF to form 
calcium titanate, as was reported by Kokubo et al. [51]. With the accumula-
tion of more Ca2+ on the surface, the overall positive surface further com-
bined with negatively charged PO43− to induce apatite nucleation. Then, they 
could spontaneously grow by consuming the Ca2+ and PO43− ions from the 
SBF, which were supersaturated with respect to apatite [45].
It is speculated that a high proportion of the amino acids with charged 
groups, such as aspartic acid residues with carboxyl group, which also exist 
Table 8.1
Composition of 1.5 × SBF (pH 7.4) 
and Order of Addition of the 












1 M HCl 50 mL
Collagen-like protein 0.5
Source: Pan, M. et al., Mater. Chem. 
Phys., 126, 811, 2011.
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in gelatin, promoted the nucleation of HA [45]. With the addition of such 
proteins, the nucleation and growth of HA in SBF on the Ti substrate were 
found to be promoted effectively, and the morphology of apatite turns from 
lamellar flake to needle-like crystals (Figure 8.48).
XRD result showed that more apatite formed and a larger aspect ratio of 
HA with protein molecules existed (Figure 8.49), which suggested that the 
presence of collagen-like protein led to the preferential growth of HA crystal 
along the c-axis, similar to the natural bone.
All the difference in characteristics lies in the modulation of collagen-
like protein on the nucleation and growth of HA. As mentioned earlier, the 
positive charge surface due to the accumulation of Ca2+ absorbs negatively 
charged groups. When protein was introduced, −COO− of special amino 
acid groups (aspartic acid residues) competed with PO43− to combine with 
Ca2+, which changed the nucleation and growth of HA on the metal surface. 
As a result, the presence of collagen-like protein accelerates the apatite depo-
sition and HA formation on the pretreated Ti substrate.
On the other hand, the fabrication process not involving an SBF medium 
always leads to obtain HA comparatively more different from natural 
mineral. For example, HA prepared via chemical precipitation during 
preparing a HA/gelatin composite coating on Ti alloy surface exhibited a 
nanorod morphology with a length of 30–50 nm and diameter of 10–15 nm 
and with a higher crystallinity (Figure 8.50). This phenomenon is caused by 
the distinction between the HA synthesis condition and the physiological 
environment.
Further addition of gelatin in this synthetic HA seemed to no longer influ-
ence the HA crystals. Gelatin just serves as joining of HA and affects the 
compactness of the composite coatings. Moreover, through different treat-
ments, gelatin can be prepared to various morphologies, which influence 
the mechanical property and bioactive property of the composite coatings. 
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Surface morphology and XRD patterns of apatite/collagen-coated NiTiSMA samples 2SBF con-
taining soluble collagen was used as the electrolyte. (From Sun, T. et al., Mater. Lett., 65(17–18), 
2575, 2011.)
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During a dip/phase inversion process, gelatin is soluble in warm water as 
solvent and insoluble in anhydrous ethanol as nonsolvent (quenching solu-
tion). An asymmetric HA/gelatin coating composed of a thin dense outer 
layer and a thick porous inner layer was formed. The porous layer is due to 
the phase inversion by water–ethanol exchange in the quench solution, while 
the dense layer is caused by evaporation of the solvent in the air. Hence, long 
immersion time in the quenching solution obviously increases the porosity 
of the coating (Figure 8.51).
8.4.4 application of Ha/gelatin Coatings
8.4.4.1  Drug Release
Metal ions and infection were always detected in tissues close to Ti alloy 
implants and became one of the major problems of these implants. Controlled 
antibiotics release systems in combination with implants have been devel-
oped to solve these issues. Composite coatings composed of gelatin and 
hydroxyapatite on Ti-6Al-4V alloy implant were developed using the dip/
phase inversion method for the delivery of water-insoluble drug ibuprofen to 
reduce the infection rate [44]. Ibuprofen was added in the quenching solution. 
c
8<80010 kV  72 mm ×80.0k SE(U)12 µ 2008 500 nm
d
500 nm1.0 kV 8.3 mm ×60.0k SE(M)
a
×5.0 kV 5 mm
b
×5.0 kV 5 mm
Figure 8.48
SEM images of the surface of pretreated Ti substrates after soaking in 1.5 × SBF (a, c) or 1.5 × SBF 
with addition of a recombinant collagen-like protein (b, d) for 8 days. (From Pan, M. et al., 
Mater. Chem. Phys., 126, 811, 2011.)
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Drug loading depended on the immersion time and drug concentration in 
the quenching solution. The in vitro release from this coating was always at 
an approximately zero-order rate and at least lasted for 30 days.
HA/gelatin coatings were also used as vehicles for bone morphogenetic 










































XRD patterns of pretreated Ti substrate (a), Ti substrates after soaking in 1.5 × SBF for 8d (b) and 
for 14d (d), Ti substrates after soaking in 1.5 × SBF with addition of a recombinant collagen-like 

























XRD pattern (a) and TEM image (b) of hydroxyapatite particles obtained through chemical 
precipitation. (From Junwu, X, J. Mater. Sci.: Mater. Med., 2009, 20, 889, 2009.)
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with the highest ability to improve bone formation. BMP-2 was blended 
with gelatin and further combined with HA particles to form BMP-2 loaded 
HA/gelatin composite coatings on a Ti alloy substrate [49]. The drug release 
behavior was studied. Results indicated that the gelatin functioned as a 
good delivery system to prolong the effect of BMP-2. With the continuous 
release of this bioactive drug, the osseointegration was better in the Ti alloy 
modified by BMP-2 loaded HA/gelatin composite coatings than in the alloy 
modified by HA coatings.
8.4.4.2  Tissue Engineering
Biomimeic HA/collagen-like protein composite coatings on Ti substrate were 
prepared by Pan et al. Osteoblastic MG-63 cells was cultured on this coat-
ing. It was found that the existence of collagen-like protein in coating could 
improve the cell adhesion, proliferation, and differentiation (Figure 8.52). The 
authors believed that this superiority is due to the RGD sequence in collagen-
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Figure 8.51
SEM images of the cross section of sample A immersed in the quenching solution for 4 days 
(a), the thin dense outer layer in sample A (b), the cross section of sample E immersed in the 
quenching solution for 2 days (c), and the surface of sample A (d). (From Junwu, X, J. Mater. Sci.: 
Mater. Med., 2009, 20, 889, 2009.)
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for osteoblasts and enhance the rate of cell spreading through forming the 
integrin-binding domain [45]. Moreover, HA in this composite coating is mod-
ulated by the collagen-like protein. That is to say, hydrophilicity and surface 
roughness, which favors cell attachment and proliferation, can be modulated 
by the collagen-like protein. Hence, Ti alloy with HA/collagen-like composite 
coatings may serve as a good implant candidate for bone regeneration.
As mentioned in Section 1.2.5, the drug release behavior of coatings com-
posed of gelatin and hydroxyapatite on Ti-6Al-4V alloy implant has been 
investigated. In addition, in vitro calcification of this implant was also stud-
ied. More apatite was found to form on the composite coatings than on the 
pure gelatin coatings and bare Ti-6Al-4V implant as controls. According to 
some former literature, the apatite formation ability on the implant played 
critical roles on facilitating the chemical fixation of biomaterials to bone tis-
sue, and ultimately affecting the in vivo success of the bone grafting materi-
als. Therefore, it is reasonable to believe that HA/gelatin composite coating 
may significantly improve the bond with the surrounding bone, in vivo, 
compared with bare Ti-6Al-4V alloy implants [44].
8.5	 HA/PAMAM	(Polyamidoamine)	Composite	Coating
Dendrimers are used for modifying HAP coatings due to their relative low 
toxicity, intrinsic biocompatibility, and ability to interact with HAP surfaces. 
The potential biomedical applications of dendrimers have become an active 





12 h 48 h 48 h 5 d
Figure 8.52
Fluorescence images of cellular actin cytoskeleton and cell nucleus on the different substrates 
after 3 h, 12 h, 48 h, and 5 d of cultivation. Arrows indicate the pseudopodia. (SBF represent 
samples with HA coating on pretreated Ti surface; CSBF represent samples with HA/collagen-
like protein composite coating). (From Pan, M. et al., Mater. Chem. Phys., 126, 811, 2011.)
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molecule, hyperbranches, which regularly extend from the core, and termi-
nal groups. Thus, dendrimers have a definite molecular weight and size. In 
addition, they can encapsulate mental complexes, nanoparticles, or other 
inorganic and organic guest molecules [52]. Dendrimers are a new class of 
hyperbranched macromolecules possessing distinctive properties such as 
well-defined globular architecture, narrow polydispersity, and tunability of 
surface functionalities. Their tunable nanometric size and chemical function-
ality offer versatility for incorporating a wide variety of functional moieties 
either through encapsulation in the interior of the dendrimer or by tether-
ing onto the periphery via covalent modification or physisorption for drug/
gene delivery and imaging [53]. Polies (amidoamine) (PAMAM) dendrimers 
have been proposed as mimics of anionic micelles or proteins. The starburst 
structures are disk-like shapes in the early generations, whereas the surface 
branch cell becomes substantially more rigid and the structures are spheres 
[54]. Because of the unique and well-defined secondary structures of the 
PAMAM, it should be a good candidate for studying inorganic crystallization.
8.5.1 Property of PaMaM
Poly(amidoamine) dendrimers (PAMAM) are arguably the most extensively 
studied dendrimers for biomedical applications, especially as carriers of 
biologically active agents. As early as 1984, PAMAM dendrimers were the 
first complete dendrimer family (G = 0–7) to be synthesized and character-
ized, followed by commercialization in 1990 [55]. They are synthesized by 
the divergent method, involving a two-step iterative reaction sequence that 
produces concentric shells of branch cells (generations) around a central ini-
tiator core. This PAMAM core–shell architecture grows linearly in diameter 
as a function of added generations, while the surface groups amplify expo-
nentially at each generation (Figure 8.53). For the PAMAM dendrimer fam-
ily initiated from an ethylenediamine core with a branch cell multiplicity 
of two, the expected mass values double, approximately, from generation to 
generation. [56]
These polymers have been called artificial proteins; they can be used as 
protein biomimics because the terminal amino groups can be functionalized 
and the dendrimers covalently linked together. PAMAM dendrimers with 
amino terminal groups have low toxicity to eukaryotic cells. Modification 
of the amino groups with poly(ethylene glycol) (PEG) or lauroyl chains can 
further improve their biocompatibility [57] (see Figure 8.54).
8.5.2 Preparation of Ha/PaMaM Composite Coating
Many methods have been developed for HA/PAMAM composites. The com-
posites can be prepared by different methods, including microarc oxidation, 
hydrothermal biomineralization and crystallization, and self-precipitation 
in SBF adding PAMAM.
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8.5.2.1  Microarc Oxidation
MAO method is usually used to prepare TiO2 coatings in different acid or 
alkaline electrolytes [58]. Some researchers also tried to prepare HA coat-
ing containing Ca and P ions in calcium and phosphate electrolytes, The 
MAO process was started by applying higher voltage and finished in a very 
short time. Such MAO coatings can provide good corrosion resistance and 
Core G = 0 G = 1
G = 44.0 nm G = 22.0 nm G = 33.1 nm
G = 55.3 nm G = 66.7 nm G = 78.0 nm
Figure 8.53
Graphical presentation of PAMAM dendrimers from core to generation G = 7 showing the 
linear increase in diameter and exponential growth of the number of surface groups. (From 
Sönke, S. and Tomalia, D.A., Adv. Drug Deliver. Rev., 57(15), 2106, 2005.)
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biochemical stability in the complex environment of the human body. It is 
expected to be applied in artificial bone joints and dental implants. The MAO 
substrate was immersed into the dendrimer solution and incubated with 
shaking. A schematic diagram of HA/PAMAM on Ti substrate is shown in 
Figure 8.55.
8.5.2.2  Hydrothermal Biomineralization and Crystallization
The formation of stable HAP nanoparticles with controlled size and 
shape can be achieved by hydrothermal crystallization using a mixture of 


















The reaction for modifying G5 PAMAM dendrimer, possessing 117 amino groups at its periph-
ery, with PEG consisting of 11 ethylene glycol units (EG11). (From Jevprasesphant, R. et al., Int. 





































Schematic diagram of the PEGylated PAMAM dendrimer film on MAO substrate. (From 
Wang, L. et al., ACS Appl. Mater. Interfaces, 3, 2885, 2011.)
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homogeneous nucleation and effective growth inhibition by adsorption of 
PAMAM predominantly onto Ca-rich nanoparticles during the initial stages 
of crystallization. Hydroxyapatite nanoparticles were synthesized in the 
presence of various generations and concentrations of PAMAM by hydro-
thermal treatment of a calcium phosphate precipitate produced by the addi-
tion of aqueous ammonium dihydrogen phosphate to a solution containing 
calcium nitrate and PAMAM at different molar ratios.
8.5.2.3  Self-Precipitation
Calcium hydroxyapatite particles as cores were produced by self-precipita-
tion in the presence of PAMAM dendrimers from SBF [60]. SBF was prepared 
by dissolving reagent-grade chemicals NaCl, NaHCO3, KCl, Na2HPO4·7H2O, 
MgCl2·6H2O, CaCl2, and Na2SO4 into deionized water and buffered at pH = 7.4 
with tris-hydroxy-methy aminomethane ((CH2OH)3CNH2) and 1 M HCl at 
37°C. PAMAM dendrimers were dissolved in SBF (pH 7.4). HA/PAMAM 
composites were allowed to self-precipitate from SBF solutions containing 
dendrimer after nucleation and crystal growth.
8.5.3 Characterization of Ha/PaMaM Composite Coating
The various morphologies of HA/PAMAM composites can be obtained, such 
as HA/PAMAM plates, nanorods, elliptical particles, and spherical cores. 
Figure 8.56 shows the morphology and size of the composites prepared by 
different methods. The HA/PAMAM plates [61] are shown in Figure 8.56a 
with an average length of 80 nm and width of ca. 30 nm. The HA/PAMAM 
plates were prepared by hydrothermal method in Ca10(PO4)6(OH)2 and G1.0 
PAMAM dendrimer mixtures. Figure 8.56b shows that the samples pre-
pared with carboxylic terminated PAMAM are composed by well-dispersed 
nanorods [62] (length ca. 65 nm and diameter ca. 26 nm). With the concen-
tration of PAMAM to 40 g, the morphology of hydroxyapatite crystals was 
nearly ellipsoid-like, as shown in Figure 8.56c. The elliptical particles have 
an average grain size of ca. 30 nm. The particle sizes of hydroxyapatite crys-
tals depended on the concentration of the PAMAM dendrimers. The par-
ticles obtained by self-precipitation were spherical sub-micrometer-sized 
hydroxyapatite particles [63] (Figure 8.56d). The particles appear hollow, and 
the size ranged from less than 50 to approximately 150 nm.
The dendrimers affected morphology of HAP crystals as growth inhibi-
tors. PAMAM has a stronger control on crystallographic faces of HAP crys-
tals, which leads to a different crystal habit of HAP crystallization. PAMAM 
dendrimer might serve as a nucleation site due to calcium binding on the 
carboxylic acid groups present on the surface and the amphipathic half-
generation dendrimer acting as a supramolecular (micellar) aggregate, which 
might serve as a nucleation site [64].
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8.5.4 application of Ha/PaMaM
8.5.4.1  Therapeutic of PAMAM
A thin layer of PAMAM/HA coated on titanium-based substrates has many 
applications on biochemical fields. The most active area in dendrimer-
based therapeutics is gene transfection by dendrimers as nonviral vectors. 
Dendrimers are very actively under investigation for the delivery of DNA 










TEM of images of HA/PAMAM composites. (a) HA/PAMAM plates, (b) HA/PAMAM nano-
rods, (c) elliptical HA/PAMAM particles, (d) hollow HA/PAMAM cores. (From Yan, S.-J. et al., 
Mater. Chem. Phys., 99(1), 164, 2006.)
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better understanding of the rules that govern dendrimer-based gene delivery, 
PolyFect, obtained by partial chemical hydrolysis of PAMAM dendrimers 
[64], based on the rigid diphenylethyne core was synthesized and their activ-
ity as transfection agents described. Under physiological conditions, the 
branches bear positively charged ammonium end groups, which can inter-
act with negatively charged phosphate groups of nucleic acids. The PolyFect 
reagent assembles DNA into compact toroidal structures, thus optimizing 
the entry of the DNA into cells. Once inside the cell, the dendrimers buffer 
the lysosomes after fusion with the endosomes [65] (Figure 8.57).
8.5.4.2  Dendrimers in Antimicrobial Application
Dendrimers exhibit low toxicity and are nonimmunogenic. They are widely 
used in biomedical applications. Based on their dimensional length scaling, 
narrow size distribution, and other biomimetic properties, dendrimers are 
















Hypothetical mechanism of DNA transfection with cationic dendrimers. (From Oliveira, J.M. 
et al., Biomaterials, 30(5), 804, 2009.)
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activity, particularly the concentration needed to kill half of the bacteria 
and the minimum inhibitory concentration (MIC) that inhibits the visible 
growth of the bacteria, have been widely used for evaluating the suscep-
tibility of potential drugs against specific pathogens. Cai et al. [59] used 
a standard, more efficient, and reproducible assay to assess the activities 
of the dendrimer derivatives. The bactericidal activity of the dendrimer 
coatings was maintained after storage for 30 days in PBS. Furthermore, the 
PAMMA/HA coating had a low cytotoxicity to human bone mesenchymal 
stem cells and did not alter the osteogene expression of the cells. It is also 
demonstrated that simple modification of calcium phosphate coated tita-
nium substrates with PAMAM dendrimers furnished the materials with 
antibacterial activity without apparently decreasing their bioactivity, as 
shown in Figure 8.58.
8.5.4.3  Dendrimers in Artificial Oxygen Carrying System
PAMAM dendrimers have recently attracted attention for studying 
drug delivery [66]. As known to all, one of the important functions of 
the blood is oxygen transport to the tissues. An immediate resuscita-
tive solution to prevent excessive blood loss is to deliver oxygen-carrying 
fluid to the patient. Hemoglobin-based oxygen carriers are being devel-
oped as resuscitative agents, and many of them are in the final phase of 
clinical trials [67]. Khopade et al. reported that the aquasomes carried by 
PAMAM/HA could load hemoglobin approximately and retain oxygen-
affinity, cooperativity, and stability for at least 30 days. Figure 8.59 shows 
the oxygen-binding characteristics of fresh blood, hemoglobin solution, 
and hemoglobin aquasome formulation (HAF) [60]. This shows that the 









3D fluorescence images of the indicated surfaces after 3 h of incubation in a suspension of 
PA01 in PBS buffer containing PI as the viability indicator. The green channels indicate all 
the bacteria on the surface and the red channels indicate those that were killed (membrane-
compromised). (From Wang, L. et al., ACS Appl. Mater. Interfaces, 3, 2885, 2011.)
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8.6	 HA/Chitosan	Composite	Coating
Although high bioactive HA is the main inorganic composition of bone tis-
sue, it is brittle and hard. The cracking of HA coatings can result from the 
stage of heating treatments such as deposit sintering because of the differ-
ence in the thermal expansion coefficients of the sintered coating and the 
substrate, and additional cracking during cooling can further damage the 
coatings. Other problems are related to the phase transformations and oxida-
tion of the substrates and the chemical reactions between the deposits and 
substrates during sintering at elevated temperatures. In addition, due to the 
favorable bioactive property and the proper body temperature and nutrition, 
HA is usually in favor of the bacteria adherence and colonization on the 
implant, which consequently causes the failure of the implant.
Therefore, it is important to modify HA or synthesize novel composites 
of polymer and HA to enhance the mechanical and antibacterial proper-
ties. It is natural to think of adding antibacterial materials into HA coating 
to effectively reduce the postoperative infection; however, it would gener-
ally lead to cytotoxicity and be detrimental for bone formation and growth, 
while bone in-growth at early stage is much critical for implant/bone 



















Oxygen-binding characteristics (oxygen saturation curve) of fresh blood, hemoglobin 
solution and hemoglobin aquasome formulation. (From Khopade, A.J. et al., Int. J. Pharm., 
241(1), 145, 2002.)
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combined biodegradability, nontoxicity, and antibacterial and hemosta-
sis properties is a foremost work. Among all the antibacterial materials, 
chitosan, generated by deacetylation of chitin, is a widely used natural 
polymer [68]. The structure with predictable pore sizes and degradation 
rates makes it particularly suitable for bone and cartilage regeneration. 
It has been proved that the addition of chitosan to the HA suspension 
was effective in improving the deposition rate of the coating and that a 
uniform coating thickness was achieved. Moreover, chitosan exhibits the 
antibacterial and osteoblastic functions that make it a good candidate in 
tissue engineering [69].
8.6.1 Structure, Properties, and application of Chitosan
8.6.1.1  Structural and Functional Features of Chitosan
Chitosan is a linear copolymer of β-(1–4) linked 2-amino-2-deoxy-β-d-
glycopyranose and 2-acetamido-2-deoxy-β-d-glucopyranose (Figure 8.60). It 
is polycationic, which has one amino group and two hydroxyl groups in the 
repeating glucosidic residue.
The primary amino groups on the molecule are active and provide reac-
tive sites for a variety of side group attachments employing mild reaction 
conditions. Thus, the facile derivatization makes chitosan an ideal candidate 
for biofabrication. In addition, as it is cationic, hemostatic, and insoluble at 
high pH, chitosan can be reversed by protonation of the amine, which makes 
the molecule anionic and water-soluble. The attached side groups on chito-
san make it a versatile material with specific functionality, altered biological 
properties, or modified physical properties.
8.6.1.2  Biodegradation and Toxicity of Chitosan
Chitosan is known to be degraded in vertebrates predominantly by 
lysozyme and by certain bacterial enzymes in the colon. This biodegrada-
tion plays a major role in the metabolic fate of chitosan in the body and 
















Chitosan structure. (From Agrawal, P. et al., Adv. Drug Deliver. Rev., 62(1), 42, 2010.)
425Investigation and Application of HA Composite Coating on the Ti Alloy
As chitosan is a nontoxic, biologically compatible polymer, it is approved 
for dietary applications in Japan, Finland, and Italy for many years, and it 
has been approved by the FDA for use in wound dressings [71]. However, 
chemical modifications implemented on chitosan could make it more or less 
toxic. In drug formulations, chitosan has been proved to be a safe excipi-
ent over the last decades. Interestingly, some studies [72] have proved that 
chitosan and its derivatives seem to be toxic to several bacteria, fungi, and 
parasites. This pathogen-related toxicity is very important as it could be ben-
eficial in the control of infectious disease, especially in implant engineering.
8.6.1.3  Application of Chitosan in Tissue Engineering
Chitosan offers several advantages, such as its ability to control the release 
of active agents and avoid the use of hazardous organic solvents while 
fabricating particles, since it is soluble in aqueous acidic solution. Owing 
to these properties, chitosan is extensively used in developing drug deliv-
ery systems. Also, hydrogels obtained from chitosan are widely used 
in bioapplications and play a crucial role in current strategies to remedy 
malfunctions in and injuries to living systems. Apart from these applica-
tions, chitosan has been extensively used in bone tissue engineering, since 
it was shown to promote cell growth and mineral rich matrix deposition by 
osteoblasts cells in culture. By the biocompatibility of chitosan, the addi-
tional local inflammation can be minimized, and the porous structures 
that design to allow osteoconduction can be easily molded. Several studies 
have focused on chitosan–calcium phosphate (CP) composites for this pur-
pose with a 3D macroporous CP bioceramic. It is revealed that the nested 
chitosan sponge enhances the mechanical strength of the ceramic phase 
through matrix reinforcement and preserves the osteoblast phenotype. 
Incorporating hydroxyapatite (HA) or CP glass, the macroporous chitosan 
scaffolds had an interconnected porosity of approximately 100 μm and 
are used for clinical applications. Chitosan–HA nanocomposite with high 
strength and bending modulus renders the material suitable for possible 
application for internal fixation of long bone fractures.
In tissue engineering approaches, especially cartilage repair, the ideal cell-
carrier substance should mimic the natural environment in the articular car-
tilage matrix. The cartilage-specific extracellular matrix (ECM) components 
such as type II collagen and glycosamine glycans (GAGs) play a critical role 
in regulating the expression of the chondrocytic phenotype and in support-
ing chondrogenesis in vitro and in vivo. The hybrid polymer fibers based on 
chitosan increased cell attachment and proliferation, delivered growth fac-
tors in a controlled fashion to promote the in-growth and biosynthetic ability 
of chondrocytes, and showed increased tensile strength, implying a possible 
use in developing a 3D load-bearing scaffold for cartilage regeneration.
In liver tissue engineering, for the structural similarity of chitosan to GAGs 
and since GAGs are components of the liver ECM, chitosan was selected as a 
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scaffold material for hepatocytes culture. The cross-linked matrix based on 
chitosan had moderate mechanical strength, good hepatocyte compatibility, 
as well as excellent blood compatibility.
In nerve tissue engineering, chitosan is suitable for nerve regenera-
tion based on its biocompatibility and biodegradability. Many researchers 
reported that neurons cultured on the chitosan membrane can grow well 
and that chitosan tube or fibers can promote repair of the peripheral ner-
vous system [73]. Chitosan-based microfibers provide very good scaffolds 
for nerve tissue engineering applications with the advantages of ease of fab-
rication, simplicity, and cost effectiveness.
In conclusion, chitosan, almost the only cationic polysaccharide in nature 
with such great innate medical potential with its exciting properties, is one 
of the most promising bio-based polymers for drug delivery, tissue engineer-
ing, gene therapy, and theranostics.
8.6.2 Preparation of Ha/Chitosan Composite Coating on Ti alloy
8.6.2.1  Plasma Spraying Process
Various methods have been used to deposit calcium phosphate ceramic coat-
ings on metallic implants, such as plasma spraying, sol-gel derived coating, 
pulsed laser deposition, electrophoretic deposition, and biomimetic coat-
ing. Among them, plasma spraying is the most widely accepted method for 
producing a calcium phosphate, especially HA-chitosan coating on metallic 
implants. On the basis of the difference in feedstock, the process is classi-
fied as atmospheric plasma spraying (APS) [74] and liquid precursor plasma 
spraying (LPPS) [75]. In the former process, powder materials are used as 
the feedstock, and they undergo rapid heating, melting, and rapid cooling 
processes. In the later process, the liquid precursor is directly used as the 
feedstock, thus avoiding a series of additional preparation processes for the 
powder feedstock involved in the APS process. Thus, the later is a simple, 
low-cost, efficient, and potentially an alternative plasma spraying technique 
for commercially synthesizing HA-chitosan coatings. The main difference 
between the two processes is the preparation of feedstock.
Step 1, disposing substrates: Choosing a Ti alloy such as Ti-6Al-4 V disk with 14 
mm diameter and 1.5 mm thickness as the substrate, its surface is grit-blasted 
with alumina abrasives (380 μm particle size, 0.4–0.7 MPa pressure) prior to 
the plasma spraying and ultrasonically cleaned in acetone and ethanol.
Step 2, preparation of feedstock: For APS process, a wet chemical synthesis 
is used to prepare HA powders. First, both Ca(OH)2 (95 wt%) and H3PO4 
(85 wt%) are diluted in water, and the later aqueous solution is added 
dropwise to the stirred dispersion of the former. The mixture is stirred for 
3–5 h at 35°C–95°C, depending on the desired crystallinity degree. Thirdly, 
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the reaction mixture is ripened for 2 or 24 h to give HA powders with the 
crystallinity degree between 20% and 80%. At last, the precipitates are 
washed with distilled water, filtered three times, and finally freeze-dried. 
The obtained powders were sieved at 400 and 150 μm. For LPPS process, 2.03 
M (NH4)2HPO4 aqueous solution is added into a stirred 1.69 M Ca(NO3)2 
aqueous solution based on the Ca/P atomic ratio of 1.67. The pH value of the 
solution is adjusted to 11 with ammonia solution (NH4OH, 30 wt%), and the 
mixture is stirred 48 h at 70°C to afford a 25 wt% HA solid content of liquid 
precursor. More porous microstructure can be obtained from lowering the 
HA solid content by adding a certain amount of deionized water into the 
former liquid precursor.
Step 3, spraying HA coatings: With Metco MN air plasma spraying system 
(Metco Ltd., USA) and AR2000 thermal spraying robot, the feedstock, acetic 
acid solution of HA powders or liquid HA precursor, is transported through 
a peristaltic pump and injected into the plasma flume through an atomizing 
nozzle (Bete Inc). Nitrogen and hydrogen are used as the primary gas and 
the secondary gas, respectively. Porous HA coatings are deposited onto the 
Ti alloy substrates with the thicknesses of about 100 μm.
Step 4, loading with chitosan: The chitosan with about 85% degree of deacety-
lation is dissolved in ultrapure water with concentrations of 10–30 g/L. Then, 
the HA-coated Ti alloy sample is immersed into the chitosan solution for 24 h 
in sterilized condition. Next, the sample is kept in a laminar flow cabinet for 
air drying, and HA/chitosan composite coating on Ti alloy is obtained.
8.6.2.2  Electrophoretic Deposition Process (EPD)
In the EPD process [76], the composite coating is achieved via the motion 
of charged particles toward an electrode under an applied electric field. Its 
main advantage is the ability to control the deposit stoichiometry, that is, the 
degree of stoichiometry of electrophoretic deposits can be controlled by the 
composition of the powder used. In its procedure, Ammonium phosphate 
solution (0.6 M) is slowly added into 1.0 M calcium nitrate solution to per-
form precipitation at 70°C, and the pH of the mixture is then adjusted to 11 
with NH4OH. Stirring is kept for 8 h at 70°C and 24 h at room temperature. 
The precipitate is washed with water and finally with isopropyl alcohol to 
afford the stoichiometric HA nanoparticles. Chitosan (MW = 200,000) with a 
degree of deacetylation of about 85% is dissolved in 1% acetic acid solution. 
Electrodeposition is performed from suspensions of 0–8 g/L HA nanopar-
ticles in a mixed ethanol–water solvent, containing 0–0.5 g/L chitosan. 
Cathodic deposits were obtained by galvanostatic method on alloy plates (10 
mm × 50 mm × 0.1 mm) at current densities ranging from 0.1 to 3 mA/cm2. 
The electrochemical cell for deposition included a cathodic substrate cen-
tered between two parallel platinum counter electrodes.
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8.6.2.3  Aerosol Deposition (AD)
This process is an alternative coating method for depositing dense ceramic 
coatings on various substrates such as metals, ceramics, and plastics. It is a 
kind of spray coating technique that can produce a dense and well-adherent 
ceramic coating at room temperature (RT). Solid powder particles are used 
as the starting materials, and the formation of the coating layer is achieved 
by the collision of the particles onto a substrate.
In the process [77], HA–chitosan powder mixture is first prepared. HA 
nanocrystalline powder having a volumetric mean diameter (d50) of 15 nm 
and chitosan powder with a degree of deacetylation of about 85% were used 
as the starting materials. The HA powder is heated at 1050°C for 2 h, and 
the chitosan powder is dry ball-milled for 12 h in a planetary mill using 
ZrO2 balls and a jar. Thereafter, the heat-treated HA powder is mechanically 
mixed with the ball-milled chitosan powder by dry ball milling, resulting in 
the preparation of the HA–chitosan powder mixture.
The alloy plate with a size of 20 mm × 20 mm × 1 mm is used as the sub-
strate, which is ground with 2000 grit SiC paper and ultrasonically rinsed 
in distilled water for 5 min. The apparatus of AD is shown in Figure 8.61. 
It consists of a carrier gas supply system with mass flow control, a powder 
chamber containing the above composite powder, and a deposition chamber 
with motored X–Y stage and nozzle evacuated by rotary vacuum pump with 
mechanical booster. Teflon tube with 6.35 mm in diameter connects the three 
parts. Tape is used to fix commercial purity Ti substrate on a steel plate, which 
is fixed to the motored X–KY stage using magnets. About 50 g of the powder 














Schematic diagram for apparatus of aerosol deposition. VG, vacuum gauge. (From Hahn, B.-D. 
et al., J. Am. Ceram. Soc., 92, 683, 2009.)
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fine particle suspension in the upper portion of the chamber. The deposition 
chamber is evacuated to 0.65 Pa. Oxygen (99% purity) is used as a carrier gas 
and flows at 5 × 10−4 m3/s for carrying fine composite particles from the pow-
der chamber, spraying them vertically onto the substrate through a nozzle 
with a slit type opening (0.5 mm × 25.4 mm) in the deposition chamber. At 
the same time, a motor for the X–Y stage was turned on, moving the substrate 
at 1 mm/s. During deposition, pressure of the deposition chamber is 920 Pa. 
The coated sample is heated to 400°C–500°C in air, cleaned in an ultrasonic 
bath. and washed using ethanol, to give the desired material.
8.6.3 Characterization and Functional Test
8.6.3.1  Composition Analysis
The HA–chitosan composite coatings can be characterized by X-ray diffrac-
tion (XRD) using monochromatized CuKα radiation at a scanning speed of 
4°/min. The HA peaks in the XRD patterns of the coatings may be some-
what reduced and broadened, compared to those of the corresponding HA–
chitosan composite powders. In XRD, the peaks for calcium phosphates, 
such as tricalcium phosphate and tetracalcium phosphate, were not always 
detected, which suggested that no significant phase change of HA occurred 
during the coating process [77].
8.6.3.2  Thermogravimetric Analysis (TGA)
To quantify the amount of chitosan in the HA–chitosan composite coating, 
the composite coating layer can be scraped from the substrate and subjected 
to TGA [79]. By applying temperatures of up to 800°C at a rate of 5°C/min, 
the relative amounts of HA and chitosan in the composite coating can be cal-
culated from the weight loss of the coating layer. The TGA curve of the pure 
HA coating shows a small weight loss upon heating up to 800°C, indicating 
its high thermal stability. The HA–chitosan composite coatings exhibited a 
remarkable weight loss in the temperature range of 200°C–600°C, which was 
attributed to the decomposition of the chitosan. At 800°C, the total weight 
losses of the HA–chitosan composite coatings can be obtained from the 
HA–chitosan powder mixtures curves. Therefore, the amount of chitosan in 
the HA–chitosan composite coating can be calculated from the weight loss 
profiles of the TGA curves.
8.6.3.3  Morphology and Roughness
The microstructures of the HA–chitosan composite coatings can be investi-
gated using scanning electron microscopy (SEM) [76]. The surface morphol-
ogy of the coatings shows different microstructures according to the amount 
of chitosan added. The coating surface becomes smoother than the pure HA 
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coatings, and the later often has a rough surface with a network structure. 
With adding chitosan, the surface morphology of the coating layer shows 
fairly dense microstructures without pores or cracks, implying that chitosan 
did not change significantly the dense nature of the HA coating layer.
8.6.3.4  Adhesive Strength Test
The tensile adhesion strength between the coating and the substrate can 
be measured using a universal testing machine, such as Instron series IX 
automated materials testing system, Instron Corp., MA, USA, according to 
ISO 13779-4. An alloy disk with 25 mm in diameter and 1 mm in thickness 
is coated with HA–chitosan on one side, and both its top and bottom sur-
faces are bonded to the supporting fixture of the universal tensile testing 
machine with thermal cure, high-strength epoxy, such as 3 M Scotch-Weld 
Epoxy Adhesive 2214, 3 M Corp., MN, USA. Perform three to five adhesion 
tests for each sample. It is proved that the adhesion strength values of the 
coatings exhibit a tendency to decrease slightly with the increasing amount 
of chitosan in the composite coating. However, even the lowest adhesion 
strength value obtained from the composite coatings is higher than those of 
HA coatings, which indicates the helpfulness of chitosan in the formation of 
composite layers [79].
8.6.3.5  Bacteria Inhibition
The antibacterial properties of HA/chitosan complex coatings can be tested 
using Staphylococcus aureus (ATCC 25923) [80]. A suspension of S. aureus bacte-
ria with a concentration of 1∼2 × 106 CFUs/mL is added to 24-well plates and 
cultured for 6, 12, and 24 h, respectively. The bacterial inhibition behavior is 
investigated with MTT assay. Optical density (OD) is detected at 490 nm, and 
the proliferation of S. aureus is determined by the OD value. SEM is used to 
analyze the bacteria adhesion on the coating surface after 24 h culture time. 
It is proved that no significant difference is found between the HA/chitosan 
complex coating and the control at 6 h. At 12 h, porous HA/chitosan com-
plex coatings with four different concentrations all demonstrated significant 
antibacterial activity, while significant bacterial growth was observed for 
the control. At 24 h, the antibacterial properties of the HA/chitosan complex 
coatings showed distinct difference. While the HA coatings loaded with 20, 
50, and 100 g/L chitosan still possessed obvious antibacterial properties, sig-
nificant growth of bacteria has been observed for coating loaded with 10 g/L 
chitosan.
8.6.3.6  Cytotoxicity on Osteoblastic Cell
Suspension of MG63 cells with number of 1 × 104/mL is added to 24-well 
plates and cultured for 2, 4, and 6 days, respectively. MTT assay is selected 
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and the OD value at 570 nm is measured [80]. The result shows that the OD 
value of HA coating loaded with chitosan is significantly lower than that of 
the control coated with pure HA. It is attributed to the intrinsic antibacterial 
property of chitosan, which is also expected to have an adverse effect on 
osteoblastic cell viability. It is also shown that the loading of chitosan is even 
beneficial for the proliferation of osteoblastic cells at low concentrations. 
It mainly relies on its positive charge to attract and break the negatively 
charged bacterial cell wall, which would also work adversely on the osteo-
blastic cells. However, at certain concentrations and contact time, the nega-
tively charged osteoblastic cells may be just attracted to the HA/chitosan 
coating surface without undergoing further impairment, which leads to 
enhanced cell adhesion and proliferation. In addition, the electrostatic inter-
action of chitosan with the negatively charged molecules would also likely 
help the adsorption of certain proteins, which would promote the adhesion 
of the osteoblast cells.
Therefore, chitosan can selectively do harm to the bacteria but not the 
osteoblastic cells. It also appears that chitosan sticks very well to the HA 
coating surface, even during the in vitro tests. By tuning the chitosan con-
centration, combined antibacterial activity and enhanced osteoblast function 
can be achieved simultaneously in the porous-HA/chitosan complex coat-
ings. Therefore, the physical and chemical properties of the chitosan can be 
controlled and optimized to allow the coexistence of antibacterial activity 
and enhanced osteoblastic cell response.
8.6.4 applications of Hydroxyapatite/Chitosan Composite Coatings
Hydroxyapatite/chitosan composite coatings can be extensively used in 
bone tissue engineering, since it was shown to promote cell growth and 
mineral rich matrix deposition by osteoblasts cells. The biocompatibility of 
chitosan minimizes additional local inflammation, and it can be molded 
into porous structures to allow osteoconduction. A study [81] in vivo has 
confirmed that 1 week after repairing the bone defect with the composite 
in the experimental group, new bone appeared around the composite and 
matured gradually. At 24 weeks after surgery, little collagenous tissues were 
observed between the material and surrounding bones. At 40 weeks after 
surgery, new bone had grown into the mature bone and total osseointegra-
tion had occurred. In the control group, however, no bone defect healing 
was observed at 40 weeks after surgery. All these results suggest that the 
composite has a good hard tissue biocompatibility and an excellent osteo-
conductivity. It is suitable for artificial bone implants and frame materials of 
tissue engineering.
In hydroxyapatite/chitosan composite, the nested chitosan sponge 
enhances the mechanical strength of the ceramic phase through matrix 
reinforcement and preserves the osteoblast phenotype. A hydroxyapatite/
chitosan multilayer nanocomposite with high strength and bending modulus 
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rendering the material suitable for possible application for internal fixation of 
long bone fractures has been prepared. In vitro osteoblast cell culture studies 
revealed the biocompatibility of the scaffolds with cells exhibiting healthy 
morphology and avid proliferation throughout the culture period. As a new 
synthesized material, hydroxyapatite/chitosan composite is promising in 
tissue engineering.
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